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ABSTRACT 
 
Unlike the central nervous system, robust axon regeneration after peripheral nerve 
injury is driven by transcriptional activation of a regeneration programme. 
Transcription factors form a vital link in the chain of regeneration, converting injury-
induced stress signals into increased expression of a wide range of downstream 
effector molecules like neuropeptides, neurotrophic factors, adhesion molecules and 
cytoskeletal adaptor proteins. To gain insight into the in vivo function of some of 
these regeneration associated molecules, we examined the effects of global or cell-
type specific, and single and combined deletions of transcription factors - STAT3, c-
Jun and C/EBPδ, and effector molecules - CAP23 and integrin β1, on axonal 
regeneration after facial nerve axotomy. The facial nerve axotomy model is a well-
established experimental paradigm, providing insights into molecular signals that 
determine axonal regeneration, target re-innervation and neuronal cell death. 
Neuronal STAT3 deletion (STAT3ΔS) caused profound and persistent defects in 
regeneration and functional recovery after mild (crush) and severe (cut) nerve 
injuries. Axotomised STAT3-deficient motoneurons appeared shrunk by 50-60% in 
size but displayed no cell death. There was also a severe reduction in microglial 
activation and recruitment of lymphocytes, in the expression of regeneration-
associated molecules CD44, α7β1 integrin, in the nuclear translocation of ATF3, and 
in perineuronal sprouting of the CGRP+ and galanin+ facial motoneurons. Deletion 
of STAT3 in Schwann cells produced no apparent deficiencies in regeneration. 
As with neuronal STAT3 deletion, neuronal deletion of c-Jun (c-JunΔS) (Raivich et al, 
2004; Ruff et al, 2012) abolishes most of the cell body response, neuronal cell death, 
and re-innervation after axotomy. Deletion of c-Jun in peripheral nerve Schwann 
cells (c-JunΔP0) had a very different effect. Neuronal cell death was increased by 2-
3 fold, even though most of the cell body response was not affected. Axonal 
regeneration was reduced, but most of the defect in target re-innervation and 
functional recovery appeared to be due to excessive neuronal cell death.  
Mutants lacking both neuronal c-jun and STAT3 did not show more exacerbated 
regeneration defects than the single deletions, suggesting that deletion of either 
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transcription factor – c-Jun or STAT3 – will produce a saturating effect on the 
regeneration-deficient phenotype. Expression of c-jun itself was not affected in the 
neuronal STAT3 null mice, and vice versa, confirming the above hypothesis. 
Double deletion of c-jun in both neurons and in Schwann cells, blocked neuronal cell 
death seen in Schwann cell c-Jun deficient mutants, and completely obliterated 
target re-innervation after facial axotomy, suppressing even the mild 20% 
regeneration seen in the neuronal c-jun null mutants. Since both neuronal and 
Schwann cell c-Jun are phosphorylated at its N-terminus following nerve injury, we 
also explored the effects of c-Jun phosphorylation. Global replacement of all 4 N-
terminal c-Jun phosphorylation sites (Ser63&73, Thr91&93) with alanines (c-jun4A) 
produced a significant increase (1.8x) in neuronal cell death, an approximate 40% 
reduction in target re-innervation and delayed functional recovery. This phenotype 
was more alike that observed with Schwann cell rather than neuronal c-Jun deletion. 
Global C/EBPδ deletion reduced axotomy induced neuronal cell death, and had 
moderate effects on microglial activation and axonal sprouting. Combined deletion of 
C/EBPδ and STAT3 did not exacerbate the defect in regeneration seen with STAT3 
deletion alone, but seemed to speed up functional recovery. 
Deletion of neuronal CAP23, a downstream effector gene, led to impaired target re-
innervation, reduced galanin+ perineuronal sprouting and early microglial function. 
Neuron-specific deletion of beta 1 integrin, another effector molecule, resulted in a 
2.5-fold increase in neuronal cell death, a commensurate 60% reduction in target re-
innervation and transiently delayed functional recovery. This phenotype was similar 
to c-junΔP0 and c-jun4A mutants. 
In summary, there appears to be two neuronal sub-populations which are controlled 
by different aspects of the regenerative programme A) one dependent on ‘intrinsic’ 
activation of transcriptional master switches like c-jun and STAT3 in neurons and B) 
the other on ‘extrinsic’ post-traumatic trophic signalling elicited by the Jun-expressing 
and N-terminal phosphorylation-dependent Schwann cells. c-Jun phosphorylation 
and neuronal β1 integrin appear to be critical co-factors in the signalling response 
elicited by the Schwann cells.   
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CHAPTER 1 – Introduction 
 
CHAPTER 1 – Introduction 
Injury to peripheral nerves triggers a regenerative programme associated with neurite 
outgrowth, re-innervation of the denervated target and recovery of function. This includes 
a series of molecular, cellular and ultrastructural responses. The rapid arrival of signals 
from the injured axon results in a remarkable shift of the injured neuron from a transmitting 
to a growth promoting phenotype. This is accomplished by the upregulation of a vast array 
of regeneration-associated genes (RAGs) including the rapid induction of transcription 
factors and enhanced synthesis of adhesion molecules, growth associated proteins, 
cytoskeletal elements, cytokines, neuropeptides and other molecules involved in 
regeneration. The molecular changes are accompanied by pronounced morphological 
changes in the surviving neurons – the cell body undergoes a ‘chromatolytic’ reaction 
characterised by swelling of the neuronal body, increase in cellular metabolism and 
protein synthesis, and a regional dispersion of Nissl bodies in the neuronal cytoplasm 
(Lieberman, 1971); and there is a rapid appearance of growth cones at the proximal tip of 
the lesioned axons; The distal nerve stump undergoes ‘Wallerian degeneration’(Waller, 
1850), leading to phagocytosis of axonal and myelin debris initially by Schwann cells and 
later also by invading macrophages (Stoll et al., 1989;Bignami and Ralston, III, 1969). 
In addition to the neuronal response, neighbouring non-neuronal glial cells – in the case of 
brain and spinal cord motoneurons, the astrocytes and microglia - become activated, with 
microglial expression of immune cell recognition molecules (ICAM1, αMβ2 and αXβ2 
integrins, B7 system etc.) and major histocompatibility complex (Bohatschek et al., 2004). 
There is also a rapid microglia-associated recruitment of lymphocytes within a day after 
injury which may assist with immune surveillance first of the injured neurons, and later on 
of the dead neurons (Kalla et al., 2001;Raivich et al., 1998). In the adult mouse facial 
motor nucleus model which has been studied in extensive detail, neuronal cell death is a 
delayed phenomenon, peaking at 2 weeks following nerve transection; the immuno-glial 
activation is characterized by two phases – a fast but moderate response starting within 
24h after neuronal injury, and a late but much stronger response to neuronal cell death, 
peaking at 14 days after axotomy. Neuronal transcription factor deletions blocking cell 
death will suppress most of the late glioimmune response (Raivich et al., 2004). However, 
these deletions also inhibit some of the early microglial activation – within 24h and long 
  CHAPTER 1 – Introduction  
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before the appearance of cell death, suggesting that these transcription factors may also 
interfere with the synthesis of injury signals from lesioned but not dying neurons. 
 
In contrast with the PNS, the CNS neurons normally fail to regenerate after injury, possibly 
due to a combination of diminished intrinsic capacity for regeneration and heightened 
susceptibility to inhibitory factors of their extracellular environment  (Sun et al., 2011;Maier 
and Schwab, 2006). Identifying the crucial elements responsible for successful 
regeneration in injured peripheral nerves, and unravelling their underlying signalling 
pathways and molecular components, is therefore, quintessential in improving 
regenerative outcomes after peripheral and central nerve injuries. Systematic gene 
expression profiling using cDNA microarrays has led to a dramatic increase in the number 
of identified genes regulated in the injured and regenerating neurons (Boeshore et al., 
2004;Bosse et al., 2001;Bosse et al., 2006;Kubo et al., 2002;Kury et al., 
2004;Michaelevski et al., 2010). Interestingly, roughly half of the regeneration-associated 
genes are part of both developmental and lesion-induced programmes, suggesting that 
regeneration partially recapitulates development. However, this proportion of shared 
developmental and lesion-induced transcripts is substantially lower – only 33% - for genes 
encoding signal transducers or factors involved in processes such as cell death, immune 
response, transport and transcriptional regulation. Most of the latter show injury-specific 
gene expression (Bosse et al., 2006). 
Transcription factors are DNA-binding proteins that can activate or repress target gene 
expression. Their effects are amplified by their ability to bind to multiple promoter regions, 
causing a large number of target genes to be switched on or off by a single transcription 
factor. This is especially interesting because deletion of an individual transcription factor 
can give rise to a vast number of regeneration defects. This introductory chapter aims to 
summarise the key events ensuing axonal injury in the PNS - the structural, biochemical 
and molecular changes taking place in the neuronal cell body and the axons, and the 
contribution of non-neuronal cellular responses. Particular attention has been focused on 
regeneration associated transcription factors and their downstream signalling targets 
involved in mounting a successful regenerative response.  
  CHAPTER 1 – Introduction  
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Structural changes after peripheral nerve injury 
Morphological changes in the neuronal perikaryon 
The neuronal cell body response to axotomy (also known as chromatolysis/retrograde 
reaction) is characterised by the dispersion of parallely arranged rough endoplasmic 
reticulum cisternae or Nissl bodies into a random, non-linear appearance. The neuronal 
cell body swells up, the nucleus is displaced to the cellular periphery and the synaptic 
terminals are retracted. This phenomenon was first described by Frank Nissl in 1894, and 
it provides a visible evidence of the transformation of the neuronal function from synaptic 
transmission to growth and repair. The neuronal cell surface gets covered by microglial 
cells (Raivich and Makwana, 2007). In successfully regenerating axons, the cell bodies 
remain swollen throughout the regrowth period and are associated with a massive 
upheaval of metabolism and protein synthesis. In neurons that fail to regenerate, for 
example those in the CNS, the neuronal cell bodies begin to atrophy both in cell volume 
and in the number of dendrites, and may persist in the atrophied state for long periods of 
time (Lieberman, 1971), highlighting the significance of the cell body reaction in successful 
regeneration 
 
Axonal changes distal to the lesion site & Schwann cell reaction 
Following peripheral nerve injury, the portion of the nerve distal to the injury site 
undergoes a process known as Wallerian degeneration (WD). WD is a set of molecular 
and cellular events by which degenerating axons and myelin are cleared after injury, and 
was first described by Augustus Waller in 1850 (Waller, 1850). Nerve injury is quickly 
followed by the appearance of axolemmal blebs (swelling of the axonal membrane) 
between 8 and 24 h after injury, and the granular disintegration of the axonal cytoskeleton 
(GDC). GDC is the disassembly of microtubules, neurofilaments, and other cytoskeleton 
components resulting in the fragmentation of the axon and this process is usually 
complete within 3 – 10 days in the PNS (Bignami et al., 1981;Bignami and Ralston, III, 
1969;Bignami et al., 1981;Bignami et al., 1981). The myelin sheath also swells, eventually 
becoming fragmented and breaking down into fatty material that is deposited around the 
axon (Lassmann et al., 1978;Lassmann et al., 1978).  
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Figure 1.1. Schematic representation of the degenerative and regenerative events associated with 
peripheral nerve injury. A. During the early phase (first few days) after axonal injury (arrowhead), local 
degenerative events are accompanied by both retrograde and anterograde degeneration of axon and 
myelin. B. During the intermediate phase (a few days to weeks), the anterograde pattern of Wallerian 
degeneration proceeds to completion with infiltrating macrophages contributing to the removal of tissue 
debris and SC undergoing mitosis. The axotomised neuronal cell body undergoes reactive, chromatolytic 
changes and the severed proximal end of the axon develops regenerative axonal sprouts. C. Of the 
numerous axonal sprouts that successfully traverse the injury site (during the first few weeks to months), 
some re-enter appropriate endoneurial tubes and continue to extend through the distal nerve stump, 
supported by SC in the bands of Büngner. The target organ/tissue (in this case skeletal muscle) undergoes 
disuse atrophy. D. Successful axon regeneration through the bands of Büngner and the re-establishment of 
neurotransmission at the neuromuscular junction results in the retraction or dying-back of unsuccessful axon 
sprouts, the reversal of muscle fibre atrophy, of neuronal cell body chromatolysis and the establishment of 
maturing SC–axon interactions (including reduced internodal spacing). E. Failure of regenerating axonal 
sprouts to cross the injury site (possibly due to the formation of a physical scarring barrier or the loss of a 
large segment of nerve) results in neuroma formation. The permanently denervated muscle fibres 
demonstrate severe atrophy, loss of their characteristic striations and pyknotic nuclei (Reproduced from 
‘Repairing injured peripheral nerves: Bridging the gap’) (Deumens et al., 2010). 
 
Schwann cells (SCs) are crucial for early clearing of neuronal debris and providing 
directional guidance cues to the regenerating axons. They undergo nuclear and 
cytoplasmic hypertrophy, and begin to phagocytose axonal and myelin ellipsoids with thick 
vimentin-rich processes (Liu et al., 1995). 1-3 days after injury, they are joined by 
macrophages, infiltrating via the disrupted blood brain barrier to complete the destruction 
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and phagocytosis of all debris (Perry et al., 1987). In all, the process of clearing takes 
about two weeks. The rapid clearing of neuronal debris is a hallmark of successful 
regeneration in the peripheral nerves, not seen after CNS injury. The SCs become mitotic 
and proliferate rapidly, aligning themselves into columns called Bands of Büngner, along 
the remaining connective tissue basement membrane to provide a path for axon regrowth 
(Gordon and Gordon, 2010). SCs are also able to attract injured neurons and aid axon 
elongation by secreting neurotrophic factors such as NGF, BDNF, NT-4 and GDNF and 
other proteins like F-spondin, collagen, laminin and fibronectin (Bhatheja and Field, 
2006;Gordon and Gordon, 2010;Raivich and Makwana, 2007).  
 
Axonal changes proximal to the lesion site – Growth Cone Formation 
While the distal stump undergoes degeneration, the proximal stump begins regeneration. 
Calcium influx after nerve injury signals the resealing of the proximal severed end by a 
vesicle mediated process. The axon forms a bulbous swelling at the tip due, partly, to the 
arrival of new axoplasm including cytoskeletal components like neurofilaments and 
microtubules (Meller, 1987), eventually giving rise to a club-like structure called a ‘growth 
cone’ as described by Ramon y Cajal in 1890 (Garcia-Marin et al., 2009). Growth cone 
formation is associated with accumulation of F-actin at the leading edge, and changes in 
intracellular calcium and sodium ion levels (Dent and Gertler, 2003).  
The growth cone plays a critical role in accurate neurite outgrowth for target re-
innervation, by interaction with surrounding non-neuronal cells and the extracellular matrix. 
Numerous filamentous projections made from actin and tubulin protrude from the injured 
tip, extending in to the extracellular milieu where they guide growth by searching for pro- 
regenerative guidance cues (Spira et al., 2003). Regenerating axon tips are progressively 
re-myelinated as they grow within the SC-lined endoneurial tubes.  
 
Molecular changes after peripheral nerve injury 
Early axonal injury sensors 
Axonal injury generates three major signalling cues to the injured neurons which triggers a 
complex, regenerative programme in the neuronal cell body.  Firstly, axonal injury 
interferes with the retrograde flow of trophic signals, disinhibiting the normally suppressed 
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regenerative process, within 12-24 hours following injury (Raivich et al., 1991b). Secondly, 
it exposes the tip of the injured axon to the intracellular content of neighbouring axons and 
SCs containing growth factors like LIF, CNTF, FGF and NT3 (Sendtner et al., 1997) and 
later to the inflamed neural tissue environment (Lindholm et al., 1987). The above two 
processes can result in de novo activated molecules carrying a nuclear localisation signal 
(NLS) which link to importins and are retrogradely transported to the cell body by dynein 
motors (Hanz et al., 2003;Curtis et al., 1994;Curtis et al., 1993). Recently, it has emerged 
that injury-induced transcription factors can also be axonally translated and retrogradely 
transported to the nucleus upon nerve injury (Ben-Yaakov et al., 2012). Thirdly, it causes a 
disruption of the tight ionic concentration gradient between the axon and the ECM by rapid 
influx of extracellular ions such as calcium and sodium through the transiently open 
plasmalemma before it is resealed. This results in depolarisation and transmission of 
successive injury-mediated action potentials. These molecular and electrical signals cause 
rapid elevation of calcium and cAMP, which in turn activate multiple signalling pathways 
(Berdan et al., 1993). 
Early signalling in neuronal perikaryon 
A crucial aspect of early neuronal signalling is the activation of a diverse array of 
intracellular signalling cascades. Mitogen activated protein (MAP) kinases pathways 
represent an important family of retrogradely transported signalling molecules through 
which extracellular signals are converted in to an intracellular response. Subfamily 
members of this group include ERK, p38 and JNK, which respond to various cytokines, 
growth factors and signals of cellular stress by phosphorylation of several substrates 
including transcription factors, cytoskeletal components and nuclear receptors (Lindwall 
and Kanje, 2005). MAPK subfamily members are activated themselves by phosphorylation 
by mitogen-associated protein kinase kinases (MEK) via extensive and convoluted ras /raf 
pathways (Chang et al., 2003). Recent studies have implicated the involvement of abl and 
AKT protein kinases and mTOR in generating a specific injury-induced response 
(Michaelevski et al., 2010). PTEN inactivation is known to activate different downstream 
pathways, such as Akt and mTOR signalling, and inhibit other signalling molecules, such 
as GSK-3 and PIP3 (Liu et al., 2010). Downstream effects of the signalling cascades are 
varied and include activation of specific nuclear transcription factors.  
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Transcriptional changes 
The arrival of injury signals is rapidly followed by the phosphorylation and nuclear 
localisation of a host of transcription factors. A brief summary of signalling from early 
sensors to mostly enzymatic cytoplasmic mediators to transcription factors and synthesis 
of effector molecules is shown in Figure 1.2.  
Data from phospho-proteomic and microarray studies have identified nearly 400 
redundant axonal signalling networks connected to 39 transcription factors (26 
transcription factor families),  implicated in the sensory neuron response to axonal injury 
(Michaelevski et al., 2010). These include c-jun, jun D, ATF3 (Activating transcription 
factor 3) , CREB (cAMP response element binding protein), STAT3 (Signal transducer and 
activator of transcription 3), C/EBPs (CCAAT/enhancer binding proteins), p53, Oct-6, NF-
κB (Nuclear factor kappa-light-chain-enhancer of activated B cells), NFATs (Nuclear factor 
of activated T-cells), KLFs (Kruppel-like factors), Sox11, SnoN, ELK-3, P311, and E47 
among others (Magoulas B., 2010;Mason et al., 2003;Moore and Goldberg, 2011;Nadeau 
et al., 2005;Raivich et al., 2004;Raivich, 2011;Schwaiger et al., 2000;Jankowski et al., 
2009;Ruff et al., 2012a;Di Giovanni et al., 2006;Moore et al., 2011). Transcription factors 
provide a vital link between injury- induced signals and downstream protein expression via 
gene regulation. Once in the nucleus, they bind to selective DNA promoter regions to 
increase or repress transcription of specific target genes. Nerve injury can also result in 
reduced activation of transcription factors such as islet-1, Fra-2, ATF2 and TDP43 (Doyle 
and Hunt, 1997;Herdegen et al., 1997a;Hol et al., 1999;Moisse et al., 2009;Sato et al., 
2009), which probably contributes to the change in gene expression of the injured neuron 
from a fully differentiated to a growing phenotype (Raivich, 2011). The activation of 
transcriptional programme is critical for expression of many  
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Figure 1.2. Cellular signalling in successful regeneration, from early sensors of injury, to cytoplasmic signals, 
transcription and downstream effectors (Modified (Raivich, 2011). 
 
target genes implicated in successful regeneration, and blocking of transcription at an 
early time point after injury frequently changes the regenerative response of injured 
neurons (Smith and Skene, 1997). Recent advances in cre/loxP technology permitting 
cell-type and/or time specific genetic knockouts (Sauer, 1998;Akira, 2000) have begun to 
provide insight into the powerful roles of these transcription factors in orchestrating 
complex axon growth and regenerative responses. Neuronal deletion of transcription 
factors frequently causes reduced regenerative ability. An overview of the observed 
phenotypes is given in Table 1.1, and the individual transcription factors discussed in more 
detail in the following sections. 
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Transcription factor 
G KO or CTS KO 
Injury 
model 
KO Phenotype References 
Neuronal c-Jun 
(CTS) 
Facial n.  Strongly reduced target re-innervation 
 Delayed functional recovery 
 Decreased RAG expression and neuronal 
sprouting 
 Strongly reduced glial activation and 
leucocyte recruitment 
 Enhanced motoneuron survival  
 Cellular atrophy 
Raivich et al., 2004,  
Makwana et al., 2010,  
Ruff et al., 2012 
Schwann cell c-Jun 
(CTS) 
Facial n. 
Sciatic n. 
 Severely impaired target re-innervation and 
functional recovery 
 Drastically reduced motoneuron survival 
 Delayed myelin breakdown 
 Reduced trophic factor expression 
Fontana et al., 2012   
Arthur-Farraj et al., 2012 
Jun 2A (G) Facial n.  Cellular atrophy Ruff et al., 2012 
Neuronal STAT3 
(CTS) 
Saphenous n. 
Facial n. 
Sciatic n. 
 Decreased sprouting 
 Impaired axonal growth 
 Phase-specific regulator of growth ‘initiation’   
 Reduced motoneuron survival 
Bareyre et al., 2011,                   
Schweizer et al., 2002, 
Ben-Yaakov et al., 2012 
ATF3 (G) Sciatic n.  Enhanced speed of regeneration, and 
increased expression of RAGs in mice 
constitutively expressing ATF3 in DRGs 
Seijffers et al., 2007 
CREB (G)   Impaired axonal/neurite growth 
 Increased apoptosis of sensory neurons 
Lonze et al., 2002, 
Lonze and Ginty, 2002, 
Redmond et al., 2002 
C/EBP β (G) Facial n.  Reduced expression of microtubule Tα1 α 
tubulin and growth cone protein GAP-43 
Nadeau et al., 2005 
C/EBP δ (G) Sciatic n. 
 
 Impaired axonal growth and reduced 
response to conditioning lesion 
 Delayed functional recovery 
 Decreased RAG expression 
Lopez de & Magoulas, 
2013 
SRF (G) Facial n.  Impaired neurite outgrowth, growth cone 
shape and axon guidance 
 Increased motoneuron death 
Stern et al., 2012 
Sox 11 (CTS) Saphenous n.  Reduced regeneration after nerve crush Jankowski et al., 2009 
p53 (G) Facial n.  Decreased neurite outgrowth 
 Reduced target re-innervation 
 Decreased motoneuron death 
Di Giovanni et al., 2006, 
Tedeschi et al., 2009, 
Qin et al., 2009 
 
Table 1.1. Transcription factor deletions and peripheral nerve regeneration: Effects of global (G) and cell type specific 
(cts) knockouts (KO) 
STAT3 
Signal Transducer and Activator of Transcription – 3  (STAT3) belongs to the STAT family 
of seven transcription factors - STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and 
STAT6 - that mediate a wide variety of biological functions in the CNS & PNS such as cell 
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growth, regulation, inflammation and embryological development (Dziennis and Alkayed, 
2008).  
 
 
Figure 1.3. Schematic diagram showing the functional domains of STAT3 
The STATs are comprised of six regular domains - an amino terminal (for STAT3 
dimerisation after activation), a coiled-coil domain (for interaction with other transcription 
factors and regulatory proteins), a DNA binding domain made up of β-sheets (for 
recognition of consensus binding regions on gene promoters), an α-helical linker domain 
(for transcriptional activation and protein-protein interaction), a classical SH2 (sequence – 
homology) docking domain, and a transcriptional activation domain (Lim and Cao, 
2006;Bromberg and Darnell, 2000). There are 2 highly conserved, phosphorylatable 
amino acids that are frequently required for STAT3 activation – a tyrosine 705 in the SH2 
domain and a serine 727 in the 78-amino acid region of the transactivation domain 
(Bromberg and Darnell, 2000;Dziennis and Alkayed, 2008). Figure 1.3 shows a schematic 
diagram of the functional domains of STAT3. 
 
STAT3 was identified as an acute phase response factor (Akira et al., 1994) and is 
expressed cytoplasmically in both neuronal and glial cells during development and in the 
adult (Gautron et al., 2006;De-Fraja et al., 1998). In the adult brain, STATs are normally 
quiescent, but are activated in specific subsets of neurons following injury (Schwaiger et 
al., 2000;Xia et al., 2002)  in response to multiple signalling pathways induced by several 
cytokines and growth factors including IL-6, LIF, CNTF, G-CSF, G-CSFR, EPO, EGF, IGF-
1, NGF withdrawal, BDNF, free radicals, excitatory neurotransmitters and other 
inflammatory mediators that are released after injury (reviewed in (Dziennis and Alkayed, 
2008). Propagation of many of these signals (IL-6, LIF, and CNTF) requires a combination 
of various ligand binding units and a common signal-transducing unit gp130 (Taga and 
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Kishimoto, 1995), through which they activate the JAK/STAT, Ras/MAPK, ERK, PI3K and 
other pathways (Akira, 2000;Heinrich et al., 2003). Activation of the gp130 receptor has 
been implicated in neuronal response to injury and regenerative axonal growth (Habecker 
et al., 2009).  
 
Injury induced ligand binding to cell-surface receptors activates the associated receptor 
tyrosine kinase Janus kinases (JAKs), which phosphorylate tyrosine residues on the 
cytoplasmic portion of the receptor complex that acts as a binding site for STAT proteins. 
STATs dock onto the phospho-tyrosines via their SH2 domain, and are also 
phosphorylated by JAK on a tyrosine residue (e.g. Y705 in STAT3). Upon activation, they 
either hetero- or homodimerise and translocate to the nucleus via importins (Cimica et al., 
2011), where they bind to consensus sequences (SIE/GAS/ISRE sequences) to induce 
gene transcription. Other mechanisms of STAT activation include phosphorylation by non-
receptor tyrosine kinases such as Src, direct or indirect phosphorylation by receptors with 
intrinsic tyrosine kinase activity (i.e. EGF, PDGF, and FGF receptors), and activation by G-
protein coupled receptors (Ram and Iyengar, 2001). STAT3 can be deactivated by 
dephosphorylation or targeted degradation, and recycled back to the cytosol (reviewed by 
(Dziennis and Alkayed, 2008;Moore and Goldberg, 2011;Lim and Cao, 2006). Further, 
Suppressor of Cytokine Signalling 3 (SOCS3) or Protein Inhibitors of Activated STATS 
(PIAS) can also inhibit STAT3 activation (Krebs and Hilton, 2001).  
 
Global STAT3 knockout animals are embryonic lethal, dying prior to gastrulation between 
E6.5 and 7.5 (Takeda et al., 1997). Cell-type specific STAT3 deletion has greatly improved 
our knowledge of its function in different tissues (Akira, 2000;Sauer, 1998). STAT3 
deletion in T-cells is associated with impaired T-cell proliferation, in macrophages with 
high susceptibility to endotoxin shock, in keratinocytes with compromised wound healing 
process, and in mammary glands with delay of involution (Akira, 2000). Nestin-promoter 
mediated neural-specific disruption of STAT3 resulted in mice which were hyperphagic, 
obese, diabetic, and infertile (Gao et al., 2004). In the last decade, there has been growing 
evidence of a role of STAT3 in axonal regeneration. In a recent broad screen for 
transcription factors involved in regeneration, STAT3 was identified in two independent 
studies using different approaches (Michaelevski et al., 2010;Smith et al., 2011).  
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In vitro, STAT3 induces neurite growth in motor and sensory neurons and this growth can 
be inhibited by the application of SOCS3 or the JAK inhibitor AG490 (Miao et al., 2006;Liu 
and Snider, 2001). Interestingly, blockade of the ERK pathway had no such effect. STAT3 
induces GAP-43, a protein found in growth cones, and GAP-43 expression is inhibited with 
AG-490, suggesting a role for the JAK/STAT3 pathway in GAP-43 expression and neurite 
outgrowth and regeneration (Wu and Bradshaw, 1996). Similarly, Qiu et al. blocked 
regeneration of DRG neurons into the dorsal columns after a conditioning lesion using the 
same drug in vivo (Qiu et al., 2005). 
 
In 1999, Haas and colleagues observed STAT3 activation at 24h and 5d after rat facial 
nerve axotomy (Haas et al., 1999). Following rat facial and hypoglossal nerve axotomy, a 
transient but significant increase in STAT3 mRNA, along with its phosphorylation and 
nuclear translocation within 3 hours in neurons and 1 day in astrocytes was observed by 
Schwaiger and his colleagues in 2000. In contrast, these changes were not observed in 
non-regenerating neurons of Clarke’s nucleus, or in the CNS dorsal columns, although 
both forms of injury upregulated c-jun and GAP43 expression (Schwaiger et al., 2000;Qiu 
et al., 2005). Transient increases in STAT3 signalling were also found in sprouting 
neurites and astrocytes following entorhinal cortex lesions in addition to a rise in gp130-
receptor cytokines, suggesting a dual role of STAT3 in both astrocytic regulation and 
axonal sprouting (Xia et al., 2002). In 2004, Nancy Lee and her colleagues showed that 
axonal STAT3, activated at the injury site, acts as both a retrograde injury signal and as a 
transcription factor which promotes the survival and regeneration of both sensory and 
motor neurons. Levels of activated STAT3 increased in the nuclei of regenerating adult 
cranial motor neurons, sciatic motor neurons and in sensory neuron nuclei after injury. 
Sciatic nerve lesion led to a very rapid activation of STAT3 in axons at the lesion site 
within 15 minutes, and by 24 hours STAT3 labelling was detected in the DRG and in the 
spinal cord (Lee et al., 2004). These levels of STAT3 decreased when regeneration was 
completed, emphasizing its role in the regenerative process. A conditional knockout of 
STAT3 in DRG neurons greatly reduced nerve outgrowth from the saphenous nerve after 
transection (Bareyre et al., 2011). 
Local activation and retrograde transport of transcription factors, including STAT3, have 
been now described in several recent studies.  In cell bodies of facial motor neurons, 
STAT activation following nerve injury can be delayed by three days following treatment 
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with a blocker of axonal transport, colchicine (Kirsch et al., 2003). Shin et al, have 
suggested a role of dual leucine zipper kinase (DLK) in the retrograde transport of p-
STAT3 to the cell body after axonal injury, but not in the phosphorylation of STAT3 at the 
site of injury. The upregulation of p-STAT3 in DRGs after axonal injury is abolished in DLK 
KO mice (Shin et al., 2012). In another study, Ben-Yaakov describes local activation and 
translation of axonal STAT3 upon injury, followed by retrograde transport to the cell body 
in association with dynein and importin a5 to modulate survival of peripheral sensory 
neurons after injury (Ben-Yaakov et al., 2012). Deletion of CNTF, which is abundantly 
present in myelinating Schwann cells but not in or around the cell bodies of axotomised 
motoneurons (Dobrea et al., 1992;Rende et al., 1992) caused a delay in the appearance 
of phosphorylated STAT3 and its nuclear translocation in neuronal cell bodies (Kirsch et 
al., 2003). This delay points to a signalling cascade beginning with local release of CNTF 
by damaged myelinating Schwann cells, its local action on adjacent axons, intra-axonal 
phosphorylation of STAT3 and its retrograde transport to the cell bodies of injured neurons 
and finally to the nucleus.  
 
Overexpression of active STAT3 also has beneficial effects on neurite outgrowth. 
Cerebellar granular cells electroporated with a constitutively active form of STAT3, 
resulted in small increase in neurite outgrowth in neurons cultured on a permissive 
substrate (Smith et al., 2011). Similarly, when DRG neurons were infected by viral gene 
transfer with a constitutively active form of STAT3, a large increase in sprouting was found 
in the spinal cord after a dorsal column injury (Bareyre et al., 2011). However, repetitive in 
vivo imaging of individual fluorescently labelled axons showed that STAT3 selectively 
regulates initiation but not later perpetuation of axonal growth, thus acting as a phase-
specific regulator of axonal outgrowth in both PNS and CNS (Bareyre et al., 2011). Strong 
pro-regenerative effects have also been observed when upstream negative regulation of 
STAT3 by SOCS3 was modified (Sun et al., 2011). Inactivation of floxed neuronal SOCS3, 
an upstream inhibitor of STAT3, using a viral vector carrying cre recombinase elicited 
pronounced axonal regeneration in the central, crushed optic nerve model (Sun et al., 
2011). This effect could be blocked by concurrent deletion of floxed STAT3. Furthermore, 
simultaneous deletion of both SOCS and PTEN (negative regulator of mTOR) causes 
sustained synergistic enhancement of robust axon regeneration, and increased neuronal 
survival after optic nerve crush (Sun et al., 2011). In a similar vein, deletion of gp130, the 
common neurokine receptor subunit that transduces the effects of IL6, LIF, CNTF etc., in 
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the sympathetic neurons of the superior cervical ganglion abolished upregulation, 
phosphorylation and nuclear translocation of STAT3 after postganglionic axotomy, while 
also blocking most of the injury response (Habecker et al., 2009;Sachs et al., 2010). 
Interestingly, injections of cAMP into the DRG in vivo lead to an increase in IL-6 and LIF 
mRNAs, and in the phosphorylation and nuclear localization of STAT3 (Wu et al., 2007). 
Some of the identified direct downstream targets of STAT3 include small proline rich 
protein 1a (SPRR1A), WNT5A and IRF1 which are known to enhance neurite outgrowth 
(Coqueret and Gascan, 2000;Fujio et al., 2004;Smith et al., 2011). Altogether, these 
studies show a general trend of early and persistent expression of phosphorylated STAT3 
during the regenerative process. 
 
Finally, a number of reports have also implicated STAT3 as an intracellular survival-
promoting factor (Qiu et al., 2005;Schwaiger et al., 2000;Schweizer et al., 2002;Smith et 
al., 2011;Liu and Snider, 2001;Alonzi et al., 2001). In vitro studies have shown that STAT3 
expression directly induces bcl-2 and bcl-xL gene expression, which are critical in 
promoting neuronal survival after injury (Gonzalezgarcia et al., 1995;Dziennis and Alkayed, 
2008). Mice lacking STAT3 in facial and spinal motoneurons (controlled by cre expression 
under NF-L promoter) showed a significant reduction in motoneuron survival after facial 
nerve lesion, which closely correlated with the extent of motoneuron loss seen in 
LIF/CNTF KO mice after nerve lesion (Sendtner et al., 1996;Schweizer et al., 2002). 
Moreover, upregulation of Reg-2 and Bcl-xl expression was reduced in axotomised 
motoneurons in STAT3 KO mice, suggesting a role of STAT3 in anti-apoptotic signalling. 
Interestingly, in the study by Schweizer et al., local application of CNTF strongly reduced 
the apparent motoneuron cell death in the absence of neuronal STAT3 (Schweizer et al., 
2002), but which other signalling pathways were involved is unclear. Recently, 
retrogradely transported axonal STAT3 was shown to primarily have anti-apoptotic effects 
in sensory neuron cell bodies after nerve injury (Ben-Yaakov et al., 2012).  
 
c-Jun 
The AP-1 transcription complex is a well-characterised regulator of neural development 
and consists of homo- or hetero-dimeric complexes between members of the Jun, c-Fos 
and ATF/CREB families. A primary component of the AP-1 complex, c-Jun, is produced as 
an immediate early gene (IEG) following nerve injury and persists at high levels in injured 
  CHAPTER 1 – Introduction  
30 
 
neurons during the entire peripheral regenerative process (Herdegen et al., 1991;Lindwall 
and Kanje, 2005;Mason et al., 2003;Raivich et al., 2004;Ruff et al., 2012a). Schwann cells 
also strongly upregulate c-Jun following axotomy, where it functions as a negative 
regulator of myelination by cross-inhibiting pro-myelin transcription factor Krox20, and 
switches on local inflammation (Arthur-Farraj et al., 2007;Latouche et al., 2009;Wilton et 
al., 2009;Parkinson et al., 2008). Mice with conditional inactivation of c-Jun in Schwann 
cells show strikingly delayed myelin loss after sciatic nerve injury (Parkinson et al., 2008).  
Numerous studies, using targeted gene deletions or pharmacological inhibition, have 
examined the activation, function and cellular basis of c-Jun and suggest a tripartite role of 
c-Jun action in neural degeneration, inflammation and repair (Raivich, 2008).  
 
Nestin-cre mediated deletion of c-Jun prevented the upregulation of axotomy-associated 
molecules (CD44, α7β1 integrin, galanin). It also decreased perineuronal sprouting 
(Makwana et al., 2010) and successful reconnection to peripheral targets by 4-5 fold, and 
strongly reduced functional recovery (Raivich et al., 2004). This massive reduction in 
target re-innervation was also observed more than 3 months after facial nerve cut, 
suggesting that it was a persistent defect, rather than just a delay in the speed of 
regeneration. Incidentally, functional recovery did not appear to require re-innervation of 
the target by the same number of neurons. Compared with the Jun-competent littermates, 
functional recovery showed a longer but nevertheless transient delay, suggesting that long 
term, target re-innervation by a fraction of neurons could produce extensive functional 
recovery (Raivich et al., 2004). Thus, although functional recovery is the clinically relevant 
parameter, a sole reliance on this parameter could overestimate the extent of re-
innervation. Non-neuronal responses like leucocyte recruitment and microglial activation 
were also severely compromised in the mutants. Interestingly, the facial motoneurons in 
the mutants showed enhanced post-axotomy survival, but were severely shrunken 
(Raivich et al., 2004), supporting the previously reported functional dichotomy of c-Jun in 
promoting post-traumatic neuronal cell death as well as axonal regeneration (Herdegen et 
al., 1997b;Herdegen and Waetzig, 2001).  
 
Since the cre recombinase in these animals was driven by a nestin-promoter expressed in 
early neuroepithelial cells giving rise to neurons, astrocytes or oligodendrocytes, as well 
as Schwann cells it is raised the question whether the defects in neuronal regeneration 
observed were due to the absence of c-Jun in neurons or other nestin+ progenitor-derived 
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cells. This issue was addressed by using transgenic mice having neuron-specific 
(synapsin promoter controlled cre-recombination) or Schwann cell-specific (myelin protein 
zero (P0) promoter controlled cre-recombination) c-Jun deletions.  
Neuron-specific c-Jun deletion mirrored the regeneration defect seen with nestin-cre 
mediated deletion of c-Jun, i.e., strongly reduced speed of axonal regeneration, 
significantly delayed functional recovery, strongly reduced target re-innervation, enhanced 
motoneuron survival but cellular atrophy and diminished astrocyte and microglial activation 
and T-cell influx. A number of different downstream effector targets of this transcription 
factor were almost completely abolished (Ruff et al., 2012a). Neural c-jun deletion also 
interfered with central axonal sprouting of the injured motoneurons (Makwana et al., 
2010). 
The absence of c-Jun in Schwann cells also caused severely impaired axonal 
regeneration - strongly reduced functional recovery and increased failure of target re-
innervation (Arthur-Farraj et al., 2012;Fontana et al., 2012).  However, in contrast with 
neuronal c-jun deletion, it strongly increased cell death of facial motor neurons and 
sensory DRG neurons after facial and sciatic nerve injuries (Arthur-Farraj et al., 
2012;Fontana et al., 2012). Comparison of the distal stumps of WT and c-Jun mutants 
revealed significant differences in expression of genes implicated in regeneration and 
trophic support such as BDNF, GDNF, Artemin, Shh, and GAP-43 that failed to upregulate 
after injury, together with genes that failed to downregulate normally after injury such as 
the myelin genes Mpz, Mbp, and Cdh1 (Arthur-Farraj et al., 2012). Local application of 
neurotrophic factors, artemin and GDNF, substantially improved this defect in regeneration 
(Fontana et al., 2012). GDNF and Artemin bind to their cognate GDNF family α 
coreceptors (GFRα) and signal via a receptor tyrosine kinase (trk) encoded by the Ret 
proto-oncogene (also c-Ret) (Durbec et al., 1996;Jing et al., 1996;Treanor et al., 1996). 
Genetic inactivation of the Ret receptor specifically in neurons resulted in regeneration 
defects without affecting motoneuron survival, suggesting a paracrine signalling 
mechanism for communication between Schwann cell neurotrophin production and 
neuronal regeneration. Altogether, these results propose a critical role of both Schwann 
cell and neuronal c-Jun in the axonal injury response, which led to the next challenge of 
understanding the mechanisms underlying c-Jun activation and signalling following axonal 
injury.  
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Activation of c-Jun mediated transcription is affected by interactions at 3 major sites: N-
terminal phosphorylation at serines 63&73 and threonines 91&93 by the Jun N-terminal 
Kinases (JNKs), dephosphorylation of Thr239 and the ensuing ubiquitination and 
degradation, and C-terminal lysine acetylation near aa 257-276 (Morton et al., 2003;Vries 
et al., 2001). The JNKs are rapidly activated following peripheral nerve injury, and are 
retrogradely transported to the cell body along with the upstream kinases MEKK1 and p-
MKK4, as well as the JNK Interacting Protein (JIP), a scaffold protein that stabilises the 
interaction between JNK and its upstream kinases (Lindwall and Kanje, 2005;Raivich, 
2008). Neuronal injury increases JNK-mediated c-Jun phosphorylation (Herdegen et al., 
1998), and application of a JNK inhibitor to explants of injured DRGs reduces c-Jun 
phosphorylation, ATF3 expression, and neurite outgrowth, without affecting survival 
(Lindwall et al., 2004). 
 
Removal of Ser63&73 phosphoacceptor sites in the junAA mutant interfered with kainic 
acid excitotoxicity in hippocampal neurons (Behrens et al., 1999) at levels similar to JNK3 
KO (Brecht et al., 2005), identifying c-Jun as an essential substrate of JNK signalling 
during kainate-induced neuronal apoptosis. While global c-Jun deletion is embryonically 
lethal, junAA mice showed normal development (albeit slightly smaller than littermate wild-
type mice) and were fertile (Behrens et al., 1999). Following optic nerve transection, there 
was a partial but significant reduction of the apoptosis of retinal ganglion cells in junAA 
mice, and Fas L has been suggested to be an important target gene regulated by N-
terminal Jun phosphorylation during apoptosis (Yoshida et al., 2002). junAA and JNK3 null 
mutants also showed better neuronal survival after targeted dopaminergic cell death 
(Brecht et al., 2005;Crocker et al., 2006). Trophic factor deprivation or DNA damage-
induced death was significantly delayed in JunAA neurons which correlated with delayed 
expression of pro-apoptotic genes (Besirli et al., 2005). In contrast, the JNK3 KO or junAA 
mutations did not interfere with neuronal cell death after facial axotomy (Brecht et al., 
2005;Ruff et al., 2012a;Ruff et al., 2012b). This difference could be attributed to the fact 
that facial axotomy affects peripheral neurons, unlike previous studies which discuss 
effects of phosphorylation deficient c-Jun on apoptosis of CNS neurons. 
 
Preliminary studies from our group after facial axotomy revealed that JunAA mice do show 
some neuronal shrinkage, but have no effect on speed of axonal regeneration for fastest 
axons, functional recovery or target re-innervation. JunAA mice also had a moderate 
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reduction in post-axotomy CD44 levels and slightly increased astrogliosis (Ruff et al., 
2012b). Complete JNK ablation decreased caspase-dependent neuronal cell death in both 
neuronal and non-neuronal cells (Weston and Davis, 2007). Deletion of JNK1 or JNK3 
single genes showed somewhat delayed functional recovery after facial nerve axotomy but 
the effects were quite moderate; and deletion of JNK2 had no effect on regeneration. 
Deletion of JNK3 also interfered with T-cell influx, and reduced CD44 levels (Ruff et al., 
2012b). The mild effects of junAA and global JNK deletions, and the fact that JNKs can act 
via c-Jun independent cytoplasmic (stathmin, MAP1b, MAP2) and nuclear (e.g. ATF2, 
ELK1, p53 etc.) targets (Barnat et al., 2010;Bjorkblom et al., 2005;Bogoyevitch and Kobe, 
2006;Westerlund et al., 2011), points to a possible parting of ways: i.e. the observed JNK 
null effects on regeneration are c-Jun independent, and the strong Jun-dependent effects 
on regeneration and survival do not require N-terminal phosphorylation. It is possible that 
complete removal of all 4 JNK dependent N-terminal phosphorylation sites (Thr91&93 as 
well as Ser63&73) will produce a more severe regeneration phenotype, a hypothesis 
which will be further investigated in this thesis. 
ATF3 
Another important regeneration associated transcription factor is Activating Transcription 
Factor-3 (ATF3), a member of the ATF/CREB family of basic leucine zipper domain (bZIP) 
transcription factors. It can form homo-dimers or hetero-dimers with other bZIP 
transcription factors like members of the AP-1 family (ATF2, JunB, JunD, c-Jun, c-fos) and 
C/EBPs (Hai and Curran, 1991;Hai and Hartman, 2001). ATF3 is normally expressed at 
low levels, but is rapidly activated in sensory, sympathetic and motor neurons by stress 
stimuli after peripheral nerve injury (Raivich and Behrens, 2006;Tsujino et al., 2000), optic 
nerve injury (Takeda et al., 2000), and NGF depletion (Mayumi-Matsuda et al., 1999) but 
not after central injury (Tsujino et al., 2000). ATF3 immunoreactivity in these regenerating 
peripheral neurons is concentrated in the nucleus, but not the nucleolus, and cytoplasmic 
immunoreactivity is sometimes detectable (Hunt et al., 2012). ATF3 expression is also 
induced in the disconnected Schwann cells and endoneurial fibroblasts distal to the 
peripheral injury site, though not on central, denervated glia (Hunt et al., 2004). The 
specific role of injury induced glial ATF3, is currently not clear. ATF3 increases the speed 
of axonal mitochondrial transport in cultured demyelinated DRG neurons, probably to 
maintain axonal homeostasis (Kiryu-Seo and Kiyama, 2011). Several pathways have been 
implicated in activating ATF3 expression such as neurotrophin deprivation (Sachs et al., 
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2007), as well as JNK/MAPK and p53-dependent mechanisms (Moore and Goldberg, 
2011). ATF3 is axonally transported from the periphery (Lindwall and Kanje, 2005), 
possibly acting as a retrograde signal like STAT3. 
 
Delivery of ATF3 to adult DRG neurons, neonatal SCG neurons and PC12 cells, 
enhanced both the number of neurons extending neurites and neurite length (Nakagomi et 
al., 2003;Pearson et al., 2003;Seijffers et al., 2006). As after conditioning peripheral injury, 
the pattern of growth consisted of long neurites rather than branched arborized ones 
(Seijffers et al., 2006). In transgenic mice constitutively expressing ATF3 in adult DRGs, 
the rate of peripheral nerve regeneration (measured by the nerve pinch test two days after 
sciatic nerve crush) was enhanced to an extent comparable to that produced by a 
preconditioning lesion (Seijffers et al., 2007). The expression of some growth-associated 
genes, such as Hsp27, SPRR1A, CAP23 and c-Jun was increased in the injured neurons, 
but not of others like the alpha 7 integrin subunit (α7), GAP-43, and STAT3. Unlike 
peripheral nerve-conditioning lesions, ATF3 overexpression also did not overcome the 
inhibition produced by CNS myelin in culture, suggesting the mechanisms responsible for 
axonal regeneration are separate from those involved in overcoming glial-associated 
inhibition (Seijffers et al., 2007). Thus, although ATF3 appears to contribute to nerve 
regeneration by increasing the intrinsic growth state of injured neurons and promoting cell 
survival, its up-regulation is not enough to fully recapitulate the peripheral nerve 
regeneration program (Seijffers et al., 2007). 
 
ATF3 can bind directly to the Hsp27 promoter and activate its expression in PC12 cells 
(Nakagomi et al., 2003). In addition to its role as an injury-induced neuronal survival factor, 
Hsp27 enhances neurite outgrowth in cultured adult DRG neurons (Williams et al., 2006), 
possibly as a result of interactions with the cytoskeleton. The growth-associated gene 
SPRR1A promotes axonal outgrowth by interacting with actin structures (Bonilla et al., 
2002) and ATF3 may regulate its expression either by binding directly to its promoter or by 
affecting other transcription factors. ATF3 also appears to have a survival role, preventing 
JNK-mediated neuronal death (Nakagomi et al., 2003).  
 
ATF3 can form heterodimers with c-Jun, leading to enhanced transcriptional activation of 
various RAGs and increased neurite outgrowth in neuronal cell lines (Hai and Hartman, 
2001;Hai and Curran, 1991). There has been a number of conflicting reports regarding the 
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correlation between increased ATF3 expression and upregulation of c-Jun in surviving 
neurons. In 2003, Pearson et al., showed that in the absence of c-Jun, ATF3 failed to 
enhance neurite outgrowth in PC12 cells, suggesting that a coincident presence of c-Jun 
and ATF3 may act synergistically (possibly via a physical interaction) to promote nerve 
regeneration (Lindwall et al., 2004;Pearson et al., 2003). In contrast, in 2006, Seijffers et 
al., showed enhanced neurite outgrowth in adult DRG neurons by ATF-3 without any 
increase in endogenous c-Jun levels (Seijffers et al., 2006). The scope of c-Jun and ATF3 
expression in DRG neurons after sciatic nerve transection also differs: ATF3 is induced in 
all injured neurons, while phosphorylated c-Jun is induced only in a small subset of mostly 
small and medium sized DRG neurons (Tsujino et al., 2000;Lindwall et al., 2004). Sciatic 
nerve injury induces prolonged activation of JNKs in the DRGs (Kenney and Kocsis, 1998). 
Inhibiting JNK in this model led to decreased activation of c-Jun and ATF3 expression, 
and to decreased axonal growth (Lindwall et al., 2004). Recent results from our group 
show that deletion of neuronal c-Jun or STAT3 interferes with the nuclear transfer of ATF3 
in the axotomised facial motor neurons (Patodia and Raivich, unpublished). This effect 
may be specific for motoneurons – in sympathetic neurons, cell-specific deletion of gp130 
interferes with the appearance of phosphorylated nuclear STAT3, but does not affect the 
nuclear translocation of ATF3 (Habecker et al., 2009). Thus, the extent to which the 
growth-promoting action of ATF3 is autonomous of c-Jun and STAT3 and dependent on 
additional injury signals needs to be explored. 
CREB 
The cAMP response element binding protein (CREB) is a member of the ATF/CREB 
family of bZIP transcription factors (Hai and Hartman, 2001), and mediates cAMP 
signalling in the nervous system by forming homo- or hetero-dimers with other bZIP 
factors (Hannila and Filbin, 2008). The brains of CREB null mice show abnormal 
development of the corpus callosum and anterior commissure (Rudolph et al., 1998). 
CREB can be phosphorylated and activated by many kinases, including PKA, PKC, 
CAMKII, CAMKIV, AKT, MAPKAP K2, and members of RSK and MSK families (Mayr and 
Montminy, 2001), and it is negatively regulated by phosphatases such as PP1 and PP2A 
(Sun et al., 1994). Important targets of CREB include arginase I and BDNF (Deng et al., 
2009;Mayr and Montminy, 2001) 
In vitro cultured DRG and SCG neurons from CREB null mice show shorter neurites than 
controls. In vivo, these mutant mice exhibit impaired axonal growth and projections. Their 
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sensory neurons undergo excess apoptosis and degeneration during the period of NGF 
dependency in the absence of CREB (Lonze and Ginty, 2002;Lonze et al., 2002). In 
addition, overexpression of a dominant negative CREB leads to decreased dendritic 
outgrowth in cortical neurons and loss of cAMP or neurotrophin associated neurite 
outgrowth on an inhibitory substrate (Redmond et al., 2002). Injection of the adenovirus 
containing constitutively active CREB into DRG neurons enhances nerve regeneration 
(Gao et al., 2004). This suggests an important role for CREB-mediated gene expression 
for both survival and axonal growth in PNS neurons. Recently, it has been suggested that 
axonal translation of CREB mRNAs may precede its phosphorylation, retrograde nuclear 
translocation and transcriptional activation of pro-survival genes (Cox et al., 2008).  
C/EBP β, δ 
The C/EBP (CCAAT/enhancer binding protein) family of transcription factors is comprised 
of six proteins (C/EBPα, β, γ, δ, ε, and ζ), each having unique properties regulating cellular 
proliferation and differentiation, particularly in hepatocytes, adipocytes and haematopoietic 
cells (Ramji and Foka, 2002). C/EBPs also play pivotal, non-redundant roles in the 
development and plasticity of the nervous system, including cell fate determination, 
apoptosis, synthesis and response to trophic factors and to brain injury and ischemia 
(Kfoury and Kapatos, 2009). All members have a highly homologous basic leucine-zipper 
(bZIP) domain which is required for dimerisation, and a DNA binding domain. The C/EBPs 
can interact with other bZIP and non-bZIP transcription factors (Huang et al., 2007). 
C/EBP was shown to be up-regulated following nerve injury in the CNS of adult Lymnaea 
stagnalis, a freshwater pond snail, capable of spontaneous regeneration following 
neuronal injury. Knockdown of C/EBP prevented extension of the distal, proximal and 
intact neurites, in vitro, and postponed recovery of locomotory activity following nerve 
crush in vivo (Aleksic and Feng, 2012). C/EBPβ is upregulated and phosphorylated across 
different classes of injured neurons, including the invertebrate Aplysia model. In this model, 
phosphorylation of C/EBPβ is mediated by the RISK1, a mitogen associated protein 
kinase homologue related to the ERK family (Sung et al., 2001). In the mouse facial nerve 
model, C/EBPβ is upregulated in mouse facial motor neurons in an injury dependent 
manner, and is important for the expression of regeneration-associated microtubule Tα1 α 
tubulin and growth cone protein GAP-43 (Nadeau et al., 2005).  
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C/EBP-δ (also known as CELF, CRP3, NF/IL-6) was first characterized as an acute phase 
inflammatory response gene (Alam et al., 1992). It is widely expressed in spinal cord 
motor neurons and DRG neurons (Sterneck et al., 1998). Expression of C/EBP-δ is 
typically low to undetectable in most cell types and tissues, but it is rapidly induced in 
sensory and sympathetic neurons (Boeshore et al., 2004;Lopez de and Magoulas, 2013) 
by a variety of extracellular stimuli, (e.g. growth hormones, insulin, IFNγ, IL-1, IL-6, LPS, 
TNFα, noradrenaline and glutamate), phosphorylated and translocated to the nucleus as 
an active transcription factor where is induces further IL-6 expression (Ramji and Foka, 
2002). The most favourable complex responsible for the transcription of the IL-6 gene 
requires the interaction between p65 and C/EBPδ, and c-Jun occurring on the NFκB site 
(Faggioli et al., 2004). A recent study showed that the anti-inflammatory and 
neuroprotective effects of chrysin on reactive microglial cell induced neurotoxicity was 
partly mediated by inhibition of C/EBPδ expression at both protein and mRNA level. 
C/EBPδ deficient microglial cultures produce less NO and TNFα in response to LPS/IFNγ, 
re-affirming its role in microglial activation and neuroinflammation (Gresa-Arribas et al., 
2010). Deletion of both C/EBPβ and C/EBPδ in mouse embryonic fibroblasts caused 
impaired production of IL-6 and TNFα in response to LPS or IL- 1, suggesting 
complementary roles of C/EBPβ and C/EBPδ in induction of proinflammatory cytokines 
(Ramji and Foka, 2002). While C/EBP-δ-deficient mice display no overt phenotype, are 
fertile and achieve normal life spans, they have a selectively enhanced contextual fear 
response (Sterneck et al., 1998). A recent study implicates C/EBPδ in axonal regeneration 
of DRG neurons after sciatic nerve crush injury (Lopez de and Magoulas, 2013). Lack of 
C/EBPδ resulted in severe impairment of the early phase of regeneration of the sciatic 
nerve – significantly smaller neurites, delayed motor and sensory function recovery, and 
failure to induce expression of   regeneration-associated genes like SPRR1A (but not of 
others like GAP-43 and galanin). In addition, following conditioning of the sciatic nerve, 
dissociated cultured DRG neurons from C/EBPδ KO mice failed to exhibit an enhanced 
axonal outgrowth (Lopez de and Magoulas, 2013). Nuclear factor IL-3 regulated (NFIL3) 
represses C/EBP target genes in neuronal outgrowth.  Targeting such intrinsic repressors 
of neuronal regeneration might promote regeneration in the damaged nervous system 
(MacGillavry et al., 2011). 
In summary, a number of intriguing findings implicate a role of C/EBPs in injury response 
in neurons, i.e., they are mediators of neuro-inflammatory responses in the brain; are 
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induced in injured neurons of invertebrates (Korneev et al., 1997;Aleksic and Feng, 2012) 
as well as vertebrates (Nadeau et al., 2005;Lopez de and Magoulas, 2013); have 
regeneration associated genes like Tα1 α tubulin, GAP-43 and SPRR1A as direct 
transcriptional targets (Nadeau et al., 2005;Lopez de and Magoulas, 2013); are 
upregulated by IL-6, an important post-injury molecule (Ramji et al., 1993); are responsive 
to regenerative cAMP signals in neurons (McCauslin et al., 2006;Yukawa et al., 1998); 
and are involved in axonal outgrowth in vitro (MacGillavry et al., 2011) and in vivo (Lopez 
de and Magoulas, 2013).  A number of alternative signalling pathways might also 
converge onto C/EBP family members following axonal injury, e.g., the JAK- STAT 
pathway has been shown to directly regulate C/EBP-β (Jiang and Zarnegar, 1997).  
Sox11 
SRY-box containing gene 11 (Sox11), a member of the Sox transcription factor family can 
partner with Brn1 or -2 to regulate transcription (Kuhlbrodt et al., 1998;Tanaka et al., 2004) 
and drive expression of neurite growth-associated genes like β-III tubulin, MAP2 
(Bergsland et al., 2006), actin-related protein complex 3 (ARPC3)(Jankowski et al., 2006), 
and SPRR1A (Jing et al., 2012;Bonilla et al., 2002). Sox11 expression in sensory and 
sympathetic ganglia rises steadily after nerve injury and during axonal regeneration; 
returning to baseline levels at the end of regeneration (Jankowski et al., 2009;Jankowski 
et al., 2006). In Neuro2a cells, Sox11 levels dramatically increased with the number of 
cells extending neurites. Cultured adult DRG neurons treated with Sox11 siRNAs exhibit a 
significant decrease in regeneration following axotomy as indicated by reduced neurite 
length and branching index (Jankowski et al., 2006). Conversely, viral-mediated Sox11 
overexpression caused increased neurite elongation and branching of cultured mouse 
DRG neurons (Jing et al., 2012). Similarly, Sox11 overexpression in crushed saphenous 
nerves accelerated target re-innervation and recovery of sensory function, and increased 
myelin thickness in vivo (Jing et al., 2012). Injection of Sox11 siRNAs into mouse 
saphenous nerve caused a transient knockdown of Sox11 mRNA that transiently inhibited 
in vivo regeneration of both myelinated and unmyelinated axons after nerve crush. Nearly 
all neurons in the ganglia of crushed nerves that were Sox11 immunopositive showed co-
labelling for ATF3 (Jankowski et al., 2009) and treatment with Sox11 siRNAs in vitro and 
in vivo caused a transcriptional and translational level reduction in ATF3 expression. 
Interestingly, ATF3 ablation using ATF3 siRNAs did not affect Sox11 levels.  Furthermore, 
expression of SPRR1A, a transcriptional target of Sox11, coincides with the expression of 
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ATF3 and GAP43 (Starkey et al., 2009). These results suggest that Sox11 may act 
upstream of ATF3 (Jankowski et al., 2009) and influence nerve regeneration by regulating 
gene expression of downstream effectors like SPRR1A (Jing et al., 2012). A recent study 
also implicates a role of Sox11 in regulating BDNF expression in DRGs following sciatic 
nerve injury (Salerno et al., 2012). 
p53 
p53 is a member of a family of tumour suppressors together with p63 and p73. Like c-jun, 
p53 is known to mediate both pro- and anti-apoptotic roles in the nervous system (Jacobs 
et al., 2006;Culmsee and Mattson, 2005). Over-expression of a dominant negative form of 
p53 in primary cortical neurons leads to growth cone collapse and decrease in neurite 
outgrowth, possibly due to a combination of reduced expression of its growth-cone 
associated target genes Coronin1b, Rab13, and GAP-43 (Di Giovanni et al., 
2006;Tedeschi et al., 2009), as well as its local, non-transcriptional activity at the growth 
cone (Qin et al., 2009). On the other hand, overexpression of wild-type p53 leads to an 
increase in growth cone size (Qin et al., 2009). Other axonal guidance molecules and their 
receptors like netrins, semaphorins and ephrins are also regulated by p53 (Arakawa, 
2005). In vivo experiments using p53 knockout mice showed a significant decrease in the 
number of fibres re-innervating the target muscles at 28 days after facial axotomy in the 
mutant mice when compared with control animals (Di Giovanni et al., 2006). Deletion of 
p53 also rescued the motor neuron death after hypoglossal nerve injury by preventing 
expression of the pro-apoptotic gene Noxa (Kiryu-Seo et al., 2005). Taken together, these 
studies suggest a role for p53 in modulating neurite growth and regeneration.  
SRF 
Serum Response Factor (SRF) mediated transcriptional gene expression is important for 
actin cytoskeletal dynamics, developmental neuronal migration, outgrowth and path-
finding of neurites, as well as synaptic targeting (Knoll and Nordheim, 2009). Following 
nerve fibre injury in vitro, SRF improves re-growth of severed neurites and survival of 
neurons by supressing active caspase 3 expression (Stern et al., 2012).  SRF-deficient 
mice have impaired cell migration, neurite outgrowth, branching, growth cone shape and 
axon guidance. Administration of constitutively-active SRFVP16, a fusion protein of SRF 
and the viral VP16 transactivation domain, enhances neuronal motility and increases 
motoneuron survival by three-fold in vivo. Further, SRF-VP16 and increased microglia and 
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T cell activation around transected motoneurons in vivo. SRF transcriptional targets after 
facial axotomy include IEGs like Egr1, Egr2 and actin cytoskeletal genes such as  actin 
isoforms (Actc1, Acta2), calponin (Cnn1), and actinin (Actn3) (Stern et al., 2012). Finally 
SRF also shares distinct and overlapping functions with transcription factor CREB (Knoll 
and Nordheim, 2009). 
Other transcription factors with potential roles in PNR 
A few other transcription factors have been shown to be consistently upregulated following 
nerve injury and appear to have growth supportive roles in vitro, but there are no studies 
as yet to substantiate their significance, if any, in peripheral nerve regeneration in vivo. 
NF-κB - Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is 
upregulated in DRGs and spinal cord after peripheral nerve crush (Ma and Bisby, 
1998;Pollock et al., 2005). It can respond to a stimulus in neurites and retrogradely travel 
to the nucleus to affect gene transcription. NF-κB signalling can either enhance of inhibit 
neurite growth depending on the phosphorylation status of its RelA/p65 subunit. 
Phosphorylation of p65 by IKKβ results in reduced neurite growth, and in neurons without 
this IKKβ activity, there is increased neurite growth (Gutierrez et al., 2008). Identified 
neuronal targets of NF-κB include genes for Bcl-2, MnSOD, glutamate receptor subunits, 
BDNF, and calcium regulating proteins (reviewed by (Mattson, 2005)). In addition, NF-κB 
has been shown to regulate expression of cell-adhesion molecules like NCAM, tenascin C 
and β1 integrin in other systems (reviewed by (Moore and Goldberg, 2011). NFκB is also 
the downstream modulator of neurite growth for fas apoptosis inhibitory molecule (FAIM) 
signalling. Blocking NFκB activation prevents the increase of neurite growth seen with 
FAIM overexpression (Sole et al., 2004).  
ELK - The ETS-like (ELK) subfamily of transcription factors comprises of ELK1, ELK3, and 
ELK4 factors (Buchwalter et al., 2004;Ducret et al., 2000). Seven days after peripheral 
axotomy, a 2.3 fold upregulation of ELK3 mRNA, but not of ELK1 or ELK4 mRNA was 
detected in adult mouse DRGs (Kerr et al., 2010). The expression of neuropeptide galanin 
mRNA is upregulated around 80-fold in DRGs following axotomy, and an 18 basepair 
sequence within its promoter/enhancer region containing overlapping putative ETS, STAT 
and Smad binding sites, has been shown to be critical for this response (Bacon et al., 
2007), making ELK3 a potentially important candidate regulating peripheral nerve 
regeneration.  
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Oct-6 - Transcription factors Oct-6 (SCIP/Tst-1), Krox-20 (Egr-2) and Sox 10 are major 
regulators of Schwann cell differentiation and myelination (Jaegle and Meijer, 
1998;Topilko et al., 1994;Bermingham et al., 1996). Oct-6 is present in the cytoplasm of 
Schwann cells associated with myelinated fibres of intact nerves. Axonal injury induces 
nuclear Oct-6 expression to promote transcription of genes, possibly those encoding 
myelin proteins (Scherer et al., 1994;Kawasaki et al., 2003). Oct-6 expression is down-
regulated in fully regenerated nerves and in nerves showing chronic axonal loss 
(Kawasaki et al., 2003).  
 
Cross-talk between transcription factors  
Transcription factors form an intricate network in which cross-talk between different 
pathways leads to an integrated and input-balanced signalling outcome (Moore and 
Goldberg, 2011;Morrison and Davis, 2003). Some axonal regeneration still occurs in the 
absence of master regulators of regeneration like c-Jun, highlighting the existence of 
alternative pathways, and of compensatory and complementary/synergistic mechanisms, 
which may be shared during axonal outgrowth.  
 
JNK signalling is interconnected with various other cellular signalling pathways, such as 
NFkB and the JAK/STAT system (Haeusgen et al., 2009;Waetzig et al., 2006), resulting in 
STAT3 phosphorylation (Levy and Lee, 2002). Besides JNK, c-Jun can also be activated 
by ERK1/2 (Leppa et al., 1998;Morton et al., 2003;Schwarz et al., 2002). On the other 
hand, STAT3 can stimulate transcription of several AP-1 members including JunB (Coffer 
et al., 1995) and c-fos (Higashi et al., 2004;Yang et al., 2003) which have STAT3 
responsive elements in their regulatory sequence. Besides the JAK/STAT pathway, gp130 
can trigger other signalling streams including the MAPK/ERK pathway (Ernst and Jenkins, 
2004). 
 
The interactions between AP-1 and STAT3 are multiple and complex, resulting in mutual 
modulation of their transcriptional activities. STAT3 and AP-1 factors can bind to 
independent but closely spaced DNA binding sites in the regulatory sequences of a 
number of genes, such as α-2 macroglobulin (Schaefer et al., 1995), VIP (Symes et al., 
1997), bcl-6 (Arguni et al., 2006), and matrix metallo-proteinases, and synergistically 
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induce maximal enhancer function (Zhang et al., 1999). AP-1 complexes can also bind 
directly to STAT3, enhancing STAT3’s transcriptional activity (Leu et al., 2001;Schaefer et 
al., 1995). Mapping of the STAT3-c-jun interactive regions by GST pull-down assays 
suggested that the STAT3-interactive region lies within its coiled-coiled domain, and in a 
portion of the DNA binding domain (Figure 1.3). The c-Jun interactive region was within its 
C-terminal residues 105 to 334.  Point mutations within these regions blocked their 
interaction (Zhang et al., 1999). SOCS3 was discovered for its ability to inhibit tyrosine 
phosphorylation of STAT3 through binding to gp130 and JAKs (Krebs and Hilton, 2001). It 
has subsequently been shown that endogenous SOCS3 can also inhibit AP-1 activity by 
blocking JNK phosphorylation (Miao et al., 2008). Therefore SOCS3 could be an important 
molecule regulating axonal regeneration by controlling changes in JNK and JAK/STAT 
signalling pathways after injury.  
 
Additional transcription factors encompassing a compensatory/complementary role include 
the C/EBP family members C/EBPβ and C/EBPδ. The promoter region of a c-Jun co-
activator, an oncogene Jab1, contains binding sequences for C/EBP, GATA, as well as a 
STAT3 consensus sequence overlapping the C/EBP site. Both, mutation of the C/EBP 
binding site and inhibition of STAT3, significantly reduced Jab1-promoter activity 
(Shackleford et al., 2011). C/EBPβ is essential for appropriate induction and maintenance 
of GAP43 mRNA following axonal injury (Nadeau et al., 2005). While there is no evidence 
of a direct binding site for C/EBP on the GAP43 gene, it contains a functionally-important 
AP-1 site for c-jun and c-fos (Weber and Skene, 1998). C/EBPβ can bind to and regulate 
both c-fos and c-jun (Nadeau et al., 2005), suggesting a coordinated induction of GAP43 
by C/EBPβ, c-fos, and c-Jun in injured neurons. It has already been shown that co-
expression of c-Fos with c-Jun induces a greater number of cells to produce neurites than 
c-Jun alone (Leppa et al., 1998). In contrast with C/EBP β, C/EBPδ causes injury induced 
expression of SPRR1A but not of galanin or GAP43 (Lopez de and Magoulas, 2013). 
ATF3 has been observed to have a similar regulatory effect as C/EBPδ, as it enhances 
the intrinsic growth state of DRG neurons by affecting the expression of SPRR1A but not 
GAP-43 (Seijffers et al., 2007). Similarly, Sox11 has been found to promote nerve 
regeneration via SPRR1A expression (Jing et al., 2012). On the other hand c-jun is 
required for the activation of both GAP43 and galanin in response to nerve injury (Raivich 
et al., 2004). Moreover, C/EBP is activated by CREB in other neuronal systems (Alberini, 
2009), and CREB-associated transcription factors interact with C/EBP in axonal outgrowth 
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in vitro (MacGillavry et al., 2011). It can therefore be speculated that the C/EBPδ pathway 
interacts with CREB/ATF3 and Sox11 signalling networks but not the AP1 pathway in 
injury-induced regeneration (Lopez de and Magoulas, 2013). 
 
We have already discussed a number of different studies investigating the complex 
association between ATF3 and c-jun expression after injury. Besides interacting with 
leucine zipper transcription factors, ATF3 can also interact with other transcription factors 
upregulated after peripheral injury, such as STAT3. This could be via co-activators or by 
synergistic binding to adjacent DNA binding sites. For example, SPRR1A, a target gene 
for ATF3, is a gp130 pathway protein and its promoter region contains functional AP-1 
binding sites (Sark et al., 1998;Pradervand et al., 2004).  
 
Damage-induced neuronal endopeptidase (DINE) is expressed after motor, sensory and 
sympathetic nerve injuries, brain and spinal cord trauma, and cerebral ischemia (Kiryu-
Seo et al., 2000;Boeshore et al., 2004), and is involved in terminal nerve branching 
(Nagata et al., 2010). DINE mRNA induction is always accompanied by the induction of 
ATF3, in various injury models (Nakagomi et al., 2003;Ohba et al., 2004). Transcription of 
DINE is increased 60-fold by Sp1 mediated recruitment of STAT3, c-jun and ATF3 to the 
DINE promoter in response to LIF up-regulation and NGF withdrawal following injury 
(Kiryu-Seo et al., 2008). 
 
NFκB can also interact with Jun, ATF, CREB and Fos transcription factors. STAT3 can 
induce the alternative NFκB pathway, and bind to DNA in a complex with p52, to induce 
transcription. p53 can also interact with p52 to regulate expression of its target genes 
(reviewed by (Perkins, 2007).  
Various mathematical models of interacting signalling pathways are being developed to 
predict regenerative outcomes after injury (Moya et al., 2011).Transgenic animal models 
with deletion of multiple signalling streams will be very useful in identification of functional 
complementary counterparts.  
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Downstream targets – effectors of the regenerative programme 
The upstream injury sensors, signalling molecules and transcription factors rapidly 
condition the injured nerve and within 1 – 4 days after injury, the neuronal perikaryon 
produces a plethora of RNA, protein and glycolipid components which play a vital role in 
executing axonal regeneration (Raivich, 2011). RAGs is an umbrella term including the 
vast number of genes that are differentially regulated during nerve regeneration and may 
be involved in cell-cell signalling, axonal growth and sprouting, and activation of non-
neuronal, cellular milieu (Skene and Willard, 1981;Boeshore et al., 2004). Absence of 
RAGs in CNS neurons is postulated to be one of the causes for their failure in 
regeneration of axons. An overview of expression and function of downstream effector 
molecules in peripheral nerve regeneration, and their transcriptional regulation is shown in 
Table 1.2. This thesis focuses on the roles and regulatory mechanisms of such identified 
downstream effectors in successful peripheral nerve regeneration, specifically axonal 
adhesion molecules, chemo-attractant signalling molecules, cell surface-cytoskeletal 
adaptors and neuropeptides, and also of neurotrophins produced in the injured nerve.  
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Downstream effectors  
(DE) 
Transcription 
Factors Driving 
DE 
Expression 
after 
Axotomy 
Effects  of DE deletion on nerve 
regeneration 
 
References 
Adhesion molecules     
α7 β1 integrin c-jun (N) ↑ - Global α7 deletion strongly 
reduces regenerative speed after 
nerve crush 
Werner et al., 2000 
Raivich et al., 2004 
 
CD44 c-jun (N) ↑ - Reduced neurite outgrowth of 
transplanted central noradrenergic 
neurons 
- Errors in  retinal axonal growth in 
development 
- But: so far no effects data on 
regeneration 
Nagy et al., 1998 
Lin and Chan., 2003 
Raivich et al., 2004 
Ruff et al., 2012 
DINE ATF3, c-jun, 
STAT3 
↑ - Reduced sprouting at developing 
NMJ 
- But: so far no effects data on 
regeneration 
Kiryo-Seo et al., 2008 
Nagata et al., 2010 
Neuropeptides     
Galanin c-jun (N) ↑ - Reduced rate of regeneration 
- Modulation of pain transmission 
after injury 
Holmes et al., 2000 
Raivich et al., 2004 
Holmes et al., 2005 
Ruff et al., 2012 
 CGRP c-jun (N) ↑ - Reduced number of axons 
crossing from proximal to distal 
stump 
Raivich et al., 2004 
Toth et al., 2009 
Ruff et al., 2012 
Guidance molecules     
Ephrin-B Sox-2 (SC) ↑ - Disordered axonal outgrowth 
from proximal to distal stump 
Parrinello et al., 2010 
Cytoskeletal adaptors     
CAP23 c-jun (N) ↑ - Reduced neurite outgrowth & 
target re-innervation 
Anderson et al., 2006; 
Verhaagen, Mattson 
and Raivich, 
unpublished 
GAP43 C/EBPβ (N) ↑ - Abnormal developmental path-
finding 
- But: so far no effects data on 
regeneration 
Strittmatter et al., 
1995 
Nadeau et al., 2005 
Neurotrophins     
BDNF c-jun (SC) ↑ - So far no effects data on 
regeneration 
Meyer et al., 1992 
 
GDNF c-jun (SC) ↑ - Increased neuronal cell death 
- Reduced functional recovery & 
speed of regeneration 
Fontana et al., 2012 
Artemin c-jun (SC) ↑ - Increased neuronal cell death 
- Reduced functional recovery & 
speed of regeneration 
Fontana et al., 2012 
LIF c-jun (SC) ↑ - So far no effects data on 
regeneration 
Curtis et al., 1994 
 
NGF c-fos (SC) ↑ - So far no effects data on 
regeneration 
Hengerer et al., 1990 
 
Table 1.2. An overview of the transcriptional regulation of expression and function of downstream effector molecules 
in successful peripheral nerve regeneration (N = neuronal, SC = Schwann cell, NMJ = neuromuscular junction) 
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Adhesion molecules  
Adhesion molecules enable the interaction of the cell surface of the axonal growth cones 
with the adjacent bands of Büngner consisting of denervated Schwann cells, and the inner 
lining of the neural tube basal membrane, both structures acting as a scaffold for the 
growing axon (Grumet et al., 1991). Signalling between adhesion molecules on axonal 
and Schwann cell surfaces is frequently bi-directional (Quintes et al., 2010;Fricker et al., 
2011), but to simplify it for the purpose of axonal regeneration it is helpful to concentrate 
on axonal molecules that act as receptors for guidance cues from Schwann cells and the 
associated extracellular matrix.  
 
Regenerating neurons up-regulate a variety of adhesion molecules. These include 
integrins (e.g., α7β1) which serve as receptors for the matrix and cell surface molecules 
such as laminin, fibronectin and paxillin (Kloss et al., 1999). There is increased expression 
of CD44, a receptor for hyaluronic acid (Jones et al., 2000) and galectin-1, a lectin 
receptor for the galactoside side chains (Horie and Kadoya, 2000). Regenerating axons 
express cell multimodal surface molecules involved in homophilic binding such as ninjurin 
(nerve injury-induced protein) (Araki and Milbrandt, 2000), gicerin/CD146, a heterophilic 
receptor for the neurite outgrowth factor (NOF) (Hiroi et al., 2003), and adhesion molecule 
FLTR3 which can form complexes with receptors for fibroblast growth factor (FGF) and 
potentiate FGF signalling (Bottcher et al., 2004). On the functional side, galectin-1 
stimulates the migration of Schwann cells from the proximal and distal stumps, assisting in 
the formation of cellular bridges permitting axonal growth into the distal part of the injured 
nerve (Horie and Kadoya, 2000). Administration of exogenous galectin-1 promotes, and its 
removal by antibody neutralisation or through gene deletion, decreases the speed of 
neurite outgrowth (Horie and Kadoya, 2000;McGraw et al., 2004). Removal of β2-
microglobulin causes enhanced synaptic stripping, and produces a moderate, 20% 
reduction in the ability of regenerating motor axons to cross the proximal to distal gap after 
nerve cut (Oliveira et al., 2004).  
 
Regenerating axons also contain an assortment of degradative enzymes including 
urokinase and plasminogen activator, metalloproteinases (MMP) 2, 3 and 9 (Demestre et 
al., 2004;Shubayev and Myers, 2004) and damage induced neuronal endopeptidase 
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(DINE) (Kiryu-Seo et al., 2000). Activation of MMP2 and MMP9 is partially dependent on 
the presence of tPA and/or UPA systems (Siconolfi and Seeds, 2003) and deletion of tPA 
and/or UPA interferes with functional recovery after peripheral nerve injury (Siconolfi and 
Seeds, 2001). As with chondroitinase, administration of exogenous MMP2 has been 
shown to degrade chondroitin sulfate proteoglycans and improve recovery and anatomic 
re-innervation following nerve transection. Furthermore, in the presence of saturating 
concentrations of MMP2, co-administration of chondroitinase ABC does not produce an 
additional improvement, suggesting that both enzymes attack the same target (Zuo et al., 
1998). Interestingly, although regenerating sympathetic neurons show increase in MMP2 
protein activity, there is no comparative increase in MMP2 mRNA (Leone et al., 2005). 
However, the axotomised dorsal root ganglion neurons show injury-caused down 
regulation of TIMP2, an inhibitor of MMP2 (Huang et al., 2011), and there is a similar 
downward trend in facial motor nucleus (Raivich, Mason, Verhaagen, unpublished), 
suggesting a regeneration-induced disinhibition of MMP2. 
 
So far, three of the injury-upregulated adhesion molecules – DINE (Kiryu-Seo et al., 2008), 
CD44 (Jones et al., 2000) and the α7β1 integrin (Werner et al., 2000a) – have been 
identified as downstream targets of the regeneration-associated transcription factors. In 
vitro, DINE expression in neuronal cell cultures is strongly upregulated by STAT3, in 
combination with an ATF3/c-Jun fusion hybrid (Kiryu-Seo et al., 2008). Global deletion of 
DINE following insertion of loxP sites into its gene is associated with a massive reduction 
in terminal sprouting of motor axons at the neuromuscular junction (Nagata et al., 2010). 
Unfortunately, these floxed DINE animals inadvertently suffer from perinatal lethality, 
precluding direct examination of DINE effect in the adult using the Cre/lox system.  
Deletion of neuronal c-Jun interferes with the upregulation of CD44, and the α7 and β1 
integrin subunits, which possibly contributes to the very poor regenerative response seen 
in these animals (Raivich et al., 2004).  CD44 expression is strongly upregulated in a wide 
variety of neural injuries (Jones et al., 2000). Antibody inhibition of CD44 reduces neurite 
outgrowth of transplanted central noradrenergic neurons (Nagy et al., 1998) as well as 
creating multiple errors in retinal axonal growth trajectory through the optic chiasm (Lin 
and Chan, 2003). Further, GFRα-1 receptor for GDNF, a direct c-jun target, can form 
complexes with integrin β1 after administration of GDNF (Cao et al., 2008), and GDNF can 
also increase the integrin levels (Chao et al., 2003;Funahashi et al., 2003). 
  CHAPTER 1 – Introduction  
48 
 
Overall, the integrins are large family of heterodimeric, transmembrane glycoproteins, 
composed of specifically paired α and β subunits (Kloss et al., 1999;Vogelezang et al., 
2001a;Werner et al., 2000b;Gardiner et al., 2005). Facial axotomy leads to a strong, cell-
type-specific, and time-point dependent increase in the immunoreactivity for several 
different integrin subunits in the affected motor nucleus, on neurons, microglia, 
lymphocytes, and the vascular endothelia (Kloss et al., 1999).  Figure 1.5 below shows the 
time course of β-1 expression after facial nerve axotomy (Kloss et al., 1999). 
 
Figure 1.4. β1-integrin immunohistochemistry in normal (0d) and axotomised facial motor nuclei (1d–42d). 
β1 expression is increased within 2 days after axotomy; Peak expression of this integrin subunit is seen 
between 7-14 days and, expression is sustained until day 42 (Kloss et al., 1999). 
 
In the case of the α7β1 integrin, global deletion of the α7 subunit causes a strong, 
approximate 40% reduction in the speed of adult motor axon regeneration after facial 
nerve axotomy, with a commensurate delay in the re-innervation of its target muscles in 
the whisker pad (Werner et al., 2000b). Interestingly, these α7-deficient mice show greater 
up-regulation of the β1 integrin following injury (Figure 1.4), which corresponds with a 
significant increase in central axonal sprouting (Werner et al., 1998) and may imply 
compensatory mechanisms involving other, closely related α subunits. Deletion of α7 
integrin subunit also abolished the ex vivo conditioning effect: explanting axotomised wild-
type sensory ganglia in vitro leads to brisk neurite outgrowth on laminin; the outgrowth is 
weaker and delayed when using previously uninjured ganglia (Ekstrom et al., 2003). In 
agreement with these observations, over-expression of α7 subunit in injured neurons also 
increases axon regeneration (Condic, 2001).  
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Figure 1.5. β1 integrin immuno-reactivity in normal (Co) and regenerating (Ax) facial motor nuclei of control 
(α7+/+) and α7 deficient (α7-/-) mice. α7 deficiency causes stronger increase in the neuronal β1 expression 
3 d after facial nerve transection, compared to control mice (Werner et al., 2000a). 
 
The absence of all γ1-dependent laminin isoforms, the primary ligands for the α7 β1 
integrin, led to similar but more marked and lasting effects. Deletion of the gene for the γ1 
laminin chain in SCs, caused a large decrease in the number of axons crossing into the 
distal portion of the crushed sciatic nerve for up to 30 days (Chen and Strickland, 2003), in 
contrast to the more transient defect in α7- deficient animals (Werner et al., 2000b).  
In addition to cell adhesion migration and axonal outgrowth, integrin signalling is important 
for non-neuronal and neuronal survival (Lemons and Condic, 2008;Previtali et al., 
2001;Tucker and Mearow, 2008). While some α subunits can only dimerise with single β 
subunits - α1, α2, α3, α5, α7 and α8 with β1, αL, αD, αM and αX with β2, and αIIb with β3; 
others like α4 (β1,7), α6 (β1,4), α9 (β1,8) and αV (β1,3,5,6,8) can partner with multiple β 
subunits (Previtali et al., 2001). Table 1.3 lists the 12 members of the β1 integrin family. 
The β1 subunit connects to actin cytoskeleton in each of this heterodimers, while the α 
subunit determines ligand specificity. Many of the β1-pairing α subunits (α1, α4, α7, α9, 
etc.) have been shown to promote axonal regeneration in vitro and following forced 
expression in vivo (Vogelezang et al., 2001b;Toyota et al., 1990), raising the expectation 
that complete removal of β1 would produce a severe regeneration-deficient phenotype.  
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β1 Family Ligands Cell type expression 
α1β1 Collagens/Sema7A 
VEGF/TGFβ/PDGF/MCP-1/IL-8 
Laminin 
Endothelial cells/fibroblasts/  
Immature Schwann cells 
α2β1 Collagens/E-cadherin/Endorepellin 
VEGF 
Endothelial cells/fibroblasts 
α3β1 Laminins/CSPG4 Epithelial cells 
α4β1 Fibronectin/VCAM1 Endothelial cells, neurons 
α5β1 Fibronectin/Endostatin Fibroblasts, neurons 
α6β1 Laminin  Epithelial cells, glia, neurons and Schwann cells 
α7β1 Laminin Muscle cells and neurons 
α8β1 Fibronectin/Vitronectin/Nephronectin Kidney and ureter bud epithelium 
α9β1 Fibronectin/VCAM1/Cytotactin/ 
Osteopontin/Tenascin-C/VEGF 
Endothelial cells 
α10β1 Collagens Chondrocytes 
α11β1 Collagens 
PDGF 
Fibroblasts 
αVβ1 Fibronectin/Vitronectin T-cells 
 
Table 1.3 - β1 family of integrins (Allodi et al., 2012)   
 
Neuropeptides 
Axon transection frequently causes increased expression of a variety of neuropeptides. 
There is a pronounced increase of calcitonin gene related peptide (CGRP), galanin, and to 
a lesser extent pituitary adenylate cyclase activating peptide (PACAP) in subpopulations 
of cranial and spinal motoneurons (Moore, 1989;Raivich, 2005;Tamas et al., 2012). 
Sensory DRG neurons show upregulation of galanin, vasculointestinal peptide (VIP), 
PACAP and neuropeptide Y (NPY) (Xu et al., 1990;Noguchi et al., 1993); sympathetic 
neurons increase in VIP, galanin, PACAP, cholecystokinin (CCK) and substance P 
(Zigmond, 2011) . In contrast, expression of substance P or CGRP in the axotomised 
sensory DRG, or NPY in the sympathetic neurons is reduced (Dumoulin et al., 
1992;Habecker et al., 2009). This is in line with the down-regulation of enzymes and 
transporter systems for adrenergic and cholinergic neurotransmitters in the sympathetic 
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and motor neurons (Zigmond and Sun, 1997;Kalla et al., 2001). Recent studies point to 
decreased expression of the Hand2 transcription factor causing the post-axotomy down-
regulation for components of the adrenergic system (Pellegrino et al., 2011); it is possible, 
similar pathways are involved in the down-regulation of some neuropeptides in the injured 
neurons. 
 
In vitro studies have shown that different neuropeptides like substance P, somatostatin, 
vasopressin, VIP, calcitonin or alpha-MSH exert a moderate but significant neurite-growth 
promoting effect on CNS and PNS neurons (Brinton and Gruener, 1987;Narumi and Fujita, 
1978;Raivich, 2011).  VIP in the SCG and galanin in the DRG may promote neuronal 
survival after injury (Klimaschewski et al., 1995;Holmberg et al., 2005). Transgenic and 
pharmacological studies have confirmed a similar role in vivo for peptides like galanin, 
CGRP and PACAP (Raivich, 2011;Moore, 1989).  Several of these upregulated 
neuropeptides have also been recently identified as in vivo downstream targets of 
regeneration-associated transcription factors. Facial axotomy leads to the appearance of 
galanin and CGRP positive sprouts peaking at day 14 within the facial nucleus (Makwana 
et al., 2010). Deletion of neuronal c-Jun interferes with the upregulation of CGRP and 
galanin in the facial motoneurons (Raivich et al., 2004;Ruff et al., 2012b). Sciatic nerve 
injury results in gradual and prolonged 3 fold increase in specific CGRP binding to the 
distal portion of crushed sciatic nerve (Raivich et al., 1992). Local siRNA mediated 
inhibition of intra-axonal CGRP synthesis strongly reduced the number of axons growing 
in the conduit between proximal and distal nerve stumps (Toth et al., 2009). Similar 
inhibitory effects were also observed by blocking the CGRP receptor expressed on 
neighbouring Schwann cells, via siRNA against the CGRP Receptor Activity Modifying 
Protein-1 (RAMP1), suggesting that the locally expressed peptide is used to recruit 
Schwann cell cooperation for neurite outgrowth (Raivich et al., 1992;Toth et al., 2009). 
 
Deletion of galanin or its type 2 receptor expressed in neurons results in a 35% reduction 
in the rate of peripheral nerve regeneration after sciatic nerve crush (Holmes et al., 2000), 
modulates pain transmission (Holmes et al., 2005), and reduces conditioning lesion 
response in DRG neurons (Sachs et al., 2007). In sympathetic neurons, targeted deletion 
of the core neurokine receptor gp130 that transduces signals for IL6, LIF, CNTF and other 
neurokines, showed drastically lowered post-axotomy expression for galanin, VIP, and 
PACAP but did not affect the up-regulation of cholecystokinin (Habecker et al., 2009). 
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Deletion of gp130 also abolished the nuclear appearance of phosphorylated STAT3 
(Habecker et al., 2009), suggesting that this transcription factor may also be involved in 
the normally occurring post-axotomy upregulation of galanin and associated 
neuropeptides.  
 
In the case of PACAP, homozygous deletion of the gene reduces initial neurite outgrowth 
in the first 24h after injury, with a moderate retarding effect (1-2 days) on the re-
innervation of peripheral target, and an increased neuro-inflammatory response 
(Armstrong et al., 2008). Reverse experiments, using local application of PACAP and 
galanin, showed that either peptide will strongly augment the peripheral branching of 
regenerating axons, increasing the number of neurons regenerating into each of the 
identified rami of the facial nerve by up to five-fold (Suarez et al., 2006). However, these 
pro-sprouting effects were actually associated with impaired outcome, underscoring the 
importance of misrouting as a major impediment to resumption of coordinated functional 
activity. 
 
Guidance Signalling 
Guidance signals – through cell surface contact or diffusible cues mediating attraction or 
repulsion – play an important role by binding to receptors on growth cone surfaces, 
triggering secondary signals and steering axon extension in the correct direction. Overall, 
there are many different families of guidance molecules, including semaphorins and their 
receptors – neuropilins and plexins (Tessier-Lavigne, 1998;Huber et al., 2003), ephrins 
(Tessier-Lavigne, 2000;Parrinello et al., 2010;Koeberle and Bahr, 2004), slits (Koeberle 
and Bahr, 2004), or inhibitory myelin components like MAG (myelin-associated 
glycoprotein) which can activate Rho via p75 neurotrophin receptor (p75NTR) (Yamashita 
et al., 2002). Moreover, lipid rafts present at the growth cone amplify guidance signals 
(Fujitani et al., 2005;Guirland et al., 2004). 
Deletion of the neuropilin-2 reduces the density of the light neurofilament-positive axons in 
the distal nerve and interferes with functional recovery (Lindholm et al., 2004;Bannerman 
et al., 2008). Axotomy induces expression of Bex1, an intracellular adaptor molecule 
which interacts with p75NTR to reduce neurite outgrowth inhibition by myelin inhibitors 
(Lindholm et al., 2004). Global deletion of Bex1 reduces the number of regenerating axons 
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crossing the sciatic nerve crush site by more than 50% and impedes functional recovery 
(Khazaei et al., 2010). Interestingly, deletion of p75 does not affect neuronal survival or 
the speed of axonal regeneration in the facial nerve model, although p75 null mice show 
enhanced neuro-inflammatory response compared to their wild-type littermates 
(Gschwendtner et al., 2003). 
In most cases, the in vivo transcriptional regulation for these molecules in neurons has not 
been clearly delineated. However, some of the Schwann cell function in creating axonal 
guidance scaffolds is under the control of post-traumatically expressed transcription factor 
Sox-2, induced by fibroblast ephrin-B signalling. Acting on the Schwann cell EphB2-
receptor, the fibroblast ligand induces Sox2, and in a Sox2-dependent manner N-cadherin 
required for sorting Schwann cells into cell cords that link proximal and distal nerve stump 
(Parrinello et al., 2010). Interference with this process through EphB2-deletion or blocking 
antibodies produces a significantly more disordered axonal outgrowth in the gap region 
between the proximal and distal part of the nerve. 
 
Growth cone and cytoskeletal adaptors 
Appearing at the tip of growing axons, the growth cones are specialized, quasi-
autonomous structures that are responsible for growth, path-finding and recognition of 
targets after nerve injury. To aid their navigatory function, they are heavily adorned by 
adhesion molecules and receptors for chemo-attractive and repulsive signals, discussed 
previously. Inside the growth cone, cytoskeletal adaptors play a crucial role in mediating 
connections between the cell surface and cytoskeletal actin-microtubule core of the 
growing axons (Baas and Ahmad, 2001;Ellezam et al., 2002;Madura et al., 2004). 
Successful axonal regeneration is accompanied by the appearance of numerous, 
functionally diverse families of molecules that regulate surface cytoskeletal interaction 
(Raivich, 2011).  
 
One such family is the GMC family of ‘integral’ membrane proteins - 
GAP43/neuromodulin, Myristoylated Alanine-Rich C Kinase Substrate (MARCKS), and 
cytoskeleton-associated protein 23 (CAP23) (Skene and Willard, 1981;Frey et al., 
2000;Bomze et al., 2001). GAP-43 and CAP-23 are among the most abundant proteins in 
axonal growth cones (Bomze et al., 2001;Goslin and Banker, 1990). Although these GMC 
molecules do not share structural homologies, they share a number of functional 
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properties (Frey et al., 2000;Laux et al., 2000). They co-distribute with phosphoinositol-4, 
5-diphosphate (PIP2), at the semi-crystalline, plasmalemmal raft regions and modify raft-
recruitment of signalling molecules such as src (Laux et al., 2000), bind to acidic 
phospholipids like PIP2, calcium/calmodulin, protein kinase C and actin filaments  via their 
unique effector domains in a mutually exclusive manner, alter the actin cytoskeleton 
polymerisation, organization and disassembly, and translate receptor-mediated calcium 
fluxes into signals guiding growth cone activity (Laux et al., 2000;Henley and Poo, 
2004;Kulbatski et al., 2004).  
 
CAP23 is widely expressed during development, maintained in selected brain structures in 
adult, at particularly high levels in the cortex, hippocampus and DRG neurons, and re-
induced by nerve injury and during nerve regeneration. CAP23-deficient mice are born 
sterile, have pronounced abnormalities at the neuromuscular junction and exhibit high 
postnatal mortality. This is probably due to the involvement of CAP23 in the maintenance 
of normal dendritic arborisation and of synapses (Kashihara et al., 2000). Their brains 
have enlarged ventricles, and pronounced axonal and synaptic ultrastructural 
abnormalities in the hippocampus and neocortex (Frey, D., L. Xu, and P. Caroni, 
unpublished observations). The absence of CAP23 leads to deficits in the stability of 
growth cone actin structures - thinner neurites with a characteristic winding pattern of 
outgrowth, unusually high densities of microtubules and pronouncedly bulbous growth 
cones - suggesting that in the absence of CAP23, growth cone actin barriers that restrict 
microtubule invasion (Forscher and Smith, 1988) are impaired. CAP23 may play a critical 
role to form an actin-based cortical cytoskeleton at the transition zone between growth 
cone and neurite (Frey et al., 2000). Neurite elongation normally starts in the tip of the 
surviving axon, but additional sprouts can develop more proximally at the Nodes of 
Ranvier. 
 
In vitro, depletion of GAP43 does not impair NGF-elicited neurite outgrowth but leads to 
poorer adhesion, unstable lamellar extensions devoid of local F-actin, reduced branching 
and enhanced sensitivity to inhibitory stimuli (Caroni, 1997). In vivo, global deletion of 
GAP43 interferes with normal developmental path-finding (Strittmatter et al., 1995), and 
that of CAP23 with inactivity induced sprouting at the neuromuscular synapse (Frey et al., 
2000). CAP23 knockouts show an almost complete absence of stimulus-induced nerve 
sprouting which can be rescued by transgenic overexpression of CAP23 or GAP43, 
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implying that GAP43 can functionally substitute for CAP23 in vivo (Frey et al., 2000). 
Overexpression of GAP43 or CAP23 induces excessive neuro-muscular sprouting 
(Caroni, 1997). Combined overexpression of both GAP43 and CAP23 in the growth cone 
of adult DRG neurons elicits a transition from local arborisation to long axon extensions in 
vitro, and strongly enhances neurite extension (60-fold) from peripheral sensory neurons 
into the injured adult mouse spinal cord in vivo. Little regeneration is observed if only one 
of the two components is overexpressed (Bomze et al., 2001). 
GAP43, but not CAP23, is upregulated in cortico-spinal neurons, following proximal 
intracortical axotomy, but not after distal spinal axotomy (Mason et al., 2003). After 
peripheral nerve axotomy, the transcriptional upregulation of the mRNAs encoding GAP43 
and CAP23 is biphasic, and it is down-regulated after target reconnection (Mason et al., 
2002). In the case of GAP43, the early phase (24h after axotomy) is c/EBPβ independent 
but followed by a c/EBPβ-dependent later phase, with an almost complete disappearance 
of increased GAP43 mRNA in c/EBPβ null mutants at day 3 (Nadeau et al., 2005). In the 
case of CAP23, upregulation in the first 24h is unaffected, but the in the 2nd phase (4-14 
days), CAP23 expression is reduced in the absence of neuronal c-Jun (Verhaagen, 
Mattson and Raivich, unpublished observations). Additionally, both GAP-43 and CAP-23 
are expressed by Schwann cells in nerve grafts, suggesting that they play a role in the 
remodelling, and particularly in the elongation, of Schwann cell processes as part of the 
Bands of Bungner (Mason et al., 2002).  
Since long term postnatal survival of GAP43 null mice is rare (Strittmatter et al., 1995), 
studies in the adult have been limited to the CAP23 deletion (Caroni, 1997;Frey et al., 
2000). Recent data using neuron-specific deletion of the floxed CAP23 gene using adeno-
associated virus carrying Cre-recombinase, resulted in an approximately 50% reduction in 
the whisker pad re-innervation (Anderson et al., 2006), the main target of regenerating 
facial nerve fibres (Werner et al., 2000b), underscoring the importance of this class of 
adaptor molecules in adult regeneration. 
 
Microtubule disassembly molecules (e.g. SCG10, stathmin, CRMP2 and RB3), a 
microtubule-targeting group of axonal adaptor molecules are also up-regulated after nerve 
injury (Iwata et al., 2002;Mori and Morii, 2002). A third family of proteins, the Rho GTPase 
family (RhoA, Rac, Cdc42 and TC10) members, act as molecular switches regulating 
cytoskeletal structure, dynamics, and cell adhesion (Etienne-Manneville and Hall, 2002). 
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Trophic molecules, like NGF and laminin, regulate neurite outgrowth by acting co-
ordinately on the same GTPase (Rankin et al., 2008). 
 
Neurotrophins, growth factors, and cytokines 
Peripheral nerve injury causes a massive increase in the synthesis and/or availability of a 
variety of neurotrophic and growth-promoting factors which assist in neuronal survival, 
immune response and axonal outgrowth following injury (Raivich and Makwana, 2007). 
These include neurotrophins-3 (Terenghi, 1999), 4/5 (NT3, NT4/5) (English et al., 2005), 
nerve growth factor (NGF) (Heumann et al., 1987), brain derived neurotrophic factor 
(BDNF) (Meyer et al., 1992), glial cell-derived neurotrophic factor (GDNF) (Naveilhan et 
al., 1997), insulin-like growth factors-1/2 (IGF1, IGF2) (Kanje et al., 1989;Glazner et al., 
1993), basic fibroblast growth factor (FGF) (Jungnickel et al., 2004), vascular endothelial 
growth factor (VEGF) (Islamov et al., 2004), leukaemia inhibitory factor (LIF) (Curtis et al., 
1994;Haas et al., 1999;Zigmond and Sun, 1997), ciliary neurotrophic factor (CNTF) 
(Kirsch et al., 2003), interleukin-1 (IL1) (Lindholm et al., 1987), interleukin-6 (IL6) (Hirota et 
al., 1996), and transforming growth factor-beta 1 (TGFb1) (Lindholm et al., 1992). 
Following nerve injury, neurotrophin receptors are upregulated on the distal portion of the 
nerve, in denervated Schwann cells and in growth cones of regenerating axons (Raivich 
and Kreutzberg, 1994). 
 
The trophic factors IGF1, IGF2, and BDNF, and the TGF β superfamily member GDNF 
have been implicated in regulating speed of the repair process by stimulating growth of 
injured axons across the gap between the proximal and distal stumps, and guiding axon 
extension along the bands of Bungner (Taniuchi et al., 1986;Vogelin et al., 2006;Zhang et 
al., 2000). Both BDNF and GDNF are induced in the distal stump of the injured axons, and 
their exogenous application promotes axonal regeneration of chronically injured neurons, 
thereby completely reversing the harmful effects associated with late nerve repair (Boyd 
and Gordon, 2003a;Boyd and Gordon, 2003b). Inhibition of endogenous BDNF (Streppel 
et al., 2002) and GDNF (Sun and Oppenheim, 2003) also decreases the post axotomy 
collateral sprouting in the peripheral nerve. Overexpression of GDNF in motoneurons has 
shown to also have positive effects on neuronal survival after axotomy (Zhao et al., 2004). 
NGF deprivation by neutralizing the endogenous activity with specific antibodies induces 
axotomy-like changes even in the intact, sensitive sensory and sympathetic neurons 
  CHAPTER 1 – Introduction  
57 
 
(Shadiack et al., 2001). Factors like IGF-1, LIF, CNTF, BDNF, NGF and NT3 prevent 
axotomy-induced motoneuron cell death (Moran and Graeber, 2004).  
Transgenic deletion of IL6, a multi-functional neurokine rapidly induced after neural injury, 
causes a mild (15%) reduction in the morphometrically-determined speed of axonal 
regeneration in the crushed facial motor nerve, and improves central axonal sprouting 
(Galiano et al., 2001). IL-6 null mice achieve only 50% of sciatic nerve function 30 days 
after sciatic nerve crush; and induction of regeneration associated gene GAP-43 is also 
blocked in these mice (Zhong et al., 1999). Combined overexpression of IL6 and its 
receptor results in improved nerve regeneration (Hirota et al., 1996). A recent study 
highlights the role of IL6 in promoting regeneration and functional recovery after SCI by 
reactivating intrinsic growth program of neurons through increased expression of  growth 
associated genes GAP-43, SPRR1A and Arginase I and enhancing synapse formation in 
vivo (Yang et al., 2012). SPRR1A is induced by gp130 cytokines (Pradervand et al., 2004) 
and associates with actin in growth cones (Bonilla et al., 2002). Previous studies have 
reported that conditioning lesion or injection of CNTF into DRGs increase SPRR1A 
expression (Wu et al., 2007). Post-lesion regulation of CNTF/LIF receptor components 
indicate a direct and sequential action of CNTF/LIF signalling in survival and regeneration 
of axotomised facial motoneurons (Haas et al., 1999).  
 
The neuropoeitic cytokines IL6, LIF and CNTF share the signalling receptor gp130 and 
may mediate their effects by activating transcription factor STAT3. Indeed, absence of the 
Schwann cell CNTF in the CNTF null mice appears to delay in the appearance of 
phosphorylated STAT3 and its nuclear translocation in neuronal cell bodies (Kirsch et al., 
2003). In LIF KO and in IL-6 KO mice, neurite outgrowth following a conditioning lesion is 
significantly reduced by 40% and 65% respectively (Cafferty et al., 2004;Cafferty et al., 
2001). Exogenous application of IGF1 and IGF2 enhances, and their antibody mediated 
inhibition reduces the pinch test-determined speed of axonal regeneration (Kanje et al., 
1989;Glazner et al., 1993); IGF1 is also partly responsible for the peripheral conditioning 
(Kanje et al., 1991). Peripheral nerve grafts from mice lacking NT4/5 display decreased 
growth by regenerating axons of wild-type animals (English et al., 2005).  
Studies into transcriptional regulation of induced neurotrophin and growth factor 
expression in peripheral nerve have concentrated particularly on the role of c-Fos and c-
Jun. Sciatic nerve lesions cause a rapid, local increase in c-fos and c-jun mRNA followed 
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within hours by an increase in NGF mRNA (Hengerer et al., 1990), with endoneurial 
fibroblasts forming a primary site of NGF synthesis (Lindholm et al., 1987;Heumann et al., 
1987). That these two sets of changes – upregulation of c-Fos, and later expression of 
NGF – are probably linked has been shown by an elegant set of cell culture experiments. 
Here, heavy metal induced overexpression of c-Fos in fibroblasts from transgenic mice 
with metallothionein promoter driven Fos resulted in a rapid upregulation of c-Jun and 
NGF, with c-Fos/Jun heterodimer binding to the AP1 site in in the first intron of the NGF 
gene critical for NGF mRNA transcription (Hengerer et al., 1990).  
 
Recent studies have shown that Schwann cell-specific deletion of floxed c-Jun using p0 
promoter driven Cre, produces a massive increase in facial motoneuron cell death, with a 
commensurate reduction in peripheral target re-innervation, as well as in functional 
recovery after facial axotomy (Fontana et al., 2012). Follow-on analysis of neurotrophin 
and growth factor expression in the injured sciatic nerves of p0:jun mice, revealed a strong 
deficit in many of the normally upregulated trophic factors, including GDNF, Artemin, 
BDNF and LIF. Interestingly, administration of recombinant GDNF and Artemin to these 
p0:jun mice, substantially reduced the post-traumatic neuronal cell death and improved 
functional recovery, underscoring the importance of Schwann cell c-Jun in providing 
trophic support for the injured and regenerating neurons (Fontana et al., 2012).  
 
Cell death signals 
Nerve axotomy elicits a complex neuronal response that leaves injured neurons poised 
precariously between death and regeneration. Even in successfully regenerating 
peripheral nerves, axotomy can induce up to 60% cell death (Kalla et al., 2001;Raivich et 
al., 2002;Raivich et al., 2004;Raivich et al., 1999a), indicating a normal physiological role 
of cell death signals in the regenerative effort. Axotomy induced neuronal death can be 
apoptotic, necrotic or a combination of both (Pettmann and Henderson, 1998). A number 
of cell surface molecules like fas and TNFR 1 & 2 have been implicated in cell death. They 
have a cytoplasmic death domain (except TNFR2) and mediate neuronal death by 
exerting pro-apoptotic signals through FADD (Fas associated death domain) (Ugolini et 
al., 2003). Downstream cytoplasmic death signals include bax and caspase family 
members, especially caspase 3 (Chan et al., 2003;Sun and Oppenheim, 2003). Bax is a 
member of the Bcl-2 protein family, which competes with the survival associated factor 
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bcl-2 and bcl-x, downstream targets of STAT3, to promote apoptosis (Liu et al., 
2011;Nielsen et al., 1999;Stephanou et al., 2000). In ischaemic brain injury in adult rats, 
bax and caspases appear to act downstream of c-jun phosphorylation via the JNK 
pathway, with a reduction in neuronal apoptosis by JNK inhibition (Guan et al., 
2006;Putcha et al., 2003). 
 
Different types of neurons can widely differ in their response to axotomy, depending on the 
intrinsic properties of the neuron as well as the regenerative environment of the axon 
(Goldberg and Barres, 2000). In neurons of the dorsal root ganglia (DRG), which extend 
branches to both the PNS and CNS, only a PNS lesion but not a CNS lesion induces 
axonal growth and neuronal survival (Lieberman, 1971). Neuronal survival following 
axotomy also depends on the distance between the injury site and the cell body (Dai et al., 
2000). Axons die back to the proximal collateral branch point which may sustain the nerve 
fibre. If the injury is too close to the cell body, it normally results in cell death (Fry and 
Cowan, 1972). Target re-innervation and motoneuronal survival are greater when the 
epineurium stays intact, i.e., following nerve crush compared with complete transection. 
Also, the developmental maturity of the animal at the time of facial nerve injury strongly 
influences neuronal survival - the same peripheral nerve lesion affects neonatal 
motoneurons much more severely resulting in almost complete cell death as compared to 
their adult counterparts which show only limited cell death (Moran and Graeber, 2004). 
 
Non-neuronal cellular changes 
Accompanying the neuronal response to peripheral injury, non-neuronal cells are also 
activated in a graded response and cause acute inflammatory changes at the lesion site, 
in the distal part of the nerve and around the cell body of injured axons. Inflammatory 
cytokines increase in expression with increasing severity of injury. Initial expression of 
MCSF, IL-6 and TGFβ1 is followed by later expression of other cytokines like IL-1β, TNFα 
and IFN-γ (Raivich et al., 1999a). Inflammatory responses to injury serve two functions – 
clearing of debris and restoring normal function, and providing protection against 
infectious pathogens (Raivich et al., 1999a). However, they exert only moderate to 
minimal influence on speed of axonal regeneration (Galiano et al., 2001;Kalla et al., 2001).  
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Microglial activation 
Resting microglia perform an immune surveillance function in the uninjured nervous 
system. Following nerve insult, they are rapidly activated and act as the first line of 
defence (Raivich, 2005). Microglial activation proceeds through several stages which are 
accompanied by changes in cytokine production (Raivich et al., 1999a;Raivich et al., 
1999b). The stage of alert (Stage 1) is the first stage of activation and occurs within 24 
hours after injury (Raivich et al., 1999a).  The microglia proliferate extensively and become 
hypertrophic, up-regulating molecules with immune function like integrins αM and β2, and 
leucocyte adhesion molecule, ICAM-1, responsible for lymphocyte recruitment and 
interaction with the injured neurons (Kloss et al., 1999;Raivich et al., 1999a;Werner et al., 
1998). In the homing stage (Stage 2), microglia proliferate and move towards the neuronal 
cell body and adhere to the damaged structures (Raivich et al., 1999a). Molecules induced 
in Stage 1 decline, whilst others like α5, α6, and β1 are upregulated around 4 days post-
injury (Kloss et al., 1999;Werner et al., 1998). They actively engage in the process of 
‘synaptic stripping’ whereby they displace synaptic inputs from the cell body of the 
regenerating neuron, which are subsequently wrapped by astrocytic cell processes 
(Graeber et al., 1993). In the presence of neuronal cell death, microglia become 
phagocytic (Stage 3a), with 3-20 microglia clustering together to form nodules which 
degrade the neuronal debris (Raivich et al., 1999a). Phagocytosis also causes activation 
of adjacent microglia, a process known as bystander activation (Stage 3b). Along with a 
massive induction of the previously expressed molecular markers, a number of new 
molecules including cell adhesion molecules for binding and internalising injury-induced 
debris and for antigen presentation, as well as proteases and pro-inflammatory cytokines 
are induced by co-stimulatory molecules ICAM-1, B7.2 and αXβ2-integrin (Kloss et al., 
1999;Raivich et al., 1999a;Werner et al., 1998;Bohatschek et al., 2004). 
Astrocytic response 
Concomitant with the proliferation of microglial cells, local astrocytes which normally 
express very low levels of the GFAP, become reactive and undergo hypertrophy (Raivich 
et al., 1999a). GFAP is synthesised de novo as early as 24 h after axotomy (Graeber and 
Kreutzberg, 1986). Following the increase in GFAP synthesis, the reactive astrocytes 
reorganize their cytoskeleton under the control of specific cytokines like IL-6 (Klein et al., 
1997), transforming from protoplasmic to fibrillary astrocytes. This dramatic increase in 
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GFAP after injury is significantly reduced in IL-6 null mice (Klein et al., 1997). Around 14 
days after axotomy, astroglia replace the microglia on the neuronal surface, forming 
insulating lamellae around the recovering neurons (Kreutzberg, 1993;Graeber and 
Kreutzberg, 1988). Successful regeneration leads to a retraction of the astrocytic 
processes and gradual repopulation of the neuronal surface with synaptic terminals 
(Raivich et al., 1999a). 
 T-cell recruitment 
Lymphocyte recruitment, as with microglial and astrocyte activation, occurs in response to 
neuronal injury and varies according to the severity of the injury (direct or indirect trauma) 
(Raivich et al., 1999a). 2-4 days after facial axotomy (indirect trauma), low-level entry of 
leucocytes (grade 1) is seen, restricted to the facial motor nucleus of the injured neuron 
(Raivich et al., 1998). Extensive post-traumatic cell death leads to a strong recruitment of 
CD3, CD11a, and CD44 immunoreactive T-cell (grade 2) at day 14, which aggregate 
around the phagocytic microglia (Raivich et al., 1998). Pro-inflammatory cytokines 
expressed by microglia and macrophages, including IL-1, IL-6, IFNγ and TNFα appear to 
have an important role in leucocyte recruitment (Raivich et al., 1998;Raivich et al., 1999a). 
More direct trauma like lesions to the brain and spinal cord elicit the entry of both 
granulocytes and macrophages (grade 3) in addition to the leukocytes and T-cells (Raivich 
et al., 1999a). These grade 3 leucocytes have a number of cytotoxic effects and result in 
considerable secondary injury contributing to axonal degeneration and tissue loss 
(Popovich et al., 1999).  
Rate of regeneration, target re-innervation and functional recovery 
Following crush injury to the peripheral nerve, axonal regeneration is typically successful 
even though axons need to regrow and remyelinate over long distances. Regeneration of 
crushed axons typically proceeds at a rate of 1-2mm per day in humans, and is much 
faster in rodents (Gutmann, 1942). Regeneration following nerve transection is much more 
complicated and a number of different theories postulate the crossing over of the proximal 
fibres to the distal stump and their extension towards their re-innervation targets (Zhang 
and Yannas, 2005).  According to the popular and widely accepted ‘basement membrane 
microtube theory’ SCs proliferate and migrate to form linear Bands of Bungner surrounded 
by basement membrane for axon elongation and myelination. The ‘neurotrophic theory’ 
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proposes that elongation of axons and supporting cells is controlled by diffusion of soluble 
growth-promoting factors from the distal stump. According to ‘contact guidance theory’, 
this extension is guided by contact with insoluble substrates which provide tracks for the 
elongating axons to attach to. As per the ‘pressure cuff theory’, regeneration across a long 
gap (>1 cm) is mechanically blocked by circumferential contractile forces exerted by 
fibroblast, resulting in neuroma formation (Lundborg, 2003). High regenerative activity 
suppress the pressure cuff theory while facilitating the rest (Zhang and Yannas, 2005). 
The rate of regeneration can be accelerated by a prior, conditioning lesion (McQuarrie et 
al., 1977). Electrical stimulation of the proximal stump also reduces the time taken for 
functional recovery, but does so by reducing the delay before regeneration begins in some 
motor axons (Al-Majed et al., 2000;Brushart et al., 2002;Gordon et al., 2008). GDNF 
microspheres implanted at the coaptation site increase fibre diameter, myelin thickness, 
regenerating axon counts, and contractile muscle force after delayed nerve repair, thereby 
partially reversing the deleterious effects of chronic nerve injury (Wood et al., 2013;Wood 
et al., 2012), as mentioned earlier. 
In addition to the robust outgrowth of crushed peripheral axons, they have also been 
shown to accurately reconnect to their original peripheral targets (Nguyen et al., 
2002;Fournier and Strittmatter, 2002). In contrast, regeneration after nerve transection is 
not generally selective for appropriate targets (Miledi and Stefani, 1969), and collateral 
branches sprouting from the severed axons can randomly grow along different nerve 
vesicles (polyneural innervation) (Angelov et al., 2005). This can result in somewhat 
misguided and inaccurate target re-innervation (Gordon and Gordon, 2010;Valero-Cabre 
and Navarro, 2002) which can lead to synkinesis/pareses, abnormally associated 
movements, and pathologically altered reflexes (Angelov et al., 2005). Successful 
peripheral regeneration and complete functional recovery depends on the correct 
alignment of cut axons and sufficient plasticity of the nervous system for axons to 
innervate appropriate targets (Navarro et al., 2007).  
Hurdles in CNS Regeneration 
There are major differences between injury induced responses of the CNS tissue 
compared with PNS nerves. The numerous factors inhibiting neuronal regeneration in the 
CNS are complex and overlapping and include (but are not limited to) slower WD, 
extensive glial cell death and differential axonal arrangement of nerves. WD is rapid and 
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robust in the PNS but slow and incomplete in the CNS (George and Griffin, 1994). 
Macrophages are rapidly recruited to sites of WD in peripheral but not central nervous 
tissue (Perry et al., 1987). Transection of dorsal roots at L1-4, which projects axons into 
the PNS and CNS, showed that while the peripheral nerve roots were completely clear of 
myelin debris at 30 days post lesion, myelin and neurofilamentous accumulations were still 
visible in the spinal cord 90 days after injury (George and Griffin, 1994). The delayed WD 
is not due to slower axonal degeneration but due to a failure of axonal and myelin debris 
removal (Vargas and Barres, 2007). Myelin debris contains several inhibitors of 
regeneration (He and Koprivica, 2004) and their prolonged presence in the CNS creates 
an inhibitory extracellular environment contributing to the failure of CNS axons to 
regenerate. 
The glial cells in the CNS also behave very differently from SCs following injury. SC 
phagocytose myelin and axonal debris, proliferate extensively in injured nerves and 
repopulate lesions sites rapidly to provide guidance pathways for axonal regrowth. 
Oligodendrocytes lack phagocytic properties (Bignami and Ralston, III, 1969), and in the 
days following injury, there is extensive glial cell death, resulting in a lesion site largely 
devoid of astrocytes and oligodendroglia.  
Unlike peripheral nerve, axons in the CNS are not structurally separated by perineurial or 
neurilemmal sheaths, but are organised into tracts of related function and myelinated 
together without distinct physical barriers separating them. Hence, following injury, there 
are no biomechanical guidance cues in the CNS that can be compared with the bands of 
Büngner in peripheral nerves. 
Facial Axotomy model 
The facial axotomy model is well-established system for studying axonal response and 
neuronal regeneration (Moran and Graeber, 2004). This model was popularised by 
Kreutzberg and his colleagues in the 1980s and has since become the prototypic 
experimental paradigm, allowing a systematic and detailed investigation of the reaction of 
neuronal and non-neuronal cells and their microenvironment to various types of 
challenges.  
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Figure 1.6. Facial Axotomy Model. Schematic drawing showing A: mouse facial nerve (yellow) B: transverse 
section showing location of facial nucleus in the brainstem (Moran and Graeber, 2004). 
 
The facial nucleus is located in the rostral pons of the brainstem and exists as a semi-
circular collection of approximately 2000 motoneurons, which project their axons within the 
facial nerve (VII cranial nerve) to muscles involved in ear, eyelid, lip and whisker hair 
movement in mice (Figure 1.6A) (Ashwell, 1982). This model has a number of obvious 
benefits. Firstly, the facial nerve is bilateral, and unilateral transection of the nerve as it 
leaves the CNS at the stylomastoid foramen, results in an intra-animal control on the 
contralateral side (Figure 1.6.B). Researchers benefit from the analytical strength of a 
paired experimental system with the normal control nucleus conveniently located on the 
other side of the brain stem. As the nucleus spans a rostral-caudal length of around 1 mm, 
multiple sections can be taken from each experimental animal providing further virtue to 
the model. Secondly, the surgical procedure is straightforward and of mild severity 
compared to other nerve injury models. Nerve crush injury allows re-innervation to take 
place within 3 weeks after injury, a reasonable time-frame for analysing end-point of 
regeneration. Nerve transection is a more severe insult. Thirdly, the injury does not involve 
disruption of the blood-brain-barrier or direct CNS trauma (Moran and Graeber, 2004). 
 
Aims of my project 
As outlined, nerve injury is accompanied by increased gene expression for a wide range of 
regeneration associated molecules. Transcription factors often act as the driving forces of 
regeneration, regulating the expression of a complex web of target genes simultaneously. 
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This thesis aims to investigate the likely role of three transcription factors – STAT3, c-jun, 
and C/EBPδ, and two downstream effector proteins – CAP23, and β1 integrin, in 
promoting axonal regeneration after peripheral nerve injury in vivo. All five molecules are 
known to be strongly upregulated following injury and during regeneration. Cell-type 
specific deletions of the individual genes were used to characterise the unambiguous roles 
of these molecules in nerve regeneration (except for C/EBPδ which was a global deletion). 
The work was undertaken in the facial axotomy injury paradigm - a reliable and highly 
reproducible model of peripheral nerve regeneration. It enabled assessment of the effects 
on the speed and extent of axonal regeneration and sprouting, recovery of motor function, 
neuronal and non-neuronal cellular response and neuronal survival, resulting from 
conditional alteration of these proteins. 
The first part of the thesis focuses on transcription factors STAT3, c-jun and C/EBPδ.  
STAT3 is slowly but assertively emerging as one of the important mediators of injury-
induced regeneration, not just in the PNS but also in the CNS. Studies involving STAT3 
gene deletions in sensory neurons or in retinal ganglion cells, or its increased expression 
via viral gene transfer, or by blocking the action of its inhibitors, have shown a promising 
role for this transcription factor in axonal regeneration and neuronal survival. However, the 
results from these studies are often conflicting – while some attribute a sustained positive 
role to STAT3, others claim its involvement is only transient in ‘jump-starting’ the 
regenerative response after cut but not crush injuries. Here, neuronal STAT3 KO mice 
were examined for their short-term and long-term effects on facial nerve injuries of varying 
severity. Particular attention was paid to measure the various indices of regeneration – 
early speed of regenerating growth cones, functional and anatomical re-innervation, 
axotomised motoneuron morphology and survival rates, early and late molecular changes 
within the injured neurons and the response of the surrounding glial cells. Schwann cell 
specific deletion of STAT3 was also examined for its role in regeneration.  
Previous deletion studies of the transcription factor c-Jun have been particularly instructive, 
confirming its significance as both a neuronal and Schwann cell-derived factor in 
regeneration. Neuron-specific deletions of c-Jun have tremendous effects on peripheral 
regeneration and result in shrunken neurons, but promote neuronal survival. Conversely, 
Schwann cell-specific deletions lead to increased neuronal death additionally to impaired 
regeneration. These findings prompted the need to investigate the effects of combined 
  CHAPTER 1 – Introduction  
66 
 
neuron- and Schwann cell-specific deletions on peripheral regeneration and motoneuron 
survival. Double knock-out mice with neuron- and Schwann cell-specific deletions using 
the cre-lox system under the synapsin and myelin protein zero promoters, respectively, 
were used to study the axonal response and neuronal regeneration in the facial axotomy 
model. Also examined was the role of N-terminal phosphorylation in c-Jun‘s regenerative 
function in response to facial motor nerve transection.  
Similarly, mice with global C/EBPδ gene deletion were analysed for effects on 
regeneration after facial nerve injury. Additionally, to identify functional complementary 
counterparts, double knockout mice with combined deletions of two transcription factors 
(for example, c-Jun and STAT3, or C/EBPδ and STAT3) were generated and analysed for 
greater synergistic reduction in regeneration compared with single deletions.   
The second part of the thesis focuses on effector proteins CAP23 and integrin β1 which 
are direct downstream targets of transcription factors, and form the basic building blocks 
of nerve repair. Preliminary studies using CAP23 floxed mice and injection of AAV-cre 
virus have shown a marked reduction in long-term ability to re-innervate the peripheral 
target in the facial axotomy model. β1 integrin is the only counterpart of α7 integrin, and 
global deletion of α7 decreases speed of axonal regeneration. Cell-type specific 
conditional mutants lacking the genes encoding these proteins in neurons were generated, 
and the effects of these mutants on axonal regeneration analysed as before. 
Comprehensive investigation of the changes resulting from these specific gene deletions, 
will allow us to obtain insight into downstream mechanisms controlled by the different 
transcription factors, and define hierarchies in the regenerative signalling pathways. 
 
Scope of this study 
Injury to peripheral nerves can occur due to several causes ranging from physical injury 
and accidental trauma to pathological conditions and degenerative diseases. Achieving 
successful regeneration and synchronised functional recovery following neural damage is 
one of the biggest challenges faced by neuroscientists and clinicians. This applies to both 
peripheral and central forms of injury. Central axons are normally unable to regenerate 
across glial scars, whether injury is due to physical trauma (e.g. spinal cord injury), 
ischemia, stroke and cerebral palsy, or inflammation-associated axonal damage as in 
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multiple sclerosis, and the modest functional recovery is almost completely due to post-
traumatic (regenerative) collateral sprouting of the surviving axonal fibres. Even though 
neurons in the PNS are capable of regeneration following peripheral nerve trauma, the 
speed and specificity in the human patient is often sub-optimal. Peripheral nerve injury 
often results in incomplete functional recovery, and the appearance of involuntary aberrant 
movements (synkinesis), that may be due to incorrect regenerative sprouting. 
Understanding the molecular mechanisms underlying nerve regeneration via various 
regeneration associated molecules and their signalling components will improve the 
success of central axonal regeneration, as well enhance the speed and specificity of 
peripheral regeneration.  
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Chapter 2 – Materials & Methods 
Animals 
All experiments were conducted in accordance with the UK Animals (Scientific Procedures) 
Act 1986, and with the approval of the Home Office. All animals were housed in UCL 
Biological Services Units in the Cruciform and Kathleen Lonsdale buildings, under 
standard conditions of a 12 hour light-dark cycle, constant temperature (21-23°C) and 
humidity (60%±5), and access to pelleted food and water ad libitum. Several lines of 
genetically engineered mice were used in this study. These were sourced from a number 
of different laboratories and are summarised in Table 2.1.  
Genetic modified mice Background Source 
STAT3 floxed SVJ129 Shizuo Akira (Osaka U, Japan) 
c-jun floxed C57BL/6 Axel Behrens (Cancer Research, UK) 
c-jun 4A C57BL/6 Axel Behrens (Cancer Research, UK) 
CEBP global KO C57BL/6 Babis Magoulas (Queen Mary, U London, UK) 
CAP23 floxed CD1 Fred Sablitzky (U Nottingham, UK) 
β1 integrin floxed C57BL/6 Reinhard Fässler (Max Planck U, Germany) 
Syn:cre C57BL/6 Axel Behrens (Cancer Research, UK) 
P0:cre C57BL/6 Axel Behrens (Cancer Research, UK) 
                                                                                                                                                            
Table 2.1. Summary of genetic modified animals 
Cell type specific single and combined deletions 
Neuronal deletion – Knock-in mice carrying floxed allele of the gene/s of interest, say (Y) 
were crossed with syn::cre transgenic animals expressing cre recombinase under the 
control of the neuron-specific synapsin promoter (Zhu et al., 2001) twice, to generate 
mutant mice (Yf/f syn:cre +), in which both alleles of Y gene were inactivated in neurons. 
Sibling animals lacking the cre transgene, with functional, unrecombined homozygous 
floxed gene Y (Y f/f syn:cre-), served as controls.  For example, Figure 2.1 describes the 
generation of mutant mice with cell type-specific deletion of STAT3 gene. To prevent 
germline Y deletion due to testicular synapsin promoter expression (Rempe et al., 2006), 
mostly female cre+ mice (Yf/f syn:cre) and cre- Yf/f males were used for breeding. 
Experimental cohorts consisting of homozygous mutants (syn:cre Yf/f) and litter-mate 
controls (Yf/f) were generated with normal Mendelian frequency (Sauer, 1998).  
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Figure 2.1.  Generation of cell-type specific STAT3 deletion by Cre/loxP recombination. Floxed-STAT3 mice, 
in which two 34 bp loxP sites were introduced 5' and 3' of the STAT3 gene (Akira, 2000), were mated with 
transgenic mice expressing Cre protein under the control of cell type-specific promoter. The cre enzyme 
recognizes the loxP sequence motifs and excises the intervening STAT3 gene to generate cell type-specific 
STAT3 deletion; littermates without cre served as controls. 
 
Schwann cell deletion – Knock-in mice carrying floxed allele of the gene of interest, say 
(Y) were crossed with P0::cre transgenic animals expressing cre recombinase under the 
control of the Schwann cell specific Myelin Protein 0 (P0) promoter (Feltri et al., 1999) 
twice. The loxP sites flanking the Y gene are recognised by cre recombinase, which 
excises the intervening Y gene in Schwann cells to generate homozygous deletion of gene 
Y specifically in Schwann cells. Experimental cohorts consisting of homozygous mutants 
(P0:cre Yf/f) and litter-mate controls lacking the cre transgene (Yf/f) were generated with 
normal Mendelian frequency. 
Combined neuronal and Schwann cell deletion – Transgenic mice having homozygous 
neuronal deletion of gene Y (syn:cre Yf/f) were crossed with transgenic mice having 
homozygous Schwann cell deletion of  the same gene Y (P0:cre Yf/f). The resulting litters 
had homozygous mice with combined neuronal and Schwann cell deletions (syn:cre 
P0:cre Yf/f), only neuronal deletion (syn:cre Yf/f), only Schwann cell deletion (P0:cre Yf/f) 
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or functional, unrecombined controls (Yf/f), which formed the four experimental groups in 
our studies. 
Jun4A  
Jun 4A mutant animals have substitution mutations where the N-terminal serines 63 and 
73 (ser63&73) and threonines 91 and 93 (thr91&93) are replaced by alanines. This 
prevents JNKs from binding to the N-terminal phosphorylation sites, thereby abolishing the 
effects mediated by JNK phosphorylation of c-jun (Behrens, CRUK). Mice having wild-type 
phosphorytable c-jun were used as controls. 
C/EBPδ 
C/EBPδ knockout mice have global homozygous deletion of the C/EBPδ gene (CEBPδ -/-
), and were previously generated in the C57BL/6 strain (Sterneck et al., 1998). Briefly, the 
replacement-type targeting vector was constructed by using 129/Sv mouse genomic DNA 
and the pGKneobpA and pGK-thymidine kinase cassettes. The coding region of the 
C/EBPδ gene was replaced by a neomycin-resistance gene, which was also used for their 
genotyping. Electroporation and selection were performed by using the CJ7 embryonic 
stem cell line.  Two independent ES cell clones with the predicted rearrangements (nos. 
433 and 466) were injected into C57BL/6 blastocysts to generate chimeras, which were 
mated to C57BL/6 females (Sterneck et al., 1998). Experimental cohorts consisted of 
homozygous null mutants (CEBPδ -/-) and wild-type controls (CEBPδ +/+). 
Genotyping 
Mice were ear-notched for identification, and less than 0.5 cm of their tail-tip biopsied for 
genotyping purposes. DNA was extracted from the tails of mice by adding 20µl of 20µg/ml 
proteinase K (Promega, Madison WI) and 750µl extraction buffer (5% 1M Tris, 20% 0.5M 
EDTA, 1% SDS, 3.3% 3M NaCl) to each tail and incubating at 55°C overnight in a rotating 
water-bath. Samples were briefly vortexed and placed on ice, before being centrifuged at 
16000g for 10 minutes. 600µl isopropanol was added to the supernatant and the solution 
mixed by inversion until threads of DNA were visible, centrifuged for a further 10 minutes 
following which the pellets were washed with 70% ethanol, air dried for 20 minutes, re-
suspended in 50µl of Tris-ETDA buffer (TE) and incubated for one hour at 65°C. The 
extracted DNA was stored at 4°C. 
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Table 2.2. PCR reaction primers, sequences and annealing temperatures 
 
DNA amplification was carried out in 25 µl PCR reactions (2.5µl 10X buffer, 5µl Q solution, 
0.25µl 25 mM dNTP, 0.125 µl of each primer (1nM/μl), 0.2µl Taq polymerase (Qiagen)  
and 1µl of DNA (diluted 1/20 with DEPC water)). The thermocycling conditions for each 
PCR were optimised on the T-Gradient PCR machine (Biometra, Germany). Table 2.2 
shows the list of primers used in this study.  
2% agarose-TAE gels were used for resolving DNA samples. 2 g agarose was added to 
100 ml 1x TAE buffer (0.4M Tris, 0.2M sodium acetate, 20mM EDTA, pH), boiled and 
ethidium bromide was added to a final concentration of 0.2µg/ml. PCR samples were 
mixed with loading buffer (1x TAE, 50% glycerol, 0.025% bromophenol blue) immediately 
prior to well loading. Samples were run against 5µl of a 100 basepair DNA ladder (NEB, 
UK) for 40 mins at a constant voltage of 100V and visualised with a UV transilluminator 
(MultiImage Light Cabinet, AIC, UK). 
 
Target gene Forward primer 
5’ - 3’ 
Reverse primer 
5’ – 3’ 
Annealing 
temp (⁰C) 
Generic cre Mac1 sense 
ATTACCGGTCGATGCAACGAGT 
Mac1 antisense 
CAGGTATCTCTGACCAGAGTCA 
60°C 
 Lck cre fwd 
CGGTCGATGCAACGAGTGATGAGG 
Lck cre rev 
CCAGAGACGGAAATCCATCGCTCG 
60°C 
Synapsin cre Syn M3 
AGCTTCAGCACCGCGGACAGT 
Nestin cre rev 
TCGTTGCATCGACCGGTAATG 
60°C 
P0 cre P0 fwd 
CCACCACCTCTCCATTGCAC 
P0 rev 
GCTGGCCCAAATGTTCGTGG 
60°C 
STAT3 WT & 
flox 
STAT3-A 
CCTGAAGACCAAGTTCATCTGTGTGAC 
STAT3-B 
CACACAAGCCATCAAACTCTGGTCTCC 
60°C 
c-Jun WT & flox Lox5 
CTCATACCAGTTCGCACAGGCGGC 
Lox6 
CCGCTAGCACTCACGTTGGTAGGC 
60°C 
C/EBP δ C/EBP del fwd 
ACGACTCCTGCCATGTACG 
C/EBP del rev 
GCTTTGTGGTTGCTGTTGAA 
60°C 
C/EBP Neo C/EBP neo fwd 
AACAAGATGGATTGCACGCAG 
C/EBP neo rev 
GAAGGCGATGCGCTGCGA 
60°C 
Cap23 WT P2 
AGCAAAGCGTGGCCGTCAAA 
P4 
CCAAAGCAAGTGAGGTCTGGGTAA 
65°C 
Cap23 Neo Pneo 
ATTCAGGGCACCGGACAGGTCGGTCTTGACAA 
P4 
CCAAAGCAAGTGAGGTCTGGGTAA 
65°C 
β1 WT & flox T56mod 
GGGTTGCCCTTCCCTCTAG 
L1 
GTGAAGTAGGTGAAAGGTAAC 
60°C 
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Surgeries 
Facial Nerve Axotomy  
Mutant and control mice of 2-5 months of age were anesthetised with 5% isoflurane 
(Merial, UK) and the depth of anaesthesia determined by using the paw withdrawal reflex. 
Oxygen was administered at 1.5L/min. The anaesthesia was subsequently maintained at 3% 
isoflurane. An incision was made below the right ear at the level of the mastoid process. 
Superficial muscles were bluntly dissected to expose the facial nerve. For facial nerve cut 
(1, 14, 30, and 90 days survival) the main branch of the facial nerve, including the retro-
auricular branch, was transected at the stylomastoid foramen. For facial nerve crush (4, 10, 
and 30 days survival), the main branch of the facial nerve was crushed approximately 
1mm distal from its exit from the stylomastoid foramen using fine forceps which were held 
in place for 10 seconds before letting go. The skin was closed with wound clips (AutoClip, 
USA) and the animal was allowed to recover in a heated chamber (32°C). Successful 
facial motor nerve transection was confirmed by the absence of motor function in the 
ipsilateral whisker hair. The animals were sacrificed after 1-90 days with an overdose of 
Euthatal (Merial, UK). 
 
 
Figure 2.2. Right facial nerve as exposed during facial axotomy. 
The dotted lines indicate the upper and lower branches of the 
seventh cranial nerve as it emerges through the stylomastoid 
foramen. The two solid lines indicate the approximate site of 
cut/crush  injuries. 
 
 
 
Retrograde tracing of the facial nerve  
Mice were anaesthetised with 10µl/g body weight of 2.5% 2,2,2-tribromoethanol (Avertin) 
(Sigma-Aldrich, Germany). A midline incision was made between the two whisker pads 
and a cavity created under both whisker pads. Anatomical re-innervation of the whisker 
pad was assessed by placing a 2.5x2.5 mm square piece of gel foam (Johnson and 
Johnson, UK) soaked in 10µl of 4% Fluoro-Gold (FG) (Fluorochrome, Denver, USA) in the 
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cavity under both whisker pads, 28 days after unilateral facial nerve lesion. Pads were left 
for 30 minutes, and then removed, and the skin sutured using 6-O prolene sutures 
(Johnson and Johnson, UK). In addition, some experiments used a double labelling 
system where 2 µl of 10% MiniRuby (MR) (Invitrogen, USA) was injected subcutaneously 
into the periorbital muscle in both upper and lower eyelids of each eye. 10µl of 10% 
buprenorphine (Vetergesic) (VetDispense, UK) was injected subcutaneously for analgesia. 
The animals recovered in a heated chamber (32°C), and allowed to survive for 48 hours to 
enable retrograde transport of the fluorescent dyes to the facial motor nuclei. 
Viral transfection of facial motor neurons 
Lentiviral injections into facial nucleus - Animals were anaesthetised using isoflurane 
anaesthetic (5% to induce, 2-3% to maintain), an incision was made along the top of the 
skull with a scalpel and connective tissue was scraped away with the scalpel until the 
bregma was exposed. Stereotactic co-ordinates for the middle of the facial motor nucleus 
was previously determined to be 5.3 mm caudal and 1.25 mm lateral to Bregma, and at a 
4.7 mm depth from the surface of the brain. Measurements were taken twice before holes 
were drilled at the appropriate sites using a dental drill. All injections were made using a 
10μL Hamilton Syringe (Hamilton Company, Switzerland) with a pulled glass tip attached 
with superglue. 2 μl of a lentivirus expressing STAT3 and GFP (obtained from Dr. 
Xuenong Bo, Queen Mary, Univ of London) was injected unilaterally into each animal 
using a Micro4 MicroSyringe Pump Controller (World Precision Instruments, Sarasota, 
USA) micropipettor. These animals underwent facial nerve axotomy 4 days post- viral 
injection, and FG retrograde tracer application 28 days post-axotomy, before being 
transcardially perfused two days later. Efficiency of viral infection was assessed by eGFP 
immunohistochemistry.  
 
Retrograde AAV and AV injection into facial nerve – Animals were anaesthetised using 
isoflurane anaesthetic (5% to induce, 2-3% to maintain) and an incision was made below 
the right ear to expose the right facial nerve. 2-3 μl of AAV2 virus (from Dr. Joost 
Verhaagen, Netherlands Institute for Neuroscience), or Ad-Cre-GFP virus (from Vector 
Biolab – Adenovirus-Type 5 (dE1/E3) expressing CMV driven cre and GFP; Titer 1x 10^10 
PFU/ml) was injected into the main branch of the facial nerve. In order to successfully 
inject the virus into the nerve, the nerve had to be partially snipped to expose cut axon tips; 
hence all animals underwent partial unilateral facial axotomy. Animals were sacrificed at 
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10 or 30 days after viral transfection, perfused and brains extracted and sectioned at the 
level of the facial nucleus. Efficiency of viral infection was assessed by eGFP 
immunohistochemistry.  
Perfusion Fixation 
Mice were terminally anaesthetised with intraperitoneal injection of Euthatal (200 mg/ml 
sodium pentobarbital) or avertin (2.5%) at 1, 14, 30 or 90 days after facial axotomy. 
Sufficient depth of anaesthesia was determined using the paw withdrawal reflex. A midline 
incision was made below the xiphoid process and the peritoneal cavity exposed. The rib 
cage was lifted, and the exposed diaphragm was incised at its junction with the anterior 
abdominal wall. The incision was continued circumferentially until adequate exposure of 
the pleural cavity was achieved. Whilst holding the xiphiod process, a deep cut was made 
along both sides of the rib cage and the anterior section of the ribcage lifted upwards so 
as to allow access to the mediastinum. A small incision was made at the base of the apex 
of the heart and a blunt-ended needle, attached to a perfusion pump (Gilson, USA), was 
inserted into the left ventricle. The inferior vena cava was cut permitting exsanguination. 
Perfusion was done trans-cardially via the left ventricle at a rate of 0.02L/min for 5 minutes 
with phosphate buffer containing 0.9% saline (PBS: 10 mM Na2HPO4, 0.85% NaCl, pH 
7.4), followed by cold (4°C) 4% paraformaldehyde in 10mM phosphate buffered saline 
solution (PFA/PBS, pH 7.4) at the same flow rate (0.02L/min) for 10 minutes. The brains 
were extracted and post-fixed on a rotator at 4°C for 2 hours with 1% PFA/PBS (for 
immunohistochemistry) or overnight with 4% PFA/PBS (for Nissl), followed by cryo-
protection in 30% sucrose in PB overnight and then frozen on dry ice for further use 
(Moller et al., 1996). For extracting facial nerve four days after facial nerve crush, the 
animals were perfused with 5 minutes of PBS at 0.02L/min followed by 10 minutes with 4% 
PFA/PBS at 0.02 L/min and 45 minutes with 1% PFA/PBS at 0.01L/min. Brains were 
extracted and placed in 30% sucrose overnight as before. The facial nerves were 
extracted and frozen immediately in flat chambers containing O.C.T (Tissue Tek, 
Netherlands) on dry ice. 
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Cryostat sectioning 
Facial Motor Nucleus 
Frozen hindbrain was fixed on a cryostat chuck using an O.C.T. compound (Tissue Tek, 
Netherlands). The chuck, housed in the cryostat (Leica CM 1900, Germany) was set to a 
temperature of -15°C while the ambient chamber temperature was set to -20°C. In the 
brainstem, 40 transverse sections of 20 µm thickness were collected, taken through the 
level of the facial motor nucleus, to incorporate both ipsilateral and contralateral facial 
nuclei in their entirety. For immunohistochemistry, 20µm sections were taken, unless 
where otherwise stated. The sections were collected on 0.5% gelatin-coated slides (Merck, 
UK), refrozen on dry ice and stored at -80°C.  
Facial Nerve 
Frozen nerve was fixed on a cryostat chuck using an O.C.T. compound (Tissue Tek, 
Netherlands). The chuck, housed in the cryostat (Leica, Germany) was set to a 
temperature of -15°C while the ambient chamber temperature was set to -20°C. 15-20 mm 
long pieces of facial nerves were sectioned longitudinally at 10µm.The sections were 
collected on 0.5% gelatin-coated slides (Merck, UK), refrozen on dry ice and stored at -
80°C 
Light microscopic immunohistochemistry 
Facial nucleus and facial nerve sections were retrieved from -80°C, rehydrated in distilled 
water and spread onto the slide using fine brushes. The sections were dried for 10-15 
minutes, circled with a PAP pen (DAKO, Cambridgeshire), and then fixed for 5 minutes in 
4% formaldehyde, followed by wash in 0.1M phosphate buffer (PB).  Antigen retrieval was 
done by immersing the slides for 2 min each in 50% acetone/H2O, 100% acetone, 50% 
acetone/H2O, followed by washing twice in PB, and once in PB/0.1% bovine serum 
albumin (PB/BSA)  (BSA; Sigma, UK). The sections were then blocked for 30 minutes in 
PB/5% goat or other serum, to match the source of the final, secondary or tertiary antibody 
(Vector, UK). These pre-incubated sections were incubated overnight at 4°C with the 
primary antibody at dilutions determined previously through titrations.  The sections are 
then incubated for 1 hour at room temperature with appropriate biotinylated secondary 
antibody. Source and dilution of all antibodies used are listed in Table 2.3.  
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Antigen Antibody Dilution Source 
  Primary     
αM (CD11b) 5C6, RtM 1:5000 Serotec, UK 
ATF3 (C-19) RbP 1:400 Santacruz Biotechnology 
αX HmP 1:400 Chemicon, UK 
β1 RtM 1:3000 Chemicon, UK 
β 7.2 RtM 1:1600 Pharmigen, UK 
CD3 RtM 1:400 Pharmigen, UK 
CD44 MAB 2137 RtM 1:400 Chemicon, UK 
CGRP RbP FMNu 1:5000 
FNe 5000 
Bachem, UK 
c-JUN (H-79) RbP (FITC-cj) 1:200 Santacruz Biotechnolgy 
eGFP RbP 1:500 Millipore, CA 
Galanin RbP FMNu 1:2000 
FNe1:5000 
Bachem, UK 
GFAP RbP 1:6000 Vector, UK 
p-STAT3 RbM 1:1000 Abcam, UK 
  Secondary     
Rabbit Ig Biot. α-Rb Ig, GtP 1:100 Vector, UK 
Rat Ig Biot. α-Rt Ig, GtP 1:100 Vector, UK 
Hamster Ig Biot. α-Hm Ig, GtP 1:100 Vector, UK 
 
Table 2.3 Summary of antibodies used. Abbreviations. FMNu – facial motor nucleus, FNe- facial nerve 
Antigens: ATF3- Activating Transcription Factor 3, CGRP - Calcitonin Gene-Related Peptide, GFAP – Glial 
Fibrillary Acidic Protein, p-STAT3 – phospho- Signal Transducer and Activator of Transcription, Ig – 
Immunoglobulin, Antibodies: RtM - rat monoclonal, RbP - rabbit polyclonal, HmP – hamster polyclonal, 
RbM – rabbit monoclonal, FITC-cj – fluorescein isothiocyanate conjugated, GtP – goat polyclonal.  
All incubations with primary and secondary antibodies were carried out in PB/BSA, and 
finished by washing in 3 changes of PB/BSA. Exposure to the biotinylated secondary 
antibody was followed by 1 hour incubation with the Avidin-Biotinylated horse radish 
peroxidase Complex (1:100) (ABC, Vector, Wiesbaden, Germany) and visualized with 
diaminobenzidine (DAB; Sigma, UK) and hydrogen peroxide (H2O2). The reaction mixture 
consisted of 0.5 g/l DAB, 1:3000 dilution of 30% H2O2 in 10mM PB, pH 7.4, and the 
sections were allowed to react for 3 - 5 minutes at room temperature. The αX, B 7.2 and 
CD3-immunoreactivity was enhanced with addition of Co/Ni to the DAB mixture. The DAB 
reaction was monitored under a light microscope and stopped by washing the sections in 
10mM PB followed by distilled water. Sections were subsequently dehydrated by 
immersion in increasing concentration of ethanols and isopropanol, and then immersed 
thrice in xylene before being mounted on a glass cover slip with Depex (BDH, UK).  
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Quantification of light-microscopic Immunohistochemistry 
A Sony 3CCD colour video camera (AVT-Horn, Aachen, Germany) was used to obtain 8-
bit digital images of the antibody stained sections. Images of both control and axotomised 
nuclei and for the glass were captured at x10 magnification, using Optimas 6.2 software 
(Bothwell, WA). Captured images were run against an algorithm to obtain mean and 
standard deviation values for optical luminosity. Standard deviation was subtracted from 
the mean for each image and the resulting values for axotomised and control sides were 
each subtracted from that of the mean optical luminosity of the empty glass slide, to obtain 
specific optical luminosity values (OLV) for each facial nucleus, on both the control and 
axotomised sides.  
Cresyl violet (Nissl) staining  
Tissue sections (20μm) of the facial motor nucleus were rehydrated in ddH2O, spread, 
and allowed to dry completely. They were fixed in 4% formaldehyde (BDH, UK) overnight 
followed by 70% ethanol overnight. 1% cresyl violet or Nissl solution was made by mixing 
4g cresyl violet powder (BDH, UK) in 40mL 100% Ethanol, shaking and inverting for 15 
minutes, then adding this mixture to 360mL warm ddH2O and filtering using Whatman size 
4 filter paper. The slides were immersed in this 1% Nissl solution for 6-8 minutes. Excess 
cresyl violet was removed by washing in water and in increasing concentrations of ethanol 
(70%, 90%, 95%). This was followed by a de-staining step in 95% ethanol containing 10 
drops of glacial acetic acid; the reaction being monitored under a light microscope. The 
de-staining was stopped by transferring the sections to 100% ethanol, isopropanol, and 
the slides immersed in xylene thrice, prior to being cover slipped using Depex (BDH, UK).  
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Figure 2.3. A 20μm Nissl-stained coronal brainstem section, showing the unaxotomised/control (co) and 
axotomised (ax) facial nuclei. The two nuclei are distinguished from each other by a puncture hole made in 
control side (shown in dotted lines, above the control nucleus). The insets show the two facial nuclei under 
higher (10X) magnification. Note the chromatolytic neurons on the axotomised side. 
 
Neuronal cell counts  
Motoneuron cell counts were determined in the axotomised and unaxotomised facial 
nuclei 30 and 90 days after a facial nerve cut, and 10 and 30 days after facial nerve crush. 
Using Nissl-stained 20 µm sections (example Figure 2.3), all the neuronal profiles 
throughout the entire nucleus were counted and corrected for cell size using the 
Abercrombie Correction coefficient (Abercrombie, 1946), according to the formula:  
N = n x [D/(D + d)],  
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Where N = the corrected neuronal number; n= the counted number of neurons; D = the 
section thickness (20um) and d = the mean neuronal diameter, calculated from the cell 
size. Neuronal cell size was determined from digital images of the stained sections 
obtained using a Sony 3 CCD video camera and Optimas 6.2 software. The mean 
diameter (d) was calculated from the mean area (Area), assuming a near spherical form, 
with the formula: d = √(4 x Area/π)  
 
Speed of facial axonal regeneration 
 Four days after facial nerve crush, the facial nerve was fixed in-situ by a long perfusion 
followed by immediate dissection and freezing on dry ice, as described earlier. Nerves 
were cut longitudinally at 10μm thickness, and the regenerating axons were visualized by 
immunostaining for galanin or CGRP immunopositive growth cones. Every fifth section 
was used per antibody, and the distance between the most distal galanin or CGRP+ 
growth cone and the crush site measured using a Leica microscope with an attached 
vernier device (Figure 2.4). The distance travelled by the fastest growing axon was 
calculated using the following formula:  
d = √(X2-X1)
2+(Y2-Y1)
2 
Where d = distance between crush site and fastest growth cone; X1, Y1 = co-ordinates of 
the injury site; X2, Y2 = co-ordinates of the most distal immuno-labelled growth cone. 
 
Figure 2.4. Speed of facial nerve regeneration as determined by the distance travelled by fastest axon 
sprout from the crush side. A longitudinal 10μm CGRP-stained facial nerve section, showing the crush site 
(identified by swelling of the nerve and concentration of granulocytes), and the furthest CGRP+ sprout. The 
distance travelled by the fastest growing axon is calculated using the formula shown above,  where  (X1, Y1) 
are co-ordinates of the injury site and (X2, Y2), the co-ordinates of the most distal immuno-labelled growth 
cone. 
In cases where the nerve was interrupted or crooked, individual line lengths were 
determined using the formula above and added or subtracted as appropriate to determine 
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total length. The average distance for each animal was calculated from four or five tissue 
sections (Werner et al., 2000). 
 
Assessment of functional recovery  
Functional recovery was assessed by scoring the post-traumatic whisker hair motor 
performance after facial nerve injury. The movement was scored by a blinded observer on 
every alternate day, starting from seven days after facial axotomy till the end of 28 days 
(or 8 days for short-term studies and 88 days for long-term studies) when retrograde 
labelling with Fluorogold is carried out. The whisker hair movement (WHM) is scored 
between 0 - 3 with 0.5-step intervals; the lack of movement in the ipsilateral vibrissae was 
assigned a score of 0, the presence of asymmetric, fibrillation-related movement of the 
vibrissae received a score of 0.5, 1 was given for mild vibrissae sweeping, 2 for 
moderately good sweep, and 3 for completely normal movement as on the unoperated 
side.  For each individual animal, WHM recovery index was calculated using the linearly 
interpolating area under the curve (AUC) function on the time course of assessment. 
 
Quantification of re-innervation 
Anatomical re-innervation of the whisker pad was determined by retrograde labelling. 
Quantification of retrograde labelling of facial motoneurons with FG or MR or both was 
done on every fifth section of the facial nucleus under a fluorescent microscope (Nikon 
Eclipse E600). FG positive cells were counted in the facial motor nucleus at 450-490 nm 
wavelength (UV light) using both 64x and 16x filters to enable counting of only strongly FG 
positive neurons. MR positive cells in each facial nucleus were counted at 510-560 nm 
wavelength (red light) and the number of double labelled cells (FG & MR positive) were 
also determined. The overall ratio of labelled neurons in the operated/unoperated side was 
calculated for each animal. Survival adjusted re-innervation (SAR) was calculated by 
dividing re-innervation ratio (FG ax/co%) by the percentage of  surviving motoneurons 
(Nissl counts ax/co%). 
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Statistical testing 
The mean ± standard error of mean (SEM) was recorded for all data. When only two 
groups were present, statistical analysis for axonal regeneration distance, functional 
recovery analysis, neuronal cell counts, and immunohistochemical staining intensities 
between mutant mice and control groups, and between the uninjured and injured sides, 
was performed using a standard two-tailed, unpaired Student’s t-test. When more than two 
groups were present, statistical analysis was done using one-way ANOVA followed by 
post-hoc Tukey test. When multiple comparisons of data were made, for example, in the 
behavioural experiments where animals were repeatedly assessed over time, repeated 
test ANOVA was done. For all statistical analyses, p < 5% was considered to represent a 
significant difference between groups. 
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Chapter 3 – STAT3 Results 
Neuronal STAT3, but not Schwann cell STAT3, is essential for 
successful nerve regeneration after facial nerve cut and crush 
injuries 
 
STAT3, a member of the Signal Transducer and Activator of Transcription family of 
transcription factors, is rapidly activated following nerve injury and retrogradely transported 
into the nucleus (Lee et al., 2004;Ben-Yaakov et al., 2012) where it induces transcription 
of downstream effector genes. Rapid and prolonged STAT3 phosphorylation following 
injury is a reliable event following peripheral nerve injury, and has been shown in both 
sensory and motor neurons (Haas et al., 1999;Schweizer et al., 2002;Bareyre et al., 2011). 
Upstream of STAT3 activation, various neurotrophic factors such as CNTF, LIF and IL6, 
have been shown to mediate their neuro-protective effects predominantly via JAK/STAT 
kinase pathways (Stahl et al., 1995). Schweizer and colleagues have previously reported 
a role of STAT3 in promoting cell survival after facial axotomy (Schweizer et al., 2002). 
Sun et al., demonstrated a role for STAT3 in regeneration of retinal ganglion cells after 
optic nerve crush (Sun et al., 2011). Another study by Bareyre et al, has shown an 
important but transient role of STAT3 in triggering regeneration of superior cervical 
ganglion cells after saphenous nerve axotomy (Bareyre et al., 2011). Since global 
deletions of STAT3 are embryonic lethal, neuron-selective or Schwann-cell selective 
deletions of STAT3 have been used here to investigate its role in cell survival, target re-
innervation, functional recovery, and speed of axonal regeneration following axotomy of 
the facial motor nerve. By analysing these indices of regeneration at shorter (10 and 30 
days after FNA) and longer periods (90 days after FNA), and after mild (crush) and severe 
(cut) injuries, we have attempted to paint an unequivocal picture of the role of STAT3 in 
peripheral nerve regeneration. This chapter also looks at the expression of various 
neuronal regeneration-associated genes by the axotomised cell bodies, as well the 
expression of non-neuronal molecules assisting in the regenerative effort, to identify direct 
functional downstream targets of STAT3.  
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Generation of mutant mice lacking neuronal STAT3  
Neuron specific STAT3 gene deletion was achieved by crossing mice with floxed STAT3 
alleles (STAT3F/F) with animals expressing cre recombinase under the control of the 
synapsin promoter (syn::cre), which targets the STAT3ΔS recombination specifically to 
neurons (Chapter 2 – Figure 2.1) (Kugler et al., 2001;Zhu et al., 2001). The neuronal 
deletion of STAT3 was confirmed by PCR and immunohistochemistry. While both the 
STAT3ΔS mutants and the STAT3F/F controls showed a single 300 bp band for the two 
flowed STAT3 alleles, only the STAT3ΔS mutants gave a positive band for ‘cre’ (Figure 
3.1). Further, homozygous STAT3ΔS recombination was associated with disappearance 
of STAT3 immunoreactivity in the injured facial motor nucleus (Figure 3.2B).  
 
 
Figure 3.1 - Generation of STAT3ΔS and STAT3 F/F mice. Neuron-specific STAT3 deletion was achieved 
using synapsin::cre deletion of floxed STAT3 (STAT3ΔS). Agarose gel electrophoresis of products from PCR 
reactions to detect STAT3 floxed/wild-type allele at 300 bp (A) and cre recombinase allele at 750 bp (B). 
While both STAT3ΔS mutants and STAT3 F/F controls expressed homozygous floxed STAT3 alleles (A), 
only the STAT3ΔS mutants showed a band for cre (B). 
 
STAT3 is induced following facial nerve axotomy 
Following nerve axotomy, there is an upregulation and translocation of p-STAT3 from the 
cytoplasm into the nucleus of the injured motoneurons. A time-course of p-STAT3 
expression shows that p-STAT3 expression is induced immediately following injury, and 
activation is sustained for up to 7 days. No expression is seen after 7 days and in the 
control, uninjured side (Figure 3.2A). Upregulation of activated STAT3 and its nuclear 
translocation following facial axotomy was completely abolished in the STAT3ΔS mutants 
(Figure 3.2B).   
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Figure 3.2. A. Time-course of phospho-STAT3 expression following axotomy. p-STAT3 expression is 
induced immediately following injury, and activation is sustained for up to 7 days. No expression is seen after 
7 days and in the control, uninjured side. B. Synapsin::cre deletion of floxed STAT3 (STAT3ΔS) removes p-
STAT3 immunoreactivity following facial nerve cut. Phospho-STAT3 immunoreactivity in the facial nucleus in 
STAT3 F/F
  
(left panel) and STAT3ΔS mice (right panel) on the uninjured (co) and injured side (ax), 4 days 
after facial nerve cut shows that STAT3 is activated and translocated to the nucleus after facial axotomy in 
STAT3 F/F mice but not in STAT3ΔS mice.    
 
Deletion of neuronal STAT3 interferes with axonal regeneration 
Effects on axonal regeneration after facial nerve axotomy at the stylomastoid foramen 
were assessed by measuring the extent of functional recovery, re-innervation of peripheral 
target, and speed of axonal elongation in the early phase of nerve regeneration. 
Regeneration and functional recovery was dramatically reduced in the STAT3ΔS mutants 
compared to their littermate controls. 
Functional recovery 
Functional recovery after facial nerve cut was assessed by scoring post-traumatic whisker 
hair movement from 0 (no movement) to 3 (strong, normal movement). As shown in Figure 
3.3 A, STAT3F/F animals commenced recovery of whisker vibrissae at 13 days and 
improved steadily over the next 2.5 weeks to day 28, reaching a maximum score of 2.4± 
0.1. Recovery in homozygous STAT3ΔS mutants was significantly delayed; first noticed at 
day 15, it then improved with a considerably flatter trajectory, reaching a maximum score 
of 0.8± 0.1 by day 28. These differences were mirrored by changes in the regeneration 
index, calculated as Area Under the Curve (AUC) for the functional recovery over days 0-
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28 (Figure 3.3B); with an index of 0.97±0.02 for the STAT3 F/F (n=5) and 0.32±0.07 for 
the STAT3ΔS mutants (n=5, p<0.01%). 
To investigate whether the effect of STAT3 deletion led to a final severe defect in 
recovery, a second experiment was performed; this time the STAT3ΔS and STAT3 F/F 
animals were allowed to survive and their whisker hair movement assessed for a period of 
90 days after facial axotomy. Overall the STAT3ΔS mutants still showed a significantly 
slower recovery compared to the STAT3 F/F controls till day 54 (Figure 3.3C). Thereafter, 
recovery of the mutants accelerated, and by day 61, the STAT3ΔS mutants had achieved 
levels of whisker function similar to that of their littermate controls. The STAT3ΔS mutants 
then followed closely parallel trajectories of functional recovery till day 90, albeit being 
slightly lower than the controls, but insignificantly so. The regenerative index for the 
mutants was still lower than the controls, but this difference was no longer significant 
(Figure 3.3D). This suggests that while STAT3 is not absolutely essential for functional 
recovery, its absence significantly delays the regenerative process. 
Regeneration following nerve transection is a complicated process and requires the 
formation of a cellular bridge to allow crossing over of the proximal fibres to the distal 
stump (Zhang and Yannas, 2005). In contrast, anatomical and functional regeneration is 
often better after crush injuries since the basal lamina scaffolds for the regenerating 
growth cones remain intact after nerve crush. To investigate whether the delay in 
achievement of function after facial nerve cut was a result of the STAT3 deficient axons 
being unable to form a cellular bridge between the proximal and distal stumps, facial nerve 
crush was performed, and functional recovery assessed as before by scoring post-
traumatic whisker hair movement from 0 (no movement) to 3 (strong, normal movement). 
While the STAT3 F/F animals started recovering motor function within 9 days after injury 
and improved steadily, already reaching a maximum score of 3.0 by day 19, recovery in 
homozygous STAT3ΔS mutants was significantly lower (Figure 3.3E). It was first noticed 
around day 15, and showed an extremely sluggish improvement to a final score of 1.3± 
0.2 by day 28 (figure 3.3.E). In terms of the overall Area under the Curve, STAT3ΔS 
mutants (0.85±0.06) had a 58% lower regenerative index (p<0.01%) compared with the 
STAT3F/F mice (2.04±0.03) (Figure 3.3.F). 
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Figure 3.3 – STAT3 is required for successful functional recovery after facial nerve cut and crush injuries. 
Time course (A,C, E) for functional recovery of whisker hair movement on a scale from 0 (no movement) to 3 
(full movement, equivalent to uninjured side) and the recovery index (B,D,F) calculated as Area Under The 
Curve (AUC) show a pronounced reduction and delay in functional recovery in STAT3ΔS mice (n=5) 
compared to STAT3
 
F/F
 
mice (n=5) at 30 days post-nerve cut and crush injuries, and a delay in recovery by 
day 90 (n= 5 for both groups).*p< 5%, ** p<1%, *** p< 0.1%, **** p<0.01% in Repeated Test ANOVA and in 
unpaired Student’s T-Test (for AUC), bars and error bars show the mean and SEM, respectively.  
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Re-innervation of peripheral target 
Regrowth of the axotomised axons and reconnection of the facial nerve to the whisker pad 
allows functional recovery and is therefore a crucial goal of the regenerative response. To 
determine whether the observed defect in functional recovery in the STAT3ΔS mutants 
was due to lack of axonal re-innervation or due to reduced function of successfully re-
innervated axons, the re-innervation pattern was analysed in mutant and control groups 
after cut and crush injuries. 
To investigate the crucial time-point when the first regenerating fibres re-innervate the 
target muscle in the whisker pad after axotomy, 15 wild-type mice underwent facial nerve 
crush and then retrograde tracing with fluorescent tracers Fluorogold (FG) & MiniRuby 
(MR) at days 8, 18 and 28 after axotomy (n=5 for each time point). A gel foam insert 
soaked with FG was implanted for 30 minutes under both whisker pads; MR was injected 
into the eyelids (Figure 3.4.A). They were sacrificed at days 10, 20 and 30 respectively, 
and the number of FG and MR positive motoneurons in the contra- and ipsi-lateral facial 
nucleus quantified. The % (ax/co) of FG+, MR+ and double labelled neurons is shown in 
Figure 3.4.B. Quantification of MR+ neurons revealed an interesting pattern - the 
percentage of injured motoneurons positively labelled for MR reduced with increasing time 
after axotomy, suggesting that MR might be taken up more readily by freshly axotomised 
neurons, rather than by axons elongating in a later stage. Hence, the number of MR+ may 
not be an accurate indicator of all reconnected axons and therefore MR was no longer 
used in these experiments.  
The number of FG positive neurons showed a more linear increase - 10 days after 
axotomy, the wild-type animals showed about 55% re-innervation (%FG ax/co). By day 20, 
they achieved almost 90% re-innervation which did not improve upon significantly by the 
end of day 30. Therefore, day 10 and day 30 were chosen as a time-points to investigate 
the arrival of the first wave of re-innervating axons, and the completion of target re-
innervation respectively. 
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Figure 3.4 – Retrograde labelling with fluorescent tracers – Fluorogold (FG) and Miniruby (MR)         A. 
Schematic diagram showing the application of fluorescent retrograde tracers, MR (in green) to eyelid (EL) 
and FG (in red) to whisker pad (WP) of control mice at different time-points after crush and cut injuries. 
These tracers are subsequently quantified in the facial nucleus after 48 hours of retrograde transport. B. 
Time-course of re-innervation after crush injury, showing percentage re-innervation of whisker-pad (WP) and 
eyelid (EL) by FG and MR respectively at 10, 20 and 30 days after facial nerve crush. 
 
Analysis of re-innervation in the STAT3F/F and STAT3ΔS animals, 10 days after facial 
nerve crush, showed that STAT3F/F animals had 257±60 FG+ motoneurons on the 
uninjured side and 181±60 on the injured side. Homozygous STAT3ΔS mutants also 
showed a similar number (276±22) on the control side, but there was a drastic reduction 
on the axotomised side, with just 58±14 FG+ motoneurons (Figure 3.5.E). In relative terms 
(as a percentage of contralateral side), STAT3F/F animals showed retrograde labelling of 
72±23%, and STAT3ΔS mutants an almost 3-fold decrease with 21±5% (Figure 3.5.F; 
p<5%). By 30 days after crush injury, while the control group had achieved 78±6% re-
innervation, the mutant group still showed only 24±3% FG+ neurons (% ax/co), a very mild 
increase since the d10 quantification (Figure 3.5. G, H; p<0.01%). 
Nerve crush injury, allows re-innervation to take place as early as 2 weeks after the injury 
(as shown above). In addition to the robust outgrowth of crushed peripheral axons, they 
have also been shown to accurately reconnect to their original peripheral targets (Nguyen 
et al., 2002;Fournier and Strittmatter, 2002). In contrast, complete nerve transection 
represents a more severe challenge, and the ensuing regeneration is generally not 
selective for appropriate targets (Miledi and Stefani, 1969), resulting in misguided and 
inaccurate target re-innervation (Gordon and Gordon, 2010;Valero-Cabre and Navarro, 
2002). To investigate an exacerbated regeneration defect after transection injury, FG was 
applied unilaterally into the right whisker pad 28 days after facial nerve cut, followed by 
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perfusion (after 48 hours), and cryo-sectioning at the level of the facial motor nuclei. 
Counting every 5th 20um section, STAT3 F/F animals showed retrograde labelling of 
62±7% neurons, and the STAT3ΔS mutants an almost 4-fold decrease with 17±4% 
(Figure 3.5.A,B; p<0.01%), exceeding the defect in functional recovery. As expected, both 
the control and mutant groups showed greater reduction re-innervation after facial nerve 
cut (62% and 17% respectively) than after facial nerve crush (78% and 24% respectively). 
However, the ratio of re-innervation in the mutants compared to controls remained 
unchanged between the two injury severities, suggesting that the re-innervation defect in 
the STAT3ΔS mutants is probably due to a lack of intrinsic regenerative ability arising from 
neuronal STAT3 deletion, rather than a problem in overcoming the cellular bridge between 
the proximal and distal stumps. 
Finally, in order to investigate whether this reduced re-innervation effect continued 
throughout the delayed regenerative response in the STAT3ΔS mutants, quantification of 
the retrograde tracer was done in mutant and control animals 90 days following axotomy. 
Again, both STAT3ΔS and STAT3 F/F animals showed similar numbers of FG+ 
motoneurons on the uninjured side. However, while STAT3 F/F animals showed 
retrograde labelling of 87±3% (ax/co %) motoneurons, the STAT3ΔS mutants still showed 
only approximately half the level of re-innervation with 45± 2% FG+ cells (ax/co %) (Figure 
3.5 C,D; p<0.01%). Altogether, these results suggest that neuronal STAT3 is 
indispensable for target re-innervation after both crush and cut injuries, but not for 
functional recovery, following axotomy. 
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Figure 3.5 - STAT3ΔS mice show impaired peripheral target (whisker pad) re-innervation after facial nerve 
crush and cut. Whisker pad re-innervation was determined by counting retrogradely labelled Fluorogold-
fluorescing facial motoneurons (FG+) at 30, and 90 days after facial nerve cut (A,C) and 10, and 30 days 
after nerve crush (E,G) in STAT3 F/F controls and STAT3ΔS mutants. Axotomised (ax)/control (co) side ratio 
– percentage re-innervation – for the FG+ motoneurons are displayed alongside (B, D, F, H). A, B. 
STAT3ΔS mutants (n=7) show almost 75% reduction in whisker pad re-innervation compared to STAT3
 
F/F
 
controls (n=7) at 30 days after facial nerve cut. C, D. Even 90 days after facial nerve cut, neuronal deletion 
of STAT3 is associated with a 50% decrease in whisker-pad re-innervation. E, F, G, H. There is also a sharp 
70 % decrease in the number of labelled neurons on the axotomised side in mutant STAT3ΔS compared 
with control animals at 10 and 30 days after nerve crush. *p< 5%, ** p<1%, *** p< 0.1%, **** p<0.01% in 
unpaired Student’s T-Test, bars and error bars show the mean and SEM respectively.  
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Speed of axonal elongation 
 
 
Figure 3.6 – Speed of regeneration and neurite elongation depends on the presence of neuronal STAT3. A. 
The crush site (shown with a dashed line) is characterised by swelling and accumulation of granulocytes, as 
well as a break in the myelin sheaths observed under UV light. Speed of regeneration was assessed by 
measuring the distance (in mm) of longitudinal outgrowth of fastest CGRP- and Galanin-immunoreactive 
axons from the crush site, 4 days after facial nerve injury. Black arrows are pointing to CGRP+ sprouts. B. 
STAT3ΔS deletion (n=4) caused a 40% decrease in outgrowth of CGRP+ neurites and 80% decrease of 
galanin+ neurites. STAT3 F/F mice showed very similar outgrowth distances for the CGRP- and Galanin-
immunoreactive axons. **p<1% in unpaired Students’s T-test. Bars and error bars show mean and SEM 
respectively. 
Speed of early outgrowth of nerve fibres was examined using the facial nerve crush 
paradigm, four days after injury. Unlike nerve ‘cut’, where regeneration depends on the 
formation of a cellular bridge between the proximal and distal nerve stumps, in crush 
injury, the basal lamina scaffolds remain intact, providing a channelled pathway for the 
regenerating axons. The growth front of the regenerating motor neurites was quantified in 
longitudinally cut, fixed, 10um thick facial nerve sections using immunoreactivity for the 
CGRP and galanin neuropeptides (Figure 3.6A). As shown in Figure 3.6 B, in the STAT3 
F/F control animals axonal growth front advanced to 7.1±0.3mm for CGRP- and to 
7.3±0.5mm for the galanin-positive axons at the end of 4 days. In STAT3ΔS mutants, this 
axonal elongation was reduced by more than 40% for CGRP positive growth cones, with 
the fastest neurites reaching a distance of 4.2±0.5 mm from the crush site (p<1%). 
Galanin positive growth cones regenerated to a maximum distance of 1.9±0.8 mm, a 
reduction of nearly 80% compared to their control counterparts (p<1%). However, galanin 
immunoreactivity was significantly reduced in the mutants, making it somewhat unreliable 
in assessing speed of elongation. 
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Neuronal STAT3 deletion abolishes neuronal cell loss after axotomy but 
affected motoneurons show atrophic phenotype 
Following axotomy, about 20-40% of lesioned motor neurons die within 30 days after 
injury, possibly due to lack of trophic support from the de-innervated target (Ferri et al., 
1998;Raivich et al., 2002). Figure 3.7A shows the effects of neuron-specific deletion of 
STAT3 on the Nissl stained sections of control and axotomised facial motor nuclei. All 
neuronal profiles were counted through the whole facial motor nucleus on the operated 
and controls sides and the number corrected using the Abercrombie correction coefficient 
(Abercrombie, 1946).   
After axotomy, STAT3F/F control animals showed a pronounced loss of neurons, an effect 
lost in the STAT3ΔS mutants. Counting motoneuron profiles on the uninjured and injured 
side throughout the facial motor nucleus revealed a 27±4% loss in STAT3F/F controls, 
compared with -9±7% in the STAT3ΔS mutants at 30 days after nerve cut (Figure 3.7 B; 
p<0.1%). However, most of the surviving axotomised STAT3ΔS motoneurons appeared 
shrunken by almost 50%, showing a dramatic reduction in cellular diameter from 19.5±0.9 
to 11.2+/-0.8um (Figure 3.7C; p<0.01%). The opposite effect was observed in their control 
counterparts which underwent chromatolytic enlargement by 15% from 19.2±0.5 um for 
the uninjured to 22.1+/-0.8um for injured motoneurons (Figure 3.7C). A similar trend for 
neuronal survival was seen at day 90 and the surviving neurons continued to be in an 
atrophic state (Figure 3.7 B,C).  
Investigation of motoneuron survival after crush injury also revealed a similar pattern as 
before. At day 10 post axotomy, STAT3F/F controls showed 18±2% motoneuron loss 
compared with -6±3% in the STAT3ΔS mutants (Figure 3.7B; p<0.1%). After 30 days, 
STAT3F/F controls showed 18±5% cell death compared with 8±2% in the STAT3ΔS 
mutants (Figure 3.7B). At both time-points, axotomised neurons in the STAT3ΔS mutants 
appeared shrunken by approximately 20%, which was less than the shrinkage seen after 
nerve transection (Figure 3.7C). 
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Figure 3.7 – Deletion of neuronal STAT3 prevents motoneuron death following axotomy but induces 
neuronal atrophy. A. Nissl-stained coronal sections of facial motoneurons on the contralateral (co) and 
axotomised (ax) side, and at higher 25 X magnification of ax side in STAT3 F/F
 
(n =7) and STAT3ΔS (n = 7) 
mice, 30 days after unilateral facial nerve cut. B. Total motoneuron count, corrected for neuronal size, 
showed a significant increase in neuronal survival after axotomy in the absence of STAT3 after d10 crush 
and d30 cut. C. Percentage change (ax/co%) in neuronal diameter measurements (in μm) showed a mild 
chromatolytic increase in neuronal size in STAT3 F/F controls, but a significant shrinkage of STAT3ΔS 
neurons after axotomy. ** p<1%, *** p< 0.1%, **** p<0.01% in unpaired Student’s T-Test, bars and error 
bars show the mean and SEM respectively.  
 
Survival adjusted re-innervation 
To investigate whether alterations in motoneuron survival contributed to the observed 
reduction in re-innervation and functional recovery, survival adjusted re-innervation (SAR) 
was calculated by dividing re-innervation (FG %ax/co) by cell survival (Nissl %ax/co). 
Figure 3.8 shows a comparison of the survival adjusted regenerative abilities between 
STAT3 F/F controls and STAT3ΔS mutants at 10 and 30 days after crush, and 30 and 90 
days after cut. At day 10 after crush, while the controls showed 89% SAR, the mutants 
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showed a 4-fold reduction with 20% SAR (p<5%). At day 30 after crush, while the controls 
had 95% SAR, the mutants showed 26% SAR (p<0.01%). The effect was even more 
dramatic at 30 days after nerve cut, with the control group demonstrating 85% SAR, and 
the mutant group only 16% SAR (p<0.01%). By day 90 after crush, even though the 
mutant group showed an increase in their SAR to 68%, it was still significantly lower than 
their control counterparts who exhibited 116% SAR (p<1%). This data suggests an 
inherent defect in the ability of the STAT3ΔS mutants to regenerate which is independent 
of their effects on cell survival. 
 
 
 
 
Figure 3.8 – Deletion of neuronal STAT3 causes a massive reduction in survival adjusted re-innervation 
after nerve cut and crush injuries. Nearly 80% reduction in SAR was seen at d10 after crush, almost 75% 
reduction at d30 after crush, 82% reduction at d30 after cut, and 40% reduction at d90 after cut.  * p<5%, ** 
p<1%, **** p<0.01% in unpaired Student’s T-Test, bars and error bars show the mean and SEM respectively.  
 
Neuronal molecular response to injury requires neuronal STAT3 
Following neuronal injury, numerous morphological changes occur in the neuronal 
perikaryon, cumulatively known as ‘chromatolysis’, enabling the injured neuron to switch 
from a ‘transmitting’ mode to a ‘growth’ mode (Lieberman, 1971). The ensuing 
regeneration programme comprises of changes in transcription factors, adhesion 
molecules, neuropeptides and growth factor signalling, and an increase in nutrient 
transport, metabolism and cytoskeletal protein synthesis (Makwana and Raivich, 2005). 
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Nerve injury induces the activation and nuclear translocation of transcription factors like c-
jun and ATF3 (Lindwall and Kanje, 2005;Raivich et al., 2004;Werner et al., 2000b). 
Neuronal deletion of STAT3 completely blocks the nuclear translocation of ATF3 (Figure 
3.9 (a) E-H, (b) D-F; p<0.1%). On the other hand, the induction of c-jun and its 
translocation to the nucleus was unaffected, quite interestingly so, by the lack of STAT3 
(Figure 3.9 (a) A-D, (b) A-C). 
Increased levels of neuropeptides, CGRP and galanin, in the facial nucleus have 
previously been associated with an enhanced sprouting and regenerative response 
(Arvidsson et al., 1990;Kerr et al., 2001;Streit et al., 1989). Axotomy of the facial nerve 
causes an increase in the immunoreactivity for CGRP and Galanin of STAT3 F/F at day 
14 (Figure 3.9 (a) I-J, M-N). This effect is almost abolished in the STAT3ΔS mutants 
(Figure 3.9 (a) K-L, O-P). Quantitation of CGRP/Galanin positive sprouts in the facial 
nucleus show a significant decrease of both neuropeptides (Galanin+ sprouts are reduced 
from 112±27 to 13±3; CGRP+ sprouts from 62±17 to 3±0.9) in the mutants compared with 
controls (Figure 3.9 (b) J, K; p<1%). 
Facial nerve axotomy in the STAT3 F/F control animals also causes an increase in the 
immunoreactivity for the adhesion molecule CD44 (Figure 3.9 (a) Q-R). This axotomy 
induced change is almost completely abolished in STAT3ΔS mice (Figure 3.9 (a) S-T). 
Direct quantification of immunoreactivity (IR) by luminosity revealed a significant decrease 
by 90% (p<0.01%) in the amount of CD44-IR on the axotomised side in the STAT3ΔS 
mutants compared with STAT3 F/F controls. This effect was seen consistently at all three 
time-points – day 1, day 4 and day 14 after axotomy (Figure 3.9 (b) G-I). 
Similarly, upregulation of β1 integrin has been associated with peripheral nerve injury and 
regeneration (Kloss et al., 1999;Werner et al., 2000b).  A significant difference was 
observed between mutant and control groups, the mutants having 76% less β1 immuno-
reactivity compared to the controls (p<5%) (Figure 3.9 (a) U-X, (b) L).   
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Figure 3.9 (a) – Neuronal axotomy response depends on the presence of STAT3. A-X:  Facial nucleus axotomy 
response 14 days after nerve cut in the STAT3 F/F controls (A,B,E,F,I,J,M,N,Q,R, U,V) and the STAT3ΔS mutant 
(C,D,G,H,K,L,O,P,S,T, W, X) mice on the contralateral side (co) (1st and 3
rd
 column), and on the axotomised side 
(ax) (2
nd
 and 4
th
 column). After axotomy, STAT3 F/F mice show a prominent increase in transcription factors c-jun 
(A-B) and ATF3 (E-F), neuropeptides CGRP (I-J) and Galanin (M-N)  and adhesion molecules CD44 (Q-R) and 
beta1-integrin subunit (U-V); most of these changes are  significantly reduced or abolished in the STAT3ΔS 
mutants, except for the activation of transcription factor c-jun, where STAT3 deletion has only a mild effect on its 
injury induced up-regulation (D). 
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Figure 3.9 (b) – Neuronal axotomy response depends on the presence of STAT3. A-L. Quantification of 
overall facial motor nucleus immunoreactivity by manual counts or OLV units at 1 (d1), 4 (d4) and at 14 
days (d 14) after nerve cut for c-jun (A-C), ATF3 (D-F), CD44 (G-I), CGRP (J), Galanin (K), and β-1 
integrin (L) in STAT3 F/F (n=5) and STAT3ΔS mice (n=5). The contralateral (co) and axotomised (ax) 
sides are indicated by blue and red bars respectively. All biochemical markers, except for c-jun, showed a 
significantly smaller increase in the STAT3ΔS mutants compared to STAT3 F/F
 
controls. *p<5%, ** p<1%, 
***p<0.1%, **** p<0.01% in unpaired Student’s T-Test, bars and error bars show the mean and SEM 
respectively. 
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Non-neuronal responses like glial activation & immune recruitment 
require neuronal STAT3 
Nerve transection not only triggers changes in the neuron but also results in activation of 
neighbouring non-neuronal cells, causing inflammatory changes at the level of the affected 
motor nucleus, associated with activation of microglia and astrocytes, as well as leukocyte 
recruitment (Graeber et al., 1989;Kalla et al., 2001;Raivich et al., 1991a;Raivich et al., 
1996;Schwaiger et al., 1998;Raivich et al., 1998). These changes become particularly 
pronounced at day 14, which is a time-point corresponding with the peak in neuronal cell 
death, microglial phagocytosis and the influx of CD3+ T-cells (Raivich et al., 1998). 
Microglia, undergo a number of changes in response to neuronal injury, from resting 
microglia (Stage 0) to state of alert (Stage 1) to homing and adhesion (Stage 2) and finally 
phagocytosis in the presence of neuronal cell death (Stage 3a) and bystander activation of 
surrounding non-phagocytic microglia (Stage 3b) (Raivich et al., 1999a). Each of these 
changes can be characterised immuno-histochemically by using antibodies against 
specific activation markers. Neuronal STAT3 deletion caused a substantial reduction in αM 
staining which serves as an early and mid-phase activation marker that normally increases 
after injury, as seen in the STAT3 F/F controls (Figure 3.10 (a) A-B). Quantification of the 
immune-labelling by optical luminosity values showed a significant, approximately 80% 
reduction in injury-induced αM integrin expression at day 1 and day 4 (Figure 3.10 (a) C-D 
(b) A,B; p<1%), and an almost 90% decrease at day 14 (Figure 3.10 (b) C; p<0.1%) in the 
STAT3ΔS animals. The late phagocytosis-associated microglial markers, αX and B7.2, 
were examined 14 days after facial axotomy (Figure 3.10 (a) E-H, I-L). Quantification of αX 
and B7.2 immunoreactive nodules by manual counts,  showed a reduction of both markers 
in STAT3ΔS mice, with a complete abolition of αX immunoreactive nodules and reduction 
in B7.2 immunoreactivity by 92% compared with littermate controls (Figure 3.10 (b) D,E; 
p< 1%).  
Injury to the facial nerve also causes local astrocytes to become reactive, undergo 
hypertrophy and rapidly increase GFAP synthesis (Raivich et al., 1999a) . Therefore, 
astrocytic activation after injury was measured by GFAP immunoreactivity. Astrocyte 
activation was unaffected by deletion of STAT3 at day 1, 4 or 14 (Figure 3.10 (a) M-P, (b) 
G-I). 
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Figure 3.10 (a) - Neuronal STAT3 is required for the non-neuronal neuroinflammatory response after facial 
axotomy. A-T: Microglial (A-L) and astrocyte (M-P) activation, and T-cell influx (Q-T) 14 days after nerve cut 
in the STAT3 F/F controls (A,B,E,F,I,J,M,N,Q,R) and the STAT3ΔS mutant (C,D,G,H,K,L,O,P,S,T) mice on 
the contralateral side (co) (1st and 3
rd
 column), and on the axotomised side (ax) (2
nd
 and 4
th
 column). Early 
and late microglial activation was detected through immunoreactivity for αM, αX and B7.2 integrin subunits, 
astrocyte activation with GFAP, and T-cells with CD3. After axotomy, STAT3 F/F mice show a prominent 
increase all 3 components of the neuroinflammatory response. In STAT3ΔS mutants, while the microglial (D, 
H, L) and T-cell response (T) was completely abolished, the astroglial response (P) remained unaltered. 
  Chapter 3 – STAT3 Results  
100 
 
 
Figure 3.10 (b) Neuronal STAT3 is also required for the non-neuronal neuroinflammatory response after 
facial axotomy. A-I. Quantification of facial nucleus microglial and astrocyte activation at 1 (d1), 4 (d4) and at 
14 days (d 14) and CD3+ T-cell influx at 14 days (d14) after nerve cut. STAT3ΔS mice show a significant 
reduction on the axotomised side for microglial components at all three time-points (A-E) and for T-cell influx 
(F) at d14. However, no effect of STAT3 deletion was seen on astroglial activation at all time-points analysed 
(G, I). The contralateral (co) and axotomised (ax) sides are indicated by blue and red bars respectively. 
*p<5%, ** p<1%, ***p<0.1%, **** p<0.01% in unpaired Student’s T-Test, bars and error bars show the mean 
and SEM respectively. 
 
Finally, facial axotomy also leads to two different phases of T-lymphocyte entry into the 
injured facial nucleus. The first is a small increase in T-cell number, 1-4 days after injury; 
the second is a much stronger 100-fold increase with a peak at day 14 (Raivich et al., 
1999a). Infiltrating T-cells were detected using immunoreactivity for CD3 at day 14 (Figure 
3.10 (a) Q-T). As shown in Figure 3.10 (b) F, neuronal STAT3 deletion resulted in an 87% 
reduction in the number of CD3 positive cells (5±2) compared with WT littermates (40±7.5), 
(p<1%).  
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Virus-mediated STAT3 transfection of facial motoneurons 
All the above experiments utilised a STAT3 KO model to establish its crucial role in 
regulating all aspects of the facial nerve regenerative response, from biochemical and 
molecular response of the neuronal soma to the reconnection of growing axons to their 
target muscles, and the achievement of motor function. The neuronal STAT3 deficient 
mice showed extremely poor regeneration even at the end of 90 days after injury, and 
even after milder crush injuries which normally facilitate quick extension of axons along 
existing tracks to the correct targets. This prompted the next question – can the 
administration of constitutively active STAT3 to these mutants help in recovering the 
normal, fast regenerative phenotype seen in the controls. To this end, we chose two 
different approaches of administering STAT3 to the regenerating motoneurons. 
 
The first approach involved the use of a lentivirus expressing STAT3 and GFP, and direct 
injection into the facial nucleus. Trial injections with rhodamine were done to reproducibly 
establish the co-ordinates of the facial nucleus as 5.3 mm caudal and 1.25 mm lateral to 
Bregma, and at a 4.7 mm depth from the surface of the brain. 2μl of LV-STAT3-GFP was 
stereo-tactically injected into right facial nuclei of STAT3ΔS mice. These animals 
underwent facial nerve axotomy 4 days post- viral injection, and FG retrograde tracer 
application 28 days post-axotomy, before being transcardially perfused two days later. 
Efficiency of viral infection was assessed by eGFP immunohistochemistry. The transverse 
spread of the virus was approximately 0.5-0.6 mm. eGFP staining was present along the 
injection tract, in the reticular neurons above the facial nucleus, but more importantly also 
in the astrocytes within the facial nucleus. However, none of the facial motoneurons 
showed positive eGFP staining, suggesting that the virus may spare transfection of the 
facial motor neurons. 
The second approach was to inject adenovirus or adeno-associated virus into the facial 
nerve and allow it to be retrogradely transported to the facial motor nucleus. 2-3 μl of 
AAV2 virus, or Ad-Cre-GFP virus expressing cre and GFP was injected into the main brain 
of the facial nerve. In order to successfully inject the virus into the nerve, the nerve had to 
be partially snipped to expose cut axon tips; hence all animals underwent partial unilateral 
facial axotomy. Animals were sacrificed at 10 or 30 days after viral transfection, perfused, 
and brains extracted and sectioned at the level of the facial nucleus.  
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Figure 3.11. Adenoviral transfection of facial and spinal motoneurons. Transfection of facial motor neurons 
(left, and inset at high magnification), and spinal motor neurons (right) following retrograde injection of 
Adenovirus-GFP-Cre into facial and sciatic nerve respectively, followed by ten days survival. 
 
While the AAV injected only transfected a few axons, AV injection showed beautiful 
transfection of many facial motoneurons when stained with an eGFP antibody (Figure 
3.11). However, by 30 days, the immuno-staining disappeared, suggesting transient 
transgene expression after adenovirus injection. These optimisation experiments have 
paved the way for future experiments analysing the effects of overexpression of 
constitutively active STAT3, or of point-mutated STAT3 (especially at its phosphorylation 
sites Tyr705 and Ser727) in STAT3ΔS mice, and thereby identify the mechanism/s 
through which neuronal STAT3 exerts its multitude of effects in peripheral nerve 
regeneration. 
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Schwann cell STAT3 is not required for axonal regeneration or neuronal 
survival after facial axotomy 
 
In contrast with its neuronal counterpart, conditional mutants with Schwann cell STAT3 
deletion did not produce any defects in functional recovery, re-innervation of peripheral 
target, and motoneuron survival after facial axotomy.  
To assess the level of functional recovery post injury, the post-traumatic whisker hair 
motor performance was scored on a scale of 0 (no movement) to 3 (normal movement as 
on uninjured side) every alternate day from day 7 after surgery till day 28 (Figure 3.12 A). 
The STAT3∆P0 animals showed an almost identical recovery pattern to the STAT3 F/F 
animals, and by day 28 post axotomy, both the mutant and control animals had achieved 
similar levels of motor function (2.3±0.1 and 2.4±0.1 respectively).   
It has been reported earlier that the whisker hair recovery occurs in a non-linear fashion, 
with only 20-30% of re-innervating neurons being capable of accounting for a majority of 
the functional movement (Raivich et al., 2004). This suggests that whisker hair function 
might not be an accurate indicator of re-innervation levels between groups. Therefore, to 
analyse differences in re-innervation of the whisker pad, fluorescent tracer FG was 
injected into the whisker pad 28 days post axotomy, and the mice allowed to survive for 48 
hours to enable retrograde transport of the tracer. The level of re-innervation at day 30 
following facial axotomy was assessed by counting the number of FG positive 
motoneurons in the injured facial nucleus and comparing them with the uninjured, control 
side. Again, there was no difference between the two groups - the overall ratio of labelled 
FG neurons on the ipsi- vs. the contra-lateral side in the STAT3∆P0 mutants (n=6) was 
56±5% as compared to 52±4% in the STAT3 F/F controls (n=5) (Figure 3.12 B).  
Finally, the level of cell survival following facial axotomy was assessed by counting all 
motoneurons through the whole facial nucleus on the control and injured side using Nissl 
stained sections, and the number corrected for neuronal sizes by Abercrombie correction 
(Abercrombie, 1946). The number of motoneurons in the STAT3 F/F controls (co side: 
1760±97; ax side: 1288 ± 88; n=5) and the STAT3ΔP0 mutants (co side: 1631 ± 115; ax 
side: 1324 ± 175; n=6) were similar to each other and in line with previously published 
data on the facial nucleus (Galiano et al., 2001;Raivich et al., 2004;Sendtner et al., 1997). 
In terms of percentages, facial axotomy led to a loss of 27% of motoneurons in the 
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STAT3∆P0 mice compared to 19% loss in the STAT3 F/F mice (Figure 3.12 C). However, 
this difference was not statistically significant. In contrast with the neuronal counterpart, 
STAT3 deletion in Schwann cells did not lead to atrophic morphology of surviving 
axotomised motoneurons (Figure 3.12 D). 
 
 
Figure 3.12. Schwann cell STAT3 is not required for axonal regeneration. A. Whisker hair movement, measured 
over a period of 28 days after facial nerve cut showed no difference between the STAT3 F/F control and 
STAT3ΔP0 mutant groups. B. Target re-innervation of the whisker pad, assessed by counting the number of 
Fluorogold positive motoneurons showed no change in the axotomy response between groups 30 d after facial 
nerve cut. C. Motoneuron cell count of Nissl-stained facial nuclei shows no change in survival 30 d after nerve cut 
in the absence of Schwann cell STAT3 when comparing control and mutant animals. D. No change was seen in 
neuronal sizes between the two groups either. Bars and error bars show the mean and SEM respectively. 
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Chapter 3 – STAT3 discussion 
Increased synthesis and activity of transcription factors like c-Jun, ATF3, and STAT-3 are 
among the most consistent changes in injured neurons and have been suggested to play 
an important role in the neural response to injury and the initiation of the neuronal repair 
program. In the current study, we used neuron-specific inactivation of STAT3 to 
demonstrate that the STAT3 transcription factor is an important regulator of the neuronal 
response to axonal disconnection. Schwann cell STAT3, on the other hand, does not play 
a role in peripheral nerve regeneration. 
 
Neuronal STAT3 controls functional recovery & speed of axonal 
elongation after PNI 
Synchronised and rapid functional recovery is arguably the overall aim of any regenerative 
response. To functionally evaluate the role of STAT3 in axon growth, we assayed post-
traumatic whisker performance. In the absence of neuronal STAT3, there is a significant 
delay in functional recovery after peripheral nerve injury. At 30 days after facial nerve cut, 
while control mice regain nearly 75% of normal whisker function, STAT3 knock-out mice 
show only 40% of normal whisker movement. It is only about 35 days after injury that they 
gain some regenerative speed, a lag of 21 days compared to the controls. Even after 
milder crush injury, the STAT3ΔS mice showed nearly 60% less motor recovery than their 
control counterparts at 30 days after injury. This suggests that impaired regeneration of 
STAT3-deficient axons is not due to an inability to cross-over from the proximal to distal 
stump but possibly due to a delay in growth induction or reduced speed of regenerating 
axons. Deletion of STAT3 in Schwann cells, on the other hand, produced no defect in 
functional recovery. 
In order to investigate the cause of this prolonged lag phase in STAT3ΔS mice, we looked 
at the maximum distance of the regenerating neurites from facial nerve crush sites, four 
days after axotomy. In the controls, the neurites regenerated at a speed of 1-2 mm per 
day as reported previously (Gutmann, 1942). But the STAT3ΔS mutants showed a 60% 
reduction in this early elongation speed, as measured by the distance travelled by the 
fastest CGRP+ growth cone, providing substantial evidence for the delay in their functional 
recovery. The fact that STAT3 deficient neurons still mount a growth response, albeit with 
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prolonged delay, achieving levels of functional recovery similar to the controls by day 90, 
highlight the existence of collateral sprouting mechanisms and/or additional compensatory 
pathways which result in functional recovery in the absence of STAT3. That being said, 
speed of recovery is a crucial criterion in determining the overall efficacy of a regenerative 
programme after injury. Long delays in regeneration can make an acute injury, chronic, 
and create a whole new plethora of impediments. Tessa Gordon and colleagues have 
demonstrated in a series of experiments that prolonged disconnection from target reduces 
the ability of injured motoneurons to regenerate (Furey et al., 2007;Gordon et al., 2011). 
Considerable research is currently being focused on methods to improve speed of 
regeneration and STAT3’s role in accelerating axonal elongation and achieving faster 
functional recovery, makes it a desirable candidate for future translational studies. 
 
Neuronal deletion of STAT3 results in impaired target re-innervation 
Compared to the impaired functional recovery outcome in STAT3ΔS mice, the defect in re-
innervation outcome was even more striking and persistent. STAT3ΔS mice showed a 3-
fold reduction in target re-innervation at 10 and 30 days after nerve crush, a 4-fold 
reduction in re-innervation at day 30 after nerve cut, and only half of normal wild-type re-
innervation even at day 90 following cut injury. When adjusted for cell survival, the 
difference between the groups became even more dramatic, with the mutants (16% SAR) 
showing more than 5-fold reduction in re-innervation after nerve cut compared to controls 
(85% SAR). The fact that the functional recovery in the mutants exceeded target re-
innervation at day 90 highlights an interesting feature of the regenerative response that full 
target re-innervation is not necessary for functional recovery. A similar phenomenon has 
been shown earlier in case of c-jun nestin:cre mice (Raivich et al., 2004). The assessment 
of whisker hair movement appears to be non-linear, providing an accurate indication of 
functional reconnections by the first 20-30% neurons, but there-after losing its predictive 
value, as more neurons reconnect to the target (Raivich et al., 2004). Also, both the 
groups showed greater re-innervation after facial nerve crush than cut, but the ratio of re-
innervation in the mutants compared to controls remained unchanged between the two 
injury severities, again highlighting the idea that the re-innervation defect in the STAT3ΔS 
mutants is probably due to an intrinsic regenerative disability arising from neuronal STAT3 
deletion, rather than a problem in overcoming the cellular bridge between the proximal and 
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distal stumps. Once again, no re-innervation defect was seen in STAT3ΔP0 mice, which 
lack STAT3 in Schwann cells. 
A recent study using mice with conditional STAT3 deletion in DRG neurons, has 
demonstrated a phase-specific role of STAT3 in regulating induction of the neuronal 
growth programme, but not subsequent perpetuation of axonal growth. Deletion of STAT3 
impairs initial regeneration of peripheral DRG axons after a saphenous nerve cut, but by 
28 days after lesion, similar proportions of STAT3-competent and STAT3-deficient axons 
re-approach their termination zone. Once regeneration has been initiated, STAT3-deficient 
axons grow with the same speed as STAT3-competent axons (Bareyre et al., 2011). They 
have postulated that axons require STAT3 when growing independently of Schwann cells; 
but once they come into contact with the Schwann cell tube, they shift into an elongation 
mode and no longer require STAT3. Thus crush lesions that do not interrupt Schwann cell 
guidance, do not induce STAT3 expression in the corresponding DRG neurons (Bareyre 
et al., 2011). Another study, involving STAT3 deletion in adult DRG neurons, followed by 
sciatic nerve crush, has shown no major differences in neurite outgrowth from STAT3 
deficient adult sensory neurons, compared with neurons expressing constitutively active 
STAT3 (Ben-Yaakov et al., 2012). These results are in stark contrast with our current data 
which shows that STAT3 is indispensable for full target re-innervation of motoneurons 
after both cut and crush injuries. Without STAT3, there is a persistent defect in 
regeneration (measured up to 90 days) and peripheral targets remain terminally 
denervated; the delayed increase in function could possibly be an effect of collateral 
sprouting, or due to the existence of alternate pathways that can promote neuronal 
regeneration in the absence of STAT3, albeit at a much lower efficiency. It is possible that 
motor (as seen after facial nerve injury) and sensory (as seen after sciatic and saphenous 
nerve injuries) fibres respond differently after nerve lesions (Lago et al., 2007). Several 
cell adhesion molecules and growth factors like BDNF are known to be differentially 
expressed in motor and sensory nerves and may play a role in differential regulation of 
regeneration of these nerves (Allodi et al., 2012). 
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STAT3 is required for both cell death & for the trophic state of the 
surviving neurons 
Absence of STAT3 in axotomised facial motoneurons prevented neuronal cell death 
following facial axotomy. Quantification of total number of motoneurons in the entire facial 
nucleus revealed a significant decrease in motoneuron death in the axotomised nuclei of 
STAT3ΔS mice at 30 days after facial nerve transection, in contrast with the STAT3F/F 
controls, which showed  approximately 30% cell death. However, most of the surviving 
STAT3ΔS motoneurons had a severely atrophic morphology, and remained shrunken by 
50% even at 90 days after axotomy. Even after crush lesion, cell death was completely 
abolished in the mutants, and the axotomised neurons were atrophic by a 20% reduction 
in cell diameter compared to the controls. Facial motoneurons which fail to reconnect with 
their target normally die because of the lack of trophic support (Sendtner et al., 1996;Ferri 
et al., 1998). It appears that in the absence of STAT3 these disconnected neurons are 
prevented from dying, and are instead held between cell survival and cell death in a 
shrunken, and most likely a non-functional state. These atrophic neurons also fail to 
upregulate various RAGs, as seen by immunohistochemistry at days 4 and 14 after 
axotomy. This phenomenon has been reported earlier in our laboratory in case of neural c-
jun knockouts (Raivich et al., 2004;Ruff et al., 2012), suggesting that STAT3, like c-jun, 
may  be acting as a ‘double-edged sword’ promoting injury-induced neuronal cell death as 
well as regeneration (Herdegen et al., 1997b). In a study published by Schweizer and 
colleagues in 2002, it was reported that conditional STAT3 deletion in motoneurons under 
a neurofilament promoter driven cre, results in the death of 45% of the axotomised 
motoneurons. However, the cell numbers in this study were not adjusted for their size 
variability by Abercrombie correction. Moreover, there was no indication that the shrunken 
neurons were included in their total motoneuron counts, suggesting that the level of cell 
death seen by Schweizer et al., could be misleading (Schweizer et al., 2002). STAT3 has 
been consistently referred to as a ‘pro-survival’ or anti-apoptotic factor, correlating with 
neuronal survival either directly (Alonzi et al., 2001;Liu and Snider, 2001;Qiu et al., 
2005;Schwaiger et al., 2000;Schweizer et al., 2002;Smith et al., 2011), or indirectly via 
inactivation of its regulator SOCS3 (Miao et al., 2006;Smith et al., 2009). STAT3 has also 
been reported to promote survival of adult motor neurons (Schweizer et al., 2002), adult 
sensory neurons (Ben-Yaakov et al., 2012) and of retinal ganglion neurons (Zhang et al., 
2008) after injury, and co-localises with anti-apoptotic proteins like bcl-2, bcl-XL  and Reg-
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2 (Dziennis and Alkayed, 2008). Our current results show that the attributed title of 
‘survival factor’ for STAT3 may be deceptive, and more experiments will be required to 
ascertain whether like c-jun, STAT3 has the ability to act as a cell death signal. In 2001, 
Wen et al., observed that after cerebral ischemia, p-STAT3 immunopositive neurons were 
also TUNEL positive, suggesting that increased expression of p-STAT3 could play a 
crucial role in ischemia-induced neuron death (Wen et al., 2001). Moreover, several 
neurotrophic factors which activate STAT3, including CNTF, (Haas et al., 1999), can also 
mediate their survival effects via other pathways like the Ras pathway which has been 
shown to support motoneuron survival (Weng et al., 1996), suggesting a dispensable role 
for STAT3 in neurotrophin-mediated survival of motoneurons. 
Further, STAT3ΔS mutant mice showed a marked and progressively widening defect in 
microglial activation with increasing time following axotomy (-78% at day 1, -80% at day 4, 
-87% at day14). The smaller reduction in microglial activation in mutant mice during the 
early phase of the axonal response, and a more drastic difference of microglial activation 
at a later stage coinciding with the peak of cell death at day 14 (Raivich et al., 
1999a;Raivich et al., 1998), confirms that the defects in microglial activation are caused by 
the reduced death of facial motoneurons in STAT3ΔS mice. T-cell recruitment from the 
periphery to the damaged brain is triggered by dying cells and quantification of CD3 
immunopositive cells at day 14 also showed a significant reduction by 87% in the mutants. 
Such a nearly total obliteration in the expression of microglial and lymphocytic markers 
reaffirms the observation that mice lacking neuronal STAT3 do not undergo motoneuron 
cell death after facial axotomy. It also highlights the importance of STAT-3 dependent 
signals from neurons in eliciting the non-neuronal responses to injury. 
STAT3 is required for the molecular & biochemical response of the cell 
body to injury 
Removal of neuronal STAT3 abolished basal and injury-induced p-STAT3 
immunoreactivity, as well as most of the molecular response following facial axotomy. 
Unpublished data from our laboratory has shown that STAT3 is an early marker of 
neuronal injury, being up-regulated within 3 hours and reaching a peak at 7 days after 
injury. Because of its early activation, it plays a potentially vital role in triggering a cascade 
of biochemical and molecular events essential for efficient regeneration. Up-regulation of 
RAGs result in the transformation of a transmitting neuron to a regenerative phenotype 
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that supports axonal elongation and sprouting. Previous studies using genetic deletion and 
antibody inhibition techniques have shown that a concoction of various transcription 
factors, neuropeptides, cell adhesion molecules, cytoskeletal elements and growth factors 
is required for successful regeneration. For example, deletion of neuronal c-jun has been 
shown to acutely impair peripheral regeneration (Raivich et al., 2004;Ruff et al., 2012). 
Overexpression of ATF3 speeds up the initiation of axonal outgrowth (Seijffers et al., 
2006), whilst deletion of the α7 integrin gene retards axonal regeneration by 35-40% 
(Werner et al., 2000). Local inhibition of neuropeptide CGRP (Dumoulin et al., 
1992;Raivich et al., 1992) and adhesion molecule CD44 (Nagy et al., 1998) and deletion 
of galanin (Holmes et al., 2000) reduced neurite outgrowth in vivo. The current results 
show that axotomy induced upregulation of all of the above molecules, except for c-jun, is 
almost completely abolished in the STAT3ΔS mice, suggesting their role in mediating 
STAT3-dependent axonal growth. In the absence of neuronal STAT3, injury-induced 
nuclear translocation of ATF3 was completely blocked, but the effect on c-jun activation 
was relatively mild. The effects of c-jun and STAT3 deletions on various RAGs appear to 
mimic each other, without affecting the expression of either transcription factor. It is likely 
that there are molecules which co-ordinate the expression of these two transcription 
factors in regulating regeneration. For example transcription of damage-induced neuronal 
endopeptidase (DINE) was shown to be increased 60-fold by Sp1 mediated recruitment of 
STAT3, c-jun and ATF3 to the DINE promoter following injury (Kiryu-Seo et al., 2008).  
 
It is probable that there are additional, unidentified, transcriptional targets of STAT3 that 
are necessary for some aspects of the axonal response.  Genetic profiling of STAT3F/F 
and STAT3ΔS mice before and after axotomy, will help in the identification of novel 
molecules involved in STAT3-dependent neuronal regeneration.  Since STAT3 appears to 
be a key regulator of the axonal reaction, pharmacological augmentation of its activity 
could represent a promising therapeutic strategy to facilitate axonal regeneration in 
patients with nerve trauma. 
 
Viral transfection of facial motoneurons 
Overexpression or viral vector–mediated knockdown of genes will allow a large range of 
investigations into gene function during regeneration after peripheral nerve injury. 
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Rescuing the regeneration deficient phenotype seen in the STAT3ΔS mutants, by 
administering constitutively active STAT3 or any of its downstream targets, will greatly 
help our understanding of the exact mechanisms of STAT3 function in regeneration. 
Stereotactic injection of lentivirus expressing STAT3 and GFP into the facial nucleus 
resulted in transfection tropism towards astrocytes, but not the motoneurons within the 
facial nucleus. So, as the next step, adeno-associated virus (AAV) or adenovirus (AV) was 
injected into the facial nerve and allowed to be retrogradely transported to the facial motor 
nucleus.  
AAV is being increasingly recognised as a useful gene therapy vector, due to its low 
immunogenicity and toxicity, and has been known to retrogradely transduce motor and 
sensory neurons (Mason et al., 2010;Hollis et al., 2010). However, in the current study, 
AAV injection transfected mostly axons, and very few motoneurons. On the other hand, 
AV injection showed transfection of several facial motoneurons within 10 days. But by 30 
days, the immuno-staining disappeared, suggesting transient transgene expression after 
adenovirus injection. This is consistent with a previous study showing intraneural 
adenoviral injection into sciatic nerve causes a peak expression of lacZ between 10-14 
days after injection, after which it decreases, suggesting that adenoviral expression in 
nerves of adult mice is limited by host cellular immune response to the virus (Jani et al., 
1999). Also, the CMV promoter is known to typically provide rapid and ubiquitous 
expression; however it is also prone to silencing over time in some tissues, specifically in 
the brain (Gray et al., 2011), explaining the disappearance of neuronal transfection by day 
30 in the facial motoneurons. 
ATF3 is rapidly, and consistently activated in sensory, sympathetic and motor neurons by 
stress stimuli after peripheral nerve injury (Raivich and Behrens, 2006;Tsujino et al., 2000), 
making it one of the most common and reliable injury markers. Several studies have also 
highlighted a synergistic action of ATF3 and c-jun, and of ATF3, c-Jun and STAT3. The 
absence of ATF3 in the STAT3 mutants might be one of the main reasons for the poor 
regeneration. AV-mediated administration of ATF3 to the STAT3 mutants might help 
improve regeneration. These optimisation experiments have also paved the way for future 
experiments analysing the effects of overexpression of constitutively active STAT3, or of 
point-mutated STAT3 (especially at its phosphorylation sites Tyr705 and Ser727) in 
STAT3ΔS mice, and thereby identify the mechanism/s through which neuronal STAT3 
exerts its multitude of effects in peripheral nerve regeneration.  
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Chapter 4 – c-Jun Results  
Neuronal and Schwann cell c-Jun together contribute to 
successful nerve regeneration, and N-terminal phosphorylation is 
not the main regulator of their regenerative function 
Upon nerve transection, the expression of many growth and survival-associated 
transcription factors is dramatically up-regulated. Increased expression of c-jun, an 
important component of the AP-1 transcription complex, is one of the most immediate, 
consistent and well-characterised changes taking place in the neuronal soma following 
axonal transection. In 2004, Raivich et al. reported that mice with a neuro-epithelial stem 
cell marker Nestin-specific c-Jun deletion (c-JunΔN), exhibit several defects in the 
neuronal regenerative response. They showed increased cell survival but of atrophic 
neurons, reduced target-muscle re-innervation, perineuronal sprouting, lymphocyte 
recruitment and microglial activation after facial nerve axotomy (Raivich et al., 2004). 
Since neuroepithelial stem cells differentiate into several distinct CNS populations such as 
neurons, oligodendrocytes, astrocytes and peripheral Schwann cells (Raivich et al., 
2004;Heffron et al., 2009), it remained unknown which of these cell types was the key 
regulator of the phenotype exhibited by c-JunΔN mice. In 2012, another publication from 
the Raivich laboratory revealed that neuronal c-Jun deletion by neuron-specific synapsin 
promoter (c-JunΔS) echoed all the regeneration deficits seen in the c-JunΔN mice (Ruff et 
al., 2012b), suggesting that neuronal c-Jun is the essential regulator of the cellular 
response to axonal injury and also the resulting neuronal survival and regeneration. 
 
Neuronal c-Jun and STAT3 are not functionally complementary 
counterparts in facial nerve regeneration 
Immuno-histo-chemical and genome wide mRNA microarrays studies (in collaboration 
with Joost Verhaagen, Netherlands Neuroscience Institute) have confirmed strong overall 
reduction for regeneration-associated molecules like α7β1 integrin, ATF3, CGRP, Galanin 
and CAP23 in c-JunΔN and c-JunΔS mice. However, some transcription factors and 
cytokines such as STAT3 and IL6 were completely unaffected by the absence of c-Jun. 
Previously reports have shown that STAT3 promotes neurite outgrowth in vitro (Miao et al., 
2006;Liu and Snider, 2001;Smith et al., 2011), and neuronal survival and functional repair 
in vivo (Schweizer et al., 2002;Bareyre et al., 2011). Our current study using neuronal 
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STAT3 deficient mice (STAT3ΔS) has shown an important role of neuronal STAT3 in 
achieving successful functional and anatomical regeneration after nerve injury. Briefly, 
removal of STAT3 gene in facial motoneurons abolished most of the molecular responses 
following facial axotomy, reduced the speed of axonal regeneration following crush, and 
prevented most cut axons from reconnecting to their target, preventing functional recovery. 
Despite blocking cell death, this was associated with a large number of shrunken neurons. 
STAT3ΔS mutants also had diminished microglial activation and T-cell influx (Chapter 3). 
Interestingly, STAT3 expression was unaffected by lack of neuronal c-Jun in the c-JunΔS 
mice and vice-versa (Chapter 3) (Ruff et al., 2012), supporting the hypothesis that 
neuronal STAT3 and c-Jun might be performing functionally complementary roles in 
peripheral nerve regeneration and are responsible for the maintenance of a residual 
neuronal regenerative program in mice lacking either transcription factor. In order to 
investigate this hypothesis, double mutant mice with combined deletion of both neuronal c-
Jun and STAT3 (STAT3+c-JunΔS) were generated by lox-P cre recombination under the 
control of neuron-specific synapsin promoter. The possibility of c-Jun and STAT3 
belonging to complementary signalling pathways in regeneration was investigated by 
exploring whether the effects of combining both deletions, produced a stronger, synergistic 
effect on regeneration, than a simple deletion of either STAT3 or c-Jun. 
 
Combined deletion of c-jun & STAT3 interferes with axonal regeneration, but not more 
than the effects seen with single deletion of either transcription factor 
The right facial nerve was cut at the stylomastoid foramen, and the animals allowed to 
survive for 30 days to allow scoring of post-traumatic whisker motor function, and analysis 
of target re-innervation and motoneuron survival. All assessments were done similarly as 
on mice with single gene deletions, to assess synergistic effects and interactions between 
the two transcription factors. 
Functional recovery was assessed by scoring ipsilateral whisker hair movement every 
other day on a scale of 0 (no movement) to 3 (normal movement). The control mice 
commenced recovery of whisker vibrissae around day 10 and improved steadily over the 
next 18 days to reach a final score of 1.8±0.1 at day 28. Recovery in the STAT3+c-JunΔS 
mutants, also started around day 10, however, the pattern of recovery was much slower 
than the control mice, achieving a maximum average score of 1.3±0.1 by day 28 (Figure 
4.1A). These differences were mirrored by changes in the regenerative index, calculated 
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as area under the curve for functional recovery over the 28 day period. The controls had 
an index of 1.04±0.06 (n=5) and the double mutants, a significantly lower index of 
0.71±0.03 (n=5; p < 1%, Figure 4.1B). Interestingly, previous studies using single gene 
deletions have shown a lower recovery index for neuronal STAT3 deletion (AUC = 
0.32±0.07) (Chapter 3 Results) and neuronal c-jun deletion (AUC = 0.44± 0.02) alone (Ruff 
et al., 2012). However, this could simply be variability between the animals, or human 
observer variability, since the scoring was done at different times and by different people. 
Overall, these results do not show a stronger delay in functional recovery in the double 
mutants, compared to the single mutants. 
To determine the cause of this defect, 28 days after nerve cut the same experimental 
cohorts were assessed for target muscle re-innervation. Whisker pads were labelled 
bilaterally with the fluorescent tracer Fluoro-Gold (FG), followed by 48 hours of retrograde 
transport. Motoneurons that successfully reconnected with their targets were identified by 
the presence of the retrograde tracer in the cell bodies, and counted on every fifth section 
throughout the facial nucleus. Control animals showed retrograde labelling of 69±7% 
neurons on the axotomised side compared with the uninjured side, which was in 
agreement with the extent of re-innervation in previous controls from single gene deletion 
experiments (Chapter 3 Results; (Ruff et al., 2012)). c-jun deletion resulted in a dramatic 
8-fold reduction of retrograde labelling to 3.8% ± 1.1% (ax/co%; p<0.1%; (Ruff et al., 2012))  
STAT3 deletion alone reduced the percentage of re-innervating neurons by 4-fold to 15±4% 
(ax/co%; p<0.01%; Chapter 3). Deletion of both neuronal STAT3 and c-jun did not 
exacerbate this defect in re-innervation. The STAT3+c-JunΔS double mutants showed a 
2.5 fold reduction in re-innervation to 26±4% (Figure 4.1C; p<0.1%). In terms of actual 
numbers, while the unaxotomised facial nucleus had 190±13 FG+ neurons, the 
axotomised side had 47±5 FG neurons. Although the re-innervation ratio was higher in the 
double mutants compared to the single mutants, the difference was statistically 
insignificant, again highlighting variability between experiments done at different times.  
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Figure 4.1. Deletion of neuronal STAT3 and c-jun interferes with axonal regeneration, functional recovery, 
target re-innervation and neuronal cell death. A,B. Functional recovery of whisker hair movement after facial 
nerve cut, also expressed as regenerative index (calculated as Area Under Curve) WHM was scored on a 
scale of 0 (no movement) to 3 (strong, normal movement); see Materials and methods for details. STAT3+c-
JunΔS double mutants show a significantly poorer overall recovery. C. Quantification of retrograde labelling 
of facial motoneurons with Fluorogold 28 days after facial nerve cut. The overall ratio of labelled neurons in 
the operated/unoperated side is shown. Peripheral target re-innervation of the whisker pad is reduced in the 
absence of STAT3 and c-jun in neurons. D. Changes in neuronal cell number in the axotomised and 
contralateral facial motor nucleus, 30 days after facial nerve cut. Quantification of Nissl-stained motoneurons 
show a strong increase in survival 30 d after nerve cut in the absence of neuronal STAT3 and c-jun. E. 
STAT3+c-JunΔS double mutants show significantly reduced survival adjusted re-innervation. F. Axotomised 
neurons in the STAT3+c-JunΔS double mutants are atrophic. Error bars indicate mean +/-standard error of 
mean (SEM), n=5 animals per group, *p<5%, **p<1%, ***p<0.1%, ****p<0.01% in Repeated Test Anova (for 
whisker movement score) and in unpaired Student’s t-test.  
To assess the effects of deleting neuronal STAT3 and c-jun on cell survival after axotomy, 
motoneuron number on the uninjured and injured sides at 30 days after injury were 
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compared. It revealed a loss of 34±4% neurons in the control group, injured side. 
Motoneuron survival was significantly increased in STAT3 and c-jun single and double 
mutants (Figure 4.1D; p<0.01%). c-Jun single mutants had 99±4% motoneuron survival 
(Ruff et al., 2012), STAT3 single mutants 109±7% (Chapter 3 – STAT3 Results), and the 
STAT3+c-JunΔS double mutants 97±2% (p < 0.01%). The opposite effect was observed 
on cell size – while the controls showed a slight chromatolytic increase in neuronal 
diameter on the axotomised side, the STAT3+c-JunΔS double mutants showed a 25% 
shrinkage from 18.4 ± 0.4 μm for the uninjured to 13.7 ± 0.6 μm for injured motoneurons 
(Figure 4.1F). These results again conform to the previous observations of increased 
motoneuron survival and cell shrinkage in the STAT3 and c-jun single mutants. 
Finally, to explore whether alterations in motoneuron survival contributed to the observed 
reduction in re-innervation and functional recovery, we looked at survival-adjusted re-
innervation. While the controls had an S.A.R. of 104±6%, the STAT3+c-JunΔS double 
mutants had a S.A.R. of only 27±5%, an almost 4-fold reduction in regeneration capability 
(Figure 4.1E; p<0.01%). A similar phenomenon was seen in the single gene deletion 
mutants compared to their control counterparts. In summary, the regenerative abilities of 
the double mutants seem to be at par with those of the single mutants at 30 days after 
facial nerve transection. Due to the absence of exacerbated deficiency or complete 
abolition of nerve regeneration in the double mutants, it seems unlikely that the two 
transcription factors belong to complementary pathways. Rather, they may be acting in 
concert to unlock a common signalling mechanism in regeneration, and the absence of 
either factor is sufficient to block that stream of regeneration. 
 
Neuronal c-Jun and Schwann cell c-jun are functionally complementary 
counterparts in facial nerve regeneration 
In our search to identify master regulator/s of regeneration which exhaustively regulate all 
aspects of the regenerative response, we explored the possibility of complementary 
function of transcription factors c-Jun and STAT3. However, what emerged was that the 
two factors do not have a synergistic or incremental effect on regeneration. In fact, their 
closely related response in terms of regulating re-innervation, functional recovery, 
neuronal survival, and molecule changes in the neuronal cell bodies and non-neuronal 
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cells suggest that they might be acting through the same pathway. This led us to 
investigate the contribution of non-neuronal cells via alternate mechanisms. 
 
c-Jun in Schwann cells is a global regulator of Wallerian degeneration, governing major 
aspects of the injury response, including expression of trophic factors, adhesion molecules, 
the formation of regeneration tracks and myelin clearance. A key function of c- Jun is the 
activation of a repair program in Schwann cells and the creation of a cell specialised to 
support regeneration (Arthur-Farraj et al., 2012). Two recent, closely-related studies have 
highlighted an important role of Schwann cell c-jun in cell survival following peripheral 
nerve regeneration (Arthur-Farraj et al., 2012;Fontana et al., 2012). The first study using a 
Schwann cell c-jun deleted mutant expressing cre recombinase under the control of 
myelin protein P0 promoter showed that after facial nerve injury, the absence of c-Jun 
caused impaired axonal regeneration and severely increased neuronal cell death. c-Jun 
deficiency resulted in decreased expression of several neurotrophic factors, including 
GDNF and Artemin, both of which encode ligands for the Ret receptor tyrosine kinase, and 
act on neurons via paracrine signalling (Fontana et al., 2012). The second study, using a 
sciatic nerve injury model, also showed that the absence of c-Jun results in the formation 
of a dysfunctional repair cell, striking failure of functional recovery, and neuronal death. 
These observations prompted the question whether transcriptional control of modulatory 
factors present in, and produced by glial cells in the peripheral system play a role in 
axonal regeneration and compensate for the loss of functional and anatomical 
regeneration in the absence of neuronal STAT3 or c-jun. In order to investigate this 
hypothesis, facial nerve regeneration was assessed in double mutant mice with deletion of 
both neuronal and Schwann cell c-jun signalling streams.  
 
Combined deletion of neuronal and Schwann cell c-jun completely abolishes target re-
innervation after facial nerve regeneration 
To investigate the significance of combined c-Jun deletion in neurons and SCs, transgenic 
mice with neuronal deletion of c-jun (c-JunΔS) were crossed with mice having Schwann 
cell c-Jun deletion (c-JunΔP0). The resulting litters had mice with combined homozygous 
neuronal and Schwann cell deletions (c-JunΔSΔP), only neuronal deletion (c-JunΔS), only 
Schwann cell deletion (c-JunΔP0) or functional, unrecombined controls (c-JunWT), which 
formed the four experimental groups in these studies. 
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Figure 4.2. Combined deletion of c-jun in neurons and Schwann cells exacerbates the defect in target re-
innervation after facial axotomy. A. Whisker pad re-innervation was determined by counting retrogradely 
labelled Fluorogold-fluorescing facial motoneurons (FG+) at 30 days after facial nerve cut. While junF/F 
animals (n=4) showed 57% reduction in re-innervation, junΔP0 mice (n=8) showed 93% reduction, junΔS 
mice 91% reduction (n=3) and junΔSΔP0 mice 99% reduction (n=5). B. Survival adjusted re-innervation 
(SAR) was calculated by dividing the ratio of re-innervation by the survival ratios for each group.  Note the 
sharp reduction in SAR in junΔS animals, and complete abolition of SAR in the junΔSΔP0 double mutants. 
*p< 5%, ** p<1%, *** p< 0.1%, **** p<0.01% in unpaired Student’s T-Test, bars and error bars show the 
mean and SEM, respectively.  
 
The effects of combined neuron- and SC-specific c-Jun inactivation on axonal 
regeneration were assessed by the extent of peripheral target re-innervation, and 
motoneuron survival, using the same cohorts of control and mutant mice. 28 days after 
nerve cut, the whisker pads were labelled on both sides with a fluorescent tracer Fluoro-
Gold (FG), followed by 48 hours of retrograde transport. Motoneurons that successfully 
reconnected with their targets were identified by the presence of the retrograde tracer in 
their somas, and counted on every fifth section throughout the facial nucleus. Although 
control c-JunWT animals showed retrograde labelling of 43 ± 15% on the axotomised side 
compared with the uninjured side, c-JunΔS animals showed an almost five fold decrease 
with 9 ± 2%, c-JunΔP0 animals showed more than six-fold decrease with just 7 ± 2% 
(p<0.1%), and the c-JunΔSΔP0 mice a striking forty-fold decrease with only 1 ± 0% 
neurons labelled with the fluorescent tracer (Figure 4.2A; p<1%). Statistically speaking, 
the extent of re-innervation in the double mutant c-JunΔSΔP0 mice was significantly lower 
than that seen with deletion of c-Jun in neurons (c-JunΔS) or Schwann cells (c-JunΔP0) 
alone. There was no difference in the number of labelled motoneurons on the 
unaxotomised side of all four groups of animals. 
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We next explored whether alterations in motoneuron survival contributed to the observed 
reduction in re-innervation. Comparison of motoneuron number on the uninjured and 
injured sides 30 days after injury revealed a loss of 42 ± 5% neurons in the c-JunWT 
control group, injured side. However, motoneuron death was strikingly increased in c-
JunΔP0 animals, with a loss of nearly 90±1% neurons on the injured side, and more than 
double the loss seen in the controls (p<0.01%). Such striking cell loss in mutants with 
Schwann cell c-jun deletion has been reported earlier (Arthur-Farraj et al., 2012;Fontana 
et al., 2012). In complete contrast to this phenotype, motoneuron survival was dramatically 
increased in the c-JunΔS mutants, with a loss of only 10±1% neurons; a four-fold 
reduction in cell death compared to the controls (p <1%). Again, this phenomenon has 
been described by earlier studies from our laboratory using neural and neuronal c-jun KOs 
(Ruff et al., 2012;Raivich et al., 2004). Interestingly, combination of the two gene deletions, 
i.e., neuronal and Schwann cell c-jun, in the c-JunΔSΔP0 mice mirrored the increased cell 
survival phenotype of the c-JunΔS mutant, with a loss of only 5±2% neurons; a 
significantly higher rate of cell survival than the controls (p<0.1%) and the c-JunΔP0 
animals (p<0.001%) (Figure 4.3(a), (b) A,B). The neuronal c-jun deletion appeared to 
completely block motoneuron loss due to the absence of Schwann cell c-jun in the c-
JunΔSΔP0 double mutants.  
The four experimental cohorts differed not just in terms of their motoneuron numbers, but 
also in terms of their morphology (Figure 4.3(a) – 40X mag). While the surviving cell 
bodies in the c-JunWT and c-JunΔP0 mice appeared chromatolytic, most of the 
axotomised neurons in the c-JunΔS animals appeared shrunken by 30% of their original 
cell diameter (p<1%), with the exception of a few chromatolytic, and possibly functional 
neurons. The axotomised neurons in the c-JunΔSΔP0 double mutants had an even more 
severe atrophic morphology, with a 40% reduction in cell diameter (p<0.01%), and 
complete absence of any normal-sized or chromatolytic neurons (Figure 4.3(b)C,D).  
The massive variation in cell survival between the groups posed another question – were 
the observed changes in re-innervation merely the effect of increased cell death in certain 
groups? To answer this question, survival adjusted re-innervation (SAR) was calculated by 
dividing the ratio of re-innervation by the survival ratios for each group.  
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Figure 4.3 (a) Deletion of c-jun in neurons and SCs affects neuronal survival and morphology after facial 
axotomy. Nissl-stained coronal sections of facial motoneurons on the contralateral (co – A,D,G,J) and 
axotomised (ax – B,E,H,K) side, and at higher 40 X magnification of ax side (C,F,I,L) in control (junF/F) and 
mutant (junΔP0, junΔS, and junΔSΔP0) animals, 30 days after unilateral facial nerve cut. Note the strong 
decrease in cell survival in junΔP0 mice, and the increase in cell survival in junΔS and junΔSΔP0 mice, but 
of severely atrophic neurons. 
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Figure 4.3 (b) Deletion of c-jun in neurons and SCs affects neuronal survival and neuronal morphology after 
facial axotomy. A, B. Total motoneuron count and percentage survival, corrected for neuronal size, showed a 
significant reduction in neuronal survival after axotomy in the absence of SC c-jun, but significant increase in 
neuronal survival in the absence of neuronal c-jun or combined deletion of neuronal and SC c-jun. C, D. 
Neuronal diameter measurements (in μm) and percentage change in diameter (ax/co%) showed a mild 
chromatolytic increase in neuronal size in junF/F controls and junΔP0 mutants, but a significant shrinkage of 
junΔS and junΔSΔP0 neurons after axotomy. ** p<1%, *** p< 0.1%, **** p<0.01% in unpaired Student’s T-Test, 
bars and error bars show the mean and SEM respectively.  
 
The controls had an SAR value of 69±16%, followed closely by the c-JunΔP0 animals with 
70±23% (Figure 4.2B). This suggests that the re-innervation defect seen in the Schwann 
cell c-Jun null mutants is entirely due to the increased neuronal cell death after axotomy. 
In contrast, the c-JunΔS animals had an SAR value of 10±2%, significantly lower than the 
controls (p<1%); and the c-JunΔSΔP0 double mutants a nearly complete abolition of 
survival-adjusted re-innervation with an SAR value of 1±0%, significantly lower than 
controls (p<0.01%), and neuronal c-Jun deletion alone (Figure 4.2B; p<0.1%). 
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N-terminal phosphorylation of c-jun is involved in neuronal survival and 
re-innervation after FNA 
The above experiments have clearly delineated an important role for neuronal and SC c-
jun in peripheral nerve regeneration. In spite of the pronounced effects of c-jun deletion on 
axonal regeneration, the exact molecular mechanisms underlying its course of action 
remain largely unknown. In addition to the presence of c-jun in different regulatory cell 
types, its phosphorylation state can influence dimer stability and can affect its biological 
role in regeneration, both in vivo and in vitro (as described previously in Chapter 1 
Introduction). c-jun can be activated by N-terminal phosphorylation at serines 63 & 73 and 
threonines 91 & 93 by Jun N-Terminal Kinases 1, 2 and 3 (JNK1-3) (Raivich, 2008). Other 
means of c-jun modulation include dephosphorylation of Thr239 which attracts FBW7 
ubiquitin ligase (FBW7L) and targets the phosphorylated protein for ubiquitination and 
subsequent degradation, and C-terminal lysine acetylation near aa257-276 (Vries et al., 
2001), which results in activated c-Jun via the ERK pathway (Raivich, 2008). Mutants with 
global deletion of JNK1, 2 or 3, and alanine replacement of the serine 63&73 sites have 
shown a mild effect of c-jun phosphorylation on peripheral regeneration (Ruff et al., 2012). 
It is possible that complete removal of all 4 JNK dependent N-terminal phosphor-acceptor 
sites (Thr91&93 as well as Ser63&73) will produce a more severe regeneration phenotype. 
This study uses homozygous c-Jun4A and wild type (wt) mice, and the facial axotomy 
model, to elucidate the effects of total ablation of c-jun N-terminal phosphorylation on 
facial nerve regeneration. Based on data characterising survival, regeneration and cellular 
response of Jun4A mutants following facial nerve injury, it is evident that N-Terminal 
phosphorylation of c-jun is not the mechanism by which neuronal c-jun triggers majority of 
its effects in regeneration. 
Abolition of c-jun N-terminal phosphorylation has moderate effects on functional recovery 
and anatomical re-innervation after facial nerve axotomy 
Axonal regeneration in c-JunWT controls and c-Jun4A mutants was evaluated by 
analysing recovery of whisker hair function and target re-innervation after facial nerve 
axotomy. 
Recovery of motor function was assessed by scoring the ipsilateral whisker hair 
movement on a scale of 0 – 3 (0= no movement, 1= mild movement, 2= moderate 
movement, and 3 = normal movement as on unoperated side), starting from 7 days after 
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axotomy, and measured at 2-3 day intervals till day 28. Functional recovery in c-jun 4A 
mutants was on average slightly lower than that in the c-jun WT controls (Figure 4.4A). 
The overall recovery of function, as measured by AUC, showed a moderate 18% reduction 
in the c-Jun4A mutants (0.65±0.05) compared to the c-JunWT controls (0.53±0.5), almost 
reaching statistical significance with p-value of 7% (Figure 4.4B). Due to the variability 
between the animals, adding animal numbers to the two groups might push this result 
towards significance. 
A fluorescent tracer, Fluorogold (FG), was used to analyse target re-innervation at 30 days 
after axotomy. A gel-foam soaked in 10μl FG was applied bilaterally for 30 minutes to the 
whisker-pads of c-jun4A and c-junWT mice at 28 days after facial axotomy. The mice were 
allowed to survive for 48 hours to enable retrograde transport of the tracer to the 
reconnected facial motoneurons in the hindbrain, after which they were perfused, and their 
brains cryo-sectioned for microscopic analysis. Counting of the FG+ motoneurons 
revealed a significant, approximately 50% reduction in re-innervation in the c-jun4A 
mutants (63±8% in c-JunWT to 37±10% in c-Jun4A mice) (Figure 4.4C; p<5%). 
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Figure 4.4. c-jun N-terminal phosphorylation and axonal regeneration. A. Time-course of functional recovery 
of whisker hair movement on a scale from 0 (no movement) to 3 (full movement, equivalent to uninjured side) 
shows a trend towards reduced functional recovery in c-jun 4A (n=10) compared to c-jun WT (n=9) at 30 
days post-injury. B. Regenerative index of functional recovery calculated as Area Under the Curve for the 
two groups. C. Re-innervation of the target whisker-pad muscle at day 30 after unilateral facial nerve 
axotomy, measured by counting the number of motoneurons positively labelled by retrogradely transported 
fluorescent dye Fluorogold (FG). There was a significant reduction in re-innervation in the c-Jun4A mice 
compared to the c-JunWT. D. The survival adjusted re-innervations showed no significant difference 
between groups. Data points and error bars in these graphs show the mean and SEM, respectively, *p<5% 
in Repeated Test Anova (for whisker movement score) and in unpaired Student’s T-test. 
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Abolition of c-jun N-terminal phosphorylation causes increased cell death and shrinkage 
following facial nerve axotomy 
After axotomy, c-junWT control animals showed 25% neuronal loss, from 1633±118 
neurons on the uninjured side to 1208±64 neurons on the injured side. Such level of cell 
death after axotomy is expected and has been reported in several studies previously. 
However, the c-jun4A mutants showed significantly higher motoneuron death – an almost 
45% reduction in cell survival from 1819 ± 91 on the unaxotomised side to 1041±131 
neurons on the axotomised side (Figure 4.5 A, B). Also, most of the surviving axotomised 
c-Jun4A motoneurons appeared shrunken by 20%, showing a striking reduction in cellular 
diameter from 18.2±0.2 to 14.7±0.5μm (Figure 4.5C; p<0.01%). The opposite effect was 
observed in their control counterparts which underwent chromatolytic enlargement by 10% 
from 17.5±0.4 μm for the uninjured to 19.2±0.3 μm for injured motoneurons (Figure 4.5C; 
p<5%).  
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Figure 4.5. N-terminal phosphorylation of c-jun is required for neuronal survival after facial axotomy. A. 
Nissl-stained coronal sections of facial motoneurons on the contralateral (co) and axotomised (ax) side, and 
at higher 25 X magnification of ax side,  in control (c-junWT) and mutant (c-jun4A) mice, 30 days after 
unilateral facial nerve cut. B. Total motoneuron count, corrected for neuronal size, showed a significant 
reduction in neuronal survival after axotomy in the c-jun4A mice. C. Neuronal diameter measurements (in 
μm) showed a significant shrinkage of c-jun4A neurons after axotomy. *p<5%, ** p<1%, ***p<0.1%, **** 
p<0.01% in unpaired Student’s T-Test, bars and error bars show the mean and SEM respectively.  
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Because the c-jun4A mutants showed 50% reduction in re-innervation, and 45% reduction 
in cell death, the next question was to investigate if the increased cell loss led to the 
reduced target reconnection in these animals. To this end, percentage re-innervation (FG+ 
ax/co%), was divided by percentage survival (Nissl counts ax/co%), to get an index of 
survival adjusted re-innervation. While the c-junWT showed 83±15% re-innervation after 
adjusting for cell survival, the c-jun4A mutants showed a tendency towards lower SAR of 
64±21% (Figure 4.4D). However, this difference was statistically insignificant, suggesting 
that the majority of the regeneration deficits in the mutants are due to excessive 
motoneuron loss.  
The expression of neuronal regeneration associated proteins is unaffected in c-Jun4A 
mice 
Following peripheral nerve transection, the chromatolytic response involves the 
upregulation of regeneration associated proteins which aid in neurite outgrowth and 
elongation. The neuropeptide galanin and the cell adhesion molecule CD44 are important 
mediators of a successful regenerative response and have previously been shown to rely 
on c-Jun upregulation following axotomy (Raivich et al., 2004). To determine whether the 
post axotomy effect of c-Jun relies on phosphorylation of the molecule at ser63&73 and 
thr91&93, the axotomy induced expression of CD44 and galanin in c-Jun4A and c-Jun Wt 
mice was compared at day 4 and day 14 after facial nerve axotomy (Figure 4.6. A-H). C-
Jun4A mice showed no significant difference in CD44 expression or in the expression of 
galanin+ sprouts at day 4 (Figure 4.6 I, K) or day 14 (Figure 4.6 J, L) following axotomy, 
indicating that c-Jun dependent upregulation of neuronal injury markers is autonomous of 
JNK phosphorylation of c-jun following injury. This was in contrast to the moderate 
reduction (-24%) in CD44 immunoreactivity seen in JunAA mice at day 4 after axotomy. 
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Figure 4.6. Neuronal axotomy response is unaffected in c-jun 4A mice. A - H. CD44 and Galanin 
immunoreactivity on the contralateral (co) and axotomised (ax) facial nucleus at day 14 (d14) following 
axotomy in c-jun WT (n=5) and c-jun 4A (n=5) animals. I - L. Quantification of CD44 and Galanin expression 
at d4 and at d14 following axotomy. Injured (co) and uninjured (ax) sides are represented by blue and red 
bars respectively. The abolition of N-terminal phosphoryable c-jun sites, does not impair induction of 
adhesion molecule, CD44 (I, J) or the expression of galanin positive sprouts (K, L) at either time point 
analysed. Bars and error bars show mean and SEM respectively. 
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c-Jun N-terminal phosphorylation is not essential for the activation and recruitment of non-
neuronal cells following axotomy 
Activation of non-neuronal cells around the cell body of injured axons is an integral part of 
the regenerative response following nerve injury (Raivich et al., 1998;Raivich et al., 1999a). 
Neuronal c-jun deletion results in a dramatic reduction in microglial activation and 
leucocyte recruitment 14 days following axotomy, with an accompanying small but 
significant reduction in astrocytic activation (Raivich et al., 2004). In contrast, c-Jun4A 
mice showed no significant difference in early microglial activation as assessed by the 
expression of the αM integrin subunit at day 4, and only a mild (-20%) but statistically 
insignificant reduction in late microglial activation at day 14 following axotomy (Figure 4.7 I, 
J). Both c-JunWt and c-Jun4a mice showed appearance of clustered microglial nodules 
(Figure 4.7. B, D). Furthermore, astrocytic activation as measured by GFAP 
immunoreactivity showed no significant difference in c-Jun4A animals compared to c-
JunWt controls (Figure 4.6 E-H, K-L).  
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Figure 4.7. Non-neuronal response following axotomy is unaffected in c-jun 4A mice. A-H. αM and GFAP 
immunoreactivity on the contralateral (co) and axotomised (ax) facial nucleus at 14 days following facial 
nerve axotomy in c-jun WT (n=5) and c-jun 4A (n=5) animals. I-L. Quantification of αM and GFAP 
expression at d4 and at d14 following axotomy. Injured (co) and uninjured (ax) sides are represented by blue 
and red bars respectively. The abolition of N-terminal phosphoryable c-jun sites, does not impair early (I, K) 
or late (J, L) microglial (I, J) and astroglial (K, L) activation after injury. Bars and error bars show mean and 
SEM respectively. 
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Overall, the c-jun4A mutation results in lesser motoneuron survival, post-traumatic 
neuronal shrinkage, less recovery and less re-innervation than their control counterparts. 
Interestingly, the molecular response in the facial nucleus is more or less normal in the 
mutants, same as in junAA animals, and JNK1-3KOs. 
Chapter 4 – c-Jun Discussion 
Previous scientific evidence has highlighted an important role for c-jun in injury-induced 
nerve repair in adult mice. While deletion of neuronal or Schwann cell c-jun has far-
reaching consequences on the success of peripheral nerve regeneration - delaying 
functional recovery and causing a strong, persistent defect in target re-innervation, there is 
still some residual regeneration in the absence of the transcription factor. Similarly, 
deletion of neuronal STAT3 greatly impedes target re-innervation, functional recovery, 
speed of regeneration, and the biochemical and molecular response from injured neurons 
and neighbouring glial cells. However, a small fraction of the neurons continue to 
regenerate with an apparently ‘normal’ rate of regeneration, accounting for delayed yet 
substantial functional recovery in these animals. This data suggests the likelihood of co-
existence of ‘two different neuronal populations’ – one that is completely devoid of 
regeneration in the absence of transcription factors, and the other that is transcriptionally 
independent in its regenerative ability. To explore this idea, regeneration was analysed in 
double mutants lacking neuronal c-jun (which functions in transcriptional control of 
downstream effectors of regeneration), and also lacking Schwann cell c-jun (which is 
important in mediating trophic signalling). Another possibility is that there are multiple 
transcription factors acting simultaneously, and their concerted action is required for the 
success of regeneration. In the absence of one, others might be increased via a 
compensatory mechanism and account for the residual regeneration in the knock-out 
mutants. In order to investigate this hypothesis, double mutant mice with combined 
deletion of both neuronal c-Jun and STAT3 were generated, and complete obliteration of 
regeneration in the absence of these factors was analysed. Finally, we also investigated c-
jun N-terminal phosphorylation as a mechanism for c-jun activation and function in injury-
induced peripheral nerve regeneration. 
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Neuronal c-Jun & STAT3 are not functionally complementary 
counterparts in facial nerve regeneration 
The possibility of c-Jun and STAT3 belonging to complementary signalling pathways in 
regeneration was investigated by exploring whether combining both deletions, produced a 
stronger, synergistic effect on regeneration, than a simple deletion of either STAT3 or c-
Jun. What emerged was that combined deletion of c-jun and STAT3 interfered with 
functional recovery and re-innervation of whisker-pad, at the same levels as that seen with 
single deletion of either transcription factor, making it unlikely for them to be 
complementary counterparts. Motoneuron loss was abolished in the combined mutants, 
and the surviving neurons were atrophic, again the same effect being seen in the single 
deletion mutants. A comparison of the early and late neuronal and non-neuronal markers 
affected by the absence of either STAT3 or c-jun (Chapter 3- STAT3 results) (Ruff et al., 
2012), also showed a striking similarity, not only in terms of the markers affected but also 
in the degree of deficiency (Table 4.1).  
Regeneration markers % change in 
STAT3ΔS 
% change in           
c-junΔS 
% change in 
STAT3+c-JunΔS 
D28 Functional recovery ↓↓ ↓↓ ↓↓ 
D28 whisker pad re-innervation ↓↓↓ ↓↓↓ ↓↓↓ 
D30 neuronal survival ↓↓ ↓↓ ↓↓ 
D4 regeneration speed (CGRP) ↓↓ ↓↓ - 
D4 regeneration speed (Galanin) ↓↓ ↓↓ - 
D4 nuclear ATF3 ↓↓↓ ↓↓↓ - 
D4 c-jun score No change Abolished - 
D4 nuclear STAT3 Abolished No change - 
D14 integrin β1(OLV) ↓↓↓ ↓↓↓ - 
D14 CGRP+ sprouts ↓↓↓ ↓↓↓ - 
D14 Galanin+ sprouts ↓↓↓ ↓↓↓ - 
D14 CD44 (OLV) ↓↓↓ ↓↓↓ - 
D14 α-M integrin (OLV) ↓↓↓ ↓↓↓ - 
D14 α-X count ↓↓↓ ↓↓↓ - 
D14 B 7.2 count ↓↓↓ ↓↓↓ - 
D14 CD3+ T-cell count ↓↓↓ ↓↓↓ - 
D14 GFAP (OLV) No change ↓ - 
 
Table 4.1. Comparison of regenerative defects in STAT3ΔS and c-junΔS mice 
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It is unlikely that either transcription factor is upstream or downstream of each other since 
normal c-jun expression in seen in STAT3ΔS mice and vice-versa. Rather, it seems that 
the two transcription factors might be co-regulating various aspects of the regeneration 
machinery by forming a ‘double-keyed lock’, whereby absence of any one key 
(transcription factor) is sufficient to prevent unbolting of the ‘lock’ (regeneration). It is even 
possible that there are other transcription factors in addition to c-jun and STAT3, and 
regeneration might be controlled by a ‘multiple-key lock’. A previous study by Kiryu-Seo et 
al, has already shown that co-ordinated action of 3 transcription factors – ATF3, c-Jun, 
and STAT3 – is required for the maximal transcription of regeneration associated gene 
DINE (Kiryu-Seo et al., 2008). As mentioned earlier, the interactions between STAT3 and 
c-jun could be multiple, overlapping and complex – ranging from direct physical interaction 
(Zhang et al., 1999;Schaefer et al., 1995) to co-ordinated retrograde transport of p-STAT3 
and JIP3/JNK3 by DLK upon axon injury (Shin et al., 2012), and concurrent recruitment by 
common STAT3 and c-jun binding proteins to gene promoter regions (Kiryu-Seo et al., 
2008). Interestingly, in a model of MPTP-mediated Parkinson’s disease, c-jun and STAT3 
deletions had completely contrasting results on neuronal survival. While neuronal deletion 
of c-Jun reduced dopaminergic neuron loss in the substantia nigra by 41%, absence of 
neuronal STAT3 had no effect on death or survival of dopaminergic neurons (Patodia and 
Raivich, unpublished data). This result adds further complexity to the relationship between 
c-jun and STAT3, suggesting that they can have convergent or divergent actions 
depending on the model of injury. Genetic profiling of their target genes by microarrays will 
help in the identification of molecular recognition patterns for both regeneration signals.  
In summary, due to the absence of exacerbated deficiency or complete abolition of nerve 
regeneration in the double mutants, it seems unlikely that the two transcription factors 
belong to complementary pathways. Rather, they may be acting in concert to unlock a 
common signalling mechanism in regeneration, and the absence of either factor is 
sufficient to block that stream of regeneration. Further investigation will shed light on the 
prospect of multiple players being involved, and identification of their individual and co-
operative roles in peripheral nerve regeneration. 
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Neuronal c-Jun & Schwann cell c-jun together regulate nerve 
regeneration after facial axotomy 
Analysis of injury-induced regeneration in the absence of neuronal c-jun and STAT3 
showed that in spite of substantial shortcomings in all aspects of the usually robust 
peripheral nerve response, a small fraction of the neurons continued to regenerate 
unaffectedly, producing small amounts of functional recovery and re-innervation, albeit 
with a slight delay. This led to the idea that trophic support from Schwann cells and other 
non-neuronal cells might be sufficient to induce elongation of some axonal fibres even in 
the absence of neuronal transcription factor mediated recovery. The success of 
regeneration after peripheral nerve injury has long been attributed to a combination of 
intrinsic and extrinsic factors. The ‘intrinsic’ mechanism involves changes in gene 
transcription, a part of a set of changes referred to as the “cell body response”. Equally 
important is the presence of a permissive environment with axon guidance cues which 
constitutes the ‘extrinsic’ component. In CNS neurons, diminished intrinsic capacity for 
regeneration together with heightened presence of inhibitory factors of their extracellular 
environment results in poor regeneration (Buchli et al., 2007;Bolsover et al., 2008). 
Schwann cells are vital contributors to the extrinsic response in peripheral nerve 
regeneration, regulating Wallerian degeneration, and releasing neurotrophic factors which 
mediate their effects in a paracrine manner via tyrosine kinase (Trk) receptors on growing 
axonal tips (Raivich, 2011). Recent studies have shown a crucial role of Schwann cell c-
jun in inhibiting myelin gene activation by Krox-20 or cAMP (Parkinson et al., 2008), and 
forming a de-differentiated Schwann cell state, essential for the generation of a growth 
supporting environment in injured nerves, and promoting regeneration after injury (Arthur-
Farraj et al., 2012). In the absence of c-Jun in Schwann cells, the expression of 
neurotrophin genes Artn, BDNF-1, GDNF, LIF, and NGF is severely down-regulated, 
causing severe defects in motoneuron survival, and axonal growth, and resulting in very 
poor functional recovery (Arthur-Farraj et al., 2012;Fontana et al., 2012). Current data 
from experiments using animals lacking both neuronal and Schwann-cell c-jun, show that 
facial nerve regeneration is completely obliterated in the absence of c-jun in the two cell-
types. Comparison of motoneuron number on the uninjured and injured sides 30 days 
after injury revealed that motoneuron survival was strikingly decreased in c-JunΔP0 
animals, with loss of nearly 90% neurons, more than double the loss seen in the controls. 
Such striking cell loss is consistent with earlier reports (Arthur-Farraj et al., 2012;Fontana 
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et al., 2012). Facial motor neurons require neurotrophic factors for their survival and rapid 
death of neurons occurs when peripheral support is completely lost (Yetiser and 
Kahraman, 2008). In complete contrast, motoneuron survival was dramatically increased 
in the c-JunΔS mutants, a four-fold reduction in cell death compared to the controls, a 
phenomenon described in earlier studies from our lab (Raivich et al., 2004;Ruff et al., 
2012). Interestingly, combination of the neuronal and Schwann cell c-jun deletions 
reflected the increased cell survival phenotype of the c-JunΔS mutant; neuronal c-jun 
deletion being sufficient to completely block motoneuron loss due to absence of Schwann 
cell c-jun in the double mutants. However, all surviving neurons were severely atrophic. 
Target re-innervation was also strongly compromised with c-JunΔS animals showing an 
almost five fold decrease, c-JunΔP0 animals more than six-fold decrease, and the c-
JunΔSΔP0 mice a striking forty-fold decrease. When adjusted appropriately for cell 
survival, the double mutants demonstrated a nearly complete abolition of re-innervation 
with a survival adjusted re-innervation value of 1%. 
This study illuminates the yet unexplained conundrum of c-jun having a dual role in cell-
death as well as regeneration. Schwann cell c-jun is a mediator of trophic factor signalling 
in peripheral regeneration, supporting neuronal survival. On the other hand, neuronal c-jun 
is essential for the increased expression of growth associated molecules, perineuronal 
sprouting and re-innervation, but also death of severely injured motoneurons.  Thus, while 
the effects of neuronal and Schwann cell c-jun on regeneration is additive, their effects on 
neuronal survival are antagonistic. Transcriptional control of modulatory factors produced 
by glial cells can compensate, to a small extent, for the loss of functional and anatomical 
regeneration in the absence of neuronal c-jun. However, deletion of both neuronal and 
Schwann cell c-jun results in loss of the cell-body response together with extremely poor 
neurotrophic environment, affecting the ability of axons to extend and re-innervate, 
ultimately leading to a complete suppression of peripheral nerve regeneration. 
 
c-Jun N-terminal phosphorylation affects neuronal survival and 
morphology, and axonal re-innervation after axotomy 
Results from previous and current experiments have highlighted a vital role for c-jun in 
peripheral nerve regeneration (Arthur-Farraj et al., 2012;Fontana et al., 2012;Raivich et al., 
2004;Ruff et al., 2012). In the absence of neuronal c-jun, speed of axonal regeneration is 
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strongly reduced, preventing most axons from making target reconnections and resulting 
in loss of function (Raivich et al., 2004;Ruff et al., 2012). Deletion of Schwann cell c-jun 
exacerbates cell death after injury, preventing target re-innervation and leading to loss of 
muscular function (Arthur-Farraj et al., 2012;Fontana et al., 2012). N-terminal 
phosphorylation of c-jun by JNKs, represented an attractive mechanism for c-jun’s post-
axotomy response, since JNKs are known to be rapidly upregulated and retrogradely 
transported to the cell body, and increase c-jun phosphorylation and stability after injury 
(Brecht et al., 2005;Herdegen and Leah, 1998;Lindwall and Kanje, 2005). Although N-
terminal phosphorylation of c-Jun plays an important role in modifying transcriptional 
activity and elicits strong effects in stroke, ischemia and excitotoxicity, its effects on 
regeneration are less clear. Jun4A mice where all 4 JNK dependent N-terminal 
phosphorylation sites - Thr91&93 as well as Ser63&73 – are removed, were used to 
assess the effect of c-jun N-terminal phosphorylation in peripheral nerve regeneration.  
Usually around 20-40% of lesioned motoneurons are lost after facial nerve axotomy 
(Raivich et al., 2002). c-JunAA mutants show neuronal shrinkage but not increased cell 
death or survival (Ruff et al., 2012b). The c-Jun4A mice showed increase in cell death 
after facial axotomy, suggesting that c-jun4A is a more severe phenotype than c-junAA.  
Also, the surviving neurons had significantly shrunken neuronal cell bodies, similar to the 
c-JunAA mice. Interestingly, late microglial activation at day 14 showed a mild (-20%), but 
statistically insignificant reduction in the c-jun4A mutants compared to controls. It has 
been implied that injury at the distal axon initiates the early response in the cell body by 
survival promoting components of JNK signalling that are retrogradely transported along 
the axon (Lindwall and Kanje, 2005). The data in this present study suggests that c-Jun N-
terminal phosphorylation may be required for normal transportation of survival factors to 
the cell body, which could be important for normal neuronal cell sizes to be regained after 
axotomy. Increased cell death in the c-jun4A mutants contradicts previously published 
reports that c-jun N-terminal phosphorylation is required for kainic acid excitotoxicity 
(Behrens et al., 1999) and for cell death following intrastriatal injections of 6-
hydroxydopamine (Brecht et al., 2005). Concomitant phosphorylation of Thr91&93 by JNK 
and of Thr95 by ATM kinase has been shown to enhance cell death after DNA damage 
(Vinciguerr et al., 2008). Furthermore, Nateri et al., in 2004 demonstrated that complete 
abrogation of all four JNP sites, as in the case of our c-jun 4A mutants, blocks FBW7 
mediated degradation (Nateri et al., 2004). Conditional deletion of c-jun in Schwann cells, 
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also showed increased cell death and reduced re-innervation after axotomy (Fontana et al, 
2012; Chapter 4-results), suggesting that the effects N-terminal phosphorylation might be 
important for c-jun action in Schwann cells. In cell culture, enhanced phosphorylation 
activation of c-Jun with anisomycin, a JNK activator, causes increased production of 
neurotrophins (Fontana et al., 2012), a function attributed to injury-induced c-jun response 
in Schwann cells (Arthur-Farraj et al., 2012;Fontana et al., 2012). However, c-jun 
mediated inhibition of myelin genes in Schwann cells does not appear to depend upon the 
classical N-terminal phosphorylation of c-jun by JNKs (Parkinson et al., 2008).  
Deletion of c-Jun, results in a 74% and 92% decrease in the expression of galanin and 
CD44 respectively, and microglial activation is impaired by 88% (Raivich et al., 2004). The 
jun4A mutation, however, did not interfere with the expression of injury-associated 
neuronal (CD44 and galanin) and non-neuronal markers (microglial, astroglial, and 
leucocyte), similar to the junAA, and JNK1-3 KOs (Ruff et al., 2012). On the other hand, as 
in the JNK1&3 null mutants, the c-jun4A strain reproduced the moderate reduction in 
functional recovery and a 50% lower number of re-innervating motoneurons at 28 days 
following facial nerve cut. This effect on regeneration, though significant, is considerably 
smaller than that observed for neuronal c-Jun deletion and is not accompanied by any of 
the molecular changes in the facial nucleus seen with deletion of c-Jun, suggesting that 
the regeneration effect of neuronal c-Jun is mostly independent of its N-terminal 
phosphorylation. However, the similar pattern of increased cell death, and reduced re-
innervation in the c-Jun4A and c-JunΔP0 mutants suggest that JNK mediated N-terminal 
phosphorylation might be important for SC c-jun arbitrated trophic signalling and neuronal 
survival following facial axotomy. 
Taken together, these results suggest that c-Jun N-terminal phosphorylation is not the vital 
mechanism through which neuronal c-Jun is activated and exerts its functions in nerve 
regeneration. c-junAA mutants and global deletion of individual JNKs, have very mild 
effects on regeneration (Ruff et al., 2012) compared to complete c-jun ablation in neurons. 
c-Jun4A mutants appear to be a combination of the c-junAA and JNK1-3 phenotypes – 
less re-innervation, functional recovery and neuronal survival, post-traumatic neuronal 
shrinkage, and very little change in neuronal molecular response - but it does not quite 
reproduce the changes seen with neural c-jun deletion. Rather its role in mediating 
excessive neuronal cell death and a moderate reduction in re-innervation after axotomy, 
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suggests the involvement of c-Jun N-terminal phosphorylation in the post-traumatic 
response of c-jun in SCs. 
In addition to the N-terminal phosphorylation sites, c-jun has additional phosphorylation 
(Thr239) and acetylation sites (Lys268, 271 and 273) in its hinge and basic regions which 
are downstream of the glycogen synthase kinase-3 (GSK3) and p300 pathways, the 
pathways being activated via PI3K or ERK 1 & 2 (Raivich, 2008;Vries et al., 2001;Wang et 
al., 2006). Therefore, understanding how neuronal c-jun mediates its regenerative effects 
in vivo may warrant a closer investigation of these alternate activation pathways through 
selective amino-acid replacements, similar to the exchange of the N-terminal serines and 
threonines. Given the striking role of c-jun in regeneration, unraveling its molecular 
pathways, will enhance its capacity for use as a clinical target to improve regeneration 
following peripheral, and potentially also central injury.  
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Chapter 5 - C/EBPδ Results 
 C/EBPδ is involved in neuronal survival, microglial activation, and 
central sprouting following facial nerve axotomy 
 
The transcriptional factor C/EBP delta belongs to the CCAAT/enhancer binding protein 
transcription factor family of basic leucine zipper binding proteins which show almost 
ubiquitous expression throughout the body, and respond to signals of injury and 
inflammation (Ramji and Foka, 2002;Sterneck et al., 1998). Like other C/EBPs, C/EBPδ 
has previously been shown to be activated by various cytokines, and is also implicated to 
play a role in axonal regeneration – controlling the expression of downstream 
regeneration-associated gene SPRR1A, and inducing axonal regeneration of DRG 
neurons after sciatic nerve crush (Lopez de and Magoulas, 2013). Here, by using mice 
with global C/EBPδ gene deletion and the facial axotomy model, we have shown that 
C/EBP acts as a moderate regulator of microglial activation, neuronal sprouting, and cell 
survival after facial nerve transection. 
 
C/EBPδ is required for efficient neuronal sprouting response, but not 
for CD44 up-regulation following nerve injury 
Upregulation of growth associated proteins by injured neurons is considered to contribute 
significantly to the success of the final regenerative outcome following injury (Raivich and 
Makwana, 2007). Numerous chromatolytic changes take place in the cell body of injured 
axons in order to support growth cone formation and efficient elongation of the axon. 
In order to investigate the involvement of C/EBPδ in the neuronal response following facial 
nerve axotomy, 20µm brainstem sections containing the injured and uninjured facial nuclei 
were immuno-histochemically stained for neuropeptide galanin (Figure 5.1 A-D) and cell 
adhesion molecule CD44. Galanin expression is increased in central axonal sprouts within 
the facial nucleus in the hindbrain, as well as in the regenerating nerves. Counts of galanin 
positive sprouts in the facial nucleus revealed a 44% decrease in galanin expression (from 
84±4 galanin+ sprouts in C/EBPδ+/+ mice to 47±5 in C/EBPδ-/- mice) in the axotomised 
facial nucleus at day 14 following axotomy (Figure 5.1.E).  
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Figure 5.1. CEBPδ is required for neuronal sprouting following axotomy. A-D. Galanin 
immunohistochemistry showing facial nerve axotomy response in the C/EBPδ+/+ controls (A, B) and the 
C/EBPδ-/- mutants (C, D) on the contralateral side (co) and on the axotomised side (ax). After axotomy, 
CEBP δ+/+ mice show a prominent increase in neuropeptide galanin (A-B). Deletion of CEBPδ significantly 
reduces the galanin-associated sprouting response (D). E-G. Quantification of overall facial motor nucleus 
immunoreactivity by manual counts or OLV units at 4 (d4) and 14 days (d 14) after nerve cut for galanin (E) 
and CD44 (F,G) in CEBPδ+/+ (n=5) and CEBPδ-/-  mice (n=5). The contralateral (co) and axotomised (ax) 
sides are indicated by blue and red bars respectively. Galanin showed a significantly smaller increase in the 
mutants compared to controls. CEBPδ was not required for induction of CD44 following injury. ***p< 0.1% in 
unpaired Student’s T-Test, bars and error bars represent mean and SEM respectively.  
 
CD44, a cell surface glycoprotein, plays an important role in cell adhesion during neurite 
outgrowth and in the glial and leucocyte response following nerve injury (Jones et al., 
1997;Jones et al., 2000). It is a hyaluronic acid receptor, and its expression is strongly 
upregulated within the facial motor nucleus after axotomy. Quantification of CD44 by 
luminosity revealed no difference in CD44 immunoreactivity between wild type and mutant 
animals at 4 or 14 days after axotomy (Figure 5.1 F, G). These results indicate that 
endogenous C/EBPδ is required for the induction of galanin positive sprouts following 
axotomy, but not for the expression of the cell adhesion molecule CD44. 
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C/EBPδ is required for microglial but not for astroglial or leucocyte 
response following injury 
In addition to the neuronal response, the expression of non-neuronal hematopoietic and 
neuro-epithelial cells which participate in inflammation, repair and lesion point stability is 
an essential part of a successful regenerative response (Raivich et al., 1998).  This non-
neuronal cellular response was assessed by measuring levels of activation of microglia 
and astroglia, and amount of leucocyte recruitment to the injured facial nucleus. The 
uninjured nuclei of both C/EBPδ+/+ and C/EBPδ-/- mice had similar levels of resting 
microglia and protoplasmic astrocytes, and no leucocytes. After axotomy, CEBPδ-/- mice 
showed a significant decrease in both early (d1, d4) and late (d14) microglial activation as 
assessed by αM immuno-staining in the facial nucleus (Figure 5.2 A-L). 38% decrease in 
the expression of the αM integrin microglial subunit was seen at day 1 (Figure 5.2 D, M), 
reducing to a 24% decrease at day 4 (Figure 5.2 H, N; p<5%) and a 16% decrease at day 
14 (Figure 5.2 L, O; p<5%). T-lymphocyte recruitment as measured by counts of CD3+ 
cells in the axotomised facial nucleus showed no significant differences between C/EBPδ-/- 
and C/EBPδ+/+ animals (Figure 5.2Q). Similarly, astrocytic activation as measured by 
GFAP immunoreactivity was unimpaired in the C/EPBδ-/- animals (Figure 5.2P).   
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Figure 5.2. CEBPδ is involved in microglial activation following axotomy.  A - L.  Facial nerve axotomy response 
after nerve cut in the CEBPδ+/+ controls (A,B,E,F,I,J) and the CEBPδ-/- mutants (C,D,G,H,K,L) on the contralateral 
side (co) (1
st
 & 3
rd
 column), and on the axotomised side (ax) (2
nd
 & 4
th
 column). After FNA, CEBPδ+/+ mice show a 
prominent increase microglial marker αM integrin (A-B, E-F, I-J) and GFAP (IHC not shown). Deletion of CEBPδ 
significantly reduces microglial activation at all three time-points analysed (C-D, G-H, K-L).  M - Q. Quantification of 
overall facial motor nucleus immunoreactivity by manual counts or OLV units at 1 (d1), 4 (d4) and at 14 days (d 14) 
after nerve cut for αM integrin (M-O), GFAP (P) and CD+ T-cells (Q) in CEBPδ+/+ (n=5) and CEBPδ-/-  mice (n=5). 
The (co) and (ax) sides are indicated by blue and red bars respectively. αM showed a significantly smaller increase 
in the mutants compared to controls. CEBPδ was not required for astrocytic activation or T-cell recruitment 
following injury. *p< 5% in unpaired Student’s T-Test, bars and error bars represent mean and SEM respectively. 
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Combined deletion of global C/EBPδ and neuronal STAT3 does not 
exacerbate the regeneration defects caused by STAT3 deletion alone 
As both STAT3 and C/EBPδ play a role in peripheral regeneration, the likelihood of them 
being functionally complementary counterparts in peripheral nerve regeneration was 
investigated. Double KO mice having global C/EBPδ deletion, and neuronal STAT3 
deletion were generated. The right facial nerve was cut at the stylomastoid foramen, 
thereby axotomising the facial motoneurons. The animals were allowed to survive for 30 
days. All assessments were done similarly and simultaneously on mice with single gene 
deletions, and on control mice, to assess synergistic effects and interactions between the 
two transcription factors. 
Functional recovery was assessed by scoring post-traumatic whisker hair movement every 
other day on a scale of 0 (no movement) to 3 (normal movement). Both the controls, and 
the mice with single deletion of C/EBPδ, showed recovery by day 11 and improved 
steadily over the next two week to a score of around 2.4 by day 28; in fact C/EBPδ 
deletion, rather than impeding motor function recovery after facial nerve cut, resulted in 
significantly faster recovery compared to controls between day 11 to day 21. Thereafter, 
the effect disappears, possibly because recovery of controls by that time is already very 
good. Recovery in the STAT3ΔS mutants was significantly poorer (as observed earlier in 
Chapter 3 –STAT3 Results), and reached a maximum score of 0.8 ± 0.1 at day28. 
Deletion of C/EBPδ in addition to neuronal STAT3 deletion resulted in significantly better 
functional recovery than STAT3 deletion alone, achieving a score of 1.6 ± 0.1 by day 28 
(Figure 5.3A). These varied trends in functional recovery are reflected by the Recovery 
Index (RI) for the four groups (Figure 5.3B). 
The same experimental cohorts were also assessed for target muscle re-innervation and 
motoneuron survival. Whisker pads were labelled bilaterally with the fluorescent tracer 
Fluoro-Gold (FG), followed by 48 h retrograde transport. Motoneurons that successfully 
reconnected with their targets were identified by the presence of the retrograde tracer in 
their somas, and counted on every fifth section throughout the facial nucleus. Control 
animals showed retrograde labelling of 70±7% on the axotomised side compared with the 
uninjured side. C/EBPδ deletion alone produced no change in re-innervation ability with 
animals showing 81 ± 3% labelling. In contrast, neuronal STAT3 deletion drastically 
reduced the percentage of re-innervating neurons to 15±4% (Figure 5.3D).  
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Figure 5.3. Deletion of C/EBPδ improves functional recovery and neuronal survival following axotomy, and 
combined deletion of C/EBPδ with neuronal STAT3 deletion does not exacerbate the regeneration defect 
seen with deletion of neuronal STAT3 alone. A. Time course for functional recovery of whisker hair 
movement on a scale from 0 (no movement) to 3 (full movement, equivalent to uninjured side) at 30 days 
post-injury. B. Overall regenerative index of functional recovery (calculated as Area Under the Curve). C. 
Percentage survival of facial motoneurons 30 days after axotomy showed increased neuronal survival in 
absence of either C/EBPδ  or neuronal  STAT3 or both. D. Quantification of Fluorogold retrograde labels 
following FNA shows reduced re-innervation in the absence of neuronal STAT3 with or without simultaneous 
global deletion of C/EBPδ. E. Survival adjusted re-innervation also shows reduced re-innervation in the 
absence of neuronal STAT3 with or without simultaneous global deletion of C/EBPδ. *p< 5%, **p<1%, 
***p<0.1%, ****p<0.01%  in unpaired t-test, bars and error bars show the mean and SEM, respectively.  
 
However, the combination of global C/EBPδ, and neuronal STAT3 deletions did not make 
the phenotype more or less severe than what was observed with neuronal STAT3 deletion, 
with the animals achieving 12±3% re-innervation by day 30 (Figure 5.3B). Survival 
adjusted re-innervation showed the same trend (Figure 5.3E). 
To explore whether alterations in motoneuron survival contributed to the observed 
reduced re-innervation and functional recovery, motoneuron number on the uninjured and 
injured sides at 30 days after injury were compared. It revealed a loss of 27 ± 4% neurons 
in the control group, injured side. However, motoneuron death was significantly decreased 
in C/EBPδ and STAT3 single and double mutants. C/EBP single mutants had 94±4% 
motoneuron survival, STAT3 single mutants 109±7%, and the double mutants 98±3% 
(Figure 5.3C; p<0.1%). The extent of microglia recruitment correlates with the severity of 
neuronal cell death (Raivich and Banati, 2004). In agreement with reduced neuronal death 
in C/EBP and STAT3 single deletions, there was a reduction in the levels of microglial 
activation in these mutants, as mentioned earlier in this and previous chapters. Therefore, 
C/EBPδ deletion, while producing a significant effect of its own on neuronal survival, is 
subsumed in double null mice, suggesting that the C/EBPδ phenotype might be a 
composite part of the overall neuronal STAT3 mediated response. 
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Chapter 5 – C/EBPδ Discussion 
C/EBPδ plays a role in neuronal survival and microglial activation 
following axotomy 
Analysis of cell survival at 30 days after facial axotomy showed a significant 22% increase 
in number of surviving motoneurons in the global C/EBPδ knock-outs compared to the 
control animals.  Increased neuronal survival has been seen earlier in the absence of 
other transcription factors like STAT3 and c-jun (Chapters 3 & 4). Motoneuron survival 
was also significantly increased in C/EBPδ and STAT3 double mutants, but no more than 
in the single mutants. 
Activation of microglia following axotomy is a hallmark feature of the regenerative 
response. Microglia respond to signals of stress and injury by extensive proliferation, 
eventually becoming phagocytic in instances of increased cell death (Raivich et al., 1999a). 
In this study, C/EBPδ-/- animals showed a mild to moderate, but statistically significant 
reduction in microglia expression compared to controls at three separate time points. 
Interestingly, the reduction in microglial activation diminished with increasing time after 
injury, going from -38% at day 1, to -26% at day 4 and -14% at day 14. C/EBPδ has been 
long implicated in mediating neuro-inflammatory responses in the brain (Alam et al., 
1992;Ramji and Foka, 2002), supporting the above finding of reduced microglial activation 
in its absence. Further, maximal reduction in microglial activation was seen at the earliest 
time-point analysed (day 1), suggesting that C/EBPδ mediated regulation of microglia is 
associated with the injury-induced inflammatory and immune response. The extent of 
microglia recruitment correlates with the severity of neuronal cell death (Raivich and 
Banati, 2004), therefore reduced microglial activation in the absence of C/EBPδ reaffirms 
a role of this transcription factor in inducing cell death. On the other hand, CD3+ T-
lymphocytes which accompany microglia in phagocytosis, showed no complementary 
decrease in expression in the C/EBPδ-/- mutants at day 14.  Further work will be required 
to assess the mechanisms of C/EBPδ mediated microglial activation and motoneuron 
death, and to determine whether the impairment in microglial activation following axotomy 
in the C/EBPδ-/- animals is a consequence of C/EBPδ absence in neuronal or other cells.  
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C/EBPδ deletion improves functional recovery in neuronal STAT3 null 
mice 
The concerted action of several transcriptional factors is the likely mechanism by which 
they control the activation and expression of a wide range of effector molecules that 
orchestrate axonal regeneration. Neuronal deletion of STAT3 severely reduced functional 
recovery and re-innervation of the peripheral target. A few studies have shown that 
C/EBPδ is associated with the transcriptional response to neuronal injury and with axonal 
elongation (Lopez de and Magoulas, 2013;MacGillavry et al., 2011). Severely 
compromised sensory and motor function after sciatic nerve injury in C/EBPδ null mice 
has been reported in a recent publication (Lopez de and Magoulas, 2013). As both STAT3 
and C/EBPδ play a role in peripheral regeneration, the likelihood of them being 
functionally complementary counterparts in peripheral nerve regeneration was 
investigated. By using double knock-out mice, the hypothesis that deletion of both 
signalling streams will lead to a massive reduction in regeneration compared to single 
gene deletions was tested. Interestingly, our studies showed that C/EBPδ deletion did not 
impede motor function recovery after facial axotomy. On the contrary, it significantly 
improved post-traumatic whisker movement, compared to controls and neuronal STAT3 
deletion alone. C/EBPδ deletion, when combined with neuronal STAT3 deletion, even 
improved recovery in the very slow recovering STAT3 mutants. The mechanism for 
increased functional recovery in the absence of C/EBPδ is as yet unknown, and may 
include factors like improved myelination. In terms of anatomical re-innervation, C/EBPδ 
deletion produced no change in re-innervation ability, on its own or in combination with 
neuronal STAT3 deletion. 
C/EBPδ mediates neurite outgrowth following facial nerve axotomy 
The neuronal response involves the upregulation of various growth-associated molecules 
inside the cell body of injured axons leading to axonal elongation at the site of injury and 
the formation of intra-brainstem sprouts around the cell body of injured axons. Centrally 
sprouting neurites express neuropeptide galanin (Makwana et al., 2010) and deletion of 
galanin results in a 35% reduction in rate of peripheral nerve regeneration after sciatic 
nerve crush (Holmes et al., 2000). In this study, global deletion of transcription factor, 
C/EBPδ resulted in a 40% reduction in the number of galanin positive sprouts in the facial 
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nucleus at 14 days following axotomy, underscoring a role for C/EBPδ in mediating neurite 
growth after injury.  
Interestingly, in 2005, Nadeau and colleagues showed a role of C/EBPβ, another member 
of the C/EBP transcription factor family, in regulating the expression of microtubule α-
tubulin protein and GAP43, a growth cone protein, after injury (Nadeau et al., 2005). 
According to two recent reports, C/EBPs are also involved in axonal outgrowth in vitro 
(MacGillavry et al., 2011), and necessary for the efficient axonal regeneration of DRG 
neurons after sciatic nerve crush in vivo (Lopez de and Magoulas, 2013). Lack of C/EPBδ 
caused a major reduction in the regenerative response of DRG neurons to a conditioning 
lesion, and affected the expression of regeneration-associated molecule SPRR1A, but not 
of galanin or GAP-43. This is in contrast with our current experiments which show 
reduction in galanin levels to nearly half in the C/EBPδ null mutants. As STAT3 has also 
been shown to regulate the expression of galanin positive sprouts following axotomy 
(Chapter3 – STAT3 Results), concerted action of the two transcription factors might be 
responsible for the pro-regenerative effects following axotomy. Taken together, these 
results indicate an important role for C/EBP family of transcription factors in axonal 
sprouting and outgrowth following injury, possibly through transcriptional activation of 
cytoskeletal elements which mediate aspects of actin rearrangement, formation of the 
growth cone, and expression of neuropeptide galanin.  
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Chapter 6 – CAP23 Results 
Neuronal CAP23 plays a role in axonal regeneration, central 
sprouting and early glial response after facial axotomy 
CAP23 is a cytoskeletal-associated protein present in growth cones, with known functions 
in actin remodelling and anatomical plasticity. CAP-23 is upregulated by facial motor 
neurons within three days following facial nerve transection (Anderson et al., 2006). 
CAP23, along with GAP43, another growth cone adaptor, has been shown to induce long 
neurite extensions in vitro, and after spinal cord injury in vivo (Bomze et al., 2001). Most 
CAP-23 KO mice die before adulthood and are therefore unsuitable for studying the role of 
CAP23 in successful axonal regeneration in adult animals. By using loxP-cre recombinase 
method, we have generated mice with neuron-selective deletion of the CAP23 gene in 
order to investigate the in vivo function of neuronal CAP23 in motor axon regeneration of 
peripheral nerves. 
 
Neuronal CAP23 deletion interferes with target re-innervation after FNA 
Effects of CAP23 on axonal regeneration were assessed by measuring the extent of 
functional recovery and re-innervation of peripheral target 30 days after PNI.  
Functional Recovery  
To assess the level of functional recovery post injury, the post-traumatic whisker hair 
motor performance was scored on a scale of 0 (no movement) to 3 (normal movement as 
on uninjured side) every alternate day from day 7 after surgery till day 28 (Figure 6.1A). 
The CAP23∆S animals had similar levels of motor performance compared to the 
CAP23F/F animals right through the 28 day assessment period, and by day 28 post 
axotomy, the control and mutant animals both had achieved similar motor performances 
(1.4±0.2 and 1.6±0.3 respectively). When represented as regeneration index, i.e., the Area 
Under the Curve for the functional recovery over days 0-28 (Figure 6.1B), the two groups 
again showed similar functional levels with the CAP23F/F mice (n=11) having an index of 
0.9±0.1 and the CAP23ΔS mutants (n=9) an index of 0.8±0.1.  
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Figure 6.1 – CAP23 regulates re-innervation following nerve axotomy. A, B - Time course (A) for functional 
recovery of whisker hair movement on a scale from 0 (no movement) to 3 (full movement, equivalent to 
uninjured side) and the recovery index (B) calculated as Area Under The Curve (AUC) shows no difference 
between functional recovery in the CAP23ΔS mutants (n=11) compared to the CAP23
 
F/F
 
controls (n=9) at 
30 days post-injury. C, D - Quantification of Fluorogold retrograde labels in the CAP23F/F and CAP23ΔS 
animals following facial axotomy shows reduced re-innervation in the absence of neuronal CAP23. (C) 
shows the number of FG labelled motor neurons in the facial nucleus on the contralateral (co) and 
axotomised (ax) sides at 30 days after facial nerve cut. CAP23ΔS mutants showed about 34% less whisker 
pad re-innervation compared to CAP23F/F
 
controls. Percentage re-innervation, calculated as a ratio of 
labelled neurons on the axotomised to the contralateral side (ax/co %) following injury, showed a significant 
reduction in re-innervation in the absence of CAP23 in the neurons. *p< 5% in unpaired t-test, bars and error 
bars in these graphs show the mean and SEM, respectively.  
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Re-innervation of the peripheral target  
To determine any differences in re-innervation efficiencies between the CAP23F/F and 
CAP23ΔS mice, a fluorescent tracer FG was injected into the whisker pads of mice 
bilaterally, 28 days post axotomy, and the mice allowed to survive for 48 hours to enable 
retrograde transport of the tracers. The level of re-innervation at day 30 following facial 
axotomy was assessed by counting the number of FG positive motoneurons in the injured 
facial nucleus and comparing them with the uninjured, control side. The overall ratio of 
labelled FG neurons on the ipsi- vs. the contra-lateral side in the CAP23∆S mutants (n=7) 
was only 53±9% as compared to 80±8% in the CAP23F/F controls (n=8) (Figure 6.1 C,D). 
This reduction of re-innervation (-34%) in the mutants is statistically significant, suggesting 
a role for neuronal CAP23 in peripheral target re-innervation but not for functional recovery. 
 
Neuronal CAP23 does not affect motoneuron survival after PNI 
Facial axotomy results in delayed neuronal cell death which peaks at day 14 after injury 
(Raivich et al., 1998), probably due to lack of trophic support resulting from failed re-
innervation (Ferri et al., 1998). The level of cell survival following facial axotomy was 
assessed by counting all motoneurons through the whole facial nucleus on the control and 
injured side using Nissl stained sections (Figure 6.2A). The number of motoneurons on the 
unoperated side of the CAP23F/F controls (3291±135; n=11) and the CAP23ΔS mutants 
(3411±191; n=8) were similar to each other and in line with previously published data on 
the facial nucleus (Galiano et al., 2001;Raivich et al., 2004;Sendtner et al., 1997). 
Compared to the unoperated side, facial axotomy led to a loss of 23±9% of motoneurons 
in the CAP23∆S (2536±142 on the axotomised side) animals compared to 33±4% loss in 
the CAP23F/F animals (2173±130 on the axotomised side). Although, there was no 
statistical significance, the mutants tended to show a mild increase in cell survival (Figure 
6.2.B). No atrophic morphology was seen on either the axotomised or the contralateral 
side. 
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Figure 6.2 – Neuronal CAP23 is not involved in neuronal cell death or survival following peripheral nerve 
injury. A. Micrographs showing cresyl-violet staining of the uninjured (co) and injured (ax) facial nucleus of 
CAP23F/F
 
and CAP23ΔS mice at day 30 post facial axotomy. B. Quantification of motoneuron number in the 
facial nucleus 30 days after axotomy did not show any difference in the neuronal numbers between the 
mutants and the controls on the contralateral (blue bars) or the axotomised (red bars) side. Bars and error 
bars represent mean and SEM respectively. 
 
Neuronal CAP23 is involved in axonal sprouting 
Transection of the facial nerve leads to axonal sprouting, which peaks at day 14 post 
axotomy. These neuronal sprouts express high levels of neuropeptides like galanin and 
CGRP which can be assessed by measuring the levels of their immunoreactivity in the 
injured facial nucleus. Quantification of the total galanin levels in the facial nucleus at day 
4 and 14 by optical luminosity showed a trend towards reduced galanin levels in the 
CAP23∆S mutants compared to the CAP23F/F animals, however the data did not achieve 
statistical significance (Figure 6.3S). On the other hand, the manual counting of sprouts 
revealed a dramatic reduction (-46%) in galanin positive sprouts in the CAP23∆S mutants 
(44.2±8.8 sprouts on the axotomised side) compared to their littermate controls (82.3±12.7 
sprouts on the axotomised side) (Figure 6.3T). These results suggest a mechanism of 
action for previously reported findings which propose a role of CAP23 in neuronal 
sprouting (Bomze et al., 2001;Frey et al., 2000).  
  Chapter 6 – CAP23 Results  
153 
 
 
  Chapter 6 – CAP23 Results  
154 
 
Figure 6.3 – Neuronal CAP23 is required for axonal sprouting but not for other aspects of neuronal injury 
response. A - P.  Facial nucleus axotomy response 14 days after nerve cut in the CAP23F/F controls 
(A,B,E,F,I,J,M,N) and the CAP23ΔS mutant (C,D,G,H,K,L,O,P) mice on the contralateral side (co) (1st and 
3
rd
 column), and on the axotomised side (ax) (2
nd
 and 4
th
 column). After axotomy, CAP23F/F mice show a 
prominent increase in adhesion molecule CD44 (A-B, E-F) and neuropeptide Galanin (I-J, M-N). Q - T. 
Quantification of overall facial motor nucleus immunoreactivity by manual counts or OLV units at 4 (d4) and 
at 14 days (d 14) after nerve cut for CD44 and Galanin in CAP23F/F (n=5) and CAP23ΔS mice (n=5). The 
(co) and (ax) sides are indicated by blue and red bars respectively. While CD44 upregulation is not altered in 
the absence of neuronal CAP23 (C-D, G-H), the number of galanin positive sprouts is significantly reduced 
in the CAP23 mutants. No galanin-positive growth cones were observed at day 4 in the uninjured or 
axotomised nucleus of mutants or controls. *p<5%; bars and error bars show mean and SEM respectively. 
 
CD44 is another axonal regeneration marker, up-regulated by the neuronal cell body 
following facial nerve transection (Jones et al., 1997;Jones et al., 2000). In order to see if 
this up-regulation was dependent on neuronal CAP23, CD44 immunoreactivity at days 4 
and 14 after axotomy was compared between the CAP23∆S mutants (n=5) and the 
CAP23F/F controls (n=5) (Figure 6.3. A-H). As demonstrated in Figure 6.3 Q, R, axotomy 
induced CD44 up-regulation was not affected by CAP23 deletion at either time-point. 
 
Neuronal CAP23 deletion affects early but not late glial response  
Nerve injury induces changes in the surrounding non-neuronal cells within the brain. Early 
microglial activation is characterised by increased immunoreactivity for thrombospondin 
(TSP), αMβ1 integrin, ICAM and IBA1 within the first 24 hours of injury. After the initial 
activation, microglia enter a proliferation phase, followed by a phagocytic phase with a 
peak at d14 post injury, which coincides with the peak of cell death (Raivich et al., 1999a). 
The level of microglial activation following facial axotomy at d4 and d14 in the CAP23 
controls and mutants was assessed by measuring αM immunoreactivity via luminosity 
(Figure 6.4 A-H). At day 4, the CAP23ΔS animals showed a moderate but significant 
reduction (-35%; p<5%) in early microglial activation in the axotomised nucleus as 
compared to the CAP23F/F controls (Figure 6.4D,Q). By day 14, this defect was no longer 
seen in the mutants, suggesting a delayed onset of microglial activation in the mutants. No 
statistical significance was found between injury-induced microglial activation at day 14 
between the two groups (Figure 6.7R).  
  Chapter 6 – CAP23 Results  
155 
 
 
  Chapter 6 – CAP23 Discussion  
156 
 
Figure 6.4 – CAP23 deletion affects early but not late glial response following FNA. A-P. Microglial (A-H) 
and astrocyte (I-P) activation after nerve cut in CAP23F/F control (A,B,E,F,I,J,M,N) and CAP23ΔS mutant 
(C,D,G,H,K,L,O,P) mice on the contralateral side (co) (1st & 3
rd
 column), and on the axotomised side (ax) 
(2
nd
 & 4
th
 column). Glial activation was detected through immunoreactivity for αM and GFAP at days 4 and 
14 after axotomy. After axotomy, CAP23F/F mice show a prominent increase in both markers at both time-
points. In CAP23ΔS mutants, both astrocytes and microglia showed a decrease in the extent of their early 
activation but reached normal levels of activation by day 14. Q - T. Quantification of microglial and astrocyte 
activation at 4 (d4) and at 14 days (d 14) after nerve cut show a significant reduction on the (ax) side for 
microglial components at d4 (Q) but not at d14. Similarly GFAP immunoreactivity showed a trend towards 
reduced activation (p=8%) in the mutants as compared with controls, at day 4 after facial axotomy. 
 
As with microglia, astrocyte response to injury proceeds through several stages. There is 
a rapid increase in synthesis of GFAP within 24 hours of axotomy and the appearance of 
GFAP positive processes at day 2-3 after axotomy (Raivich et al., 1999a). The level of 
astrocytic activation following facial axotomy at d4 and d14 was assessed by measuring 
levels of GFAP immunoreactivity via luminosity. As demonstrated in Figure 6.4. S, T, no 
significant difference was seen between the CAP23∆S and the CAP23F/F animals at day 
4 or 14, however on day 4 there was a trend for mutants to have reduced astrogliosis on 
the axotomised side (p=8%; Figure 6.4S). 
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Neuronal CAP23 is required for axonal re-innervation and sprouting  
The CAP23ΔS mutants showed reduced re-innervation of the peripheral target by 34% at 
day 30 after facial axotomy compared to their littermate controls. Interestingly, this defect 
in axonal regeneration was not reflected by the pattern of whisker hair function recovery in 
the mutants, suggesting that with moderate reductions in re-innervation, functional 
recovery can be normal. 
Facial axotomy leads to enhanced axonal sprouting, accompanied by an increase in 
immunoreactivity for neuropeptides like galanin and CGRP in the axotomised facial 
nucleus.  These molecules are also present in growth cones and can enhance growth 
cone extension by overcoming the inhibitory cues in the extracellular environment. In 
CAP23ΔS animals, a significant reduction in galanin positive sprouts by nearly 50% was 
seen at day 14 post injury in the axotomised facial nucleus. No significant changes were 
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seen in overall luminosity measurement of galanin immunoreactivity in the facial nucleus, 
as this measurement included cellular galanin, as well as those localized to the growth 
cones. Cellular galanin peaks at day 4 post injury, but is still present at day 14 (Werner et 
al., 2000b). In 2000, Frey et al., showed that overexpression of CAP23 in adult neurons of 
transgenic mice promoted nerve sprouting and CAP23 knockout mice failed to produce 
stimulus induced nerve sprouting at adult neuromuscular junction (Frey et al., 2000). 
Experiments with pre- and post-synaptic toxins have shown that in the presence of CAP23, 
sprouting is stimulated by a mechanism that responds to reduced neurotransmitter release 
and may be independent of post-synaptic activation (Caroni, 1997). Terminal Schwann 
cells respond to the change in neurotransmitter release and mediate the growth promoting 
signal (Son and Thompson, 1995) which, in the presence of CAP23, results in axonal 
sprouting. At the structural level, CAP23, along with the other GMC proteins, is a major 
intrinsic determinant of anatomical plasticity in neurons, and appears to support axonal 
sprouting by remodelling the actin cytoskeleton for the formation of stable growth cones 
(Laux et al., 2000). In the absence of CAP23, actin structures do not accumulate at the 
leading edge and motile growth cones cannot form, causing loss of directed outgrowth and 
axonal sprouting, as demonstrated in the current results. These results point towards a 
role of CAP23 mediated axonal sprouting in re-innervation after peripheral nerve injury.  
 
Neuronal CAP23 is involved in early microglial activation, but not 
in regulation of neuronal survival after axotomy 
Activation of microglial cells and astrocytes show a graded response after injury. Microglial 
activation occurs in four stages - passing through initial alert and homing stages to later 
phagocytic and bystander activation phases. αM expression, therefore, has a biphasic 
profile, with an early peak during days 1-4 and a late peak at day 14, accompanied by a 
peak in cell death  (Moller et al., 1996). Deletion of CAP23 affects microglial activation in a 
stage-specific way, causing a significant reduction (-45%) in early microglial activation at 
day 4, with only a mild (-12%) and statistically insignificant reduction at day 14, in the 
axotomised facial nucleus. The conundrum of activated microglia being potentially harmful 
or beneficial to injured neurons has been a long-standing debate (Streit, 1993;Polazzi and 
Monti, 2010). Their ability to enhance or inhibit neuronal survival and regeneration is the 
outcome of a delicate balance of their neuroprotective and neurotoxic effects. In the 
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current study, reduction in early microglial activation (at day 4) in the absence of neuronal 
CAP23 did not affect neuronal survival at day 30.  This suggests a role for CAP23 in 
regulating early microglial activation in immune surveillance and inflammatory response, 
rather than in neuronal survival. To test this hypothesis, motoneuron survival was 
assessed in mutant and control groups 30 days after axotomy. Indeed, no difference was 
seen in the ratios of unaxotomised to axotomised motoneuron numbers. 
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Chapter 7 - β-1 integrin Results 
β-1 integrin is required for neuronal survival following axotomy, 
but its effects on cellular injury response are moderate 
Peripheral nerve injury is normally accompanied by a strong increase in regeneration-
associated molecules that have been suggested to play a key role in successful nerve 
repair. Integrins are a large family of glycoprotein receptors for extracellular matrix 
proteins, and consist of different heterodimers composed of an α and a β subunit. Both α7 
and β1 integrin subunits are upregulated after axonal injury and have been detected on 
regenerating axons and growth cones as part of the neuronal response to axonal injury 
(Kloss et al., 1999). Global deletion of the gene encoding α7 integrin results in problems in 
neurite outgrowth, and reduced speed of axonal regeneration and re-innervation of 
peripheral targets after axotomy (Werner et al., 2000). β1 integrin, the only counterpart of 
α7, plays a critical role for the NT3-mediated outgrowth of sensory neurons in-vitro, and is 
strongly increased in α7 null mice, probably as a compensatory mechanism (Werner et al., 
2000). In neural c-Jun-deficient mice, α7 upregulation is dramatically reduced, and this 
reduction of α7 may be the one of the reasons for such poor regeneration in these animals 
(Raivich et al., 2004). Similarly, neuronal deletions of c-jun and STAT3 almost completely 
abolish injury-induced β1 expression, identifying β1 as an important transcriptional target 
and downstream effector molecule in regeneration (Ruff et al., 2012) (Chapter 3 – STAT3 
results). 
By using the standard facial axotomy model and neuron-specific β1 knockout mice, this 
chapter aims to characterise the role of neuronal β1 in regulating the speed and extent of 
axonal regeneration and sprouting, motor function recovery, neuronal survival, and the 
expression of regeneration, inflammation and astrocytic markers. Transgenic mice with 
neuron-specific deletion of β1-integrin were generated by crossing mice with floxed β1-
integrin alleles with mice expressing synapsin promoter-controlled cre recombinase. 
Littermates without ‘cre’ served as controls. Altogether, these results suggest a moderate 
effect of neuronal β1-integrin deletion on the molecular and cellular response to injury, at 
levels comparable to that of α7 deletion; and a strong reduction in target re-innervation, 
probably due to its effect of greatly reducing neuronal cell survival. 
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β1 integrin is required for efficient axonal regeneration  
After nerve transection, the injured neurons respond by axonal sprouting and elongation of 
growth cones towards the target muscle, ultimately resulting in recovery of nerve function. 
To investigate the efficiency of axonal elongation, the overall movement of whisker hair, a 
key target of facial innervation, was scored blindly, on a scale of 0 (no movement) to 3 
(strong, normal movement). Twenty-eight days after the facial nerve was cut, both control 
and mutant mice showed strong normal movement on the uninjured side. On the injured 
side, β1F/F control animals showed an average motor score of 2.38 ± 0.15, but motor 
performance was slightly lower in β1ΔS mice (2.25 ± 0.10) (Figure 7.1A). In terms of 
regenerative index (RI), calculated as area under the curve for the 28 day recovery period, 
the β1F/F had an index of 1.23±0.05, while the mutants had an approximately 10% lower 
index of 1.09±0.07. However, this overall regenerative index was not significantly different 
between the groups (Figure 7.1B). 
To determine differences in muscle re-innervation, the fluorescent tracer Fluorogold was 
injected into the whisker pad 28 days after the facial nerve was cut, followed by a 48 hour 
period of retrograde transport. Fluorogold application on the uninjured side served as 
intra-animal control, with similar numbers of retrogradely labelled motoneurons per section, 
586 ± 30 and 543 ± 53 on the uninjured side in control and mutant mice, respectively. The 
overall ratio of labelled neurons on the axotomised versus the contralateral side (ax/co 
ratio) in control animals was 69.4% ± 3.7%. In the absence of β1 integrin, it was 28.4% ± 
4.5%, nearly 2.5-fold lower (Figure 7.1D; p < 0.01%) than their control litter-mates. 
Speed of axonal elongation was determined by analysing early re-innervation after crush 
injury. Unilateral facial nerve crush was performed on 5 β1 F/F controls and 5 β1ΔS 
mutant mice, and eight days later FG was bilaterally applied to the whisker pads. The 
animals were allowed to survive for another two days, before being sacrificed. While both 
groups showed similar number of neurons on the uninjured side (170 ± 17 in controls and 
147 ± 9 in mutants), there was a significant reduction in the number of neurons on the 
axotomised side for the mutants compared to the controls (33± 18 in controls and 0.4± 0.4 
in mutants).  
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Figure 7.1. Beta-1 integrin and axonal regeneration. A. Time-course of functional recovery of whisker hair 
movement on a scale from 0 (no movement) to 3 (full movement, equivalent to uninjured side) shows a trend 
towards reduced functional recovery in β1ΔS mice (n=6) compared to β1 F/F mice (n=4) at 30 days post-
injury. B. Regenerative index of functional recovery calculated as Area Under the Curve for the two groups. 
C, D. Re-innervation of the target whisker-pad muscle at day 10 after unilateral facial nerve crush and 30 
days after facial nerve cut, measured by counting the number of motoneurons positively labelled by 
retrogradely transported fluorescent dye Fluorogold (FG). There was a significant reduction in re-innervation 
in the β1ΔS mice compared to the β1 F/F at both time-points and after both injury severities. E. Survival 
adjusted re-innervation (SAR) gives an index of the regenerative abilities of surviving axotomised neurons.  
There was a moderate reduction in SAR after d10 crush and after d30 cut in the β1ΔS mice. Data points and 
error bars in these graphs show the mean and SEM, respectively, *p<5%, **p<1%, ***p<0.1%, ****p<0.01% 
in Repeated Test Anova (for whisker movement score) and in unpaired Student’s T-test. 
Comparison of the ax/co ratios showed 20% ± 10% re-innervation ratio in the controls, but 
almost no re-innervation in the mutants, with an ax/co value of 0.3%±0.3% (p<1% for log 
ax/co; Figure 7.1C).  
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Absence of β1 integrin increases axotomy-induced cell death  
A substantial number of neurons die after nerve transection, probably due to failed target 
re-innervation and subsequent lack of trophic support (Sendtner et al., 1996). To assess 
whether neuronal β1 plays a role in axotomy-induced cell death, all motoneurons in the 
facial motor nucleus were counted using 20 μm Nissl-stained serial brain-stem sections.  
Ten days after facial nerve crush, the control animals did not show much loss of neurons, 
with 1659 ± 63 on the operated and 1489 ± 42 neurons on the unoperated side. However, 
13%±4% cell death was seen in the β1ΔS mice (1167 ± 67 motoneurons on the 
axotomised and 1339 ± 71 on the unoperated side (p < 0.1%)). This was a 22% higher 
cellular loss compared to the wild-type animals (Figure 7.2 B, D; p<1%).  
One month after facial nerve transection, there was much higher neuronal cell death in 
both groups, compared to that seen with crush injury. But while there was a loss of 17±3% 
neurons in the injured facial motor nucleus of control mice (1481 ± 61 neurons on the 
operated side compared to 1786 ± 65 neurons on the unoperated side) (Figure 7.2 A, C, 
D), in β1ΔS mice, neuronal loss by axotomy was increased more than 3-fold to 56±4% 
(717 ± 73 motoneurons on the axotomised and 1609 ± 44 on the unoperated side, p < 
0.01% (Figure 7.2.A, C, D).  
To investigate the increased cell death in the mutants as a causal factor for their reduced 
re-innervation, Survival Adjusted Re-innervation (SAR) was calculated by dividing the re-
innervation ratios by the survival ratios for each group. While the controls showed a SAR 
of 84%±5% at d30 after nerve transection, the mutants showed a  moderate 25% lower 
SAR of 63%± 6% (Figure 7.1E; p<5%), compared to a drastic 60% reduction in re-
innervation seen earlier (when not adjusted for increased cellular loss). This suggests that 
the involvement of β1 in regulating target re-innervation at d30 is mostly due to its effect of 
greatly reducing neuronal cell survival. However, at ten days after facial nerve crush, while 
the controls showed an SAR of 19%±10%, the mutants showed a  98% greater reduction 
in SAR with a value of only 0.3%± 0.3% (Figure 7.1E; p<5%). The much stronger effect 
seen at d10 compared to d30 after axotomy, suggests a transient effect of β1 deletion on 
regeneration. This is similar to the transitory effect seen with global deletion of the gene 
encoding α7 integrin subunit, where the mutants showed reduced re-innervation at day 9 
after crush injury, but the re-innervation defect disappeared by day 21 (Werner et al., 
2000a). 
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Figure 7.2. Neuronal β1 integrin is required for motoneuron survival after facial axotomy. A. Nissl-stained 
coronal sections of facial motoneurons on the contralateral (co) and axotomised (ax) side in β1 F/F and 
β1ΔS mice, 30 days after unilateral facial nerve cut. B. Total motoneuron count, corrected for neuronal size, 
showed a significant reduction in neuronal survival 10 days after facial nerve crush in the β1ΔS mice. C. 
Total motoneuron count, corrected for neuronal size, showed a significant reduction in neuronal survival 30 
days after facial nerve cut in the β1ΔS mice. D. Motoneuron survival expressed as a percentage of the 
unaxotomised side show in similar trend of significantly reduced neuronal survival in β1ΔS mutant mice after 
milder crush injury and more severe cut injury.  ** p<1%, *** p< 0.1%, **** p<0.01% in unpaired Student’s T-
Test, bars and error bars show the mean and SEM respectively.  
 
Measurement of neuronal diameters showed normal chromatolytic morphology of 
axotomised neurons in both groups, after both cut and crush injuries (data not shown 
here). Overall, these data highlight a role for β1 integrin in the survival of facial 
motoneurons following nerve axotomy. 
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Effect of β1-integrin deletion on neuronal axotomy response  
In order to understand the molecular mechanism of β1 function during the chromatolytic 
response, the expression of regeneration associated molecules was explored in β1ΔS 
mice. Since previous studies have pointed to an important role of the neuropeptides 
galanin and CGRP, the neuronal adhesion molecules α7 integrin, and the CD44 
hyaluronic acid receptor in neurite elongation (Jones et al., 1997;Jones et al., 
2000;Werner et al., 2000b;Wynick, 2001;Lin and Chan, 2003), we determined if their 
expression was affected in the absence of neuronal β1 integrin at 14 days after axotomy. 
As demonstrated in Figure 7.3, all four molecules show a strong increase in protein 
expression on the axotomised sides of both β1F/F control animals and β1ΔS mutant 
animals. Quantification of the staining intensity was done by manual counting and/or by 
measuring their optical luminosity values (OLV) using Optimas software. Quantification of 
CD44 immunoreactivity by luminosity revealed a 20% higher increase in axotomy-induced 
expression in the mutants compared to the controls (Figure 7.3S; p<5%). There was no 
difference in the optical luminosity values for injury-induced expression of α7- integrin, 
CGRP, and galanin between groups (Figure 7.3 V,Q,T). Besides being present in the 
neuronal somas, galanin and CGRP are also present at the growing tips of axonal sprouts, 
and can be quantified manually by counting under a light microscope. While there was no 
difference between the number of CGRP-positive sprouts in the axotomised facial nuclei 
of the controls and mutants, the number of galanin-positive sprouts were reduced by 
nearly 35% in the β1ΔS mutant mice (from 313 ± 53 β1F/F ax side, to 201 ± 21 β1ΔS ax 
side). However this difference marginally shied away from being statistically significant 
(Figure 7.3U). Quantification of injury-induced expression of CD44, CGRP and galanin at 
4 days after crush, did not show any difference between the two groups (data not shown). 
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Figure 7.3. Beta-1 integrin and neuronal axotomy response. Facial nucleus axotomy response 14 days after 
nerve cut in the β1F/F controls (A,B,E,F,I,J,M,N) and the β1ΔS mutant (C,D,G,H,K,L,O,P) mice on the 
contralateral side (co) (1st and 3
rd
 column), and on the axotomised side (ax) (2
nd
 and 4
th
 column). After 
axotomy, β1 F/F mice (n=5) show a prominent increase in neuropeptides CGRP (A-B) and Galanin (E-F) 
and adhesion molecules CD44 (I-J) and α7-integrin subunit (M-N); most of these changes are reproduced in 
the β1ΔS mutants (n=5), except for a significantly higher expression of CD44 (L, S). Quantification of overall 
facial motor nucleus immunoreactivity by manual counts or OLV units (Q-V) showed a 20% higher increase 
in CD44 (S), and a trend towards reduced galanin sprouting (U) in the mutants. The contralateral (co) and 
axotomised (ax) sides are indicated by blue and red bars respectively. *p<5% in Student’s unpaired T-test. 
Bars and error bars show mean and SEM respectively. 
 
Effect of β1-integrin deletion on non-neuronal axotomy response  
Nerve transection not only triggers changes in the neuron itself, but also results in reactive 
changes in non-neuronal, brain-resident cells of neuro-epithelial (astrocytes) and 
hematopoietic (microglia and T cells) origin (Raivich et al., 1999a;Raivich et al., 
1999b;Schwaiger et al., 1998). Immunohistochemistry was carried out on day 4 and 14 
tissue using antibodies that stain for T-cells (CD3), activated microglia (αM), phagocytic 
microglia (αX), and astrocytes (GFAP) (Raivich and Kreutzberg, 1994). 
Early and late microglial activation, as measured by the increase in immunoreactivity for 
the αM integrin subunit, at days 4 and 14 after axotomy was completely unaffected by the 
absence of neuronal β1 integrin as seen in β1ΔS mice. The numbers of infiltrating 
lymphocytes and phagocytic microglia were counted under a light microscope. There was 
no difference in the number of CD3+ T-cells in the axotomised facial nucleus of β1F/F and 
β1ΔS mice (Figure 7.4 I-L, S). Interestingly, the number of αX+ phagocytic cells was 
increased by 3-fold in the β1ΔS mutant animals (from 5.2 ± 0.7 in controls to 15.6 ± 3.4 in 
mutants (Figure 7.4. E-H, R; p<5%), a response corroborating the increased cell death 
seen in the mutants after nerve cut and crush injuries. Astroglial activation measured by 
GFAP immunoreactivity also showed a nearly 40% higher axotomy-induced increase in 
β1ΔS mice, compared to their control counterpart (Figure 7.4 M-P, T; p<5%).  
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Figure 7.4. Beta-1 integrin and non-neuronal axotomy response. Facial nucleus axotomy response 14 days 
after nerve cut in the β1F/F controls (A,B,E,F,I,J,M,N) and the β1ΔS mutant (C,D,G,H,K,L,O,P) mice on the 
contralateral side (co) (1st and 3
rd
 column), and on the axotomised side (ax) (2
nd
 and 4
th
 column). After 
axotomy, β1 F/F mice (n=5) show a prominent increase in microglial activation (A-B; E-F), T-cell recruitment 
(I-J) and astrocytic activation (M-N); these changes are reproduced in the β1ΔS mutants (n=5), with 
significantly higher expression of αX (G, H, R) and GFAP (O, P, T). Quantification of overall facial motor 
nucleus immunoreactivity by manual counts or OLV units (Q-T) showed a 66% higher increase in αX (R), 
and a 40% higher expression of GFAP (T) in the mutants. The contralateral (co) and axotomised (ax) sides 
are indicated by blue and red bars respectively. Bars and error bars show mean and SEM respectively, *p<5% 
in unpaired Student’s T-test. 
 
Chapter 7 - β1 integrin Discussion 
Adhesion molecule β1 integrin is upregulated on regenerating axons and growth cones 
following axonal injury (Kloss et al., 1999). Deletion of neuronal c-Jun or neuronal STAT3 
interferes with the upregulation β1 integrin subunit (Ruff et al., 2012) (Chapter 3 – STAT3 
results), which possibly contributes to the very poor regenerative response seen in these 
animals.  This implicates β1 as an important transcriptional target and downstream 
effector molecule in regeneration, warranting further investigation of its in vivo function in 
peripheral nerve regeneration. By using the standard facial axotomy model and neuron-
specific β1 knockout mice, we have shown an important role for this integrin in regulating 
axonal re-innervation and neuronal survival after facial nerve cut and crush injuries.  
Neuronal β1 integrin deletion, like α7 deletion, has a transient effect on 
axonal regeneration 
After nerve transection, the injured neurons respond by axonal sprouting and elongation of 
growth cones towards the target muscle, ultimately resulting in recovery of nerve function. 
Both α7 and β1 integrin subunits are present in growth cones at the tip of the elongating 
axons within a regenerating nerve and participate in maintaining cellular contact between 
neurons and SCs. Previous studies have shown that following FNA, transgenic deletion of 
the α7 subunit leads to a reduced rate of axonal outgrowth and delayed re-innervation of 
the whisker-pad, a peripheral target of the facial nerve. This delay in regeneration is 
transient with the α7 null mutants catching up with the controls by day 21 after axotomy 
(Werner et al., 2000). Similar to α7 deletion, in the absence of β1 integrin, survival 
adjusted re-innervation was reduced by 98% at day 10, but by day 30 the reduction was 
only 25% compared to control mice that expressed normal functional β1 integrin in their 
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neurons. This suggests the presence of other axonal molecules which promote  
regeneration, leading to a compensation of regenerative function in the absence of α7β1 
integrin, albeit with a slight delay. On the other hand, motor performance, as assessed by 
post-traumatic whisker movement, was only slightly lower in β1ΔS mice and the overall 
regenerative index was not significantly different between the groups. Collateral sprouting 
could be playing a role (Raivich and Makwana, 2007) as many branches re-innervating the 
whisker pad could be originating from one neuron. This non-linear correlation between re-
innervation and functional recovery has been previously observed, with only 20-30% of 
nerve re-innervation accounting for substantial functional recovery (Raivich et al., 2004). 
Facial axotomy is also followed by increase in the number of CGRP/galanin + central 
sprouts. The β1ΔS mutants showed a trend towards reduced galanin-positive sprouts 
within the facial nucleus by nearly 35%. In contrast, the α7 null animals showed enhanced 
sprouting after axotomy (Makwana et al., 2010). However, this could be due to the 
particularly strong, apparently compensatory, increase of the β1 subunit after axotomy in 
the α7 deficient mice (Werner et al., 2000a). These results highlight an important role of β1 
integrin, possibly in combination with other α subunits, in regulating axotomy induced 
sprouting. 
Finally, the absence of the α7 or β1 integrin subunits did not have a major impact on the 
cellular response in the axotomised facial nucleus. The moderate effects of increased 
microglial and astrocytic activation in the β1 null mutants could be secondary to the 
increased neuronal cell death seen in these mutants. The absence of α7 did not appear to 
affect the response to injury by glia or lymphocytes, suggesting that the immune 
surveillance of the injured CNS is unaffected by the absence of the α7 subunit (Werner et 
al., 2000). The effect of α7 deletion on neuronal survival and activation of phagocytic 
microglial nodules is as yet unknown and further investigation will provide more clues. 
Overall, the lack of major changes in the central neuroglial response to injury suggests a 
peripheral site of action for α7β1 adhesion molecule in interaction with the extracellular 
matrix in the injured peripheral nerve, to drive neuronal survival and prompt axonal 
regeneration after injury. 
β1 integrin is required for neuronal survival after FNA 
In addition to cell adhesion migration and axonal outgrowth, integrin signalling is important 
for neuronal survival (Lemons and Condic, 2008;Previtali et al., 2001;Tucker and Mearow, 
  Chapter 7 - β1 integrin Discussion  
170 
 
2008). A substantial number of neurons die after nerve transection (Sendtner et al., 1996). 
Deletion of the β1 integrin in motoneurons strongly reduced neuronal survival after facial 
axotomy. The effect was quite pronounced, reducing survival by half from 80% in the 
controls to just about 40% in the mutant mice at d30 after facial nerve cut. Even after 
milder crush injury, where the two ends of the nerve stump are not completely 
disconnected, the mutants still had a 22% higher neuronal loss compared to the controls. 
Motoneuron numbers in the mutant and control mice without injury were similar, so lack of 
β1 does not seem to impede developmental survival, the effect is just post-traumatic. 
In the current study, it is unclear whether the neurons are dying from lack of retrograde 
trophic support due to an inability to reconnect with the appropriate targets in the absence 
of β1 guidance-signalling, or whether the lack of β1 is somehow directly triggering cell 
death, and hence there is less re-innervation. Deprivation of trophic factors can lead to 
failure of re-innervation, and eventually cell death (Sendtner et al., 1996). Laminins are 
present in SCs as well as in the basal membranes, and may provide trophic support to the 
regenerating axons (Ide, 1996). Laminin-integrin interactions stimulate extension and 
directional guidance of neurites and growth cones (Woolley et al., 1990;Wallquist et al., 
2002). The α7β1 integrin is a specific receptor for laminin-1 (α1β1γ1), laminin-2 (α2β1γ1), 
and laminin-4 (α2β2γ1) (Previtali et al., 2001). Increased cell death in the absence of 
neuronal β1-integrin could be due to reduced laminin-based trophic factor signalling. 
To investigate the increased cell death in the mutants as a causal factor for their reduced 
re-innervation, survival adjusted re-innervation was analysed for the two groups. This is 
important to understand if the reduced re-innervation in the mutants is due to a reduced 
intrinsic regenerative ability of the β1 deficient neurons or if it is simply due to increased 
motoneuron death, while the surviving neurons continue to regenerate with the same 
efficiency as the wild-type neurons. The mutants showed a  moderate 25% lower SAR 
than the controls,  compared to a drastic 60% reduction in re-innervation seen earlier 
(when not adjusted for increased cellular loss), suggesting that the majority of β1 effects 
on re-innervation is due to its regulation of neuronal cell survival. Overall, this data 
demonstrates an important role for β1 integrin in survival of facial motoneurons following 
nerve axotomy. What remains to be seen is which of the various α subunits, that form 
hetero-dimeric partners with β1 subunit, might be involved in regulating neuronal cell 
death.  
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Neuronal β1-integrin deletion increases CD44 expression after FNA 
Nerve transection causes pronounced changes distal to the site of axotomy, but also in 
and around the cell body of the affected neurons. Somas of injured motoneurons increase 
protein synthesis of adhesion molecules and neuropeptides (Makwana and Raivich, 2005). 
In order to understand the molecular mechanism of β1 function during the neuronal 
chromatolytic response, the expression of regeneration associated molecules CD44, 
CGRP, galanin and α7 integrin was explored in β1ΔS mice. Axotomy-induced expression 
of CD44 was increased by 20% in the mutants compared to the controls. CD44 expression 
is strongly upregulated in a wide variety of neural injuries (Jones et al., 2000). Like β1 
integrin, it is an adhesion molecule, and is suggested to be supportive of neurite outgrowth. 
Antibody mediated inhibition of CD44 reduces neurite outgrowth of transplanted central 
noradrenergic neurons (Nagy et al., 1998) as well as creating multiple errors in retinal 
axonal growth trajectory through the optic chiasm (Lin and Chan, 2003). Deletion of 
neuronal c-Jun or neuronal STAT3 interferes with the upregulation of CD44 and β1 
integrin (Ruff et al., 2012), (Chapter 3 -Results). Therefore the increase in CD44 
expression could be a transcriptionally mediated compensatory mechanism that accounts 
for the absence of β1 in the mutants. Alternatively, it could be an auxillary effect of the 
increased cell death in the β1ΔS mutants, since early expression of this molecule at 4 
days after nerve crush did not show any difference between the two groups. 
The number of centrally sprouting axons expressing the neuropeptide CGRP was 
unaffected, while galanin-positive central sprouts showed a trend towards a moderate 
reduction. Surprisingly, no change was seen in the expression of α7 integrin subunit either. 
β1 is the only dimeric partner for α7 subunit. Global deletion of the α7 subunit caused a 40% 
decrease in the speed of regeneration of the facial nerve in vivo, and a compensatory 70% 
increase in β1-subunit expression.  Since β1 can dimerise with several different α subunits, 
many of which have been implicated in axonal regeneration in vitro (Werner et al., 
2000b;Vogelezang et al., 2001a;Toyota et al., 1990), it can be supposed that the 
regeneration defect in the β1ΔS animals might be due to other closely related α subunits.  
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Deletion of neuronal β1-integrin causes increased astrocytic and 
phagocytic microglia activation 
Nerve transection not only triggers changes in the neuron itself, but also results in reactive 
changes in non-neuronal cells such as astrocytes, microglia and T cells. Activated 
microglial cells proliferate and upregulate activation markers such as αMβ2 integrin 
(Raivich and Kreutzberg, 1994).  
Early and late microglial activation, as well as T-cell recruitment was completely 
unaffected by the absence of neuronal β1 integrin. Neuronal cell death, leads to a further 
transformation of microglia into phagocytotic cells, which usually form microglial clusters 
that remove neural debris (Raivich et al., 1999a). The number of αX+ phagocytic cells was 
increased by 3-fold in the mutant animals, a response corroborating the 3-fold increase in 
cell death seen in the mutants after nerve cut and crush injuries. Phagocytic microglia 
show strong immunoreactivity for aM-, aX-, a5-, a6-, b1-, and b2- subunits at 14 days 
following axotomy and could reflect processes which facilitate endocytosis and 
degradation of neuronal debris (Raivich et al., 1999a).  
Following nerve injury, reactive astrocytes are also activated, upregulating cytoskeletal 
proteins like GFAP and converting to a fibrillary phenotype (Raivich et al., 1999a;Graeber 
and Kreutzberg, 1986). Astroglial activation measured by GFAP immunoreactivity also 
showed a nearly 40% higher axotomy-induced increase in β1ΔS mice, compared to their 
control counterparts. The main function of reactive fibrillary astrocytes is to create a 
physical barrier between damaged and healthy cells, by transiently enveloping injured 
neuronal somas with thin and flat cytoplasmic processes.  Severe damage or inflammation 
can lead to much stronger astrocytic proliferation, eventually forming glial scars which are 
inhibitory to neurite outgrowth (Raivich et al., 1998). In the current study, the strong 
increase in astrocyte response might be responsible for reduced regeneration due to 
scarring. It could also be an ancillary effect of the increased neuronal cell death seen in 
the β1ΔS mutants. 
In summary, the current study suggests that the β1 integrin subunit is an important 
mediator of axonal regeneration, particularly by reducing excessive injury-induced cell 
death. Moreover, the lack of major changes in the central neuroglial response to injury 
indicates a peripheral site of action for this cell adhesion molecule in the interaction with 
the extracellular matrix in the injured peripheral nerve.   
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Unlike the central nervous system, axon regeneration after peripheral nerve injury is 
usually robust. There are two major determinants of successful nerve regeneration in the 
PNS - intrinsic growth ability and an extrinsic permissive environment (Raivich and 
Makwana, 2007). The ‘intrinsic’ growth ability is driven by transcriptional activation of a 
regeneration programme, whereby transcription factors convert injury-induced stress 
signals into increased expression of a wide range of downstream effector molecules like 
neuropeptides, neurotrophic factors, adhesion molecules and cytoskeletal adaptor 
proteins. These downstream effector proteins regulate the actin-tubulin machinery of 
growth-cones, integrate intracellular signalling with stimulatory and inhibitory signals from 
the local environment, and translate them into axon elongation. The importance of the 
intrinsic growth state of injured neurons is perfectly exemplified by the preconditioning 
lesion example, whereby prior lesion to the peripheral branch of sensory DRG neurons, 
results in increased growth of their central axons after dorsal column injury (Neumann and 
Woolf, 1999). The ‘extrinsic’ factors depend on the existence of a local permissive 
environment, which consists of the molecular network organized by Schwann cells and 
macrophages at the injury site, and by astrocytes and microglia around the cell bodies 
(Raivich, 2005). This environment also produces neurotrophic factors, cytokines, 
neuropeptides, cell adhesion molecules and numerous ECM molecules which act on the 
neuronal cell bodies and growing axons to support their extension towards the final 
destination. Even though all these different molecules appear to be tangibly involved, their 
direct injury-associated transcriptional regulation is still unclear – for example, little is 
known about the factors involved in down-regulating the sensitivity to inhibitory and 
chemorepulsive stimuli in peripheral regeneration even though there is evidence for the 
presence of such regeneration blockers. Nevertheless, recent advances using cell-type 
specific deletion of transcription factors and their downstream targets is allowing more and 
more pieces of the puzzle to be placed together, making visible broad lines of identified 
chain of activities contributing to recovery, and underscoring the role of transcription 
factors as master-switches of the regeneration programme. However, our knowledge of 
regeneration associated transcription factors and their targets is still limited. To gain 
insight into the in vivo function of some of these regeneration associated molecules, we 
examined the effects of global or cell-type specific deletions of transcription factors - 
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STAT3, c-jun and C/EBPδ, and effector molecules - CAP23 and integrin β1, on axonal 
regeneration after facial nerve axotomy. The facial nerve axotomy model is a well-
established experimental paradigm, providing insights into molecular signals that 
determine axonal regeneration, target re-innervation and neuronal cell death. 
 
Conditional mice mutants, lacking STAT3 in their neurons, had profound defects in the 
usual retrograde response, with a severe early and persistent reduction by 75-90% in 
microglial activation and recruitment of lymphocytes, and 4 days after crush injury in the 
speed of axonal elongation in the distal stump. At 30 days, axotomised STAT3-deficient 
motoneurons appeared shrunk by 50-60% in size but displayed no cell death in contrast to 
results from earlier studies (Schweizer et al., 2002). Functional recovery was dramatically 
reduced and the mutants showed 80% less target muscle re-innervation. Interestingly, 
functional recovery tends to catch up after prolonged periods of regeneration, possibly due 
to rerouting and collateral sprouting, while anatomic re-innervation is still brought down – 
in the case of STAT3 deletion, the re-innervation of the whisker hair pad, a major target of 
facial nerve regeneration, 3 months after nerve cut still only received approximately a third 
of the normal number of axons. Interestingly, the effects of STAT3 deletion are milder in 
the dorsal root ganglia (Bareyre et al., 2011;Ben-Yaakov et al., 2012) suggesting the 
presence of complementary or alternative pathways, in the peripheral sensory neurons. As 
with neuronal c-Jun deletion which interferes with regeneration (Raivich et al., 2004), 
expression of RAGs like CD44, α7β1-integrin, perineuronal sprouting of the CGRP+ and 
galanin+ facial motoneurons, as well as the nuclear translocation of ATF3 was also greatly 
diminished or abolished in the STAT3 mutants. However, c-Jun expression itself was not 
affected, suggesting that deletion of either transcription factor – c-Jun or STAT3 – will 
produce a very similar regeneration-deficient phenotype. Mutants lacking both neuronal c-
jun and STAT3 did not show more exacerbated regeneration defects than the single 
deletions, further verifying the above observation, and demonstrating that the combination 
of the two factors is not complementary in peripheral nerve regeneration. 
 
Several studies have shown a key role for the transcription factor c-Jun in allowing 
regeneration to occur (Arthur-Farraj et al., 2012;Fontana et al., 2012;Raivich et al., 
2004;Ruff et al., 2012b). In the facial nerve axotomy model, deletion of c-Jun throughout 
brain neuroepithelium-derived cells (Raivich et al., 2004) or just in neurons (Ruff et al., 
2012b) abolishes most of the cell body response after axotomy. It also abolishes post-
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traumatic neuronal cell death, causes most of the motoneurons to atrophy, and very 
strongly reduces the ability of their axons to regenerate, reinnervate their peripheral 
targets and contribute to functional recovery, as also confirmed in this thesis.  
 
Deletion of c-Jun in peripheral nerve Schwann cells (the c-junΔP0 mutants) produced a 
very different effect (Arthur-Farraj et al., 2012;Fontana et al., 2012). Neuronal cell death is 
increased by 2-3 fold, even though most of the cell body response is not affected. Axonal 
regeneration is reduced, but most of the defect in target re-innervation and functional 
recovery appears to be due to excessive neuronal cell death. Deletion of Schwann cell c-
Jun interferes with local production of neurotrophins, including BDNF, LIF, GDNF and 
Artemin; in the same vein supplementation with exogenous GDNF and Artemin promotes 
neuronal survival, target re-innervation as well as functional recovery (Fontana et al., 
2012). When the two phenotypes were combined by deleting c-jun in both neurons and in 
Schwann cells, an almost complete abolition of re-innervation was seen in the mutants, 
significantly lower than the already low levels of re-innervation seen in the single mutants. 
In terms of axotomy-induced neuronal cell death, the neuronal c-jun deletion phenotype 
appeared to supersede the deletion in Schwann cells, with the axotomised motoneurons 
showing massively increased cell survival, and severely atrophic morphology. Thus, the c-
JunΔS and c-JunΔP0 mutations appear to have additive effects on regeneration, but their 
effects on neuronal survival are antagonistic. 
 
Since both neuronal and Schwann cell c-Jun are strongly phosphorylated at the N-
terminus following nerve injury, we explored c-Jun phosphorylation as the mechanism 
behind the striking functions of c-Jun in regeneration. Global replacement of all 4 N-
terminal c-Jun phosphorylation sites (Ser63&73, Thr91&93) with alanines (jun4A) did not 
interfere with the expression of injury-associated neuronal and non-neuronal markers. On 
the other hand, as in the JNK1&3 null mutants, the jun4A strain reproduced the moderate 
reduction in functional recovery and a 50% lower number of re-innervating motoneurons at 
28 days following facial nerve cut. However, this effect on regeneration is considerably 
smaller than that observed with neuronal c-Jun deletion, suggesting that the regeneration 
effect of c-Jun is mostly independent of its N-terminal phosphorylation. The mutation 
produced a significant increase (1.8x) in neuronal cell death, but mostly of shrunken 
neurons, a phenomenon also seen in the junAA mutants (Ruff et al., 2012b). Thus the 
jun4A mutants seem to be a combination of the junAA and global JNK deletions. The 
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moderate effects of these mutants suggest that c-Jun activation specifically in the 
neuronal, non-peripheral part of the transcriptional regeneration program is not affected by 
N-terminal phosphorylation. However, c-jun N-terminal phosphorylation appears to be 
important for neuronal survival, implicating a role in trophic signalling elicited by the c-Jun 
in Schwann cells. At present, no information is available with regards to the regeneration-
associated c-Jun effects of Thr239 dephosphorylation, or for C-terminal acetylation.  
 
C/EBPδ has recently emerged as another important regeneration associated transcription 
factor. Lack of C/EPBδ causes a major reduction in the regenerative response of DRG 
neurons to a conditioning lesion, and affects the expression of regeneration-associated 
molecule SPRR1A (Lopez de and Magoulas, 2013). In 2005, Nadeu et al., showed a role 
of C/EBPβ, another member of the C/EBP transcription factor family, in regulating the 
expression of microtubule α-tubulin protein and GAP43, a growth cone protein, after injury 
(Nadeau et al., 2005). The current studies demonstrate the involvement of CEBPδ in early 
and late microglial activation and in neuronal cell death, but not in the astroglial or 
leucocyte response following peripheral nerve injury. Global C/EBPδ deletion impaired 
central axonal sprouting, causing a 40% reduction in the number of galanin positive 
sprouts in the facial nucleus at 14 days following axotomy. Since STAT3 has also been 
shown to regulate the expression of galanin positive sprouts, and neuronal survival 
following axotomy, it appeared that concerted action of the two transcription factors might 
be responsible for the pro-regenerative effects following axotomy. Indeed, combined 
deletion of global C/EBP and neuronal STAT3 did not exacerbate the regeneration defects 
caused by STAT3 deletion alone. Rather deletion of C/EBPδ, improved functional 
recovery in the neuronal STAT3 null mice. 
We next explored the in vivo functional and anatomical effects of deleting two downstream 
effector molecules, CAP23 and integrin β1, on regeneration. Deletion of neuronal CAP23, 
a cytoskeletal protein and candidate target of regeneration associated transcription factors, 
led to impaired early microglial function and almost 50% reduction in galanin+ 
perineuronal sprouting at day 14. This observation fits in with the implicated role of C/EBP 
family of transcription factors in axonal sprouting and outgrowth following injury, possibly 
through transcriptional activation of cytoskeletal elements which mediate aspects of actin 
rearrangement, and formation of the growth cone.  
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Neuron-specific deletion of beta 1 integrin resulted in approximately 2.5-fold increase in 
neuronal cell death, a commensurate 60% reduction in target re-innervation and 
transiently delayed functional recovery. These preliminary results suggest that the β1ΔS 
phenotype is roughly on par with that observed for the global α7 deletion. This coincides 
with the fact that α7 is the main neuronal α subunit that appears upregulated following 
axotomy (Kloss et al., 1999;Vogelezang et al., 2001b;Werner et al., 2000). The neuronal 
response of the cell body was largely unaffected, and the mutations interfered primarily 
with the post-traumatic trophic response, resulting in massive amounts of cell death. The 
β1ΔS mutant mice also showed 69% increase in the number of phagocytic microglia 
compared to control mice, and significantly higher astrocytic activation, which are probably 
related to the increased cell death seen in these mutants. The β1ΔS phenotype showed a 
striking similarity to the jun4A and c-junΔP0 mice, specifically in terms of immensely 
increased neuronal cell death, reduced axonal regeneration and sprouting, and minimal 
effects on the cellular response within the facial nucleus. 
In summary, this data suggests the likelihood of co-existence of two different and mutually 
exclusive neuronal populations which are controlled by different aspects of the 
regenerative programme - a larger population dependent on ‘intrinsic’ activation of 
transcriptional master switches like c-jun and STAT3 in neurons, and which is completely 
devoid of regeneration on the absence of these neuronal transcription factors; and the 
other, a smaller population dependent on ‘extrinsic’ post-traumatic trophic signalling 
elicited by Schwann cells. This smaller population of neurons is independent of the cell 
body transcription cascade in its regenerative ability. Neuronal β1 integrin appears to be a 
critical co-factor in trophic signalling elicited by the Jun-expressing and N-terminal 
phosphorylation-dependent Schwann cells. This notion of the two neuronal populations 
being exclusive, but collectively exhaustive is further strengthened by the complete 
obliteration of re-innervation in mice having simultaneous deletion of c-jun in neurons and 
in Schwann cells. This bifurcation of the neuronal populations also provides an 
explanation for the bivalent role of c-jun in regeneration - Neuronally expressed c-Jun 
regulates the cellular response to injury and is essential for cell death, while Schwann cell 
c-Jun is an important regulator of peripheral nerve growth that is necessary for neuronal 
survival. Unlike c-jun, the Schwann cell counterpart of STAT3 was not involved in trophic 
signalling in regeneration.  
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Since the neuronal transcription factor - dependent regeneration programme provides the 
bulk of the regenerative response seen after peripheral nerve injury, with only about 20% 
neurons continuing to regenerate in their absence (Chapter 3- STAT3 Results; Chapter 4- 
c-jun results), (Raivich et al., 2004;Ruff et al., 2012), it is important to identify the various 
components of the transcription signalling cascades. As mentioned before, transcription 
factors trigger the activation of multiple intracellular signalling pathways, causing the 
expression of a cocktail of regeneration-associated genes and other downstream effector 
molecules which interact with each other and the extracellular environment to determine 
the fate of the injured neurons. By using conditional/global deletions and the facial 
axotomy paradigm, we have identified and described distinct as well as overlapping roles 
of transcription factors STAT3, c-Jun and C/EBPδ, and effector molecules CAP23 and β1 
integrin in achieving a desirable regenerative outcome after peripheral nerve injury. 
Comparison of the cellular and molecular responses following deletion of c-Jun or STAT3 
shows a complete overlap: both deletions interfered with induction of regeneration-
associated adhesion molecules α7β1 integrin and CD44, both deletions abolished 
neuronal cell death but induced atrophy, and both also prevented microglial activation and 
T-cell recruitment. Interestingly, both transcription factors had little or no effect on reactive 
astrocyte expression. Neuronal c-Jun and STAT3 double mutants confirmed this overlap 
between the two transcription factors. The effects of STAT3 and C/EBPδ deletion also 
showed a partial overlay. The high degree of co-operation among these regeneration 
associated transcription factors proposes that they may contribute to a larger 
transcriptional complex that collectively regulates intrinsic growth ability. In fact, these 
transcription factors may be the multiple keys required to unbolt the lock on regeneration. 
In the absence of any key, regeneration cannot be triggered. It is unclear how these 
multiple factors interact with each other to induce transcription of their target genes.  
 
STAT3, c-Jun, and ATF-3 are activated by the LIF-gp130 signalling and JNK signalling 
pathways for the transactivation of DINE gene (Kato et al., 2002;Kiryu-Seo et al., 
2000;Kiryu-Seo and Kiyama, 2004). One of proposed theories is that Sp1, a general 
transcription factor, functions as a scaffolding protein to recruit c-Jun, ATF3, and STAT3, 
and binds directly to the GC-rich region located proximally to the transcription start site of 
the DINE promoter (Kiryu-Seo et al., 2008). It has been reported earlier that gene 
promoters without the AP1 site or the STAT3 binding site were activated by c-Jun or 
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STAT3 through an interaction with Sp1 (Chen and Chang, 2000;Kardassis et al., 1999). 
This Sp1 mediated recruitment of c-Jun/ATF3/STAT3 provides a reasonable and practical 
explanation for increased expression of numerous effectors simultaneously in injured 
neurons. It is possible that there are several other players in addition to these three 
transcription factors for co-ordinated control of intrinsic regenerative ability. 
 
In addition to the concerted action of transcription factors as described above, there may 
be other transcription factors that are complementary to the c-Jun-STAT3 axis. A large 
number of regeneration associated transcription factors have been identified by microarray 
and gene profiling studies (Michaelevski et al., 2010). Candidate genes include p53, SRF, 
Sox11, NF-κB, ELK, Oct-6 etc., and their known in vitro /in vivo  functions in regeneration 
have been described earlier (Chapter 1- Introduction). Identification of functionally 
complementary counterparts is important to understand what compensatory mechanisms 
are in place, and how they act together in order to produce a reliable and robust 
regenerative effort.  However, this is easier said than done. Although a large number of 
molecules are widely-known markers of injured neurons, their complex interactions with 
other transcription factors, and their varied roles in different cell types makes the 
assessment of their role in the injured nervous system difficult. For example, because of 
the highly contrasting response of c-Jun in neurons and Schwann cells, future therapies 
will have to be specifically targeted to a particular cell-type to avoid undesirable effects. 
Further, the role of STAT3 appears to be much more prominent in motoneurons than in 
sensory or sympathetic neurons. Therefore to truly understand the signals which govern 
cell survival, axonal regeneration and target re-innervation following axotomy, it is not 
enough to take these molecules out of their context and study them individually.  
It is important to mention here that most experimental approaches have their limitations, 
and the ones used in these studies are no exception. The use of cre/loxP technology for 
generating cell-type-specific gene deletions, as used in our studies, has greatly expanded 
the versatility with which biological questions can be addressed in vivo. However, there 
can be problems associated with the cre/loxP recombination system such as irregular or 
non-specific pattern of transgene expression due to promoters being ‘leaky’, variable 
recombination efficiencies, as well as potential influences of genetic background and 
breeding strategies of mice. Overlooking these issues can influence accuracy of the 
genetic targeting strategies, and overestimate phenotypic interpretations. For example, in 
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our mouse models with neuron-specific gene deletions, mostly female cre+ mice and cre- 
males were used for breeding to prevent germline gene deletion due to testicular synapsin 
promoter expression (Rempe et al., 2006). Secondly, a method of manual counting of 
neurons followed by Abercrombie correction was employed to analyse levels of cell 
survival after axotomy. The Abercrombie method counts neuronal segments in histological 
sections and then applies a correction formula to convert the segment count to neuronal 
number. However, this correction has been widely criticised for assuming the cellular 
diameter or nuclear height to be constant, and for missing out on neuronal segments 
(Coggeshall, 1992;Hedreen, 1998).  The preferred approach is the ‘physical dissector’ or 
stereological approach which identifies ‘tops’ of neuronal profiles in a known volume, 
giving the numerical density of the neuronal population (Coggeshall, 1992;West, 2002). 
However, due to the atrophic nature of surviving motoneurons seen in many of our 
conditional KO mice models, manual counting of neurons provided a more reliable 
estimate compared to stereological measurements. Finally, antibodies against specific 
antigens can cross-react with other proteins, giving false-positives in the tissue. Specificity 
of antibody mediated stain must therefore be controlled and verified by other methods 
such as disappearance of staining in knock-outs, Western blotting, and RNA analysis to 
name a few.  
In conclusion, if regeneration were akin to a tree, transcription factors would represent the 
main trunk of the regenerative response, controlling the arborisation of smaller branches 
symbolising downstream effector molecules which play niche roles in fine tuning 
specialised aspects of regeneration. This branching pattern of regeneration results in 
multiple, overlapping pathways acting in concert to create an intricate system that 
balances cell death and survival, recruits non-neuronal cells and culminates in target re-
innervation and functional recovery. Without the central trunk, the branches are not 
supported, therefore the tree of regeneration collapses, as seen in the current studies. 
Discovering complementary/compensatory molecules in regeneration, along with 
signalling cascades and molecular targets of known players will undoubtedly be a huge 
step forward in devising clinical therapies following traumatic peripheral and even central 
nerve injuries. 
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Following axotomy, the activation of multiple intracellular signaling cascades causes the
expression of a cocktail of regeneration-associated transcription factors which interact with
each other to determine the fate of the injured neurons.The nerve injury response is chan-
neled through manifold and parallel pathways, integrating diverse inputs, and controlling a
complex transcriptional output.Transcription factors form a vital link in the chain of regener-
ation, converting injury-induced stress signals into downstreamprotein expression via gene
regulation. They can regulate the intrinsic ability of axons to grow, by controlling expres-
sion of whole cassettes of gene targets. In this review, we have investigated the functional
roles of a number of different transcription factors – c-Jun, activating transcription factor 3,
cAMP response element binding protein, signal transducer, and activator of transcription-3,
CCAAT/enhancer binding proteins β and δ, Oct-6, Sox11, p53, nuclear factor kappa-light-
chain-enhancer of activated B cell, and ELK3 – in peripheral nerve regeneration. Studies
involving use of conditional mutants, microarrays, promoter region mapping, and different
injury paradigms, have enabled us to understand their distinct as well as overlapping roles
in achieving anatomical and functional regeneration after peripheral nerve injury.
Keywords: transcription, axotomy, facial nerve, neurite, DRG, regeneration, c-Jun, ATF3, STAT3
INTRODUCTION
Injury to peripheral nerves elicits a sequence of molecular, cel-
lular, and ultrastructural responses which are vital in triggering
a successful regenerative program associated with neurite out-
growth, re-innervation of the denervated target and recovery of
function. The rapid arrival of signals from the injured axon results
in a remarkable shift of the injured neuron from a transmit-
ting to a growth promoting phenotype. This is accomplished by
the upregulation of a vast array of regeneration-associated genes
(RAGs) including the rapid induction of transcription factors and
enhanced synthesis of adhesion molecules, cytoskeletal elements,
growth factors, cytokines, neuropeptides, and other molecules
involved in regeneration.
The molecular changes are accompanied by pronounced mor-
phological changes in the surviving neurons – the cell body under-
goes a “chromatolytic” reaction characterized by swelling of the
neuronal body, increase in cellular metabolism and protein syn-
thesis, and a regional dispersion of Nissl bodies in the neuronal
cytoplasm (Lieberman, 1971); and there is a rapid appearance
of growth cones at the proximal tip of the lesioned axons. The
distal nerve stump undergoes “Wallerian degeneration” (Waller,
1850;Dubový, 2011), leading to phagocytosis of axonal andmyelin
debris by Schwann cells and later also by invading macrophages.
In addition to the neuronal response, neighboring non-
neuronal glial cells – in the case of brain and spinal cord
motoneurons, the astrocytes, and microglia – become activated,
with microglial expression of immune cell recognition molecules
(ICAM1, aMb2, and aXb2 integrins, B7 system, etc.) and major
histocompatibility complex (Werner et al., 1998; Bohatschek et al.,
2004). There is also a rapid microglia-associated recruitment of
lymphocytes within a day after injury which may assist with
immune surveillance ﬁrst in the absence, and later on in the pres-
ence of neuronal cell death (Raivich et al., 1998; Kalla et al., 2001).
In the adult mouse facial motor nucleus model which has been
studied in extensive detail, neuronal cell death is a delayed phe-
nomenon, peaking at 2 weeks following nerve transection; the
glioimmune activation is characterized by two phases – a fast
but moderate response starting within 24 h after neuronal injury,
and a late but much stronger response to neuronal cell death,
peaking at 14 days after axotomy. Neuronal transcription factor
deletions blocking cell death will suppress most of the late glioim-
mune response (Raivich et al., 2004; Patodia et al., 2011). However,
these deletions also inhibit some of the early microglial activa-
tion – within 24 h and long before the appearance of cell death,
suggesting that these transcription factors may also interfere with
the synthesis of injury signals from lesionedbut not dyingneurons.
In contrast with the PNS, the CNS neurons normally fail to
regenerate after injury, possibly due to a combination of dimin-
ished intrinsic capacity for regeneration and a heightened sus-
ceptibility to increased inhibitory factors of their extracellular
environment (Maier and Schwab, 2006; Sun et al., 2011). Identi-
fying the crucial elements responsible for successful regeneration
in injured peripheral nerves, and unraveling their underlying sig-
naling pathways and molecular components will be quintessential
in improving regenerative outcomes after peripheral and central
nerve injuries.
Systematic gene expression proﬁling using cDNA microarrays
has led to a dramatic increase in the number of identiﬁed genes
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regulated in the injured and regenerating neurons (Bosse et al.,
2001, 2006; Costigan et al., 2002; Kubo et al., 2002; Boeshore et al.,
2004; Kury et al., 2004; Michaelevski et al., 2010). Interestingly,
roughly half of the RAGs are part of both developmental and
lesion-induced programs, suggesting that regeneration partially
recapitulates development. However, this proportion of shared
developmental and lesion-induced transcripts was substantially
lower – only 33% – for genes encoding signal transducers or fac-
tors involved in processes such as cell death, immune response,
transport, and transcriptional regulation. Most of the latter show
injury-speciﬁc gene expression (Bosse et al., 2006).
Transcription factors are DNA binding proteins that can acti-
vate or repress target gene expression. Their effects are ampliﬁed by
their ability to bind to multiple promoter regions, causing a large
number of genes to be switched on or off by a single transcription
factor. In this review,wewill be discussing the keymolecular events
ensuing peripheral nerve injury, focusing on various transcrip-
tion factors that have been implicated to play a role in neuronal
regeneration.
EARLY AXONAL INJURY SENSORS
Axonal injury generates three major signaling cues to the injured
neurons:
A. It interferes with the retrograde ﬂow of trophic signals, disin-
hibiting the normally suppressed regenerative process, within
12–24 h following injury (Raivich et al., 1991).
B. It exposes the tip of the injured axons to the intracellular
content of neighboring axons and Schwann cells containing
growth factors like LIF, CNTF, FGF, and NT3 (Elde et al., 1991;
Sendtner et al., 1997; Kirsch et al., 2003), and later to the
inﬂamed neural tissue environment (Lindholm et al., 1987).
The above two processes can result in de novo activated mole-
cules carrying a nuclear localization sequence (NLS)which link
to importins and are retrogradely transported to the cell body
by dynein motors (Schmied et al., 1993; Hanz et al., 2003).
C. It causes a disruption of the tight ionic concentration gradient
between the axon and the extracellular matrix by rapid inﬂux
of extracellular ions such as calcium and sodium through the
transiently open plasmalemma before it is resealed (Yoo et al.,
2003). This results in depolarization and transmission of suc-
cessive injury-mediated action potentials. Thesemolecular and
electrical signals cause rapid elevation of calcium and cAMP,
which in turn activate multiple downstream pathways (Berdan
et al., 1993).
TRANSCRIPTIONAL CHANGES
The arrival of injury signals is rapidly followed by the phos-
phorylation and nuclear localization of a host of transcrip-
tion factors. A brief summary of signaling from early sen-
sors to mostly enzymatic cytoplasmic mediators to transcrip-
tion factors and synthesis of effector molecules is shown in
Figure 1. Data from phospho-proteomic and microarray studies
FIGURE 1 | Cellular signaling in successful regeneration, from early sensors of injury, to cytoplasmic signals, transcription, and downstream effectors
(Modified Raivich, 2011).
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have identiﬁed nearly 400 redundant axonal signaling networks
connected to 39 transcription factors (26 transcription factor fam-
ilies), implicated in the sensory neuron response to axonal injury
(Michaelevski et al., 2010). These include c-Jun, Jun D, activating
transcription factor 3 (ATF3), cAMP response element binding
protein (CREB), signal transducer and activator of transcription
(STAT3), CCAAT/enhancer binding proteins (C/EBPs), p53, Oct-
6, nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-κB), nuclear factor of activated T-cells (NFATs), Kruppel-
like factors (KLFs), Sox11, SnoN, ELK3, P311, and E47 among
others (Schwaiger et al., 2000; Mason et al., 2003; Raivich et al.,
2004; Nadeau et al., 2005; Di Giovanni et al., 2006; Jankowski
et al., 2009; Ruff et al., 2009; Magoulas and Lopez-de Heredia,
2010; Moore and Goldberg, 2011; Raivich, 2011). Once in the
nucleus, they bind to selective DNA promoter regions to increase
or repress transcription of speciﬁc target genes. Nerve injury can
also result in reduced activation of transcription factors such as
islet-1, Fra-2, ATF2, and TDP43 (Doyle and Hunt, 1997; Herde-
gen et al., 1997a; Hol et al., 1999; Moisse et al., 2009; Sato et al.,
2009), which probably contributes to the change in gene expres-
sion of the injured neuron from a fully differentiated to a growing
phenotype (Raivich, 2011). The activation of transcriptional pro-
gram is critical for expression of many target genes implicated
in successful regeneration, and blocking of transcription at an
early time point after injury changes the regenerative response
of injured neurons (Smith and Skene, 1997). Recent advances
in cre/loxP technology permitting cell-type and/or time spe-
ciﬁc genetic knockouts (Sauer, 1998; Akira, 2000) have begun
to provide insight into the powerful roles of these transcription
factors in orchestrating complex axon growth and regenerative
responses. An overview of the observed phenotypes is given in
Table 1.
C-Jun
The AP-1 transcription complex is a well-characterized regulator
of neural development and consists of homo- or hetero-dimeric
complexes between members of the Jun, c-Fos, and ATF/CREB
families. A primary component of theAP-1 complex, c-Jun, is pro-
duced as an immediate early gene (IEG) following nerve injury and
persists at high levels in injured neurons during the entire periph-
eral regenerative process (Herdegen et al.,1991;Kenney andKocsis,
1998; Mason et al., 2003; Raivich et al., 2004; Lindwall and Kanje,
2005; Ruff et al., 2009). Schwann cells also strongly upregulate c-
Jun following axotomy, where it functions as a negative regulator
of myelination and switches on local inﬂammation (Arthur-Farraj
et al., 2007; Latouche et al., 2009; Wilton et al., 2009). Numerous
studies, using targeted gene deletions or pharmacological inhibi-
tion, have examined the activation, function, and cellular basis
Table 1 |Transcription factor deletions and peripheral nerve regeneration: effects of global (G) and cell-type specific (cts) knockouts (KO).
Transcription factor
G KO or CTS KO
KO phenotype Reference
Neuronal c-Jun (CTS) Strongly reduced target re-innervation Raivich et al. (2004), Makwana et al.
(2010), Ruff et al. (2009)Delayed functional recovery
Decreased RAG expression and neuronal sprouting
Strongly reduced glial activation and leukocyte recruitment
Enhanced motoneuron survival
Cellular atrophy
Schwann cell c-Jun (CTS) Severely impaired axonal regeneration Ruff et al. (2009)
Drastically reduced motoneuron survival
Jun 2A (G) Cellular atrophy Ruff et al. (2009)
Jun 4A (G) Moderately reduced target re-innervation and functional recovery Patodia et al. (unpublished)
Cellular atrophy
ATF3 (G) Enhanced speed of regeneration in mice constitutively expressing ATF3 in DRGs Seijffers et al. (2007)
CREB (G) Impaired axonal/neurite growth Lonze et al. (2002), Lonze and Ginty
(2002), Redmond et al. (2002)Increased apoptosis of sensory neurons
Neuronal STAT3 (CTS) Strongly reduced target re-innervation Bareyre et al. (2011), Patodia et al. (2011)
Delayed functional recovery
Decreased RAG expression and neuronal sprouting
Strongly reduced glial activation and leukocyte recruitment
Enhanced motoneuron survival
Cellular atrophy
C/EBPβ (G) Reduced expression of microtubule Tα1 α tubulin and growth cone protein GAP-43 Nadeau et al. (2005)
C/EBPδ (G) Impaired axonal growth and reduced response to conditioning lesion Magoulas and Lopez-de Heredia (2010),
Patodia et al. (unpublished)Reduced microglial activation
Sox 11 (CTS) Reduced regeneration after nerve crush Jankowski et al. (2009)
p53 (G) Growth cone collapse Di Giovanni et al. (2006), Tedeschi et al.
(2009), Qin et al. (2009)Decreased neurite outgrowth
Reduced target re-innervation
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of c-Jun and suggest a tripartite role of c-Jun action in neural
degeneration, inﬂammation, and repair (Raivich, 2008).
Nestin-cre mediated deletion of c-Jun prevented the upreg-
ulation of axotomy-associated molecules (CD44, α7β1 integrin,
galanin). It also decreased perineuronal sprouting (Makwana et al.,
2010) and successful reconnection to peripheral targets by four to
ﬁvefold, and strongly reduced functional recovery (Raivich et al.,
2004). This massive reduction in target re-innervation was also
observed more than 3months after facial nerve cut, suggesting
that it was a persistent defect, rather than just a delay in the
speed of regeneration. Incidentally, functional recovery did not
appear to require re-innervation of the target by the same num-
ber of neurons. Compared with the Jun-competent littermates,
functional recovery showed a longer but nevertheless transient
delay, suggesting that long term, target re-innervation by a fraction
of neurons could produce extensive functional recovery (Raivich
et al., 2004). Importantly, though functional recovery is clinically
the critical parameter, a sole reliance on this parameter could over-
estimate the extent of re-innervation. Non-neuronal responses
like leukocyte recruitment and microglial activation were also
severely compromised in the mutants. Interestingly, the facial
motoneurons in the mutants showed enhanced post-axotomy
survival, but were severely shrunken (Raivich et al., 2004), sup-
porting the previously reported functional dichotomy of c-Jun in
promoting post-traumatic neuronal cell death as well as axonal
regeneration (Herdegen et al., 1997b; Herdegen and Waetzig,
2001).
Because this cre Recombinase was driven by a nestin-promoter
expressed in early neuroepithelial cells giving rise to neurons,
astrocytes, or oligodendrocytes, as well as Schwann cells it is raised
the question whether the effects observed in neuronal regenera-
tion were due to the absence of c-Jun in neurons or other nestin+
progenitor-derived cells. This issue was addressed by using trans-
genic mice having neuron-speciﬁc (synapsin promoter controlled
cre-recombination) or Schwann cell-speciﬁc [myelin protein zero
(P0) promoter controlled cre-recombination] c-Jun deletions.
Neuron-speciﬁc c-Jun deletion mirrored the regeneration defect
seen with nestin-cre mediated deletion of c-Jun, i.e., strongly
reduced speed of axonal regeneration, signiﬁcantly delayed func-
tional recovery, strongly reduced target re-innervation, enhanced
motoneuron survival but cellular atrophy and diminished astro-
cyte and microglial activation and T-cell inﬂux (Ruff et al.,
2009). The absence of c-Jun in Schwann cells also caused severely
impaired axonal regeneration. However, it strongly increased neu-
ronal cell death after nerve injury (Ruff et al., 2009). These results
suggest a critical role of both Schwann cell and neuronal c-Jun
in the axonal injury response, which led to the next challenge
of understanding the mechanisms underlying its activation and
signaling following axonal injury.
Activation of c-Jun mediated transcription is affected by inter-
actions at three major sites: N-terminal phosphorylation at serines
63 and 73 and threonines 91 and 93 by the Jun N-terminal kinases
(JNKs) and the ensuing ubiquitination and degradation, dephos-
phorylation of Thr239, and C-terminal lysine acetylation near aa
257–276 (Vries et al., 2001; Morton et al., 2003). The JNKs are
rapidly activated following peripheral nerve injury, and are ret-
rogradely transported to the cell body along with the upstream
kinases MEKK1 and p-MKK4, as well as the JNK interacting pro-
tein (JIP), a scaffold protein that stabilizes the interaction between
JNKand its upstreamkinases (Lindwall andKanje,2005), reviewed
in Raivich (2008). Neuronal injury increases JNK-mediated c-Jun
phosphorylation (Herdegen et al., 1998; Kenney and Kocsis, 1998),
and application of a JNK inhibitor to explants of injured DRGs
reduces c-Jun phosphorylation, ATF3 expression, and neurite
outgrowth, without affecting survival (Lindwall et al., 2004).
Removal of Ser63 and 73 phosphoacceptor sites in the JunAA
mutant interfered with kainic acid excitotoxicity in hippocam-
pal neurons (Behrens et al., 1999) at levels similar to JNK3 KO
(Brecht et al., 2005), identifying c-Jun as an essential substrate of
JNK signaling during kainate-induced neuronal apoptosis. While
global c-Jun deletion is embryonically lethal, JunAA mice showed
normal development (albeit slightly smaller than littermate wild-
type mice) and were fertile (Behrens et al., 1999). Following optic
nerve transection, there was a partial but signiﬁcant reduction of
the apoptosis of retinal ganglion cells in JunAA mice, and Fas L
has been suggested to be an important target gene regulated by
N-terminal Jun phosphorylation during apoptosis (Yoshida et al.,
2002). JunAA and JNK3 null mutants also showed better neuronal
survival after targeted dopaminergic cell death (Brecht et al., 2005;
Crocker et al., 2006). Trophic factor deprivation or DNA damage-
induced death was signiﬁcantly delayed in JunAA neurons which
correlated with delayed expression of pro-apoptotic genes (Besirli
et al., 2005). In contrast, the JNK3 KO or JunAA mutations did
not interfere with neuronal cell death after facial axotomy (Brecht
et al., 2005; Ruff et al., 2009). This difference could be attributed
to the fact that facial axotomy affects peripheral neurons, unlike
previous studies which discuss effects of phosphorylation deﬁcient
c-Jun on apoptosis of CNS neurons.
Preliminary studies from our group after facial axotomy
revealed that JunAA mice do show some neuronal shrinkage, but
have no effect on speed of axonal regeneration for fastest axons,
functional recovery, or target re-innervation (Ruff et al., 2009).
Deletion of JNK1 or JNK3 single genes showed somewhat delayed
functional recovery after facial nerve axotomy but the effects were
quite moderate; and deletion of JNK2 had no effect on regenera-
tion (Ruff et al., 2009). The mild effects of JunAA and global JNK
deletions, and the fact that JNKs can act via c-Jun independent
cytoplasmic (stathmin, MAP1b, MAP2) and nuclear (e.g., ATF2,
ELK1, p53, etc.) targets (Björkblom et al., 2005; Bogoyevitch and
Kobe, 2006; Barnat et al., 2010; Westerlund et al., 2011), points to
a possible parting of ways: i.e., the observed JNK null effects on
regeneration are c-Jun independent, and the strong Jun-dependent
effects on regeneration and survival do not require N-terminal
phosphorylation. Recent studies using Jun4A mice where all four
JNK dependent N-terminal phosphorylation sites – Thr91 and 93
as well as Ser63 and 73 – are removed (Patodia et al., unpublished
observations) partially conﬁrm this notion. The Jun4A mutation
does not interfere with the expression of injury-associated neu-
ronal and non-neuronal markers. On the other hand, as in the
JNK1 and 3 null mutants, the Jun4A strain reproduces the mod-
erate reduction in functional recovery and a 40% lower number
of reinnervating motoneurons at 28 days following facial nerve
cut. However, this effect on regeneration is considerably smaller
than that observed for neuronal c-Jun deletion, suggesting that
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the regeneration effect of c-Jun is mostly independent of its N-
terminal phosphorylation. At present, no information is available
with regards to the regeneration-associated Jun effects of Thr239
dephosphorylation, or for C-terminal acetylation.
ACTIVATING TRANSCRIPTION FACTOR 3
Activating transcription factor 3 is a member of the ATF/CREB
family of basic leucine zipper domain (bZIP) transcription factors.
It can form homo- or hetero-dimers with other bZIP transcrip-
tion factors like members of the AP-1 family (ATF2, JunB, JunD,
c-Jun, c-fos) and c/EBPs (Hai andCurran, 1991;Hai andHartman,
2001). ATF3 is normally expressed at low levels, but is rapidly
activated in sensory, sympathetic, and motor neurons by stress
stimuli after peripheral nerve injury (Tsujino et al., 2000; Raivich
and Behrens, 2006; Hyatt Sachs et al., 2007; Zigmond and Vac-
cariello, 2007), optic nerve injury (Takeda et al., 2000), and NGF
depletion (Mayumi-Matsuda et al., 1999) but not after central
injury (Tsujino et al., 2000). ATF3 expression is also induced in
the disconnected Schwann cells and endoneurial ﬁbroblasts distal
to the peripheral injury site, though not on central, denervated glia
(Hunt et al., 2004). Several pathways have been implicated in acti-
vating ATF3 expression such as neurotrophin deprivation (Hyatt
Sachs et al., 2007), as well as JNK/SAPK and p53-dependent mech-
anisms (Moore and Goldberg, 2011). ATF3 is axonally transported
from the periphery (Lindwall and Kanje, 2005), possibly acting as
a retrograde signal.
Delivery of ATF3 to adult DRG neurons, neonatal SCG neurons
and PC12 cells, enhanced both the number of neurons extend-
ing neurites and neurite length (Nakagomi et al., 2003; Pearson
et al., 2003; Seijffers et al., 2006). As after conditioning peripheral
injury, the pattern of growth consisted of long neurites rather than
branched arborized ones (Seijffers et al., 2007). In transgenic mice
constitutively expressing ATF3 in adult DRGs, the rate of periph-
eral nerve regeneration (measured by the nerve pinch test 2 days
after sciatic nerve crush) was enhanced to an extent comparable to
that produced by a preconditioning lesion (Seijffers et al., 2007).
The expression of some growth-associated genes, such as Hsp27,
SPRR1A, and c-Jun was increased in the non-injured neurons,
but not of others like the alpha 7 integrin subunit (α7), GAP-
43, CAP23, and STAT3. Unlike peripheral nerve-conditioning
lesions, ATF3 overexpression also did not overcome the inhibi-
tion produced by CNS myelin in culture, suggesting the mecha-
nisms responsible for axonal regeneration are separate from those
involved in overcoming glial-associated inhibition (Seijffers et al.,
2007).
Activating transcription factor 3 can bind directly to the Hsp27
promoter and activate its expression inPC12 cells (Nakagomi et al.,
2003). In addition to its role as an injury-induced neuronal sur-
vival factor, Hsp27 enhances neurite outgrowth in cultured adult
DRGneurons (Williams et al., 2006), possibly as a result of interac-
tions with the cytoskeleton. The growth-associated gene SPRR1A
promotes axonal outgrowth by interacting with actin structures
(Bonilla et al., 2002) andATF3may regulate its expression either by
binding directly to its promoter or by affecting other transcription
factors. ATF3 also appears to have a survival role, preventing JNK-
mediated neuronal death (Nakagomi et al., 2003). Thus, although
ATF3 appears to contribute to nerve regeneration by increasing
the intrinsic growth state of injured neurons, its upregulation is
not enough to fully recapitulate the peripheral nerve regeneration
program (Seijffers et al., 2007).
Activating transcription factor 3 can form hetero-dimers with
c-Jun, leading to enhanced transcriptional activation of various
RAGs and increased neurite outgrowth in neuronal cell lines (Hai
and Curran, 1991; Hai and Hartman, 2001; Pearson et al., 2003).
There has been a number of conﬂicting reports regarding the cor-
relation between increased ATF3 expression and upregulation of
c-Jun in surviving neurons. In 2003, Pearson et al., showed that
in the absence of c-Jun, ATF3 failed to enhance neurite outgrowth
in PC12 cells, suggesting that a coincident presence of c-Jun and
ATF3may act synergistically (possibly via a physical interaction) to
promote nerve regeneration (Pearson et al., 2003; Lindwall et al.,
2004). In contrast, Seijffers et al. (2006) showed enhanced neurite
outgrowth in adult DRG neurons by ATF3 without any increase
in endogenous c-Jun levels. The scope of c-Jun and ATF3 expres-
sion in DRG neurons after sciatic nerve transection also differs:
ATF3 is induced in all injured neurons, phosphorylated c-Jun only
in a small subset of mostly small and medium sized DRG neu-
rons (Kenney and Kocsis, 1998; Tsujino et al., 2000; Lindwall et al.,
2004). Sciatic nerve injury induces prolonged activation of JNKs
in the DRGs (Kenney and Kocsis, 1998). Inhibiting JNK in this
model led to decreased activation of c-Jun and ATF3 expression,
and to decreased axonal growth (Lindwall et al., 2004). Recent
results from our group show that deletion of neuronal c-Jun or
STAT3 interferes with the nuclear transfer of ATF3 in the axo-
tomized facial motor neurons (Patodia and Raivich, unpublished).
This effect may be speciﬁc for motoneurons – in sympathetic neu-
rons, cell-speciﬁc deletion of gp130 interferes with the appearance
of phosphorylated nuclear STAT3, but does not affect the nuclear
translocation of ATF3 (Habecker et al., 2009). Thus, the extent to
which the growth promoting action of ATF3 is autonomous of c-
Jun and STAT3 and dependent on additional injury signals needs
to be explored.
cAMP RESPONSE ELEMENT BINDING PROTEIN
TheCREB is amember of theATF/CREB family of bZIP transcrip-
tion factors (Hai and Hartman, 2001), and mediates cAMP signal-
ing in the nervous system by forming homo- or hetero-dimers
with other bZIP factors (Hannila and Filbin, 2008). The brains
of CREB null mice show abnormal development of the corpus
callosum and anterior commissure (Rudolph et al., 1998). CREB
can be phosphorylated and activated by many kinases, including
PKA, PKC, CAMKII, CAMKIV, AKT, MAPKAP K2, and members
of RSK and MSK families (Mayr and Montminy, 2001), and it is
negatively regulated by phosphatases such as PP1 and PP2A (Sun
et al., 1994). Important targets of CREB include arginase I and
BDNF (Mayr and Montminy, 2001; Cai et al., 2002; Deng et al.,
2009).
In vitro cultured DRG and SCG neurons from CREB null mice
show shorter neurites than controls. In vivo, these mutant mice
exhibit impaired axonal growth and projections. Their sensory
neurons undergo excess apoptosis and degeneration during the
period of NGF dependency in the absence of CREB (Lonze and
Ginty, 2002; Lonze et al., 2002). In addition, overexpression of a
dominant negative CREB leads to decreased dendritic outgrowth
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in cortical neurons and loss of cAMP or neurotrophin associated
neurite outgrowth on an inhibitory substrate (Redmond et al.,
2002). This suggests an important role for CREB-mediated gene
expression for both survival and axonal growth in PNS neurons.
Recently, it has been suggested that axonal translation of CREB
mRNAs may precede its phosphorylation, nuclear translocation,
and transcriptional activation of pro-survival genes (Cox et al.,
2008).
SIGNAL TRANSDUCER AND ACTIVATOR OF
TRANSCRIPTION-3
Signal transducer and activator of transcription-3 belongs to the
STAT family of seven transcription factors – STAT1,STAT2,STAT3,
STAT4, STAT5a, STAT5b, and STAT6 – that mediate a wide vari-
ety of biological functions in the CNS and PNS such as cell
growth, regulation, inﬂammation, and embryological develop-
ment (Dziennis and Alkayed, 2008). The STATs are comprised
of six regular domains – an amino terminal (for STAT3 dimer-
ization after activation), coiled-coil domain (for interaction with
other transcription factors and regulatory proteins),DNA binding
domainmade up of β-sheets (for recognition of consensus binding
regions on gene promoters), α-helical linker domain (for tran-
scriptional activation and protein–protein interaction), a classical
SH2 (sequence – homology) docking domain, and a transcrip-
tional activation domain (Bromberg and Darnell, 2000; Lim and
Cao, 2006). There are two highly conserved, phosphorylatable
amino acids that are frequently required for STAT3 activation – a
tyrosine 705 in the SH2 domain and a serine 727 in the 78-amino
acid region of the transactivation domain (Bromberg and Darnell,
2000; Dziennis and Alkayed, 2008).
Injury-induced ligand binding to cell-surface receptors acti-
vates the associated receptor tyrosine kinase Janus kinases (JAKs),
which phosphorylate tyrosine residues on the cytoplasmic por-
tion of the receptor complex that acts as a binding site for
STAT proteins. STATs dock onto the phospho-tyrosines via their
SH2 domain, and are also phosphorylated by JAK on a tyrosine
residue (e.g.,Y705 in STAT3). Upon activation, they either hetero-
or homodimerize and translocate to the nucleus via importins
(Cimica et al., 2011), where they bind to consensus sequences
(SIE/GAS/ISRE sequences) to induce gene transcription. Other
mechanisms of STAT activation include phosphorylation by non-
receptor tyrosine kinases such as Src,direct,or indirect phosphory-
lation by receptors with intrinsic tyrosine kinase activity (i.e., EGF,
PDGF, and FGF receptors), and activation by G-protein coupled
receptors (Ram and Iyengar, 2001). STAT3 can be deactivated by
dephosphorylation or targeted degradation, and recycled back to
the cytosol (reviewed by Lim and Cao, 2006; Dziennis and Alka-
yed, 2008; Moore and Goldberg, 2011). Further, Suppressor of
Cytokine Signaling 3 (SOCS3) or protein inhibitors of activated
STATS (PIAS) can also inhibit STAT3 activation (Krebs andHilton,
2001).
In the adult brain, STATs are normally quiescent, but are acti-
vated following injury in response to multiple signaling path-
ways induced by several cytokines and growth factors includ-
ing IL-6, LIF, CNTF, G-CSF, G-CSFR, EPO, EGF, IGF-1, NGF
withdrawal, BDNF, free radicals, excitatory neurotransmitters
and other inﬂammatory mediators that are released after injury
(reviewed in Dziennis and Alkayed, 2008). Propagation of many
of these signals (IL-6, LIF, and CNTF) requires a combination of
various ligand binding units and a common signal-transducing
unit gp130 (Taga and Kishimoto, 1995), through which they
activate the JAK/STAT, Ras/MAPK, extracellular regulated-signal
kinase (ERK), PI3K, and other pathways (Akira, 2000; Heinrich
et al., 2003). Activation of the gp130-receptor has been implicated
in neuronal response to injury and regenerative axonal growth
(Habecker et al., 2009; Hyatt Sachs et al., 2010).
Signal transducer and activator of transcription-3 was identi-
ﬁed as an acute phase response factor (Akira et al., 1994) and is
expressed cytoplasmically in both neuronal and glial cells during
development and in the adult (De-Fraja et al., 1998; Gautron et al.,
2006). Nervous system insult leads to STAT3 activation in speciﬁc
subsets of neurons with the pattern of activation dependent on the
nature of the insult (Schwaiger et al., 2000; Xia et al., 2002). Global
STAT3 knockout animals are embryonic lethal, dying prior to gas-
trulation between E6.5 and 7.5 (Takeda et al., 1997). Cell-type
speciﬁc STAT3 deletion has greatly improved our knowledge of
its function in different tissues (Sauer, 1998; Akira, 2000). STAT3
deletion in T-cells is associated with impaired T-cell proliferation,
in macrophages with high susceptibility to endotoxin shock, in
keratinocytes with compromised wound healing process, and in
mammary glands with delay of involution (Akira, 2000). Nestin-
promoter mediated neural-speciﬁc disruption of STAT3 resulted
inmicewhichwere hyperphagic,obese,diabetic, and infertile (Gao
et al., 2004).
In the last decade, there has been growing evidence of a role
of STAT3 in axonal regeneration. In vitro, STAT3 induces neu-
rite growth in motor and sensory neurons and this growth can be
inhibited by the application of SOCS3 (Liu and Snider, 2001;Miao
et al., 2006). STAT3 induces GAP-43, a protein found in growth
cones, and GAP-43 expression is inhibited with the JAK inhibitor
AG-490, suggesting a role for the JAK/STAT3 pathway in GAP-
43 expression and neurite outgrowth and regeneration (Wu and
Bradshaw, 1996).
Haas et al. (1999) observed STAT3 activation at 24 h and
5 days after rat facial nerve axotomy. Following rat facial and
hypoglossal nerve axotomy, a transient but signiﬁcant increase
in STAT3 mRNA, along with its phosphorylation and nuclear
translocation within 3 h in neurons and 1 day in astrocytes was
observed by Schwaiger et al. (2000). In contrast, these changeswere
not observed in non-regenerating neurons of Clarke’s nucleus,
although both forms of injury upregulated c-Jun and GAP-43
expression (Schwaiger et al., 2000). Transient increases in STAT3
signaling were also found in sprouting neurites and astrocytes
following entorhinal cortex lesions in addition to a rise in gp130-
receptor cytokines, suggesting a dual role of STAT3 in both astro-
cytic regulation and axonal sprouting (Xia et al., 2002). Lee et al.
(2004) showed that axonal STAT3, activated at the injury site, acts
as both a retrograde injury signal and as a transcription factor
which promotes the survival and regeneration of both sensory
and motor neurons. Levels of activated STAT3 increased in the
nuclei of regenerating adult cranial motor neurons, sciatic motor
neurons and in sensory neuron nuclei after injury. Sciatic nerve
lesion led to a very rapid activation of STAT3 in axons at the lesion
site within 15min, and by 24 h STAT3 labeling was detected in
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the DRG and in the spinal cord (Lee et al., 2004). These levels of
STAT3 decreased when regeneration was completed, emphasizing
its role in the regenerative process.
Deletion of CNTF, which is abundantly present in myelinating
Schwann cells but not in or around the cell bodies of axotomized
motoneurons (Dobrea et al., 1992; Rende et al., 1992) caused a
delay in the appearance of phosphorylated STAT3 and its nuclear
translocation in neuronal cell bodies (Kirsch et al., 2003). This
delay points to a signaling cascade beginning with local release
of CNTF by damaged myelinating Schwann cells, its local action
on adjacent axons, intra-axonal phosphorylation of STAT3 and
its retrograde transport to the cell bodies of injured neurons and
ﬁnally to the nucleus. Recent studies using repetitive in vivo imag-
ing of individual ﬂuorescently labeled axons have shown that
STAT3 selectively regulates initiation but not later perpetuation
of axonal growth, thus acting as a phase-speciﬁc regulator of
axonal outgrowth in both PNS and CNS (Bareyre et al., 2011).
Altogether, these studies show a general trend of early and persis-
tent expression of phosphorylated STAT3 during the regenerative
process.
A number of in vitro and in vivo studies have also implicated
the role of STAT3 as an intracellular survival-promoting factor.
In vitro studies using cell lines have shown that STAT3 expression
directly induces bcl-2 and bcl-xL gene expression,which are critical
in promoting neuronal survival after injury (Dziennis and Alka-
yed, 2008). Mice lacking STAT3 in facial and spinal motoneurons
(controlled by cre expression under NF-L promoter) showed a sig-
niﬁcant reduction in motoneuron survival after facial nerve lesion,
which closely correlated with the extent of motoneuron loss seen
in LIF/CNTF KO mice after nerve lesion (Sendtner et al., 1996;
Schweizer et al., 2002). Moreover, upregulation of Reg-2 and Bcl-
xl expression was reduced in axotomized motoneurons in STAT3
KO mice, suggesting a role of STAT3 in anti-apoptotic signaling.
Interestingly, in the study by Schweizer et al. (2002) local appli-
cation of CNTF strongly reduced the apparent motoneuron cell
death in the absence of neuronal STAT3, but which other signaling
pathways were involved is unclear.
Preliminary data from our lab suggests an important role for
neuronal STAT3 in axonal regeneration (Patodia et al., 2011).
Conditional mice mutants, lacking STAT3 in their neurons, had
profound defects in the usual retrograde response, with a severe
early and persistent reduction by 75–90% in microglial activation
and recruitment of lymphocytes, and 4 days after injury in speed
of axonal elongation in the distal stump. At 30 days, axotomized
STAT3-deﬁcient motoneurons appeared shrunk by 50–60% in
size but displayed no cell death in contrast to results published
earlier (Schweizer et al., 2002). Functional recovery was dramat-
ically reduced and the mutants showed 80% less target muscle
re-innervation. As with neuronal c-Jun deletion which interferes
with regeneration (Raivich et al., 2004), expression of RAGs like
CD44, β1 integrin, CGRP, galanin as well as the nuclear translo-
cation of ATF3 was also greatly diminished or abolished in the
STAT3 mutants. However, c-Jun expression itself was not affected,
suggesting that deletion of either transcription factor – c-Jun
or STAT3 – will produce a very similar regeneration-deﬁcient
phenotype.
CCAAT/ENHANCER BINDING PROTEIN β, δ
The C/EBP family of transcription factors is comprised of six pro-
teins (C/EBPα, β, γ, δ, ε, and ζ), each having unique properties
regulating cellular proliferation and differentiation, particularly
in hepatocytes, adipocytes, and hematopoietic cells (Ramji and
Foka, 2002). C/EBPs also play pivotal, non-redundant roles in the
development and plasticity of the nervous system, including cell
fate determination, apoptosis, synthesis and response to trophic
factors and responses to brain injury and ischemia (Kfoury and
Kapatos, 2009). All members have a DNA binding domain and
a highly homologous bZIP domain which is required for dimer-
ization. The C/EBPs can interact with other bZIP and non-bZIP
transcription factors (Huang et al., 2007).
CCAAT/enhancer binding protein-δ (also known as CELF,
CRP3, and NF/IL-6) expression is typically low to undetectable
in most cell-types and tissues, but it is rapidly induced by a vari-
ety of extracellular stimuli (e.g., growth hormone, insulin, IFNγ,
IL-1, IL-6, LPS, TNFα, noradrenaline, and glutamate), phospho-
rylated, and translocated to the nucleus as an active transcription
factor where is induces further IL-6 expression (Ramji and Foka,
2002). The most favorable complex responsible for the transcrip-
tion of the IL-6 gene requires the interaction between p65 and
C/EBPδ, with c-Jun occurring on the NF-κB site (Faggioli et al.,
2004). C/EBPδ is elevated in hypoxia, glaucoma, carcinoma, trau-
matic brain injury and in the brains of Alzheimer’s disease patients
(Huang et al., 2007; Yang et al., 2007). A recent study showed that
the anti-inﬂammatory and neuroprotective effects of chrysin on
reactive microglial cell induced neurotoxicity was partly medi-
ated by inhibition of C/EBPδ expression at both protein and
mRNA levels. C/EBPδ-deﬁcient microglial cultures produce less
NO and TNFα in response to LPS/IFNγ, re-afﬁrming its role
in microglial activation and neuroinﬂammation (Gresa-Arribas
et al., 2010). C/EBPβδ double knockout in mouse embryonic
ﬁbroblasts showed particularly impaired production of IL-6 and
TNFα in response to LPS or IL-1, suggesting complementary
roles of C/EBPβ and C/EBPδ in induction of proinﬂammatory
cytokines (Ramji and Foka, 2002).
CCAAT/enhancer binding protein β is upregulated and phos-
phorylated across different classes of injured neurons, including
the invertebrate Aplysia model. In this model, phosphorylation of
Aplysia C/EBPβ is mediated by the RISK1, a mitogen associated
protein kinase homolog related to the ERK family (Sung et al.,
2001). In the mouse facial nerve model, C/EBPβ is important
for the expression of regeneration-associated microtubule Tα1 α
tubulin and growth cone protein GAP-43, suggesting that C/EBPβ
is a critical component of the regenerative response (Nadeau et al.,
2005).
In the case of C/EPBδ, which is upregulated in sensory and
sympathetic neurons (Boeshore et al., 2004; Magoulas and Lopez-
de Heredia, 2010), initial studies using cultured primary sensory
neurons from C/EPBδ null mice show impaired axonal growth
and a reduced response to the conditioning lesion (Magoulas and
Lopez-de Heredia, 2010). Preliminary results from our studies also
conﬁrm this ﬁnding in the motor, facial nerve injury model as well
as indicate a role for C/EBPδ in early and late microglial activation
(Patodia et al., unpublished).
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In summary, a number of intriguing ﬁndings implicate a role
of C/EBPs in injury response in neurons, i.e., they are mediators of
neuro-inﬂammatory responses in the brain; are induced in injured
neurons of invertebrates (Korneev et al., 1997; Sung et al., 2001)
as well as vertebrates (Nadeau et al., 2005); have RAGs like Tα1
α tubulin and GAP-43 as direct transcriptional targets (Nadeau
et al., 2005); and are upregulated by IL-6, an important post-injury
molecule (Ramji et al., 1993). A number of alternative signaling
pathways might also converge onto C/EBP family members fol-
lowing axonal injury, e.g., the JAK–STAT pathway has been shown
to directly regulate C/EBPβ (Jiang and Zarnegar, 1997).
Oct-6
Transcription factors Oct-6 (SCIP/Tst-1), Krox-20 (Egr-2), and
Sox 10 are major regulators of Schwann cell differentiation and
myelination (Topilko et al., 1994; Bermingham et al., 1996; Jaegle
and Meijer, 1998). A fragment distal to the Oct-6 gene, con-
taining two DNase I-hypersensitive sites, acts as the Schwann
cell-speciﬁc enhancer (SCE) and is responsible for the complex
signaling between Schwann cells and axons driving myelination,
during both normal peripheral nerve development and regenera-
tion (Mandemakers et al., 2000). Oct-6 is present in the cytoplasm
of Schwann cells associated with myelinated ﬁbers of intact nerves.
Axonal injury induces nuclear Oct-6 expression during the acute
degenerative stage, reaching peak expression levels in the subse-
quent regenerative stage (Scherer et al., 1994;Kawasaki et al., 2003),
suggesting that at the time of regeneration, Oct-6 is translocated
to the nucleus to promote transcription of genes, possibly those
encoding myelin proteins. Oct-6 expression is down-regulated in
fully regenerated nerves and in nerves showing chronic axonal
loss (Kawasaki et al., 2003). Therefore, Oct-6 may be a marker
for dedifferentiation of adult Schwann cells and active nerve
regeneration.
Sox11
SRY-box containing gene 11 (Sox11), a member of the Sox tran-
scription factor family, is highly expressed in developing sensory
neurons and at low levels in adult neurons (Jankowski et al., 2006;
Moore andGoldberg, 2011). There has been limited study of Sox11
targets in axonal growth, but Sox11 can partner with Brn1 or -2 to
regulate transcription (Kuhlbrodt et al., 1998; Tanaka et al., 2004)
and drive expression of neurite growth-associated genes like β-III
tubulin, MAP2 (Bergsland et al., 2006) and actin-related protein
complex 3 (Arpc3; Jankowski et al., 2006). Sox11 expression in
sensory and sympathetic ganglia is highly sensitive to nerve cut
and crush injuries, rising steadily after injury and during subse-
quent regeneration, and returning to baseline levels at the end of
regeneration (Boeshore et al., 2004; Jankowski et al., 2006, 2009).
In Neuro2a cells, Sox11 levels dramatically increased with the
number of cells extending neurites. In vitro experiments using
cultured adult DRG neurons treated with Sox11 siRNAs exhibit
a signiﬁcant decrease in regeneration following axotomy as indi-
cated by reduced neurite length and branching index (Jankowski
et al., 2006). This suggests a correlation between Sox11 and neurite
growth.
Injection of Sox11 siRNAs into mouse saphenous nerve caused
a transient knockdown of Sox11 mRNA, that transiently inhibited
in vivo regeneration after nerve crush. Electron microscopy analy-
sis of Sox11 RNAi-injected nerves showed that regeneration of
both myelinated and unmyelinated axons was inhibited. Nearly
all neurons in the ganglia of crushed nerves that were Sox11
immunopositive showed co-labeling for ATF3 (Jankowski et al.,
2009) and treatment with Sox11 siRNAs in vitro and in vivo caused
a transcriptional and translational level reduction in ATF3 expres-
sion. Interestingly,ATF3 ablation usingATF3 siRNAs did not affect
Sox11 levels, suggesting that Sox11 may act upstream of ATF3 and
inﬂuence regulation of its gene expression (Jankowski et al., 2009).
These anatomical and expression data support an intrinsic role for
Sox11 in axonal regeneration that may involve interaction with
ATF3.
p53
p53 is a member of a family of tumor suppressors together with
p63 and p73. Like c-Jun, p53 is known to mediate both pro- and
anti-apoptotic roles in the nervous system (Culmsee and Matt-
son, 2005; Jacobs et al., 2006). p53 can undergo multiple types of
post-translational modiﬁcations including acetylation, phospho-
rylation, and ubiquitination, which can affect its localization and
function (Lavin and Gueven, 2006; Tedeschi et al., 2009). In vitro
and in vivo experiments have shown that p53 plays a role in pro-
moting neurite growth. Overexpression of a dominant negative
form of p53 in primary cortical neurons leads to growth cone
collapse and decrease in neurite outgrowth, possibly due to a
combination of reduced expression of its growth cone associated
target genes Coronin1b, Rab13, and GAP-43 (Di Giovanni et al.,
2006; Tedeschi et al., 2009), as well as its local, non-transcriptional
activity at the growth cone (Qin et al., 2009). On the other hand,
overexpression of wild-type p53 leads to an increase in growth
cone size (Qin et al., 2009). Other axonal guidance molecules and
their receptors like netrins, semaphorins, and ephrins are also reg-
ulated by p53 (Arakawa, 2005). In vivo experiments using p53
knockout mice showed a signiﬁcant decrease in the number of
ﬁbers reinnervating the target muscles at 28 days after facial axo-
tomy in themutantmice when comparedwith control animals (Di
Giovanni et al., 2006). Taken together, these studies suggest a role
for p53 in modulating neurite growth and regeneration. Given its
well described role in apoptosis of neurons andnon-neuronal cells,
it will be interesting to investigate its effects on neuronal survival
after peripheral nerve injury.
NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF
ACTIVATED B CELLS
Nuclear factor kappa-light-chain-enhancer of activated B cells is
an inducible transcription factor dimer made up of 5 subunits,
bound as homo- or hetero-dimers: RelA/p65, c-Rel, RelB, p50, and
p52. Inhibitor of κB (Iκβ) family of proteins can bind to NF-κB
dimer and prevent its nuclear translocation. Dissociation or pro-
teasomal degradation of IκB reveals NF-κB’s nuclear localization
sequence (NLS), allowing it to move to the nucleus and mod-
ulate gene transcription by binding to promoter and enhancer
sequences (reviewed by Moore and Goldberg, 2011).
Nuclear factor kappa-light-chain-enhancer of activated B cells
is signiﬁcantly upregulated in DRGs and spinal cord after periph-
eral nerve crush (Ma and Bisby, 1998; Pollock et al., 2005). It can
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respond to a stimulus in neurites and retrogradely travel to the
nucleus to affect gene transcription. NF-κB signaling can either
enhance of inhibit neurite growth depending on the phosphory-
lation status of its RelA/p65 subunit. Phosphorylation of p65 by
IKKβ results in reduced neurite growth, and in neurons without
this IKKβ activity, there is increased neurite growth (Gutierrez
et al., 2008). Identiﬁed neuronal targets of NF-κB include genes
for Bcl-2, MnSOD, glutamate receptor subunits, BDNF, and cal-
cium regulating proteins (reviewed byMattson,2005). In addition,
NF-κB has been shown to regulate expression of cell-adhesion
molecules like NCAM, tenascin C and β1 integrin in other systems
(reviewed by Moore and Goldberg, 2011). NF-κB is also the down-
stream modulator of neurite growth for fas apoptosis inhibitory
molecule (FAIM) signaling. Blocking NF-κB activation prevents
the increase of neurite growth seen with FAIM overexpression
(Sole et al., 2004).
ELK
The ETS-like (ELK) subfamily of transcription factors comprises
of ELK1, ELK3, and ELK4 factors which can have different poten-
tial protein–protein interactions, and respond differently to MAP
kinase signaling pathways (Ducret et al., 2000; Buchwalter et al.,
2004). Seven days after peripheral axotomy, a 2.3-fold upregu-
lation of ELK3 mRNA, but not of ELK1 or ELK4 mRNA was
detected in adult mouse DRGs (Kerr et al., 2010). The expression
of neuropeptide galanin mRNA is upregulated around 80-fold
in DRGs following axotomy, and an 18 bp sequence within its
promoter/enhancer region containing overlapping putative ETS,
STAT, and Smad binding sites, has been shown to be critical for
this response (Bacon et al., 2007), making ELK3 a potentially
important player in peripheral nerve regeneration. It would be
interesting to see if the injury-induced ELK3 isoforms can dif-
ferently affect neuronal survival and/or regeneration after axonal
injury.
CROSS-TALK BETWEEN TRANSCRIPTION FACTORS
Transcription factors forman intricate network inwhich cross-talk
between different pathways leads to an integrated and input-
balanced signaling outcome (Morrison and Davis, 2003; Moore
and Goldberg, 2011). Some axonal regeneration still occurs in the
absence of master regulators of regeneration like c-Jun, highlight-
ing the existence of alternative pathways, and of compensatory and
complementary/synergistic mechanisms, which may be shared
during axonal outgrowth.
Jun N-terminal kinase signaling is interconnected with various
other cellular signaling pathways, such as NFkB and the JAK/STAT
system (Waetzig et al., 2006; Haeusgen et al., 2009), resulting in
STAT3 phosphorylation (Levy and Lee, 2002). Besides JNK, c-Jun
can also be activated by ERK1/2 (Leppa et al., 1998; Schwarz et al.,
2002; Morton et al., 2003). On the other hand, STAT3 can stimu-
late transcription of several AP-1 members including JunB (Coffer
et al., 1995) and c-fos (Yang et al., 2003; Higashi et al., 2004) which
have STAT3 responsive elements in their regulatory sequence.
The interactions between AP-1 and STAT3 are multiple and
complex, resulting in mutual modulation of their transcriptional
activities. STAT3 and AP-1 factors can bind to independent but
closely spaced DNA binding sites in the regulatory sequences of
a number of genes, such as α-2 macroglobulin (Schaefer et al.,
1995), VIP (Symes et al., 1997), bcl-6 (Arguni et al., 2006), and
matrix metallo-proteinases and synergistically induce maximal
enhancer function (Zhang et al., 1999). AP-1 complexes can also
bind directly to STAT3, enhancing STAT3’s transcriptional activity
(Schaefer et al., 1995; Leu et al., 2001). Mapping of the STAT3–c-
Jun interactive regions by GST pull-down assays suggested that the
STAT3-interactive region lies within its coiled-coiled domain, and
in a portion of the DNA binding domain. The c-Jun interactive
region was within its C-terminal residues 105–334. Point muta-
tions within these regions blocked their interaction (Zhang et al.,
1999). SOCS3 was discovered for its ability to inhibit tyrosine
phosphorylation of STAT3 through binding to gp130 and JAKs
(Krebs and Hilton, 2001). It has subsequently been shown that
endogenous SOCS3 can also inhibit AP-1 activity by blocking JNK
phosphorylation (Miao et al., 2008). Therefore SOCS3 could be an
important molecule regulating axonal regeneration by controlling
changes in JNK and JAK/STAT signaling pathways after injury.
Additional transcription factors encompassing a compen-
satory/complementary role include the C/EBP family members
C/EBPβ and C/EBPδ. The promoter region of a c-Jun coactivator,
an oncogene Jab1, contains binding sequences for C/EBP, GATA,
as well as a STAT3 consensus sequence overlapping the C/EBP
site. Both, mutation of the C/EBP binding site and inhibition of
STAT3, signiﬁcantly reduced Jab1-promoter activity (Shackleford
et al., 2011). C/EBPβ is essential for appropriate induction and
maintenance of GAP-43 mRNA following axonal injury (Nadeau
et al., 2005). While there is no evidence of a direct binding site for
C/EBP on the GAP-43 gene, it contains a functionally important
AP-1 site for c-Jun and c-fos (Weber and Skene, 1998). C/EBPβ can
bind to and regulate both c-fos and c-Jun (Nadeau et al., 2005),
suggesting a coordinated induction of GAP-43 by C/EBPβ, c-fos,
and c-Jun in injured neurons. It has already been shown that co-
expression of c-Fos with c-Jun induces a greater number of cells
to produce neurites than c-Jun alone (Leppa et al., 1998).
We have already discussed a number of different studies investi-
gating the complex associationbetweenATF3 and c-Jun expression
after injury. Besides interacting with leucine zipper transcription
factors, ATF3 can also interact with other transcription factors
upregulated after peripheral injury, such as, STAT3. This could
be via co-activators or by synergistic binding to adjacent DNA
binding sites. For example, SPRR1A, a target gene for ATF3, is a
gp130 pathway protein and its promoter region contains func-
tional AP-1 binding sites (Sark et al., 1998; Pradervand et al.,
2004). The levels of SPRR1A expression in DRGs of injured
wild-type mice are higher than in DRGs of non-injured trans-
genic mice expressing constitutively active ATF3, suggesting that
other downstream signals in addition to ATF3 are likely to govern
SPRR1A expression. C/EBPβ, for example, is induced after periph-
eral nerve injury (Nadeau et al., 2005) and a functional C/EBPβ
binding site is located on the SPRR1Apromoter (Pradervand et al.,
2004).Recently, transcriptionof DINE (damage-inducedneuronal
endopeptidase), an enzyme involved in terminal nerve branching
(Nagata et al., 2010), was shown to be increased 60-fold by Sp1
mediated recruitment of STAT3, c-Jun, and ATF3 to the DINE
promoter in response to LIF upregulation and NGF withdrawal
following injury (Kiryu-Seo et al., 2008).
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Nuclear factor kappa-light-chain-enhancer of activated B cell
can also interact with Jun, ATF, CREB, and Fos transcription fac-
tors. STAT3 can induce the alternative NF-κB pathway, and bind
to DNA in a complex with p52, to induce transcription. p53 can
also interact with p52 to regulate expression of its target genes
(reviewed by Perkins, 2007).
Mathematical models of interacting signaling pathways have
been developed to predict regenerative outcomes after injury
(Moya et al., 2011).Transgenic animal models with deletion of
multiple signaling streams will be very useful in identiﬁcation of
functional complementary counterparts.
DOWNSTREAM TARGETS OF TRANSCRIPTION FACTORS
Transcription factors rapidly condition the injured nerve and
within 1–4 days after injury, the neuronal perikaryon produces a
plethora of RNA, protein, and glycolipid components which play a
vital role in executing axonal regeneration. Downstream targets of
the transcription factors include a vast number of RAGs that may
be involved in cell–cell signaling, axonal growth and sprouting, and
activation of the non-neuronal, cellular milieu. Successful axonal
regeneration is accompanied by the appearance of functionally
diverse families of molecules that regulate surface cytoskeletal
interaction. Examples of regeneration-associated cytoskeletal fam-
ilies include the GMC family of “integral” membrane proteins –
GAP-43, MARCKS, and CAP23 (Skene and Willard, 1981; Bomze
et al., 2001), microtubule disassembly molecules (e.g., SCG10,
stathmin, CRMP2, and RB3; Iwata et al., 2002; Mori and Morii,
2002), and the Rho GTPase family (RhoA, Rac, Cdc42, and TC10)
members which act as molecular switches regulating cytoskeletal
structure, dynamics, and cell-adhesion (Etienne-Manneville and
Hall, 2002). Regenerating neurons also upregulate adhesion mole-
cules like integrinsα7 andβ1 (Kloss et al., 1999),CD44 (Jones et al.,
2000), galectin-1 (Horie and Kadoya, 2000), β2-microglobulin
(Oliveira et al., 2004), ninjurin (Araki and Milbrandt, 2000), and
gicerin/CD146 (Hiroi et al., 2003). Neurotrophins like BDNF and
GDNF are induced in the distal stump of the injured axons,
and their exogenous application promotes axonal regeneration of
chronically injured neurons (Boyd and Gordon, 2003a,b). In vitro
studies have shown that different neuropeptides like substance
P, somatostatin, vasopressin, calcitonin, and alpha-MSH exert a
moderate but signiﬁcant neurite growth promoting effect on CNS
and PNS neurons (Narumi and Fujita, 1978; Brinton and Gruener,
1987;Raivich, 2011). Transgenic and pharmacological studies have
conﬁrmed a similar role in vivo for peptides like galanin (Holmes
et al., 2000; Wynick et al., 2001), CGRP (Toth et al., 2009), and
PACAP (Pituitary Adenylate Cyclase Activating Peptide; Kimura
et al., 2003; Suarez et al., 2006; Armstrong et al., 2008).
CONCLUDING REMARKS
Injury to peripheral nerves can occur due to several causes rang-
ing from physical injury and accidental trauma to pathological
conditions and degenerative diseases. Achieving successful regen-
eration and synchronized functional recovery following neural
damage is one of the biggest challenges faced by neuroscientists
and clinicians. Transcription factors are master switches control-
ling the expression of multiple gene programs, and orchestrating
complex axon growth and regenerative responses. Blocking tran-
scription using RNA polymerase II inhibitors at an early stage
after injury inhibits the capacity of dissociated neurons to elon-
gate neurites (Smith and Skene, 1997), highlighting their crucial
role in efﬁcient regeneration after nerve injury. In this review, we
have attempted to summarize the roles of a number of different
transcription factors in peripheral nerve regeneration and their
complex web of interactions. An overview of the observed phe-
notypes following global and cell-type speciﬁc deletions is given
in Table 1. Understanding the molecular mechanisms underlying
nerve regeneration via various regeneration-associated molecules
and their signaling components will not only help to enhance the
speed and speciﬁcity of peripheral regeneration but improve the
success of central axonal regeneration, as well.
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Transection of peripheral nerves or their axons (axotomy)
usually results in successful regeneration, by a part of the
axon still connected to its cell body growing back to
and reinnervating the peripheral target (Lieberman 1971;
Kreutzberg 1996). Recent studies using transgenic animal
models and viral vectors have demonstrated important
regeneration-promoting roles for several newly expressed
cell adhesion molecules (Werner et al. 2000; Hiroi et al.
2003, Makwana et al. 2009), neurotrophic and growth factor
signals (English et al. 2011; Makwana et al. 2009) and
neuropeptides (Sachs et al. 2007). The fact that many of
these molecular changes occur at the same time following
injury has focused interest on axotomy-induced transcription
factors that may orchestrate this regenerative response.
Deletion of CCAAT enhancer binding protein (cEBP) beta,
cEBP delta, sox11 and signal transducer and activator of
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Abstract
Although neural c-Jun is essential for successful peripheral
nerve regeneration, the cellular basis of this effect and the
impact of c-Jun activation are incompletely understood. In the
current study, we explored the effects of neuron-selective
c-Jun deletion, substitution of serine 63 and 73 phosphoac-
ceptor sites with non-phosphorylatable alanine, and deletion
of Jun N-terminal kinases 1, 2 and 3 in mouse facial nerve
regeneration. Removal of the floxed c-jun gene in facial
motoneurons using cre recombinase under control of a neu-
ron-specific synapsin promoter (junDS) abolished basal and
injury-induced neuronal c-Jun immunoreactivity, as well as
most of the molecular responses following facial axotomy.
Absence of neuronal Jun reduced the speed of axonal
regeneration following crush, and prevented most cut axons
from reconnecting to their target, significantly reducing func-
tional recovery. Despite blocking cell death, this was associ-
ated with a large number of shrunken neurons. Finally, junDS
mutants also had diminished astrocyte and microglial activa-
tion and T-cell influx, suggesting that these non-neuronal re-
sponses depend on the release of Jun-dependent signals
from neighboring injured motoneurons. The effects of substi-
tuting serine 63 and 73 phosphoacceptor sites (junAA), or of
global deletion of individual kinases responsible for N-terminal
c-Jun phosphorylation were mild. junAA mutants showed de-
crease in neuronal cell size, a moderate reduction in post-
axotomy CD44 levels and slightly increased astrogliosis.
Deletion of Jun N-terminal kinase (JNK)1 or JNK3 showed
delayed functional recovery; deletion of JNK3 also interfered
with T-cell influx, and reduced CD44 levels. Deletion of JNK2
had no effect. Thus, neuronal c-Jun is needed in regeneration,
but JNK phosphorylation of the N-terminus mostly appears to
not be required for its function.
Keywords: brain repair, peripheral nerve regeneration,
phosphorylation, transcription factor.
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transcription (STAT)3 has been associated with a reduction
in the initiation of axonal outgrowth and/or functional
recovery (Nadeau et al. 2005; Jankowski et al. 2009;
Magoulas and Lopez De Heredia 2010; Bareyre et al.
2011). The effects were particularly pronounced with
brain-wide deletion of c-Jun, which prevented the up-
regulation of axotomy-associated molecules (CD44, alpha7-
beta1 integrin, galanin), decreased successful reconnection to
peripheral targets by 4- to 5-fold, and strongly reduced
functional recovery (Raivich et al. 2004). Interestingly, cre
recombinase-mediated deletion of floxed c-Jun was also
associated with enhanced neuronal post-axotomy survival,
but of severely shrunken motoneurons. Because this cre
recombinase was driven by the nestin-promoter, expressed in
early neuroepithelial cells giving rise to neurons, astrocytes
or oligodendroglia, as well as in Schwann cell precursors, it
is still unclear whether the effects observed in neuronal
regeneration were due to its absence in neurons or other
nestin+ progenitor-derived cells (Rao 1999; Akiyama et al.
2001; Kanu et al. 2010).
The activator protein 1 (AP1) transcription complex is a
well-characterized regulator of neural development and
response to trauma, excitotoxic or hypoxic-ischemic injury
and consists of homo- or heterodimeric complexes between
members of the Jun, c-Fos and activating transcription factor
(ATF)/cyclic adenosine monophosphate (AMP) response
element-binding protein (CREB) families (Angel and Karin
1992). Its primary component, c-Jun, is produced as an
immediate early gene following nerve injury and persists at
high levels during the entire peripheral regenerative process
(Herdegen et al. 1991; Jenkins and Hunt 1991). With the
exception of retinal ganglion cell neurons (Herdegen et al.
1993; Koistinaho et al. 1993), up-regulation of c-Jun is either
transient or absent following transection of central fibers, and
may contribute to the reduced ability of centrally injured
neurons to regenerate (Anderson et al. 1998). Activation of
the c-Jun mediated transcription apparatus is affected by
interactions at three major sites: (i) N-terminal phosphory-
lation at Ser 63 and 73 and Thr 91 and 93 (Smeal et al. 1994;
Morton et al. 2003) and the ensuing ubiquitination and
degradation (Nateri et al. 2004), (ii) dephosphorylation of
Thr239 (Morton et al. 2003) and (iii) the C-terminal lysine
acetylation near aa257–276 (Vries et al. 2001). The best
studied is N-terminal phosphorylation through Jun N-termi-
nal kinases 1, 2 and 3 (JNK1–3), which can alter AP1
binding activity in the absence of de novo protein synthesis
(De´rijard et al. 1994; Kallunki et al. 1994). These JNK
mitogen-activated protein kinases are rapidly activated
following peripheral nerve injury and increase the amount
of phospho-c-Jun in the process (Waetzig et al. 2006).
Depending on the type of neural injury, deletion of JNK1, 2
and 3 has been shown to a prodegenerative or protective
effect (Pirianov et al. 2007; Haeusgen et al. 2009). Removal
of serine 63 and 73 phosphoacceptor sites in the junAA
mutant also interferes with exitotoxicity (Behrens et al.
1999), but relatively little is known about their involvement
in axotomy response and neurite outgrowth in vivo. In the
current study, we therefore examined the function, cellular
basis and possible activation of c-Jun in peripheral regener-
ation, using mutants with neuron-specific deletion of c-Jun,
global deletion of JNK1, 2 or 3, and alanine replacement of
the serine 63 and 73 sites.
Materials and methods
Animals, surgical procedures and tissue treatment
Mice carrying floxed c-jun allele (junF/F) (Behrens et al. 2002) were
crossed with syn::cre animals expressing cre recombinase under the
control of the synapsin promoter syn::cre (Zhu et al. 2001), twice, to
obtain homozygous CNS neuron-specific deletion of jun (junDS). To
prevent germline c-jun deletion due to testicular synapsin promoter
expression (Hoesche et al. 1993; Street et al. 2005), only female
cre+ mice (syn::cre junF/F) and cre- junF/F males were used for
breeding, generating junDS mutants and junF/F littermate controls
with normal Mendelian frequency. Homozygous JunAA, with serine
63 and 73 residues replaced with alanine (A) (Behrens et al. 1999)
and wild-type (wt) mice were derived as offspring of heterozygous
(AA/wt) breeder pairs. JNK1, 2 and 3 null mouse strains (Yang
et al. 1997; Dong et al. 1998; Kuan et al. 1999) were crossed with
C57Bl/6 mice, to obtain F1 heterozygotes, and in the second step,
the F2 homozygote and wild-type breeder pairs that were used to
generate mutants and their controls as described in detail elsewhere
(Brecht et al. 2005).
Mutant and wild-type controls 8–10 weeks old were anesthetised
with 10 lg/g 2,2,2-tribromoethanol (Sigma, Dorset, UK), the right
facial nerve was either crushed (for the day 4 time point) or cut for
all other time points at the stylomastoid foramen, and the animals
killed after 4–30 days with an overdose of Euthatal. The animals
were first perfused as described by Moller et al. (1996) with 150 mL
phosphate-buffered saline (PBS) followed by 200 mL of 4%
paraformaldehyde in PBS, 2 h post-fixed with 1% paraformalde-
hyde in PBS, cryoprotected in 30% sucrose in PBS and then frozen
on dry ice. The immunohistochemical methods, assessment of
axonal regeneration and functional recovery, retrograde tracing and
quantification of neuronal survival were performed as previously
(Moller et al. 1996; Raivich et al. 1998, 2002, 2004) and described
in detail in the Methods section of the Supplementary material.
Results
Generation of mutant mice
Cell type specific c-jun gene deletion was achieved by
crossing mice with a floxed c-jun allele (junF/F) with animals
expressing cre recombinase under the control of the synapsin
promoter (syn::cre), which targets the junDS recombination
specifically to neurons (Ku¨gler et al. 2001; Zhu et al. 2001).
Homozygous JunAA and wild-type (wt) mice were derived
as offspring of heterozygous (AA/wt) breeder pairs. JNK1, 2
and 3 knockout mice and their controls were produced from
F2 homozygous breeder pairs derived from heterozygous
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mice on C57Bl/6 background. All mutants used in the
current study displayed normal brain structure and histology
on H&E and NeuN stains on forebrain (cortex, hippocampus,
basal ganglia) and hind-brain (cerebellum, metencephalon)
sections (not shown). Homozygous junDS recombination
was associated with disappearance of basal immunoreactivity
throughout the brain, for example in hippocampus and
dentate gyrus (Fig. 1a and b), or the uninjured facial motor
nucleus (Fig. 1c and d). Motoneuron c-Jun immunoreactivity
is strongly up-regulated by facial nerve cut (Fig. 1f) and this
increase was abolished in the junDS mutant (Fig. 1e).
Previous study from our groups revealed the disappearance
of phospho-serine63 immunoreactivity in the neuronal nuclei
of the axotomized facial motor nucleus in junAA mice but
also a persistence of phosphoserine 73-like and as well as of
total c-Jun immunoreactivity. In the same study, single JNK
deletions were not associated with changes in overall
phospho-Jun immunoreactivity (Brecht et al. 2005). This
persistence of total c-Jun immunoreactivity in neuronal
nuclei of the axotomized facial motor nucleus in the junAA
mice was also reconfirmed in the current study (data not
shown).
Deletion of neuronal c-jun interferes with axonal
regeneration
Effects on axonal regeneration after facial nerve axotomy at
the stylomastoid foramen were assessed by the extent of
functional recovery, reinnervation of peripheral target, and
speed of axonal elongation in the early phase of nerve
regeneration. Functional recovery after facial nerve cut was
scored by observed whisker hair movement from 0 (no
movement) to 3 (strong, normal movement on uninjured side)
by two observers unaware of the animal genotype three times
per week for 28 days. As shown in Fig. 2a, junF/F animals
commenced recovery of whisker vibrissae at 12 days and
improved steadily over the next 2.5 weeks to day 28.
Recovery in homozygous junDS mutants was significantly
delayed (p < 0.01 in unpaired t-test, unless indicated, all
further tests are also unpaired t-test); first noticed at day 19, it
then improved but with a less steep trajectory than in the junF/
F mice. These differences were mirrored by changes in the
regeneration index, calculated as area under the curve for the
functional recovery over days 0–28 (Fig. 2b); with an index of
1.00 ± 0.04 for the junF/F (n = 5 animals) and 0.44 ± 0.02 for
the junDS mutants (n = 6 animals, p < 0.001).
To determine whether this defect was due to lack of axonal
reinnervation or simply reduced function of successfully
reinnervated axons, a gelfoam insert soaked with fluorescent
tracer Fluorogold (FG) was implanted for 30 min under both
whisker pads 28 days after facial nerve cut. The contralateral
whisker pad served as an intra-animal, uninjured control.
This was followed by 48 h of recovery and retrograde
transport to the facial nucleus, and then by perfusion,
freezing the brainstem and cutting through the whole
brainstem at the level of the facial motor nuclei. The
distribution of FG-labelled motoneurons on the the previ-
ously uninjured and on the injured side is shown in
Fig. 2c,d,g and h. Counting every fifth 20 um section,
junF/F animals (n = 5) revealed 168 ± 10 FG+ motoneurons
on the uninjured and 57 ± 5 on the injured side. Homozy-
gous junDS mutants (n = 6) also showed a very similar
number (173 ± 9) on the control side, but there was a very
drastic reduction on the axotomized side, with just 7 ± 2
FG+ motoneurons (Fig. 1e, p < 0.001). In relative terms (as
percent of contralateral side) junF/F animals showed retro-
grade labelling of 32.9 ±4.4%, and junDS mutants a more
than 8-fold decrease with 3.8% ± 1.1% (Fig. 1f, p < 0.001),
exceeding the defect in functional recovery.
As a next step, we explored whether these defects can be
attributed to lack of activation of Jun protein function (as
opposed to one that is simply absent) by performing these
experiments in phosphorylation-deficient homozygous mu-
tants lacking N-terminal phosphoacceptor sites serine-63 and
73 (junAA), or Jun N-terminal Kinases 1, 2 or 3 (JNK1–3),
following them for up to 50 days after facial nerve cut. In the
case of JunAA (Fig. 3a and b), functional recovery in
mutants was on average just barely lower than that in the
(a) (b)
(c) (d)
(e) (f)
Fig. 1 Synapsin::cre deletion of floxed c-jun (junDS) removes c-Jun
immunoreactivity in normal brain and following facial nerve cut. (a, b)
Hippocampus, (c, d) uninjured facial motor nucleus, (e, f) facial nu-
cleus 14 days after facial nerve cut. Micrographs on the left (a, c, e)
show the junDS mutants, those on the right (b, d, f) the control, junF/F
animals. Note the strong c-Jun immunoreactivity on the right, in the
junF/F hippocampus and hippocampal dentate gyrus (hip and dg), as
well as in the large motoneuron nuclei of the facial nucleus (d, f),
particularly following nerve injury (f). Scale bar: 0.2 mm.
 2012 The Authors
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wild-type controls, with the only significant difference
(p < 0.05) at 12 days following facial nerve cut. Homozy-
gous deletion of JNK2 (Fig. 3i and j) had no significant
effect. In contrast, deletion of JNK1 (Fig. 3e and f) and
JNK3 (Fig. 3m and n) showed a significant delay in
functional recovery at different time points after nerve cut.
Similar effects were also observed for the regeneration index,
with significant reduction for JNK1 (Fig. 3f, p < 0.02) and a
similar trend for JNK3 (Fig. 3n, p = 0.074).
To see whether these defects were matched by a deficit in
target reinnervation, we next determined the extent of 48 h
retrograde transport of Fluorogold, 50 days after facial nerve
cut. However, as shown for junAA in Fig. 3c and d, for JNK1
in Fig. 3g and h, for JNK2 in Fig. 3k and l and for JNK3 in
Fig. 3o and p, all 4 mutants revealed reconnection rates that
were very similar to those for their wild-type controls.
As functional recovery following nerve cut depends on the
gradual formation of a non-neuronal cellular bridge between
the proximal and distal nerve stump and could be affected by
JNK deletions, we also examined the extent of early nerve
fibre outgrowth following facial nerve crush, where, despite
axotomy, the basal lamina scaffolds remain intact. The
growth front of the regenerating motor neurites 4 days after
facial nerve crush was quantified in longitudinal facial nerve
sections of 10 um thickness using immunoreactivity for the
calcitonin gene related peptide (CGRP) and galanin neuro-
peptides expressed in axotomized facial motoneurons (Wer-
ner et al. 2000). As shown in Fig. 4a, in the junF/F control
animals’ axonal growth front advanced to 5.8 ± 0.1 mm for
CGRP- and to 5.4 ± 0.2 mm for the galanin-positive axons.
In junDS mutants, this axonal elongation was reduced by
approx. 60% for both types of neuropeptide containing axons
(p < 0.0001). In contrast to junDS, homozygous deletion of
JNK1 (Fig. 4c), JNK2 (Fig. 4d) or JNK3 (Fig. 4e) did not
affect the extent of axonal elongation, compared with their
wild-type controls. Similar lack of effect on early phase of
regeneration following nerve crush was also observed for
junAA (Fig. 4b).
Neuronal c-Jun deletion abolishes neuronal cell loss after
nerve cut but affected motoneurons show atrophic
phenotype
Facial axotomy is normally associated with the cell death of
20–40% of lesioned motoneurons within 30 days after nerve
cut (Raivich et al. 2002) and pan-CNS deletion of c-Jun has
been shown to interfere with this process (Raivich et al.
2004). Figure S1a–f shows the effects of neuron-specific
deletion of jun on the Nissl stained sections of control
(Figure S1a and c) and axotomized (Figure S1b and d–f)
facial motor nuclei. After facial nerve cut, junF/F control
animals showed a pronounced loss of neurons (Figure S1b),
an effect lost in the junDS mutants. However, many of the
axotomized junDS motoneurons appeared shrunken and with
much paler Nissl staining (Figure S1d, compare also Fig-
ure S1e and f). Counting motoneuron profiles on the
uninjured and injured side throughout the facial motor
nucleus revealed a 38 ± 5% loss in junF/F controls, compared
with just 1 ± 4% in the junDS mutants (Figure S1i).
(a) (b)
(e) (f)
(c) (d)
(g) (h)
Fig. 2 Neuronal c-Jun is required for successful functional recovery
and target reinnervation after facial nerve axotomy. (a, b) Time
course for functional recovery of whisker hair movement on the scale
from 0 (no movement) to 3 (full movement, equivalent to uninjured
side) (a) and the recovery index (b) calculated as area under the
curve (AUC) show pronounced reduction and delay in recovery junDS
mice (n = 6 mice) compared with the junF/F controls (n = 5 mice).
*p < 0.05 in unpaired t-test, bars and error bars in these and all
following graphs show the mean and SEM, respectively. In panel (a),
the significance levels were adjusted for multiple testing using Bon-
ferroni correction. (c–h) Peripheral target (whisker pad) reinnervation
using 48 h retrograde transport of FluoroGold to facial motor nucleus
30 days after nerve cut. (c, d, g, h) Micrographs showing FluoroGold
labelling on the contralateral control (co; c, g) and axotomized side
(ax; d, h). Retrograde labelling on the uninjured side is confined to a
discrete facial subnucleus (c, g); after injury, motoneurons reinner-
vating the whisker pad are found throughout the facial nucleus (f). (e,
f) Number of retrogradely labelled, counted motoneurons on the
contralateral and axotomized side (e) and the axotomized/control
side ratio (f). Neuronal deletion of c-Jun is associated with a more
than 8-fold decrease in whiskerpad reinnervation (c, d and arrow
in h).
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However, opposite effects were observed on cell size
(Figure S1m): in junF/F controls, average neuronal cell
diameter showed a trend towards increase on the axotomized
side, from 21.5 ± 0.7 um for the uninjured to 23.2 ± 0.8 um
for injured motoneurons (p = 0.085), the junDS mice a
decrease from 22.1 ± 0.3 to 15.5 ± 0.8 um (p < 0.005).
Compared with controls, the junAA mutants exhibited no
effect on neuronal loss (33% ± 8% vs. 35% ± 2% for control
and mutant mice, see Figure S1j), but still a significant
14 ± 2% decrease in neuronal size 30 days after facial nerve
cut (p < 0.05, Figure S1n). Deletion of JNK1 or JNK3 was
not associated with changes in neuronal loss (Figure S1k and
l) or neuronal cell size (Figure S1o and p, respectively).
Neuronal molecular response to injury depends on
neuronal c-Jun
In neurons capable of regeneration, axonal injury engenders
a switch to a regeneration programme comprising of
transcription factor changes, followed by adhesion mole-
cules, neuropeptides and growth factor signalling, and an
Fig. 3 (a–c, e–g, i–k, m–o) Functional recovery (time course: a, e, i,
m; recovery index: b, f, j, n) and whisker pad reinnervation determined
by counting retrogradely labelled Fluorogold-fluorescing facial moto-
neurons (FG+) 30 days after axotomy (c, g, k, o) in JunAA (a–d), JNK1
null (e–h), JNK2 null (i–l) and JNK3 null (m–p) mutants (KO) and their
wild-type counterparts (WT). (d, h, l, p) Axotomized (ax)/control (co)
side ratio – percent reinnervation – for the FG+ motoneurons. Overall,
there was very little effect for junAA (n = 23 mutants and 17 control
animals) and JNK2 (n = 30 mutants and 17 controls), but deletion of
JNK1 (n = 7 mutants and 9 controls) or JNK3 (n = 18 mutants and 12
controls) was associated with reduced functional recovery (e, f, m).
However, none of the four mutants showed an effect on the anatomical
reinnervation of the whisker pad at 30 days after facial nerve cut,
detected using Fluorogold retrograde labelling (third and fourth col-
umn, n = 7/7, 9/10, 6/5 and 6/9 for the junAA, JNK1, JNK2 and JNK3
null mutants and their controls, respectively. *p < 0.05 in unpaired t-
test. In panels (a, e, i and m), the significance levels were adjusted for
multiple testing using Bonferroni correction. Filled bars in the third
column (c, g, k and o) show FG+ motoneuron number on the control,
contralateral side, and empty bars the axotomized side in the same
group of animals. In all other graphs, filled bars or circles represent
wild-type, and empty bars, mutant animals.
 2012 The Authors
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increase in nutrient transport, metabolism and cytoskeletal
protein synthesis (Makwana and Raivich 2005, Raivich and
Makwana 2007). As animals for the day 4 time point were
used for speed of regeneration experiment in the crushed
facial nerve (Fig. 4), the day 4 facial motor nucleus data are
following nerve crush; the day 14 data are following cut.
As shown in left upper part of Fig. 5, axotomy of the facial
nerve in the junF/F control animals causes an increase in the
immunoreactivity for the adhesion molecules CD44 (Fig. 5a
and b) and the beta1 integrin subunit (Fig. 5e and f),
neuropeptides CGRP (Fig. 5i and j) and galanin (Fig. 5m
and n) and the ATF3 transcription factor (Fig. 5q and r).
These axotomy-induced changes are decreased or even, as in
the case of CD44, completely abolished in the junDS mice
(Fig. 5c,d,g,h,k,l,o,p,,s and t). Direct quantification of immu-
noreactivity in Fig. 6 revealed a significant decrease
(p < 0.05) in the amount of immunoreactivity on the
axotomized side in the junDS mouse mutants compared with
junF/F controls (Fig. 6a,b,g,h,m,n,s,t,y and ad), as well as a
smaller (Fig. 6a,b,h,n,s and y) or even no increase (Fig. 6g,m
and t) of the immunoreactivity from the control to the
axotomized side, on average, junDS mice showed an up to
80–100% smaller increase 4 days after facial nerve crush, or
14 days after nerve cut. To determine, whether these changes
depend on c-Jun phosphorylation, we next examined changes
in CD44, CGRP and ATF3 immunoreactivity in the JNK1, 2
and 3 knockouts and the JunAA mutants at 4 days after nerve
crush and 14 days after facial nerve cut. Compared with their
controls, JunAA and JNK3 null mutants showed a significant
but moderate reduction in CD44 immunoreactivity, at one of
the two tested time points – Fig. 6f ()24%), and Fig. 6k
()37%), respectively, for the axotomized to control side
difference. The CGRP levels in the case of JNK3 also ATF3
levels were not affected. Deletion of JNK1 (Fig. 6c,i,o,u,z
and ae,) or JNK2 (Fig. 6d,j,p,v,aa and af,) had no effect on
one of the three tested immunohistochemical neuronal
injury-associated markers.
As shown in the Supplementary materials, very similar
results – massive inhibition in case of neuronal c-Jun
deletion, but at most just moderate effects following deletion
of JNK1 or JNK3, or in the junAA mutants were also
observed for glial activation and for recruitment of T cells
into the facial motor nucleus (Figures S2 and S3).
Discussion
The present data confirm the essential role of neuronal c-Jun
for the ability of injured neurons to regenerate following
axonal disconnection. Removal of the loxP targeted (floxed)
jun gene with cre recombinase under the control of a neuron-
specific synapsin promoter abolished basal and injury-
induced neuronal c-Jun immunoreactivity, as well as most
of the molecular response following facial axotomy. This
absence of neuronal Jun strongly reduced the speed of axonal
regeneration following crush, prevented the vast majority of
transected axons after cut from reconnecting to their
peripheral target, and impaired functional recovery. Despite
blocking neuronal cell death, this was also associated with a
large number of shrunken neurons. Finally, junDS mutants
also had diminished astrocyte and microglial activation and
T-cell influx, demonstrating that this non-neuronal response
depends on the release of Jun-dependent signals from
neighboring injured motoneurons.
Compared with complete jun gene excision in neurons, the
effects of removing serine 63 and 73 phosphoacceptor sites
(junAA), or of global deletion of individual kinases respon-
sible for N-terminal c-Jun phosphorylation were mild. The
reason global JNK null or junAA mutants were used, because
unlike the case with floxed c-Jun, only global mutants were
available, and because our primary question was whether the
regeneration effects of c-Jun could be reproduced by
interfering with its N-terminal phosphorylation. Interestingly,
the junAA mutants showed decrease in neuronal cell size, a
very moderate reduction in post-axotomy CD44 levels and
slightly increased astrogliosis. Deletion of JNK1 or JNK3
showed reduced functional recovery; deletion of JNK3 also
interfered with T-cell influx, and somewhat reduced CD44
levels. Deletion of JNK2 had no effect. Thus, neuronal c-Jun
is needed in regeneration, but most of this activity may not
Fig. 4 Facial nerve regeneration relies on the presence of neuronal c-
Jun. Longitudinal outgrowth of fastest CGRP- and galanin-immuno-
reactive axons in mm below the crush site, 4 days after facial nerve
injury. (a–e) Effects of junDS (a, n = 6 control junF/F and 4 junDS
animals), junAA (b, n = 5 control and 4 mutant mice) and JNK1 (c,
n = 7 controls and 4 null mutant mice), JNK2 (d, n = 2 controls and 3
null mutant mice) and JNK3 (e, n = 5 controls and 5 null mutant mice).
Note the very similar outgrowth distances for the CGRP- and galanin-
immunoreactive axons. JunDS deletion caused a 65–70% decrease in
neurite outgrowth, all other mutations had no significant effect.
*p < 0.05 in unpaired t-test. Only sections stained for CGRP immu-
noreactivity were available for junAA and its controls.
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require the presence of individual JNKs or that of the 63 and
73 acceptor sites.
Although cell-type selective excision of target genes is
now standard tool in identifying cell-specific function, this
can lead to problems if the promoter used to drive cre
recombinase is too broad. For example, the nestin promoter
used in brain-wide jun deletion is expressed in early
neuroepithelial cells giving rise to neurons, but also to
astrocytes or oligodendroglia. Outside the brain, nestin
expression is also found in the islet, liver and muscle stem
cells, as well as in Schwann cell precursors (Rao 1999;
Akiyama et al. 2001; Kanu et al. 2010), raising the question
whether the regeneration differences observed in that study
were also due to jun deletion in other cells of neuroepithelial
origin. Schwann cells strongly up-regulate c-Jun following
axotomy, and removal of Schwann cell c-Jun (Parkinson
et al. 2008) has recently been shown to interfere with axonal
regeneration. This problem is resolved in the present study
because synapsin promoter expression is highly restricted,
limited to the testis and to maturing and mature neurons in
the CNS and peripheral ganglia (Hoesche et al. 1993; Street
et al. 2005).
In the currently used facial axotomy model, deletion of
neuronal c-Jun produces four sets of effects: it interferes with
the expression of numerous target genes involved in
molecular changes after facial nerve axotomy, it impairs
the flow of activation and recruitment signals to neighboring
non-neuronal cells, it abolishes regenerative capacity in most
neurons, and it promotes the survival of shrunken and
probably still axotomized neuronal cell bodies. Peripheral
nerve cut and crush injuries sometimes elicit differing
responses at the level of neuronal cell body (Bareyre et al.
(a) (b) (c) (d)
(e) (f) (g) (h)
(i) (j) (k) (l)
(m) (n) (o) (p)
(q) (r) (s) (t)
Fig. 5 Biochemical components of neuronal axotomy response de-
pend on the presence of c-Jun. (a–t) Facial nucleus axotomy response
14 days after nerve cut in the junF/F controls (a, b, e, f, i, j, m, n, q, r)
and the junDS mutant (c, d, g, h, k, l, o, p, s, t) mice. Contralateral side
(co) -first and third column, Axotomized side (ax) – second and fourth
column. After axotomy, junF/F mice show a prominent increase in
adhesion molecules CD44 (a–d) and beta1-integrin subunit (e–h),
neuropeptides CGRP (i–l) and galanin (m–p) and TF ATF3 (q–t); these
changes are reduced or abolished in the junDS mutants. Scale bar
0.2 mm.
 2012 The Authors
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2011), but in the current case, the molecular responses
studied were strongly affected by both types of axotomy, and
this response reduced in the absence of c-Jun. Overall, Jun-
dependent molecular changes in injured neurons appear
pivotal for the latter three sets of functional effects. In the
case of axonal regeneration, alpha7beta1 integrin, CD44,
galanin and ATF3 have been shown to play an important role
in neurite outgrowth. Deletion of the alpha7 integrin gene
retards axonal regeneration by 35–40% (Werner et al. 2000),
removal of the galanin gene delayed sensory functional
recovery (Sachs et al. 2007); and antibody inhibition of
CD44 reduces neurite outgrowth of transplanted central
noradrenergic neurons (Nagy et al. 1998) as well as creating
multiple errors in retinal axonal growth trajectory through the
optic chiasm (Lin and Chan 2003). Over-expression of ATF3
also speeds up the initiation of axonal outgrowth, involved in
the in vivo conditioning response (Seijffers et al. 2007). In all
four target genes, enhanced expression after injury depends
on the presence of neuronal c-Jun. CD44, a7 and galanin
have previously described AP1 consensus binding sequences
(Lee et al. 1993; Nishida et al. 1997; Anouar et al. 1999)
and ATF3 has been identified as a downstream target of
c-Jun (Mei et al. 2008). Neuronal p53, cathepsinB and noxA
have been implicated in axotomy-induced cell death (Kiryu-
Seo et al. 2005; Sun et al. 2010; Tedeschi and Di Giovanni
2009), and axotomy-induced chemokines including fractal-
kine and monocyte chemotactant protein (MCP)1 (Harrison
et al. 1998; Flu¨gel et al. 2001; Schreiber et al. 2001) could
contribute to non-neuronal recruitment and activation; here
the extent of Jun-dependence for the effects of these signals
will need to be demonstrated in future studies.
Previous studies revealed that activation of the c-Jun-
mediated transcriptional apparatus is affected by interactions
at three major sites: (i) N-Terminal phosphorylation at serine
Fig. 6 Effects of neuronal deletion of jun (junDS, a, b, g, h, m, n, s, t, y,
ad, first and second column), the global deletion of JNK1 (c, i, o, u, z, ae,
third column), JNK2 (d, j, p, v, aa, af, fourth column), and JNK3 (e, k, q,
w, ab, ag, fifth column), and of the junAA mutation (f, l, r, x, ac, ah, sixth
column) on changes in neuronal markers following axotomy. Quantifi-
cation of overall facial motor nucleus immunoreactivity for galanin (a, g)
and beta 1 integrin (m, s), CD44 (b–f and h–l), CGRP (n–r and t–x) and
ATF3 (y–ah) using OLV units. To facilitate finding the staining and time
point on the graph, the row labels (second column, top right of each
graph) are the same for the graphs in the third to sixth column). (a–e,
m–r, y–ac) 4 days after facial nerve crush, (g–l, s–x, ad–ah) 14 days
after facial nerve cut. Filled bars: contralateral (co), empty bars: axo-
tomized (ax) facial nucleus. In each graph, the first two bars represent
the data for control animals (wild-type or junF/F) and the third and fourth
bar those for the mutant ones. *p < 0.05 (unpaired t-test) for the dif-
ference on the axotomized side between the mutant and control group.
p < 0.05 (unpaired t-test) for the difference in immunostaining increase
due to axotomy (staining intensity on the control side subtracted from
that on the axotomized side) between the respective mutant and the
wild-type or junF/F control group. n = 3–7 animals per group, in each
control, and in each mutant group. All five tested markers – galanin,
beta1 integrin, CD44, CGRP and ATF3 showed significantly smaller
increase or even (g, m, t) the absence of increase, in the junDSmutants
compared with junF/F controls, at both time points – day 4 and day 14.
There was no effect for JNK1 or JNK2, and significant but slight de-
crease for CD44 at day 14 for JNK3 null and at day 4 for junAA.
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63 and 73 and threonine 91 and 93 (Smeal et al. 1994;
Morton et al. 2003), (ii) dephosphorylation of threonine 239
involved in the ubiquitination and removal of c-Jun (Morton
et al. 2003) and (iii) C-terminal lysine acetylation near
aa257–276 via p300 (Vries et al. 2001; also see Raivich 2008
for a review of the signalling pathways involved in the
activation of these Jun-domains). In the case of N-terminal
phosphorylation, axonal injury is associated with retrograde
transport of phosphorylated JNK, the upstream kinases
{[Mitogen-activated protein (MAP)] kinase kinase (MEK or
MKK)} kinase (MEKK)1 and phospho - MKK4, as well as
the JNK-interacting protein, a scaffold protein that stabilises
the interaction between JNK and its upstream kinases
(Lindwall and Kanje 2005a,b). Moreover, phosphorylation
of Jun will improve dimer stability and thus affect its
biological role in the nervous system. Substitution of JNK
phosphorylation motifs with those for protein kinase A (PKA)
abolishes c-Jun-mediated JNK effects (Smeal et al. 1994).
Replacement of the serine 63 and 73 phosphoacceptor sites in
the junAA mice prevents kainic acid excitotoxity (Behrens
et al. 1999), to a similar extent as global JNK3 deletion (Yang
et al. 1997; Brecht et al. 2005). Although JNKs have no
effect on retinal photoreceptor apoptosis (Grimm et al. 2001),
junAA and JNK3 null mutants show better neuronal survival
after targeted dopaminergic cell death (Brecht et al. 2005).
Complete JNK ablation – either by deletion or inhibition – has
also been shown to decreased caspase-dependent neuronal
cell death in both neuronal and non-neuronal cells (Weston
and Davis 2007).
Importantly, not all effects of JNK deletion need to be
mediated through N-terminal phosphorylation of Jun, and
thus would not be observed in the case of junAA – in the
current study, this primarily concerns the speed of functional
recovery which is normal in junAA, but reduced in JNK1
and 3 null mutations. Interestingly, deletion of JNK3 also
strongly reduces cell death of neonatal facial motor neurons
after nerve cut, but does not interfere with up-regulation of c-
Jun or the phosphorylation of the serine 63 and 73 residues
(Keramaris et al. 2005). In parentheses, single deletions of
JNK2 or 3 significantly decreased cell death in neonatal
models (Keramaris et al. 2005); as shown in the current
study, this effect was not observed following adult axotomy
in animals lacking JNK1, 2 or 3 (or the serine 63 and 73
phosphorylation sites), pointing to differences in molecular
mechanisms involved in neonatal and adult post-axotomy
cell death. So far more than 50 proteins have been shown to
be substrates for JNK (Bogoyevitch and Kobe 2006),
including various transcription factors in addition to c-Jun
(e.g. ATF2, E twenty-six (ETS)-like transcription factor
(ELK)1, p53, STAT1/3, etc.), nuclear hormone receptors,
apoptosis-regulating bcl2 family members, and signalling
and structural molecules involved in cell movement and
process outgrowth such as MAP2 (Bjo¨rkblom et al. 2005),
MAP1b (Barnat et al. 2010) and stathmin (Westerlund et al.
2011). Nuclear JNK localization is a requirement for JNK-
mediated cell death (Bjo¨rkblom et al. 2008) but effects on
neurite outgrowth can be mediated by JNK phosphorylation
of cytoplasmic targets (Bjo¨rkblom et al. 2005; Barnat et al.
2010; Westerlund et al. 2011).
With regards to neurite outgrowth, global in vitro inhibition
of JNK1/2 and 3 with 10 lM SP600125 strongly reduces and
at 200 lM completely blocks outgrowth from the sensory
nodose ganglion and dorsal root neurons (Lindwall et al.
2004; see also Barnat et al. 2010), as well as from sympa-
thetic neurons (Lindwall and Kanje 2005a). In vitro studies
also showed that deletion of JNK2 or JNK3 interferes with
initial dorsal root ganglia (DRG) neurite outgrowth, and
deletion of JNK1 and particularly of JNK2 with neurite
length. It is possible that combined deletion of all 3 JNKs
would have a more pronounced effect, but unfortunately
combined deletion of JNK1 and 2 or of all 3 JNKs is
embryonic lethal (Kuan et al. 1999; Sabapathy et al. 1999).
Interestingly, functional recovery was not affected in junAA
mice (Fig. 3a), suggesting the better performance in the JNK1
and 3 wild-type animals could be due to extra-Jun effects of
the JNKs. The regeneration effects shown in the current study
in Fig. 3e–p were moderate, with deletions of JNK1 or JNK3
reducing functional recovery, but not interfering with the
extent of reinnervation 50 days after facial nerve cut.
In the cerebellar granule cell neurons, inhibition of JNK
with 10 uM SP600125, or of the more upstream JNK
pathway with mixed lineage kinase inhibitor CEP11004
blocks the ATF3 up-regulation and the ATF3/Phospho-c-Jun
mediated cell death following potassium deprivation (Mei
et al. 2008). However in the current study, deletion of
JNK1,2 or 3, or the junAA mutation had no effect on the
post-axotomy increase in ATF3 (Fig. 6y–ah), or on neuronal
cell death (supplementary Fig. 1). Interestingly, although the
junAA mutation did not reduce the cell death it did enhance
cell shrinkage. This could suggest that N-terminal phosphor-
ylation brought about through retrograde transport of the
kinases (Lindwall and Kanje 2005b) may be important in
maintaining the trophic state of surviving neurons. Theoret-
ically, activated JNKs will also lead to the phosphorylation
of threonine 91 and 93, which depends on the presence of
negatively charged phospho-threonine 95, a target of ataxia
teleangiectasia mutated kinase but not of JNK (Vinciguerra
et al. 2008). Acting in concert, phosphorylation of the three
threonines will enhance cell death in response to DNA
damage (Vinciguerra et al. 2008). Because the three Thr
residues are still present in junAA, a similar mechanism may
be involved in responsible for reduced functional recovery in
the JNK1 or JNK3 null mutants, but not in the junAA mice.
Preliminary data using mutant jun4A mice where all 4 JNK-
dependent sites were replaced by alanines (S. Patodia,
G. Raivich and A. Behrens, unpublished data), do show
similar neuronal shrinkage as in junAA, but in addition a
moderate but significant decrease in functional recovery (as
 2012 The Authors
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with JNK1 or JNK3 deletions) as well as an approximately
40% reduction in whisker pad target reinnervation 30 days
after facial nerve cut. Nevertheless, this reinnervation effect
is 3–4 times smaller in magnitude than that observed
following neuronal deletion of c-Jun (Fig. 2e and f).
It is possible that removal of all 4 phosphoacceptor sites is
also needed to reproduce the massive reduction in T-cell
influx in the JNK3 null mutants 14 days after facial nerve
cut, a peak phase in neuronal cell death, microglial
phagocytosis and lymphocyte recruitment (Raivich et al.
1998), but this would need to be ascertained in future studies.
What the current study does is that it confirms that the pro-
regeneration, pro-inflammatory and pro-cell death c-Jun
effects observed with nestin-promoter driven expression of
Cre recombinase are indeed due to to the neuronal expression
of c-Jun. By comparison, the JNK phosphorylation of the
N-terminus mostly appears to not be required for these
functions.
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